data_2jte_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jte _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 N--CA 1.429 -1.497 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -138.99 149.44 44.7 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.408 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.0 p -137.56 157.67 46.02 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 123.041 0.213 . . . . 0.0 110.874 -177.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 45.3 ttt180 -119.31 138.08 53.27 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.6 p -78.22 134.34 37.6 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.883 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.5 mt -98.29 -18.08 18.56 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.587 0.708 . . . . 0.0 109.566 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -142.56 150.14 53.22 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -78.5 157.75 28.85 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.875 1.716 . . . . 0.0 110.015 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -150.73 132.93 15.38 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.403 ' HA ' HG23 ' A' ' 24' ' ' THR . 82.1 m -96.14 122.38 38.93 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.967 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.77 125.97 7.21 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.1 p -90.55 -36.43 14.47 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 122.549 1.166 . . . . 0.0 108.376 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.461 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 57.3 m-80 -89.09 166.12 14.07 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.261 175.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -81.77 -33.21 31.04 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.7 3.34 14.25 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.408 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 34.7 tt0 -110.84 128.44 55.78 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tt -85.67 125.38 33.13 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.215 -170.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 16' ' ' THR . 91.6 m -90.26 119.41 30.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 174.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -135.37 159.11 42.59 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -100.1 -178.37 3.82 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -91.85 137.73 32.13 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.429 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 95.83 15.66 41.85 Favored Glycine 0 CA--C 1.496 -1.103 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.858 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 20.0 mm-40 -95.94 127.25 41.8 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.9 mm -87.66 116.64 30.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 174.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.408 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 57.9 mt -105.98 144.12 15.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -88.51 109.26 19.9 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.436 HD22 ' HG3' ' A' ' 36' ' ' LYS . 6.2 tt -73.09 124.83 26.33 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -175.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.7 mm -97.37 -51.43 10.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.338 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -152.07 134.59 15.33 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.89 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.436 ' HG3' HD22 ' A' ' 33' ' ' LEU . 50.6 mtmt -90.33 -25.84 20.27 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.555 0.693 . . . . 0.0 109.169 175.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -96.44 103.05 14.93 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.19 -0.913 . . . . 0.0 108.551 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.7 p -104.11 8.81 36.48 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.132 0.968 . . . . 0.0 108.94 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.03 -22.3 38.63 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -119.06 146.92 44.68 Favored 'General case' 0 N--CA 1.413 -2.286 0 CA-C-N 114.806 -0.697 . . . . 0.0 109.529 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.86 109.97 21.18 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.71 -23.47 3.98 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.723 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -107.14 126.92 53.0 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.413 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 35.5 m0 -108.88 150.65 27.38 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 88.5 tttt -108.59 129.1 55.32 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -140.8 160.51 26.63 Favored Glycine 0 N--CA 1.408 -3.233 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.7 tm-20 -117.78 123.75 46.75 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.6 tp -142.77 133.73 25.65 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 67.7 17.46 9.84 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 124.079 0.862 . . . . 0.0 111.169 171.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.01 3.1 62.12 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.677 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 9.5 mptt -115.84 125.75 53.07 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 122.394 -0.474 . . . . 0.0 110.417 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 10.6 pt-20 -112.42 112.92 24.83 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.014 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -145.84 -166.66 12.08 Favored Glycine 0 N--CA 1.423 -2.229 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 34.6 m -114.21 151.09 16.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-O 120.97 0.414 . . . . 0.0 110.163 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -154.48 150.55 22.16 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.862 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.85 130.74 23.85 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 121.953 1.769 . . . . 0.0 110.544 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -67.79 -9.53 45.03 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -68.87 -16.66 63.83 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.074 0.549 . . . . 0.0 111.745 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -91.45 -3.93 56.1 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.09 163.16 30.54 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.63 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.23 142.57 42.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -86.84 144.5 26.99 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.922 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.4 mm -102.98 -44.33 9.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.651 0.738 . . . . 0.0 109.355 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.413 -2.289 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -178.015 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.47 ' HA ' ' OXT' ' A' ' 64' ' ' SER . 45.6 mt-10 . . . . . 0 N--CA 1.424 -1.729 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -132.42 137.1 47.18 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.526 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 5.6 p -120.82 133.34 55.32 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.083 0.468 . . . . 0.0 109.946 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -99.55 129.84 45.75 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.3 p -62.92 128.78 37.46 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.158 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -97.35 -19.32 18.58 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -151.5 162.78 25.75 Favored Pre-proline 0 C--N 1.31 -1.141 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.7 165.68 11.94 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 121.729 1.619 . . . . 0.0 110.412 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -150.59 130.37 13.24 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.5 m -98.37 118.62 35.43 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.821 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.35 126.81 7.65 Favored Glycine 0 N--CA 1.417 -2.625 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.0 t -102.32 7.92 40.46 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -127.6 152.36 47.74 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.77 -40.51 96.87 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -98.25 14.35 28.12 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.726 0.774 . . . . 0.0 111.602 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -97.61 129.04 44.75 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 172.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.7 119.71 19.26 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.291 0.567 . . . . 0.0 111.821 -168.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.2 m -95.0 119.65 33.87 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -133.62 161.73 33.84 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -101.94 173.5 6.36 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.272 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -92.38 109.63 21.02 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.86 27.81 1.83 Allowed Glycine 0 C--N 1.304 -1.233 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.954 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -119.68 158.67 25.98 Favored 'General case' 0 C--O 1.251 1.164 0 CA-C-O 121.038 0.447 . . . . 0.0 111.146 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.6 mm -101.44 117.13 46.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.526 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 67.9 mt -94.53 134.3 32.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -89.3 109.59 20.47 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 tt -70.41 118.15 12.86 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -176.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.3 mm -93.27 -41.36 12.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.262 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.3 t -154.48 146.34 23.46 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.473 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -103.15 -3.55 25.66 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.964 174.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -115.1 103.14 10.59 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.603 0.716 . . . . 0.0 111.668 -176.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.5 p -118.46 9.88 12.49 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-O 122.111 0.957 . . . . 0.0 109.209 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.36 -21.28 46.36 Favored Glycine 0 N--CA 1.435 -1.402 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.044 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -125.98 142.17 51.64 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.3 125.94 30.15 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.372 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 114.38 -21.1 15.31 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.74 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -101.42 116.81 33.62 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 121.049 0.452 . . . . 0.0 110.416 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.425 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 40.6 m0 -108.77 155.54 20.65 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.589 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 16.8 ttmm -113.88 129.73 56.56 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.7 158.96 27.73 Favored Glycine 0 N--CA 1.414 -2.832 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -112.63 123.6 50.66 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.596 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 49.4 tp -147.05 130.44 16.67 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.945 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.596 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 59.3 m-80 66.05 18.65 11.07 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.716 1.206 . . . . 0.0 112.847 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.31 -18.72 20.61 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.012 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.26 144.37 44.91 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.528 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -102.03 116.36 32.51 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -125.63 -177.89 15.08 Favored Glycine 0 N--CA 1.409 -3.146 0 C-N-CA 119.962 -1.113 . . . . 0.0 111.067 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 27.4 m -114.23 146.69 18.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -154.38 153.85 28.68 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.814 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 16.5 Cg_exo -71.08 129.34 16.06 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.303 2.002 . . . . 0.0 110.334 174.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.64 -20.87 63.87 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 124.284 1.033 . . . . 0.0 113.296 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -73.82 0.83 11.99 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -104.74 -0.86 26.92 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 122.264 -0.273 . . . . 0.0 111.529 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -141.19 146.72 37.31 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.977 -176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 p -108.22 132.43 56.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -78.76 126.81 31.22 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.373 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.1 mm -91.51 -54.12 7.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.227 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.47 ' OXT' ' HA ' ' A' ' 7' ' ' GLU . 19.4 m . . . . . 0 N--CA 1.421 -1.91 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.495 ' HB3' HE22 ' A' ' 62' ' ' GLN . 45.9 mt-10 . . . . . 0 N--CA 1.433 -1.307 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -126.47 135.3 51.18 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.495 ' SG ' HD11 ' A' ' 33' ' ' LEU . 12.9 m -126.03 164.81 20.04 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.479 HH11 ' HA2' ' A' ' 28' ' ' GLY . 65.7 ttp85 -129.96 134.35 47.4 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.8 p -74.34 136.53 42.52 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.9 mt -98.7 -18.37 18.07 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.647 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -144.7 150.31 46.39 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.74 143.49 41.85 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 121.97 1.78 . . . . 0.0 110.046 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -138.05 135.45 35.88 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -111.89 128.77 56.24 Favored 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.239 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . -82.13 126.56 7.49 Favored Glycine 0 N--CA 1.421 -2.323 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.5 p -96.18 -5.96 39.33 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.326 1.06 . . . . 0.0 109.85 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -142.18 153.75 44.28 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 113.503 -1.681 . . . . 0.0 106.599 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.21 -28.99 70.07 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -171.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -82.68 -7.36 59.65 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.286 0.565 . . . . 0.0 111.235 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.5 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 42.9 tt0 -102.46 114.14 28.09 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.533 ' CD1' ' HA3' ' A' ' 53' ' ' GLY . 3.9 mp -83.34 145.33 29.11 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -172.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -94.82 131.55 40.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.832 -1.077 . . . . 0.0 108.962 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.459 ' CD2' HD22 ' A' ' 48' ' ' LEU . 97.1 m-85 -132.07 152.87 50.95 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 123.068 0.547 . . . . 0.0 110.299 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -100.26 -176.07 3.12 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 171.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.3 122.04 34.39 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.479 ' HA2' HH11 ' A' ' 10' ' ' ARG . . . 100.57 21.57 12.53 Favored Glycine 0 C--N 1.313 -0.712 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.617 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 20.7 mm-40 -94.88 137.18 34.28 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.5 mm -89.56 124.55 42.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 108.093 -1.076 . . . . 0.0 108.093 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.5 mt -99.87 134.74 38.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -89.29 102.37 15.03 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 172.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 9' ' ' CYS . 6.8 tt -72.56 125.3 27.11 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 -175.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.6 mm -98.99 -42.37 10.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.951 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.3 m -153.35 131.45 11.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.747 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -87.16 -41.02 14.08 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -87.49 105.14 17.1 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.246 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.5 p -112.04 0.02 15.83 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.77 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.92 -40.17 2.52 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.9 115.24 28.41 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.127 0.489 . . . . 0.0 109.765 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.43 124.68 22.41 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.243 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 109.52 -16.56 31.58 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.549 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -106.87 124.78 50.11 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 120.951 0.405 . . . . 0.0 110.51 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -110.82 153.07 25.91 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 86.6 tttt -106.24 129.4 54.29 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.75 166.18 25.68 Favored Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -118.8 130.42 55.77 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.459 HD22 ' CD2' ' A' ' 25' ' ' PHE . 38.6 tp -144.95 127.01 15.57 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 63.39 21.41 12.77 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.179 0.992 . . . . 0.0 111.884 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.24 4.93 62.47 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.274 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -114.73 136.98 52.47 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -125.25 127.17 46.32 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.78 0.8 . . . . 0.0 110.188 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.533 ' HA3' ' CD1' ' A' ' 23' ' ' LEU . . . -163.18 -157.03 8.9 Favored Glycine 0 N--CA 1.415 -2.702 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.561 -175.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.9 m -115.95 151.05 17.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-O 120.977 0.418 . . . . 0.0 111.893 -173.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -151.98 150.04 24.93 Favored Pre-proline 0 N--CA 1.434 -1.23 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.248 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 7.1 Cg_exo -74.5 128.77 12.18 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 121.831 1.688 . . . . 0.0 109.463 175.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -62.23 -20.17 63.94 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -171.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -71.77 -10.44 59.77 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.17 -1.32 57.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.248 0.546 . . . . 0.0 110.59 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -139.85 174.98 9.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.436 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.35 146.83 26.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.495 HE22 ' HB3' ' A' ' 7' ' ' GLU . 53.6 tp60 -74.62 147.87 41.23 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.9 mm -95.69 -55.63 5.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.9 p . . . . . 0 N--CA 1.414 -2.24 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.68 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 19.2 mm-40 . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 90.9 m-85 -120.16 132.51 55.42 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.821 0.82 . . . . 0.0 112.073 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.2 m -123.83 143.15 50.51 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.551 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -99.36 130.93 45.68 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.9 p -70.51 128.74 37.19 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 123.549 0.53 . . . . 0.0 109.917 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.0 mt -99.77 -18.57 17.14 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.591 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -140.64 145.35 39.92 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.66 141.11 40.82 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.115 1.876 . . . . 0.0 109.929 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -142.86 142.35 31.77 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 m -107.53 117.79 35.04 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.638 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.15 116.34 8.37 Favored Glycine 0 N--CA 1.425 -2.079 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 m -83.06 -20.15 35.51 Favored 'General case' 0 N--CA 1.388 -3.527 0 CA-C-O 122.438 1.113 . . . . 0.0 108.044 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -114.35 155.53 26.09 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -73.19 -29.86 63.13 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.332 0.587 . . . . 0.0 110.138 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -84.87 9.07 15.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.861 0.838 . . . . 0.0 110.533 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -112.09 133.37 54.29 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mt -78.62 133.43 37.27 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -173.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.1 m -98.08 120.14 37.96 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 173.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -134.23 155.09 50.78 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.49 169.35 8.7 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -79.39 130.33 35.32 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -175.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.14 23.38 13.12 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.999 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -107.73 138.09 44.59 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.5 mm -94.31 125.04 46.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 55.5 mt -109.17 135.45 48.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -90.52 104.68 17.23 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 4.7 tt -69.39 129.02 38.6 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.508 -177.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.7 mm -100.07 -37.85 6.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.443 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.9 m -148.87 122.16 8.99 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 121.522 -0.736 . . . . 0.0 111.589 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -80.77 -2.95 49.2 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.526 0.679 . . . . 0.0 111.651 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -136.32 124.68 23.34 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.495 0.664 . . . . 0.0 109.665 173.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.1 p -113.18 17.07 18.95 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 122.015 0.912 . . . . 0.0 109.217 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.97 -12.79 62.35 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 107.918 -2.073 . . . . 0.0 107.918 -170.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -131.65 149.55 52.45 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.82 104.29 13.94 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.71 -27.66 1.32 Allowed Glycine 0 C--N 1.297 -1.625 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -112.97 121.83 45.83 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -107.98 147.9 30.45 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.971 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -105.83 130.01 53.89 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -146.99 163.89 28.61 Favored Glycine 0 N--CA 1.417 -2.572 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -109.43 123.39 49.27 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.4 tp -136.77 121.07 18.01 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.617 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 63.94 23.08 13.21 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 124.154 0.909 . . . . 0.0 111.437 174.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.08 -19.79 37.03 Favored Glycine 0 N--CA 1.427 -1.911 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.748 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -100.23 126.4 46.52 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 117.717 0.758 . . . . 0.0 111.2 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 6.7 pt-20 -102.04 100.89 11.19 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.991 175.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -131.57 -163.92 10.97 Favored Glycine 0 C--N 1.286 -2.235 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.638 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.5 m -114.47 150.99 16.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 116.871 0.335 . . . . 0.0 110.812 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -147.61 155.16 45.26 Favored Pre-proline 0 N--CA 1.433 -1.296 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.438 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.53 133.79 38.57 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.153 1.902 . . . . 0.0 110.851 176.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -62.72 -15.12 51.56 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.249 1.02 . . . . 0.0 112.842 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -101.77 -13.19 17.82 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -80.8 -7.5 59.43 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.176 0.512 . . . . 0.0 111.964 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -136.88 139.54 41.71 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.03 125.47 57.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -78.35 113.99 16.84 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.426 0.632 . . . . 0.0 111.047 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.0 pt -85.36 -48.32 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.946 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.2 m . . . . . 0 N--CA 1.408 -2.564 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.456 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.48 ' HB3' ' NE2' ' A' ' 62' ' ' GLN . 41.6 mt-10 . . . . . 0 N--CA 1.432 -1.336 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -122.87 138.4 54.67 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.278 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.8 m -128.26 137.23 51.9 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.689 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -101.48 136.89 40.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.1 p -72.93 133.63 44.43 Favored 'General case' 0 N--CA 1.417 -2.077 0 O-C-N 123.519 0.512 . . . . 0.0 109.944 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.2 mt -99.13 -18.17 17.83 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -144.87 150.72 47.23 Favored Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.38 154.21 21.36 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 121.807 1.671 . . . . 0.0 110.383 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -150.97 136.11 17.56 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.403 ' HA ' HG21 ' A' ' 24' ' ' THR . 26.0 m -103.11 128.75 49.92 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.9 137.15 16.17 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 t -89.48 -15.42 33.1 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 122.345 1.069 . . . . 0.0 108.331 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -115.42 157.25 24.21 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.778 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.75 -30.6 71.29 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.937 0.875 . . . . 0.0 110.351 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.01 12.22 27.0 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.8 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -114.37 115.0 26.65 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tt -70.78 120.03 15.79 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.479 -166.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.403 HG21 ' HA ' ' A' ' 16' ' ' THR . 87.0 m -89.76 120.1 30.73 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.018 175.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -135.13 161.8 34.3 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -105.17 174.98 5.65 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -87.8 123.25 32.4 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.25 8.05 15.54 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -92.81 137.11 32.65 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.763 0.316 . . . . 0.0 110.401 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mm -99.05 117.28 43.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.2 mt -102.99 141.72 18.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -174.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -90.09 114.72 26.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.7 tt -74.07 127.53 33.16 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.6 mm -102.95 -52.48 8.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.216 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.0 m -143.96 130.98 20.51 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.958 -0.11 . . . . 0.0 110.799 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -88.29 -15.98 34.33 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.823 0.821 . . . . 0.0 110.379 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -114.07 121.67 44.55 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.79 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.0 p -123.64 17.48 9.57 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.05 -47.85 1.0 Allowed Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -100.63 161.3 13.69 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.687 -0.757 . . . . 0.0 109.812 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.03 85.52 2.22 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 176.15 -47.96 0.12 Allowed Glycine 0 CA--C 1.49 -1.486 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -82.85 121.3 26.76 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.9 m0 -107.9 144.19 35.48 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -103.31 129.33 50.29 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.19 168.23 27.15 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -123.28 129.11 50.89 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.4 tp -138.79 115.77 10.89 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.796 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 62.97 23.93 14.28 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 123.907 0.883 . . . . 0.0 111.672 173.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.28 -14.28 39.82 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.885 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 9.6 mptt -103.27 136.37 43.17 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.0 146.68 46.44 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.67 -160.99 26.21 Favored Glycine 0 N--CA 1.422 -2.276 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.03 152.36 16.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 116.947 0.374 . . . . 0.0 110.122 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -149.76 152.05 33.9 Favored Pre-proline 0 N--CA 1.425 -1.684 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.06 129.29 11.29 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.678 1.586 . . . . 0.0 111.611 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -49.93 -29.7 8.83 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.509 1.524 . . . . 0.0 113.507 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -68.08 -10.58 55.02 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -96.31 -9.55 29.92 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.79 160.84 38.71 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.967 -175.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 p -128.3 133.51 66.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.48 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 51.5 tt0 -73.9 116.86 15.01 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.334 0.588 . . . . 0.0 110.007 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.4 pt -91.3 -23.76 5.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.57 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.419 -1.98 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.785 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.429 -1.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -123.38 158.29 31.43 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.2 p -135.84 134.12 38.52 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.146 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -100.24 135.73 41.21 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.4 p -60.85 135.68 57.85 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 124.856 1.262 . . . . 0.0 110.867 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.406 HD11 ' HB ' ' A' ' 61' ' ' VAL . 92.4 mt -108.13 -19.08 13.61 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.232 0.539 . . . . 0.0 109.904 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -148.05 152.38 39.85 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.53 148.37 42.38 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.587 1.525 . . . . 0.0 109.538 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -139.11 132.78 30.57 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.5 m -107.38 129.87 54.87 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.68 138.9 15.12 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -91.8 -16.49 26.73 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -125.63 169.92 12.02 Favored 'General case' 0 N--CA 1.402 -2.852 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.905 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -77.32 -28.11 53.08 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -174.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.27 -12.15 57.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.255 1.026 . . . . 0.0 110.154 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.03 107.58 18.49 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -71.96 133.41 45.34 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.24 -169.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.3 m -102.5 120.85 41.23 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.162 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -133.85 161.75 33.89 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -111.28 171.39 7.51 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -84.58 113.3 21.15 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.47 24.01 2.48 Favored Glycine 0 N--CA 1.425 -2.074 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.879 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -119.94 147.47 44.71 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.7 mm -100.36 119.85 49.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.503 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 61.7 mt -103.07 138.1 28.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -88.63 112.87 23.59 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.405 HD22 ' HG3' ' A' ' 36' ' ' LYS . 5.0 tt -76.1 122.45 24.3 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -174.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.1 mt -97.01 -39.14 8.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.335 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.2 t -160.56 138.77 9.92 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.285 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.405 ' HG3' HD22 ' A' ' 33' ' ' LEU . 89.9 mttt -89.75 -8.4 52.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.283 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.35 129.99 49.9 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.357 0.598 . . . . 0.0 110.269 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.9 p -125.42 23.9 7.43 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.79 0.805 . . . . 0.0 109.722 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.0 -39.39 2.86 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -174.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -104.43 139.85 38.78 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.16 102.1 14.63 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.17 -26.69 1.87 Allowed Glycine 0 C--N 1.303 -1.275 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -98.9 126.24 44.51 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.417 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 36.6 m0 -107.27 154.24 21.54 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.561 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -115.33 128.74 56.3 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.37 160.98 28.53 Favored Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.211 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.2 tm-20 -117.52 131.34 56.72 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.504 0.668 . . . . 0.0 110.748 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 68.7 tp -141.34 127.68 19.86 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 67.89 15.36 9.55 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.466 1.106 . . . . 0.0 111.395 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.74 0.77 62.19 Favored Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.353 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 4.4 mptp? -105.92 129.52 54.05 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.36 121.86 46.31 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.58 -174.09 15.6 Favored Glycine 0 N--CA 1.412 -2.904 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.361 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 35.4 m -115.31 150.93 17.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 O-C-N 123.884 0.403 . . . . 0.0 109.988 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -160.71 151.2 15.06 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.616 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.96 138.05 36.3 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 122.158 1.905 . . . . 0.0 110.768 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.78 -16.76 63.47 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -173.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -72.91 -1.46 16.97 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 120.987 0.423 . . . . 0.0 111.576 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -102.42 -3.09 27.54 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.78 156.02 44.92 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.89 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.406 ' HB ' HD11 ' A' ' 12' ' ' LEU . 14.4 p -118.91 136.05 57.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -78.81 117.71 20.18 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.2 pt -87.65 -9.4 10.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.433 0.635 . . . . 0.0 111.678 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--N 1.283 -2.321 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.672 177.315 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.537 ' HA ' ' OXT' ' A' ' 64' ' ' SER . 14.5 mp0 . . . . . 0 N--CA 1.426 -1.662 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -131.92 145.37 51.47 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.9 m -127.96 142.91 51.11 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.539 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -104.05 132.31 50.43 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.0 p -76.49 134.84 39.39 Favored 'General case' 0 C--N 1.288 -2.109 0 CA-C-O 121.155 0.502 . . . . 0.0 111.724 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.6 mt -95.5 -17.97 21.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.873 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -141.44 154.32 66.76 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.571 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.79 134.71 8.6 Favored 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 122.011 1.808 . . . . 0.0 109.375 169.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -135.25 138.15 43.25 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.0 m -107.5 122.42 46.62 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.039 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.09 106.81 2.72 Favored Glycine 0 N--CA 1.413 -2.838 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.77 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.7 -33.28 21.55 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 90.5 m-20 -88.8 153.95 20.66 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.892 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -62.11 -37.45 85.15 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.793 0.33 . . . . 0.0 111.661 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -90.91 10.67 25.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.629 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 46.8 tt0 -110.44 125.55 53.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 mt -82.86 139.51 33.43 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -175.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.4 m -99.32 119.44 37.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -134.88 159.78 40.35 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -101.11 -179.7 4.12 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -85.51 133.55 34.07 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.54 17.4 39.2 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.101 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -92.42 142.57 27.28 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.8 mm -99.99 123.55 52.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.9 mt -114.31 142.34 27.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -89.17 115.27 26.56 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 tt -66.11 133.82 51.51 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.454 ' C ' ' HG ' ' A' ' 35' ' ' SER . 48.4 mm -112.48 -49.41 5.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.427 0.632 . . . . 0.0 109.436 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.454 ' HG ' ' C ' ' A' ' 34' ' ' ILE . 28.3 m -149.94 118.5 6.52 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.631 -0.668 . . . . 0.0 111.596 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.422 ' HB2' ' HZ1' ' A' ' 36' ' ' LYS . 9.2 mtmp? -73.45 -26.08 60.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.505 0.669 . . . . 0.0 109.833 173.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -101.98 111.97 24.44 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.2 p -110.12 -2.29 17.02 Favored 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.43 -10.88 33.28 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -125.8 143.78 50.92 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.17 86.72 5.04 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.199 0.523 . . . . 0.0 109.614 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.91 -30.27 0.39 Allowed Glycine 0 CA--C 1.489 -1.591 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -89.63 123.22 33.49 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -108.99 134.21 51.94 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -99.12 129.61 45.39 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.54 165.18 26.85 Favored Glycine 0 N--CA 1.423 -2.195 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 41.7 tt0 -110.77 131.95 54.61 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 123.772 0.337 . . . . 0.0 110.346 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.9 tp -148.27 119.72 7.92 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.098 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 62.06 34.08 16.73 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.965 0.906 . . . . 0.0 112.212 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.9 -10.99 68.2 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.651 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 4.6 mptp? -105.82 129.7 53.95 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-N 117.482 0.641 . . . . 0.0 111.083 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.383 0.0 OUTLIER -111.99 106.29 14.93 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 122.662 1.22 . . . . 0.0 111.002 170.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.61 -171.57 12.55 Favored Glycine 0 N--CA 1.425 -2.084 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.354 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.0 m -114.63 150.82 16.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-O 121.303 0.573 . . . . 0.0 111.403 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -152.42 148.76 21.43 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.956 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.67 129.76 21.85 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 121.569 1.512 . . . . 0.0 109.498 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.75 -22.6 58.24 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -172.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -69.19 -8.2 43.46 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -91.96 -0.7 57.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.641 0.257 . . . . 0.0 110.907 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -144.73 165.95 26.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.719 0.295 . . . . 0.0 110.861 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 p -131.57 134.37 60.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -71.27 118.2 13.77 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.3 pt -96.51 -23.78 4.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-O 121.953 0.882 . . . . 0.0 110.522 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.537 ' OXT' ' HA ' ' A' ' 7' ' ' GLU . 44.9 m . . . . . 0 N--CA 1.4 -2.938 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 . . . . . 0 N--CA 1.418 -2.038 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -130.23 139.45 50.79 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.49 -175.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 p -124.01 147.62 47.67 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.342 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -108.15 135.61 49.21 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.4 HG23 ' CD1' ' A' ' 25' ' ' PHE . 43.2 p -79.44 136.65 37.0 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.399 0.619 . . . . 0.0 112.268 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.0 mt -99.96 -18.01 17.28 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.672 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -145.55 156.37 52.95 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -84.2 151.2 12.23 Favored 'Trans proline' 0 C--O 1.253 1.265 0 C-N-CA 122.142 1.895 . . . . 0.0 111.323 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -137.55 125.8 23.16 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 m -112.99 110.88 21.23 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.47 144.49 44.2 Favored Glycine 0 N--CA 1.412 -2.958 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.992 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.1 p -89.93 -21.44 22.47 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -121.11 157.2 30.64 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -87.87 12.01 14.2 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.471 1.129 . . . . 0.0 109.853 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -78.65 -31.35 46.76 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 170.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -82.32 150.03 27.43 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 113.333 -1.758 . . . . 0.0 107.148 173.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -103.58 126.33 50.66 Favored 'General case' 0 C--N 1.281 -2.396 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.625 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.3 m -94.53 120.43 34.75 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.204 -176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.4 ' CD1' HG23 ' A' ' 11' ' ' THR . 23.4 p90 -134.77 158.88 43.02 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.411 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -99.63 -179.3 4.15 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -81.1 133.77 35.53 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.2 27.29 28.52 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.118 176.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -105.97 151.47 24.57 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mm -101.26 124.48 55.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.7 mt -110.02 143.88 19.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -89.33 104.97 17.48 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.447 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.4 tt -71.62 128.23 35.13 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.215 0.531 . . . . 0.0 109.758 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.35 -50.51 9.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.957 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.8 m -144.21 131.24 20.5 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.944 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HG3' HD21 ' A' ' 33' ' ' LEU . 44.5 mtmt -97.98 -22.52 16.25 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.598 0.713 . . . . 0.0 110.476 174.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -109.8 86.44 2.3 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 p -87.4 -18.23 30.48 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.703 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.81 -43.0 1.02 Allowed Glycine 0 C--N 1.28 -2.571 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -120.36 111.14 17.38 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.85 109.25 1.69 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 152.14 -33.0 0.87 Allowed Glycine 0 C--N 1.287 -2.183 0 N-CA-C 107.545 -2.222 . . . . 0.0 107.545 -174.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -100.34 124.6 46.03 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 35.6 m0 -107.86 146.09 32.78 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.21 129.09 55.78 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.22 159.65 27.93 Favored Glycine 0 N--CA 1.41 -3.082 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.2 tm-20 -110.73 130.55 55.54 Favored 'General case' 0 N--CA 1.414 -2.244 0 O-C-N 124.402 0.707 . . . . 0.0 109.358 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.509 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 43.0 tp -144.66 127.42 16.26 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.254 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.509 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 51.9 m-80 65.26 17.98 11.22 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.754 1.221 . . . . 0.0 111.484 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.01 -15.4 55.28 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.36 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 12.1 mptt -100.52 133.54 44.81 Favored 'General case' 0 CA--C 1.489 -1.379 0 CA-C-N 117.013 0.406 . . . . 0.0 110.31 -175.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -111.38 121.61 45.69 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.041 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.22 -170.01 13.93 Favored Glycine 0 C--N 1.287 -2.168 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.1 m -115.22 150.88 17.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 120.796 0.332 . . . . 0.0 110.591 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -156.13 149.06 18.23 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.134 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 34.8 Cg_exo -66.72 136.99 44.11 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.072 1.848 . . . . 0.0 111.398 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -63.2 -13.36 36.59 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.108 0.963 . . . . 0.0 112.743 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -71.91 -10.6 60.01 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.165 0.586 . . . . 0.0 111.922 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -107.61 8.62 29.24 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.666 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.13 154.33 43.79 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.427 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.16 131.6 72.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -76.53 127.54 33.02 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.8 mm -90.51 -49.79 13.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.41 -2.475 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -179.709 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -110.8 134.42 52.52 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.594 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.466 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 12.9 p -120.03 146.32 45.99 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-O 121.173 0.511 . . . . 0.0 110.233 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -106.0 134.66 48.77 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.0 p -66.74 140.12 57.85 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 123.823 0.849 . . . . 0.0 110.25 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.5 mt -107.04 -20.22 13.38 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.818 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -153.4 152.27 27.23 Favored Pre-proline 0 C--N 1.316 -0.853 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.28 110.85 3.15 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 121.626 1.551 . . . . 0.0 111.29 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -109.4 131.4 55.1 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.435 ' HA ' HG21 ' A' ' 24' ' ' THR . 24.2 m -110.6 129.6 55.77 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.94 150.28 39.1 Favored Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.0 t -98.74 5.66 47.44 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.734 1.254 . . . . 0.0 108.284 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -156.0 173.25 17.07 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.504 -1.68 . . . . 0.0 106.658 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -79.62 -30.35 41.39 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -174.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.13 -21.77 60.66 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.182 0.992 . . . . 0.0 109.313 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -87.99 110.45 20.6 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.1 135.13 38.57 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.581 0.705 . . . . 0.0 111.6 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.435 HG21 ' HA ' ' A' ' 16' ' ' THR . 94.7 m -98.92 122.54 42.3 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.569 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -133.39 157.77 44.71 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.529 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -109.84 -167.41 1.2 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 122.745 0.418 . . . . 0.0 110.568 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -89.22 141.71 28.29 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.85 29.97 49.61 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.272 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.03 157.53 23.35 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 122.154 -0.615 . . . . 0.0 112.272 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.6 mm -111.73 124.78 68.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.466 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 65.3 mt -114.48 143.62 23.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -89.49 116.01 27.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.5 tt -79.73 118.99 22.04 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 34' ' ' ILE . 61.3 mt -89.52 -47.99 14.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.52 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.1 m -155.88 140.77 17.2 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 122.149 -0.344 . . . . 0.0 110.621 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -90.86 -16.56 28.02 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -106.9 103.03 12.35 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.063 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.0 p -107.18 3.02 25.19 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.784 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.86 -14.91 41.1 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -130.54 116.38 18.08 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.31 118.59 10.21 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.48 -22.76 7.32 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -105.3 122.37 45.81 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.7 m0 -108.18 155.06 20.86 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -110.56 129.85 55.7 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.85 164.23 25.51 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.431 ' HB2' HD13 ' A' ' 34' ' ' ILE . 25.2 tt0 -124.94 123.93 40.95 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.4 tp -125.2 117.45 23.88 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 m120 66.14 21.85 11.12 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.193 0.997 . . . . 0.0 110.82 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.16 -10.02 58.1 Favored Glycine 0 N--CA 1.435 -1.393 0 CA-C-N 115.661 -0.699 . . . . 0.0 113.712 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 3.3 mptp? -97.84 132.3 43.57 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 117.852 0.826 . . . . 0.0 109.405 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.85 148.05 29.0 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 123.673 0.608 . . . . 0.0 111.917 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.49 -172.06 40.81 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.21 156.58 16.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 116.809 0.304 . . . . 0.0 110.809 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -158.35 156.05 26.82 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.114 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -74.48 136.21 21.24 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.116 1.877 . . . . 0.0 110.913 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -61.33 -21.97 64.49 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -174.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -73.16 -4.65 34.13 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -102.45 4.52 38.85 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.933 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.92 164.38 33.92 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.1 p -134.64 140.64 45.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 52.6 tt0 -85.28 133.01 34.17 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.255 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.6 mt -79.3 -67.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 N--CA 1.403 -2.822 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 177.763 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -120.22 133.5 55.47 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.578 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.558 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 3.4 p -122.3 149.3 43.93 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.993 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 51.2 ttt180 -118.79 133.92 55.51 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.3 p -74.92 135.66 41.45 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.4 mt -103.01 -17.6 15.36 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -138.44 150.86 67.85 Favored Pre-proline 0 N--CA 1.438 -1.07 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.304 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -76.7 161.03 34.16 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.09 1.86 . . . . 0.0 110.643 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -149.19 124.59 10.27 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.7 m -101.92 124.85 48.24 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.98 134.07 12.52 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.1 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -95.31 -15.16 23.33 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 122.304 1.05 . . . . 0.0 108.493 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -112.38 168.41 9.66 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -86.43 -27.5 24.1 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.729 0.776 . . . . 0.0 109.647 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.86 -28.03 60.5 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.863 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -82.36 116.78 22.0 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.539 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -89.72 143.22 26.98 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.046 0.45 . . . . 0.0 110.481 -169.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.2 m -92.66 128.38 38.5 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.177 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 98.8 m-85 -129.03 147.08 50.86 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.143 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -104.62 171.61 7.23 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 172.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -78.71 133.95 37.12 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 122.557 0.343 . . . . 0.0 110.871 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.56 16.88 57.93 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.995 -0.621 . . . . 0.0 113.388 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 27.5 mm-40 -92.72 147.38 22.92 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.1 mm -98.72 118.31 45.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.558 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 53.4 mt -99.13 135.22 35.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.075 -175.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -89.65 107.1 18.89 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.402 HD21 ' HG3' ' A' ' 36' ' ' LYS . 8.0 tt -70.5 140.22 51.81 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 121.11 0.481 . . . . 0.0 110.706 -173.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mm -108.72 -44.92 6.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.311 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.3 t -157.44 145.23 18.89 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.519 ' HE3' ' CZ2' ' A' ' 44' ' ' TRP . 51.1 mtpt -102.86 1.23 33.71 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-O 121.746 0.784 . . . . 0.0 109.645 175.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -121.63 115.76 23.34 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.609 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -124.63 3.76 8.25 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.806 0.812 . . . . 0.0 109.847 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.23 -21.62 39.04 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -114.8 135.46 54.16 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.764 -0.718 . . . . 0.0 109.195 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.65 99.8 11.54 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 134.25 -14.2 4.57 Favored Glycine 0 N--CA 1.421 -2.327 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.187 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -107.45 125.74 51.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.287 0.565 . . . . 0.0 110.329 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.519 ' CZ2' ' HE3' ' A' ' 36' ' ' LYS . 43.3 m0 -113.71 164.9 13.11 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.235 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -118.31 129.97 55.76 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.54 158.02 27.4 Favored Glycine 0 N--CA 1.421 -2.358 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 1.1 tm-20 -112.1 131.52 55.39 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 123.239 0.616 . . . . 0.0 109.831 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 51.0 tp -144.56 132.62 21.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 68.76 13.79 8.91 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.407 1.083 . . . . 0.0 111.838 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.14 9.47 56.99 Favored Glycine 0 N--CA 1.427 -1.903 0 C-N-CA 121.151 -0.547 . . . . 0.0 111.776 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -123.75 126.75 47.07 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.073 0.463 . . . . 0.0 110.849 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -99.69 125.87 45.63 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.297 177.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.26 -172.47 17.48 Favored Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.3 m -115.13 158.19 15.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 117.215 0.507 . . . . 0.0 110.871 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -162.03 156.46 19.01 Favored Pre-proline 0 C--N 1.319 -0.726 0 O-C-N 124.004 0.815 . . . . 0.0 109.595 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 6.6 Cg_exo -75.8 127.58 10.25 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.206 1.937 . . . . 0.0 109.428 172.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -65.6 -17.54 64.66 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.627 0.371 . . . . 0.0 111.941 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -65.7 -14.03 60.45 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -87.32 -2.9 58.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.179 0.514 . . . . 0.0 110.818 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.94 177.82 7.61 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.431 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.49 135.54 43.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -81.65 129.48 34.71 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.85 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.2 mm -77.38 -68.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.399 -3.004 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.341 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 9.3 mm-40 . . . . . 0 N--CA 1.426 -1.661 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -121.85 138.85 54.23 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.581 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 8.0 p -125.47 142.25 51.61 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.75 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -101.61 135.79 42.53 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 64.2 p -77.5 128.63 34.51 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-O 121.258 0.551 . . . . 0.0 111.65 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.1 mt -98.9 -18.14 18.02 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.138 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -142.52 143.95 28.59 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -74.24 141.75 29.51 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.9 1.733 . . . . 0.0 109.853 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -137.37 128.43 27.6 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.455 ' HA ' HG21 ' A' ' 24' ' ' THR . 24.3 m -100.84 118.0 36.03 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.702 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.7 125.71 17.07 Favored Glycine 0 N--CA 1.427 -1.957 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.3 p -82.26 -20.51 37.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.746 1.26 . . . . 0.0 108.633 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 44.0 m-80 -115.42 161.9 17.9 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.99 -19.81 29.81 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.582 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -79.91 -3.39 47.88 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.3 1.047 . . . . 0.0 108.9 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 36.7 tt0 -107.19 126.12 51.99 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -86.8 135.13 33.46 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.571 -167.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.455 HG21 ' HA ' ' A' ' 16' ' ' THR . 90.0 m -100.3 119.85 39.04 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.29 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -134.85 151.92 51.31 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.738 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -99.71 179.49 4.52 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 173.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.3 139.85 36.43 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.63 10.34 55.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.222 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -95.49 156.8 16.17 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 122.589 -0.359 . . . . 0.0 110.256 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.9 mm -110.33 116.25 51.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.581 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 62.5 mt -101.75 131.51 49.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -90.77 102.67 15.42 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 6.0 tt -69.03 134.47 49.47 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.656 -173.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.0 mm -101.2 -51.2 9.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.411 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.9 m -146.62 141.64 27.11 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.739 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -91.58 -22.65 20.21 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 172.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -101.78 112.57 25.21 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.462 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.8 p -106.39 2.23 26.33 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.92 0.867 . . . . 0.0 109.069 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.45 -44.1 1.54 Allowed Glycine 0 N--CA 1.427 -1.925 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -99.02 134.24 42.15 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.85 102.11 7.09 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.54 -27.34 1.66 Allowed Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -99.06 128.7 45.24 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 24.5 m0 -108.06 159.92 16.2 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 53.0 tttm -128.32 128.37 44.47 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -150.12 160.08 28.38 Favored Glycine 0 N--CA 1.425 -2.094 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -175.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.19 127.12 53.23 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 68.7 tp -133.22 111.14 10.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.7 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.5 m120 63.82 18.94 11.48 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 124.712 1.205 . . . . 0.0 113.099 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.81 -25.24 5.9 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.136 -1.03 . . . . 0.0 113.846 177.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -106.09 142.32 35.98 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 117.697 0.748 . . . . 0.0 110.888 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 14.1 pt-20 -118.76 114.22 22.34 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -132.46 -166.85 11.64 Favored Glycine 0 N--CA 1.42 -2.383 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.66 153.16 16.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -161.73 147.74 10.84 Favored Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 123.88 0.737 . . . . 0.0 109.482 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.43 134.88 29.79 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 121.833 1.688 . . . . 0.0 109.937 174.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.26 1.43 2.91 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -76.37 -22.31 54.99 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 122.942 0.497 . . . . 0.0 110.635 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -91.38 2.09 56.65 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -174.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.12 171.29 15.55 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 122.363 -0.21 . . . . 0.0 110.529 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.47 132.04 40.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -70.18 117.34 11.62 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.031 0.443 . . . . 0.0 110.736 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.6 mt -67.81 -50.16 62.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.426 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 N--CA 1.411 -2.405 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 N--CA 1.445 -0.693 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -121.45 144.48 48.66 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.593 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.5 p -131.12 150.49 52.12 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.526 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -110.14 133.99 52.65 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.92 125.99 30.15 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-O 121.011 0.434 . . . . 0.0 111.313 175.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.1 mt -96.41 -9.58 29.57 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.936 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -142.27 141.14 20.37 Favored Pre-proline 0 N--CA 1.431 -1.379 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.708 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.33 132.1 18.75 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.065 1.843 . . . . 0.0 109.648 171.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 24' ' ' THR . 87.1 t80 -124.94 122.28 36.88 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.0 m -101.44 120.54 40.44 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.34 143.28 38.82 Favored Glycine 0 N--CA 1.423 -2.192 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.276 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 p -85.18 -33.63 22.25 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 122.605 1.193 . . . . 0.0 108.309 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 40.8 m-80 -103.67 158.4 16.4 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 173.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.39 5.67 49.81 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.737 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.94 -20.23 42.5 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 170.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 19' ' ' ASN . 17.6 mt-10 -81.61 159.3 24.07 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 113.548 -1.66 . . . . 0.0 106.992 171.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -121.06 136.32 55.01 Favored 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 118.932 -1.107 . . . . 0.0 108.593 -178.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 88.7 m -89.53 121.04 31.36 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.304 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 89.1 m-85 -121.91 159.16 27.44 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.561 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -117.29 165.59 13.28 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.39 125.33 23.38 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 123.416 0.686 . . . . 0.0 110.028 174.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.97 13.06 57.03 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.512 -0.851 . . . . 0.0 114.028 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -92.41 144.68 25.12 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.8 mm -99.07 123.96 52.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.593 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 50.6 mt -106.93 135.28 45.97 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.588 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -89.86 117.75 28.93 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 171.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.419 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.4 tt -73.94 119.82 18.67 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.749 -175.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.1 mm -92.82 -40.35 11.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.392 -176.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.6 t -161.17 144.48 12.86 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.043 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.419 ' HG3' HD21 ' A' ' 33' ' ' LEU . 94.6 mttt -100.46 4.21 43.54 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -120.84 102.39 8.34 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.456 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.2 p -115.96 7.44 14.38 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.38 -17.44 53.59 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 108.671 -1.771 . . . . 0.0 108.671 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -121.62 151.04 40.84 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.885 -0.657 . . . . 0.0 110.253 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.42 99.29 9.33 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.26 -38.9 1.01 Allowed Glycine 0 CA--C 1.49 -1.476 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -176.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -95.79 119.9 35.11 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -109.08 159.18 17.07 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -108.22 129.84 55.18 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.42 159.4 25.26 Favored Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.37 135.29 54.08 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.001 0.429 . . . . 0.0 110.654 -177.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.4 tp -138.88 122.31 17.22 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 124.039 0.935 . . . . 0.0 108.882 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.8 m120 68.87 11.56 8.38 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.307 1.043 . . . . 0.0 112.513 175.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.56 -8.17 43.47 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 3.5 mptp? -102.76 130.93 49.88 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -120.9 135.05 55.28 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-O 121.333 0.587 . . . . 0.0 111.183 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -153.22 -167.22 15.41 Favored Glycine 0 N--CA 1.416 -2.692 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.3 m -115.32 153.51 16.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 120.772 0.32 . . . . 0.0 111.091 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -157.12 150.95 19.33 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.49 136.74 19.79 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 121.559 1.506 . . . . 0.0 109.758 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.66 -16.19 62.44 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.068 0.461 . . . . 0.0 110.795 -176.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -53.39 -29.27 33.8 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 124.481 1.113 . . . . 0.0 111.687 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -94.02 -1.1 55.0 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.32 148.54 36.45 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -174.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.67 134.0 61.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -78.81 128.15 32.99 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.113 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.42 -58.25 3.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.404 -2.754 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 177.654 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 N--CA 1.439 -0.975 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -114.17 138.98 49.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.519 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 7.8 p -122.56 133.17 54.57 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.904 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -99.69 135.21 41.44 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.8 p -81.05 129.3 34.48 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.258 0.552 . . . . 0.0 111.135 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.1 mt -97.69 -16.65 19.85 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.571 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -142.84 153.27 60.82 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -81.79 142.59 12.76 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.927 1.751 . . . . 0.0 110.079 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -126.89 130.48 50.24 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.486 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.402 ' HA ' HG21 ' A' ' 24' ' ' THR . 49.7 m -100.32 113.38 26.05 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.16 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.97 145.37 29.71 Favored Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 176.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.9 p -92.19 -35.53 13.78 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.01 0.91 . . . . 0.0 108.701 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -107.28 -179.04 3.81 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.737 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -93.93 8.27 41.93 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.905 0.86 . . . . 0.0 109.472 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -91.22 -32.15 15.89 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.93 156.27 32.16 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.874 172.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.0 tt -102.44 115.18 30.04 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.402 HG21 ' HA ' ' A' ' 16' ' ' THR . 63.8 m -83.59 120.04 25.47 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -134.36 161.83 33.89 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -96.66 170.04 9.47 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -82.99 137.08 34.29 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.55 26.15 21.24 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.481 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -102.65 148.81 25.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mm -105.27 112.5 39.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.519 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 58.9 mt -100.94 139.0 23.3 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -88.24 106.75 18.41 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.461 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.5 tt -68.66 122.64 18.94 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.491 -174.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.7 mt -97.42 -44.71 12.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.378 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.0 m -150.12 138.86 20.8 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.795 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.461 ' HG3' HD21 ' A' ' 33' ' ' LEU . 50.3 mtmt -97.75 5.14 49.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.4 118.81 32.15 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 113.638 -1.619 . . . . 0.0 108.656 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.9 p -133.57 -0.29 3.22 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.37 0.605 . . . . 0.0 110.273 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.25 -41.41 2.14 Favored Glycine 0 C--N 1.306 -1.126 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -174.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -97.79 116.45 30.03 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.39 114.05 6.49 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 128.3 -17.71 5.88 Favored Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -174.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -113.94 128.96 56.62 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.847 0.356 . . . . 0.0 111.118 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.402 ' CE2' ' HG2' ' A' ' 36' ' ' LYS . 34.0 m0 -108.87 169.67 8.53 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 58.9 tttm -137.54 128.92 28.04 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.49 173.07 31.61 Favored Glycine 0 C--N 1.297 -1.605 0 C-N-CA 120.285 -0.96 . . . . 0.0 112.121 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -108.91 134.22 51.88 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 123.67 0.788 . . . . 0.0 109.814 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.7 tp -153.47 129.71 10.47 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 64.3 20.03 12.01 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.714 0.806 . . . . 0.0 112.403 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.46 3.66 64.67 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 116.13 -0.487 . . . . 0.0 113.039 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -117.4 150.67 38.48 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -121.87 140.81 51.94 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -160.54 -169.31 23.65 Favored Glycine 0 C--N 1.288 -2.086 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.53 152.14 16.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.064 0.459 . . . . 0.0 110.307 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -157.45 148.68 16.69 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.283 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 20.3 Cg_exo -65.69 125.89 15.11 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.487 1.458 . . . . 0.0 109.245 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -61.29 -18.68 59.67 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -171.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -72.57 -14.36 61.61 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.936 0.335 . . . . 0.0 111.239 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -80.35 -14.74 58.1 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.597 0.237 . . . . 0.0 111.192 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.06 166.55 20.81 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.57 142.3 35.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -70.3 140.87 52.38 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.9 pt -91.17 -42.14 13.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-O 121.255 0.55 . . . . 0.0 111.316 -173.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.411 -2.377 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.555 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 35.8 mt-10 . . . . . 0 N--CA 1.43 -1.456 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -128.45 137.96 52.07 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.97 0.414 . . . . 0.0 110.138 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.426 ' SG ' HD13 ' A' ' 33' ' ' LEU . 59.8 m -124.47 153.81 41.44 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.986 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -117.46 132.17 56.61 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 p -72.46 128.51 35.82 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 120.811 0.339 . . . . 0.0 111.235 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.8 mt -89.16 -18.03 27.98 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.99 157.21 64.54 Favored Pre-proline 0 C--N 1.309 -1.181 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.43 138.63 15.77 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.297 1.332 . . . . 0.0 109.462 173.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 24' ' ' THR . 68.8 t80 -122.6 117.94 27.02 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.792 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 m -109.98 127.54 54.85 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.91 153.37 28.14 Favored Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.57 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -98.15 -20.71 17.15 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -105.16 166.57 10.31 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -82.72 -9.58 59.29 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.654 0.74 . . . . 0.0 109.538 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -78.32 -30.05 48.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.699 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -78.86 151.49 31.8 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.181 173.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -112.91 139.2 48.75 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 96.2 m -95.13 120.67 35.75 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.668 0.747 . . . . 0.0 111.121 -177.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 91.7 m-85 -122.55 147.17 46.7 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.829 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -90.29 172.55 8.69 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 176.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -75.41 129.94 38.15 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.3 39.03 20.2 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.793 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -117.97 154.9 31.18 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.0 mm -96.21 128.61 47.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 O-C-N 123.556 0.535 . . . . 0.0 109.994 -175.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 52.7 mt -112.23 134.54 54.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -90.04 110.23 21.23 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 171.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.5 tt -74.45 123.84 25.46 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mm -96.94 -43.66 12.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.387 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.9 m -156.39 135.23 11.81 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.267 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -85.54 -27.01 25.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 170.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -95.35 102.71 14.54 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.639 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.3 p -109.2 -0.91 19.03 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.802 0.811 . . . . 0.0 109.98 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.12 -41.25 1.58 Allowed Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 107.746 -2.141 . . . . 0.0 107.746 -173.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -115.32 166.32 11.99 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.436 -0.882 . . . . 0.0 109.639 175.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.81 149.13 23.69 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 171.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 100.38 -25.86 26.71 Favored Glycine 0 C--N 1.301 -1.39 0 C-N-CA 120.369 -0.919 . . . . 0.0 110.88 -176.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -111.56 116.9 31.61 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -108.89 157.26 18.79 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.577 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -105.06 130.02 53.35 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.34 147.55 19.26 Favored Glycine 0 N--CA 1.417 -2.569 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.96 136.28 44.74 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.459 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 27.4 tp -145.47 128.19 16.24 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.459 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 38.3 m-80 62.91 20.31 12.14 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.938 0.895 . . . . 0.0 112.067 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.42 -3.42 75.55 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.321 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -102.41 133.71 46.92 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.34 120.85 43.13 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -136.67 -172.09 12.45 Favored Glycine 0 C--N 1.286 -2.216 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.76 151.13 16.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.162 0.506 . . . . 0.0 110.848 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -151.4 150.86 27.86 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.3 Cg_exo -76.75 135.92 16.43 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 121.872 1.715 . . . . 0.0 110.748 175.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -64.72 -14.87 60.35 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.893 0.377 . . . . 0.0 111.432 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -63.42 -19.87 65.06 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.436 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -98.78 0.86 45.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -144.52 167.85 21.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.173 0.511 . . . . 0.0 111.759 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.3 p -132.88 139.17 50.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -83.18 128.34 34.4 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.8 pt -101.77 -30.71 3.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.058 0.456 . . . . 0.0 110.719 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.416 -2.17 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.717 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 3.4 mm-40 . . . . . 0 N--CA 1.42 -1.943 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -130.96 138.22 49.61 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.1 p -123.57 138.85 54.48 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 65.3 ttt180 -107.86 134.26 51.05 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.406 HG23 ' CD1' ' A' ' 25' ' ' PHE . 45.4 p -77.81 133.97 38.1 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-O 121.504 0.669 . . . . 0.0 111.59 -176.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.22 -7.77 24.31 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.783 0.801 . . . . 0.0 109.515 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -147.17 156.03 46.7 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -85.59 155.63 10.48 Favored 'Trans proline' 0 N--CA 1.436 -1.876 0 C-N-CA 121.852 1.702 . . . . 0.0 109.008 170.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -149.19 129.61 13.86 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.464 ' HA ' HG21 ' A' ' 24' ' ' THR . 19.0 m -115.69 125.81 53.31 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.048 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.93 151.84 24.18 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.0 t -94.73 1.52 55.48 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 122.629 1.204 . . . . 0.0 108.256 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -141.69 165.16 28.23 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.67 -6.73 58.11 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -83.27 -24.28 32.32 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 122.168 0.985 . . . . 0.0 109.103 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -94.44 131.09 40.49 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -87.41 129.39 35.06 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.972 0.891 . . . . 0.0 112.512 -169.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.464 HG21 ' HA ' ' A' ' 16' ' ' THR . 91.1 m -97.1 121.37 38.91 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.205 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.406 ' CD1' HG23 ' A' ' 11' ' ' THR . 10.5 p90 -133.69 160.09 38.6 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.045 0.45 . . . . 0.0 112.175 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -94.23 171.32 8.9 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.62 145.66 31.58 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.33 16.23 78.61 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.419 -0.42 . . . . 0.0 113.263 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 8.9 tp10 -97.98 148.29 23.63 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.849 0.357 . . . . 0.0 110.732 -175.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.3 mm -96.86 121.17 47.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.4 mt -113.84 140.85 32.21 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -89.43 121.9 32.11 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.0 tt -79.01 133.2 36.83 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -174.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.4 mt -106.84 -44.0 7.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-O 121.128 0.489 . . . . 0.0 110.232 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -150.17 130.77 13.97 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 121.973 -0.455 . . . . 0.0 111.839 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -88.36 -23.71 23.31 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -97.87 109.5 22.24 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.556 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.7 p -111.61 -5.64 14.48 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.776 0.798 . . . . 0.0 110.126 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.94 -17.16 30.09 Favored Glycine 0 C--N 1.309 -0.967 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -128.36 128.94 45.49 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.39 115.04 16.83 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.66 -15.59 6.29 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -110.34 124.1 51.07 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -108.77 155.51 20.68 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.775 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 38.3 ttmt -117.2 129.46 55.96 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.61 173.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.64 168.13 26.0 Favored Glycine 0 N--CA 1.416 -2.68 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 1.8 tm-20 -115.34 129.9 56.74 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.097 0.475 . . . . 0.0 110.365 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.8 tp -156.64 138.82 14.62 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 73.02 12.24 5.07 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.659 1.184 . . . . 0.0 110.921 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.44 14.76 59.58 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 27.3 mmmt -126.06 154.98 42.26 Favored 'General case' 0 CA--C 1.468 -2.21 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -175.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.29 126.23 34.85 Favored 'General case' 0 C--N 1.257 -3.427 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.117 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -156.75 -161.66 10.92 Favored Glycine 0 CA--C 1.469 -2.832 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -176.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.5 147.51 17.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.793 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -150.51 154.87 36.07 Favored Pre-proline 0 N--CA 1.426 -1.626 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.679 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.06 128.05 13.51 Favored 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 122.14 1.893 . . . . 0.0 111.372 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.26 -19.38 64.5 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.031 0.933 . . . . 0.0 112.264 -175.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.39 -4.78 44.13 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -102.31 -0.33 33.0 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 121.127 0.489 . . . . 0.0 112.104 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -141.42 155.58 45.87 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.209 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 p -120.75 139.3 48.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.434 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 50.0 tt0 -79.83 122.06 26.17 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.679 0.752 . . . . 0.0 111.613 -177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.6 mm -93.7 -31.06 4.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.541 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.42 -1.967 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 -178.691 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 . . . . . 0 N--CA 1.431 -1.407 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -113.11 153.19 28.62 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.591 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.6 p -133.99 138.36 45.38 Favored 'General case' 0 C--N 1.267 -2.983 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.205 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -99.7 138.23 37.08 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 42.4 p -63.09 142.93 58.19 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 124.332 1.053 . . . . 0.0 110.406 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.7 mt -113.08 -18.78 12.08 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.322 0.582 . . . . 0.0 110.165 175.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -149.4 147.66 23.96 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.38 123.64 8.84 Favored 'Trans proline' 0 C--O 1.253 1.264 0 C-N-CA 122.052 1.835 . . . . 0.0 110.51 173.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -129.98 134.0 47.16 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.429 ' HA ' HG22 ' A' ' 24' ' ' THR . 46.8 m -116.28 131.69 56.87 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 120.933 0.397 . . . . 0.0 110.544 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.04 134.68 11.86 Favored Glycine 0 N--CA 1.413 -2.887 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.5 p -91.15 -34.71 14.92 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -79.27 145.93 33.26 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 113.377 -1.738 . . . . 0.0 108.692 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.41 -35.86 80.55 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.775 0.672 . . . . 0.0 110.631 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.417 ' O ' HG21 ' A' ' 54' ' ' VAL . 31.0 t70 -86.42 4.96 37.29 Favored 'General case' 0 C--O 1.203 -1.371 0 CA-C-O 121.62 0.724 . . . . 0.0 110.213 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -104.35 134.7 47.11 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.19 135.42 33.8 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.73 0.3 . . . . 0.0 111.564 -170.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 16' ' ' THR . 94.1 m -103.24 120.06 40.04 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -135.02 154.42 51.73 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -104.94 -176.69 3.15 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.94 122.96 35.84 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 176.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.39 8.73 8.29 Favored Glycine 0 C--N 1.294 -1.796 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.244 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -110.41 154.33 23.72 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.1 mm -108.13 122.48 62.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.114 0.483 . . . . 0.0 109.762 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.591 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 58.6 mt -105.79 130.15 57.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.95 127.51 36.04 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.99 121.75 20.62 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mm -100.59 -41.33 8.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.603 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.4 m -151.68 139.55 19.94 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.272 -0.268 . . . . 0.0 111.524 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -103.4 -14.32 16.31 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.89 0.476 . . . . 0.0 110.366 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -110.47 97.42 6.87 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-O 121.986 0.898 . . . . 0.0 109.375 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 p -105.18 0.5 27.38 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.058 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.52 -25.83 18.3 Favored Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -174.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -117.78 174.73 6.01 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.885 -0.657 . . . . 0.0 109.557 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.39 141.28 37.18 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.73 -30.23 5.47 Favored Glycine 0 C--N 1.312 -0.774 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.411 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -81.98 115.35 21.1 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.135 0.493 . . . . 0.0 110.166 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.469 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 44.9 m0 -108.57 154.19 22.31 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.897 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -116.29 129.64 56.38 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.07 176.51 23.3 Favored Glycine 0 N--CA 1.413 -2.876 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -123.04 133.87 54.31 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.3 tp -149.97 139.7 21.74 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.429 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.8 m120 67.66 10.07 7.51 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.794 1.237 . . . . 0.0 111.35 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.47 -2.97 49.97 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.21 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.38 138.43 51.36 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 122.375 -0.485 . . . . 0.0 110.203 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -93.5 144.06 25.71 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.36 177.93 36.6 Favored Glycine 0 N--CA 1.413 -2.836 0 C-N-CA 119.851 -1.166 . . . . 0.0 111.186 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 34.3 m -114.51 152.01 16.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -160.19 147.69 12.69 Favored Pre-proline 0 N--CA 1.419 -1.983 0 O-C-N 124.184 0.928 . . . . 0.0 108.824 -177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -69.05 129.31 18.11 Favored 'Trans proline' 0 C--O 1.251 1.159 0 C-N-CA 121.736 1.624 . . . . 0.0 108.954 172.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -57.83 -20.7 37.96 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 123.974 0.91 . . . . 0.0 113.091 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -69.04 -13.21 62.31 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -91.69 2.46 56.46 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.256 0.55 . . . . 0.0 111.315 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -140.37 169.86 16.89 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.541 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 p -128.93 122.2 56.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -73.07 121.59 20.43 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.5 pt -85.77 -6.81 10.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -173.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 C--N 1.298 -1.663 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.559 174.837 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 64' ' ' SER . 44.7 mt-10 . . . . . 0 N--CA 1.437 -1.093 0 CA-C-O 120.97 0.414 . . . . 0.0 109.897 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -139.93 151.1 45.3 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 121.4 0.619 . . . . 0.0 111.233 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.6 p -130.19 153.38 48.62 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.051 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.51 HH11 ' HA2' ' A' ' 28' ' ' GLY . 59.5 ttp85 -113.41 134.41 54.66 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.6 p -79.36 131.56 36.15 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.01 -177.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.5 mt -95.18 -12.07 27.0 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.672 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -133.17 149.86 73.82 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.632 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -85.98 120.65 1.97 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.282 1.988 . . . . 0.0 108.925 168.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 89.1 t80 -146.45 123.11 11.17 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.381 0.61 . . . . 0.0 111.328 -173.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.496 ' HA ' HG22 ' A' ' 24' ' ' THR . 87.9 m -91.93 135.33 34.03 Favored 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.87 125.8 33.33 Favored Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -36.75 67.24 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -101.19 148.08 25.51 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 112.791 -2.004 . . . . 0.0 105.956 176.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -15.54 57.17 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.138 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -73.66 -20.51 60.54 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.722 172.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -89.06 143.31 26.94 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 tt -84.7 125.11 32.23 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.093 0.473 . . . . 0.0 111.132 -171.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.496 HG22 ' HA ' ' A' ' 16' ' ' THR . 91.1 m -87.65 121.02 29.54 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.039 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 15' ' ' TYR . 36.1 p90 -133.89 161.43 34.79 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.246 0.546 . . . . 0.0 111.945 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -112.99 173.64 6.28 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -78.69 123.86 27.59 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.51 ' HA2' HH11 ' A' ' 10' ' ' ARG . . . 102.09 13.48 31.25 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.525 -0.845 . . . . 0.0 114.16 177.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -93.58 143.98 25.8 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 117.079 0.44 . . . . 0.0 110.165 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.9 mm -99.33 113.04 33.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.9 mt -107.43 134.06 50.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -88.58 127.88 35.56 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.401 HD21 ' HG3' ' A' ' 36' ' ' LYS . 3.8 tt -74.15 126.26 30.18 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.055 -174.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 47' ' ' GLU . 59.7 mt -101.39 -52.81 8.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.3 m -143.26 128.54 18.81 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.697 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.401 ' HG3' HD21 ' A' ' 33' ' ' LEU . 58.2 mtpt -85.5 -33.41 21.81 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -97.68 108.19 20.85 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.575 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.1 p -119.33 6.43 11.17 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.435 0.636 . . . . 0.0 110.635 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.06 -22.15 7.65 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -141.28 139.31 33.65 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.16 89.63 7.34 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.42 -30.74 0.16 Allowed Glycine 0 CA--C 1.483 -1.914 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -99.69 121.88 41.88 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.473 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 25.8 m0 -107.94 141.64 39.26 Favored 'General case' 0 C--N 1.273 -2.737 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 23.0 ttmm -102.54 129.47 49.09 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 175.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.94 175.16 25.58 Favored Glycine 0 N--CA 1.417 -2.619 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.413 ' HB2' HD12 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -123.95 129.69 51.36 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.187 0.494 . . . . 0.0 109.79 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.429 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 47.4 tp -137.96 119.6 15.05 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.959 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.429 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 59.3 m-80 64.82 21.6 12.39 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.742 1.217 . . . . 0.0 112.543 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.74 -11.58 49.78 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.728 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -103.57 134.82 46.27 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 116.884 0.342 . . . . 0.0 110.48 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.39 141.48 46.07 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -167.16 -165.19 24.15 Favored Glycine 0 CA--C 1.467 -2.946 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 26.0 m -114.4 147.03 18.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 120.99 0.424 . . . . 0.0 110.56 -178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -147.95 150.6 36.12 Favored Pre-proline 0 C--N 1.296 -1.738 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.201 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.58 136.77 29.0 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 121.798 1.665 . . . . 0.0 112.202 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -69.02 -8.16 42.34 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.659 0.784 . . . . 0.0 112.488 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -96.49 0.22 49.96 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 120.817 0.341 . . . . 0.0 111.487 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -99.92 -11.43 20.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.197 0.522 . . . . 0.0 110.996 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.12 145.08 41.2 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.598 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.02 125.76 66.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -68.99 121.52 16.79 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.476 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.4 mm -85.34 -45.79 17.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 43.9 m . . . . . 0 N--CA 1.41 -2.467 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 64' ' ' SER . 4.7 mm-40 . . . . . 0 N--CA 1.42 -1.928 0 CA-C-O 120.77 0.319 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -146.24 144.67 30.03 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.995 0.426 . . . . 0.0 111.187 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.45 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 8.0 p -126.71 147.85 49.92 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.655 -172.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -101.9 136.0 42.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.0 p -69.17 139.47 54.62 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.66 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.0 mt -107.75 -18.87 13.71 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.482 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -147.37 151.05 39.31 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.18 141.12 23.02 Favored 'Trans proline' 0 C--O 1.25 1.101 0 C-N-CA 121.977 1.784 . . . . 0.0 111.091 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -147.41 139.14 24.09 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.1 m -112.79 131.34 55.73 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 120.978 0.418 . . . . 0.0 110.622 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.76 119.9 5.22 Favored Glycine 0 N--CA 1.409 -3.139 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.9 m -82.08 -28.62 32.26 Favored 'General case' 0 N--CA 1.383 -3.807 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -94.31 165.93 12.34 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.788 -1.551 . . . . 0.0 107.85 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -26.62 33.07 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-O 121.425 0.631 . . . . 0.0 109.856 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -92.61 9.75 33.39 Favored 'General case' 0 C--O 1.212 -0.886 0 CA-C-O 121.643 0.735 . . . . 0.0 110.712 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -109.85 131.43 55.07 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.19 130.97 35.52 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.513 -169.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.3 m -93.79 119.7 33.09 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -134.39 145.63 49.12 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.321 0.581 . . . . 0.0 112.366 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -96.47 161.69 13.8 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.391 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.64 123.13 24.3 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.39 11.41 21.8 Favored Glycine 0 C--N 1.294 -1.772 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -100.06 152.74 19.87 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-O 120.93 0.395 . . . . 0.0 110.625 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.3 mm -109.35 111.82 37.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.45 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 67.8 mt -96.42 135.54 30.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -88.31 117.49 27.27 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.3 tt -76.78 124.7 28.08 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.412 ' C ' ' HG ' ' A' ' 35' ' ' SER . 48.8 mm -94.35 -50.15 12.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.258 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 34' ' ' ILE . 52.5 m -156.3 133.24 10.45 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.083 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -84.45 -16.5 42.36 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.882 0.848 . . . . 0.0 108.972 172.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -98.03 99.21 10.47 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.257 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.4 p -105.98 -3.38 21.76 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.89 0.852 . . . . 0.0 109.836 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.96 -42.46 1.49 Allowed Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -176.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -121.61 128.09 51.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.18 121.32 14.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.489 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.95 -25.58 4.12 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -106.57 123.53 48.24 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 177.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.432 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 43.6 m0 -108.7 153.4 23.5 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -114.82 129.45 56.7 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -141.49 160.74 26.95 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.8 125.17 50.07 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.9 tp -147.62 119.01 7.86 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.459 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 72.12 21.81 3.85 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.193 0.997 . . . . 0.0 113.036 174.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.37 0.29 35.1 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.664 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 8.5 mptt -127.22 132.66 50.37 Favored 'General case' 0 CA--C 1.488 -1.423 0 O-C-N 122.419 -0.459 . . . . 0.0 110.073 -177.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 10.5 pt-20 -107.65 95.85 5.98 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 122.502 1.144 . . . . 0.0 109.433 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.94 -175.45 18.98 Favored Glycine 0 C--N 1.274 -2.9 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.495 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 33.0 m -114.14 152.56 15.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -152.89 155.43 32.2 Favored Pre-proline 0 N--CA 1.418 -2.041 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.662 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.28 134.46 12.78 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.746 1.631 . . . . 0.0 111.284 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -44.86 -37.34 3.82 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 125.458 1.503 . . . . 0.0 113.21 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -63.09 -16.97 61.71 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -96.24 1.56 52.23 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.86 170.38 16.0 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.038 0.446 . . . . 0.0 111.696 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.22 131.42 40.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -83.32 125.69 31.9 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.194 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.1 mm -89.95 -52.5 10.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 23.2 t . . . . . 0 N--CA 1.413 -2.305 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.44 -0.931 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -124.8 139.37 53.91 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.587 0.708 . . . . 0.0 110.597 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.691 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 5.6 p -129.59 162.28 28.61 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -121.11 145.8 47.42 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 25' ' ' PHE . 72.0 p -71.31 141.41 50.48 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.794 0.683 . . . . 0.0 109.631 177.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -105.13 -18.79 14.03 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -141.71 156.29 66.17 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -177.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -76.73 120.9 5.68 Favored 'Trans proline' 0 N--CA 1.429 -2.275 0 N-CA-C 108.065 -1.552 . . . . 0.0 108.065 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -111.4 115.37 29.14 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.0 m -98.38 111.3 23.69 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.715 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.43 135.63 18.73 Favored Glycine 0 N--CA 1.425 -2.05 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 176.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -113.6 5.55 16.6 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -127.15 156.24 42.1 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.54 -1.664 . . . . 0.0 107.324 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.15 -24.77 43.05 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -95.16 -4.4 46.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.806 0.812 . . . . 0.0 110.42 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -93.07 115.82 28.46 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 24' ' ' THR . 0.5 OUTLIER -83.78 144.58 29.22 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.874 0.369 . . . . 0.0 110.023 -170.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.408 ' N ' HD12 ' A' ' 23' ' ' LEU . 88.6 m -98.88 129.41 45.23 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.35 0.595 . . . . 0.0 111.492 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.419 ' HB3' HG23 ' A' ' 11' ' ' THR . 90.9 m-85 -127.74 151.84 48.49 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.221 -176.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.424 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 3.5 mpt_? -108.82 174.5 5.84 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -81.75 116.37 21.42 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 117.914 0.324 . . . . 0.0 111.864 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.12 38.12 4.42 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.527 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.428 ' OE2' HD21 ' A' ' 48' ' ' LEU . 9.5 pt-20 -131.56 156.85 45.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 117.942 0.871 . . . . 0.0 111.871 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.9 mm -87.92 137.24 21.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.463 -173.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.691 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 40.1 mt -114.12 136.9 49.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.89 116.96 28.36 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.7 tt -77.93 123.78 27.2 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.8 mm -103.53 -40.69 6.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.319 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.0 m -153.04 134.96 14.69 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.007 -0.433 . . . . 0.0 111.892 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -91.9 -9.93 41.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.683 0.754 . . . . 0.0 109.539 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -117.78 119.52 35.17 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.96 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 p -115.34 0.1 13.34 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-O 121.576 0.703 . . . . 0.0 109.415 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.54 1.46 53.25 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -148.66 132.11 16.66 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.57 106.06 6.93 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 149.12 -31.12 1.19 Allowed Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -105.81 131.16 53.49 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.966 0.412 . . . . 0.0 110.724 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -113.24 151.26 31.27 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 84.5 tttt -109.2 129.03 55.5 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.29 157.94 22.73 Favored Glycine 0 N--CA 1.412 -2.914 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.221 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -116.67 129.29 56.05 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.428 HD21 ' OE2' ' A' ' 29' ' ' GLU . 55.4 tp -162.92 149.48 12.61 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 72.4 0.58 3.65 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.603 1.161 . . . . 0.0 111.216 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.79 0.53 42.44 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.83 169.88 10.33 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -175.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -130.25 142.03 50.58 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.475 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 45' ' ' LYS . . . -163.53 -173.13 31.86 Favored Glycine 0 C--N 1.291 -1.951 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -114.71 152.83 16.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 120.843 0.354 . . . . 0.0 110.706 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -153.87 150.94 23.83 Favored Pre-proline 0 N--CA 1.439 -1.022 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.671 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 17.1 Cg_exo -70.16 132.12 22.05 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.723 1.616 . . . . 0.0 109.692 173.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.6 -10.75 20.07 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -62.59 -31.95 72.86 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 124.41 1.084 . . . . 0.0 111.211 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -88.97 4.02 49.56 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -173.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.2 171.09 14.91 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -138.31 136.3 44.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -80.99 127.75 32.93 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.141 0.496 . . . . 0.0 111.528 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.405 ' C ' ' HG ' ' A' ' 64' ' ' SER . 33.1 mm -86.37 -62.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 63' ' ' ILE . 68.4 m . . . . . 0 N--CA 1.405 -2.68 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 N--CA 1.424 -1.758 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -125.51 143.83 50.83 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.904 -1.118 . . . . 0.0 111.188 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.661 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 7.2 p -125.48 153.08 44.09 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.255 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -116.18 134.09 55.31 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.8 p -62.77 149.1 44.88 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 122.8 0.44 . . . . 0.0 112.037 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.54 -19.17 10.15 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -151.86 153.93 32.22 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.49 143.41 38.46 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.859 1.706 . . . . 0.0 109.224 169.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -135.0 127.86 31.28 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.4 m -93.27 115.85 28.44 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.306 -177.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.87 118.47 5.04 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.2 p -106.63 -7.32 17.43 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.983 0.897 . . . . 0.0 109.742 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -108.87 149.96 28.37 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -69.54 -22.95 63.52 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.094 0.474 . . . . 0.0 112.276 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -94.17 -2.44 52.59 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.296 1.046 . . . . 0.0 109.972 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -103.83 127.37 51.33 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.689 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.55 ' CD1' ' HA3' ' A' ' 53' ' ' GLY . 3.0 mp -84.89 135.66 33.97 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -177.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.2 m -96.2 123.26 39.76 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.94 176.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -133.75 159.59 40.13 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.202 0.525 . . . . 0.0 111.867 177.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -117.67 173.64 6.62 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -78.46 141.89 37.92 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.89 11.69 42.54 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.555 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -105.85 147.26 28.9 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.575 0.703 . . . . 0.0 112.317 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.9 mm -102.86 127.68 56.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.661 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 62.0 mt -114.39 135.01 55.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -89.39 118.52 29.11 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 tt -81.27 124.24 29.16 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mm -98.66 -47.23 12.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.905 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.0 m -153.46 124.55 7.42 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -75.69 -25.48 56.74 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.163 0.506 . . . . 0.0 109.843 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -90.71 121.39 32.56 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.173 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -122.77 -2.39 8.82 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.253 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.84 -7.41 41.71 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -145.66 131.86 19.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.36 126.86 30.84 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.38 -38.22 2.18 Favored Glycine 0 C--N 1.304 -1.234 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.649 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -98.82 127.58 44.79 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 120.798 0.333 . . . . 0.0 110.483 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 31.6 m0 -108.95 153.75 23.13 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.039 176.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 65.0 tttm -114.21 128.48 56.39 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.07 173.68 28.89 Favored Glycine 0 N--CA 1.424 -2.152 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.15 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -115.52 130.35 56.85 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 124.616 1.166 . . . . 0.0 109.626 -177.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 39.3 tp -154.66 135.7 13.85 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 56.4 m-80 65.59 16.26 10.42 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.397 1.079 . . . . 0.0 111.84 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.33 6.83 77.45 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.837 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.86 155.1 27.43 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -133.6 138.09 45.8 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.612 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.55 ' HA3' ' CD1' ' A' ' 23' ' ' LEU . . . -164.65 -156.71 9.12 Favored Glycine 0 CA--C 1.483 -1.945 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.054 -175.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.76 154.09 17.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 120.943 0.401 . . . . 0.0 111.506 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -158.53 148.85 15.63 Favored Pre-proline 0 N--CA 1.434 -1.228 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.125 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -74.35 135.76 20.86 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 121.77 1.647 . . . . 0.0 110.21 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -69.55 -7.25 36.81 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 120.821 0.343 . . . . 0.0 111.794 -176.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.6 -21.09 65.37 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.464 0.706 . . . . 0.0 112.035 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -107.11 9.77 30.31 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -173.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.93 164.3 34.15 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.9 p -131.34 135.25 59.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -78.26 133.11 37.73 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.1 mm -86.83 -67.22 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.398 -3.067 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.964 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.675 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.54 156.89 20.57 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 ttt -139.06 99.55 3.79 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.06 95.32 0.16 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.165 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.61 23.47 12.63 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 80.97 75.5 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 125.786 1.634 . . . . 0.0 109.138 -174.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -98.52 151.27 20.81 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.706 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -138.99 149.44 44.7 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.408 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.0 p -137.56 157.67 46.02 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 123.041 0.213 . . . . 0.0 110.874 -177.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 45.3 ttt180 -119.31 138.08 53.27 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.6 p -78.22 134.34 37.6 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.883 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.5 mt -98.29 -18.08 18.56 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.587 0.708 . . . . 0.0 109.566 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -142.56 150.14 53.22 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -78.5 157.75 28.85 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.875 1.716 . . . . 0.0 110.015 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -150.73 132.93 15.38 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.403 ' HA ' HG23 ' A' ' 24' ' ' THR . 82.1 m -96.14 122.38 38.93 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.967 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.77 125.97 7.21 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.1 p -90.55 -36.43 14.47 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 122.549 1.166 . . . . 0.0 108.376 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.461 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 57.3 m-80 -89.09 166.12 14.07 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.261 175.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -81.77 -33.21 31.04 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.7 3.34 14.25 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.408 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 34.7 tt0 -110.84 128.44 55.78 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tt -85.67 125.38 33.13 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.215 -170.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 16' ' ' THR . 91.6 m -90.26 119.41 30.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 174.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -135.37 159.11 42.59 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -100.1 -178.37 3.82 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -91.85 137.73 32.13 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.429 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 95.83 15.66 41.85 Favored Glycine 0 CA--C 1.496 -1.103 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.858 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 20.0 mm-40 -95.94 127.25 41.8 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.9 mm -87.66 116.64 30.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 174.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.408 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 57.9 mt -105.98 144.12 15.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -88.51 109.26 19.9 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.436 HD22 ' HG3' ' A' ' 36' ' ' LYS . 6.2 tt -73.09 124.83 26.33 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -175.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.7 mm -97.37 -51.43 10.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.338 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -152.07 134.59 15.33 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.89 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.436 ' HG3' HD22 ' A' ' 33' ' ' LEU . 50.6 mtmt -90.33 -25.84 20.27 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.555 0.693 . . . . 0.0 109.169 175.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -96.44 103.05 14.93 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.19 -0.913 . . . . 0.0 108.551 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.7 p -104.11 8.81 36.48 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.132 0.968 . . . . 0.0 108.94 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.03 -22.3 38.63 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -119.06 146.92 44.68 Favored 'General case' 0 N--CA 1.413 -2.286 0 CA-C-N 114.806 -0.697 . . . . 0.0 109.529 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.86 109.97 21.18 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.71 -23.47 3.98 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.723 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -107.14 126.92 53.0 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.413 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 35.5 m0 -108.88 150.65 27.38 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 88.5 tttt -108.59 129.1 55.32 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -140.8 160.51 26.63 Favored Glycine 0 N--CA 1.408 -3.233 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.7 tm-20 -117.78 123.75 46.75 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.6 tp -142.77 133.73 25.65 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 67.7 17.46 9.84 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 124.079 0.862 . . . . 0.0 111.169 171.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.01 3.1 62.12 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.677 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 9.5 mptt -115.84 125.75 53.07 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 122.394 -0.474 . . . . 0.0 110.417 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 10.6 pt-20 -112.42 112.92 24.83 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.014 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -145.84 -166.66 12.08 Favored Glycine 0 N--CA 1.423 -2.229 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 34.6 m -114.21 151.09 16.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-O 120.97 0.414 . . . . 0.0 110.163 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -154.48 150.55 22.16 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.862 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -66.85 130.74 23.85 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 121.953 1.769 . . . . 0.0 110.544 175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -67.79 -9.53 45.03 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -68.87 -16.66 63.83 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.074 0.549 . . . . 0.0 111.745 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -91.45 -3.93 56.1 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.09 163.16 30.54 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.63 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.23 142.57 42.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -86.84 144.5 26.99 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.922 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.4 mm -102.98 -44.33 9.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.651 0.738 . . . . 0.0 109.355 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.413 -2.289 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -178.015 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.349 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.89 -39.05 2.42 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 117.251 0.525 . . . . 0.0 110.218 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 mmt -113.11 2.11 15.55 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.702 0.763 . . . . 0.0 110.02 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.01 167.17 33.74 Favored Glycine 0 N--CA 1.424 -2.114 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.38 -27.57 46.87 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.979 0.419 . . . . 0.0 110.908 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -142.43 93.29 2.51 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.611 0.72 . . . . 0.0 110.324 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.47 ' HA ' ' OXT' ' A' ' 64' ' ' SER . 45.6 mt-10 -108.44 132.52 53.7 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.047 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -132.42 137.1 47.18 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.526 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 5.6 p -120.82 133.34 55.32 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.083 0.468 . . . . 0.0 109.946 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -99.55 129.84 45.75 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.3 p -62.92 128.78 37.46 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.158 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -97.35 -19.32 18.58 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -151.5 162.78 25.75 Favored Pre-proline 0 C--N 1.31 -1.141 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.7 165.68 11.94 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 121.729 1.619 . . . . 0.0 110.412 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -150.59 130.37 13.24 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.5 m -98.37 118.62 35.43 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.821 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.35 126.81 7.65 Favored Glycine 0 N--CA 1.417 -2.625 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.0 t -102.32 7.92 40.46 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -127.6 152.36 47.74 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.77 -40.51 96.87 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -98.25 14.35 28.12 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.726 0.774 . . . . 0.0 111.602 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -97.61 129.04 44.75 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 172.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.7 119.71 19.26 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.291 0.567 . . . . 0.0 111.821 -168.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.2 m -95.0 119.65 33.87 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -133.62 161.73 33.84 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -101.94 173.5 6.36 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.272 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -92.38 109.63 21.02 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.86 27.81 1.83 Allowed Glycine 0 C--N 1.304 -1.233 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.954 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -119.68 158.67 25.98 Favored 'General case' 0 C--O 1.251 1.164 0 CA-C-O 121.038 0.447 . . . . 0.0 111.146 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.6 mm -101.44 117.13 46.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.526 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 67.9 mt -94.53 134.3 32.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -89.3 109.59 20.47 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.6 tt -70.41 118.15 12.86 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -176.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.3 mm -93.27 -41.36 12.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.262 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.3 t -154.48 146.34 23.46 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.473 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -103.15 -3.55 25.66 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.964 174.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -115.1 103.14 10.59 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.603 0.716 . . . . 0.0 111.668 -176.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.5 p -118.46 9.88 12.49 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-O 122.111 0.957 . . . . 0.0 109.209 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.36 -21.28 46.36 Favored Glycine 0 N--CA 1.435 -1.402 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.044 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -125.98 142.17 51.64 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.3 125.94 30.15 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.372 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 114.38 -21.1 15.31 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.74 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -101.42 116.81 33.62 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 121.049 0.452 . . . . 0.0 110.416 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.425 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 40.6 m0 -108.77 155.54 20.65 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.589 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 16.8 ttmm -113.88 129.73 56.56 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.7 158.96 27.73 Favored Glycine 0 N--CA 1.414 -2.832 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -112.63 123.6 50.66 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.596 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 49.4 tp -147.05 130.44 16.67 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.945 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.596 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 59.3 m-80 66.05 18.65 11.07 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.716 1.206 . . . . 0.0 112.847 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.31 -18.72 20.61 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.012 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.26 144.37 44.91 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.528 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -102.03 116.36 32.51 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -125.63 -177.89 15.08 Favored Glycine 0 N--CA 1.409 -3.146 0 C-N-CA 119.962 -1.113 . . . . 0.0 111.067 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 27.4 m -114.23 146.69 18.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -154.38 153.85 28.68 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.814 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 16.5 Cg_exo -71.08 129.34 16.06 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.303 2.002 . . . . 0.0 110.334 174.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.64 -20.87 63.87 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 124.284 1.033 . . . . 0.0 113.296 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -73.82 0.83 11.99 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -104.74 -0.86 26.92 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 122.264 -0.273 . . . . 0.0 111.529 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -141.19 146.72 37.31 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.977 -176.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 p -108.22 132.43 56.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -78.76 126.81 31.22 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.373 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.1 mm -91.51 -54.12 7.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.227 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.47 ' OXT' ' HA ' ' A' ' 7' ' ' GLU . 19.4 m . . . . . 0 N--CA 1.421 -1.91 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.477 -2.331 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 42.95 -79.03 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.327 1.851 . . . . 0.0 115.799 171.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.4 mtp -86.89 -4.73 59.21 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 122.969 0.508 . . . . 0.0 112.06 -173.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.98 -119.62 0.84 Allowed Glycine 0 C--N 1.3 -1.462 0 C-N-CA 120.338 -0.934 . . . . 0.0 114.574 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.67 -153.95 0.42 Allowed 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 123.288 0.635 . . . . 0.0 109.831 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -62.4 125.15 22.92 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 123.543 0.527 . . . . 0.0 109.837 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.495 ' HB3' HE22 ' A' ' 62' ' ' GLN . 45.9 mt-10 -106.15 145.31 31.67 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.468 -176.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -126.47 135.3 51.18 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.495 ' SG ' HD11 ' A' ' 33' ' ' LEU . 12.9 m -126.03 164.81 20.04 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.479 HH11 ' HA2' ' A' ' 28' ' ' GLY . 65.7 ttp85 -129.96 134.35 47.4 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.8 p -74.34 136.53 42.52 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.9 mt -98.7 -18.37 18.07 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.647 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -144.7 150.31 46.39 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.74 143.49 41.85 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 121.97 1.78 . . . . 0.0 110.046 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -138.05 135.45 35.88 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.9 m -111.89 128.77 56.24 Favored 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.239 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . -82.13 126.56 7.49 Favored Glycine 0 N--CA 1.421 -2.323 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.5 p -96.18 -5.96 39.33 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.326 1.06 . . . . 0.0 109.85 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -142.18 153.75 44.28 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 113.503 -1.681 . . . . 0.0 106.599 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.21 -28.99 70.07 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -171.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -82.68 -7.36 59.65 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.286 0.565 . . . . 0.0 111.235 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.5 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 42.9 tt0 -102.46 114.14 28.09 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.533 ' CD1' ' HA3' ' A' ' 53' ' ' GLY . 3.9 mp -83.34 145.33 29.11 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -172.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -94.82 131.55 40.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.832 -1.077 . . . . 0.0 108.962 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.459 ' CD2' HD22 ' A' ' 48' ' ' LEU . 97.1 m-85 -132.07 152.87 50.95 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 123.068 0.547 . . . . 0.0 110.299 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.6 mtm180 -100.26 -176.07 3.12 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 171.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.3 122.04 34.39 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.479 ' HA2' HH11 ' A' ' 10' ' ' ARG . . . 100.57 21.57 12.53 Favored Glycine 0 C--N 1.313 -0.712 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.617 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 20.7 mm-40 -94.88 137.18 34.28 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.5 mm -89.56 124.55 42.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 108.093 -1.076 . . . . 0.0 108.093 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.5 mt -99.87 134.74 38.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -89.29 102.37 15.03 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 172.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.495 HD11 ' SG ' ' A' ' 9' ' ' CYS . 6.8 tt -72.56 125.3 27.11 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 -175.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.6 mm -98.99 -42.37 10.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.951 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.3 m -153.35 131.45 11.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.747 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -87.16 -41.02 14.08 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -87.49 105.14 17.1 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.246 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.5 p -112.04 0.02 15.83 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.77 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.92 -40.17 2.52 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.9 115.24 28.41 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.127 0.489 . . . . 0.0 109.765 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.43 124.68 22.41 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.243 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 109.52 -16.56 31.58 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.549 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -106.87 124.78 50.11 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 120.951 0.405 . . . . 0.0 110.51 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -110.82 153.07 25.91 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 86.6 tttt -106.24 129.4 54.29 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.75 166.18 25.68 Favored Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -118.8 130.42 55.77 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.459 HD22 ' CD2' ' A' ' 25' ' ' PHE . 38.6 tp -144.95 127.01 15.57 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 63.39 21.41 12.77 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.179 0.992 . . . . 0.0 111.884 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.24 4.93 62.47 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.274 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -114.73 136.98 52.47 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -125.25 127.17 46.32 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.78 0.8 . . . . 0.0 110.188 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.533 ' HA3' ' CD1' ' A' ' 23' ' ' LEU . . . -163.18 -157.03 8.9 Favored Glycine 0 N--CA 1.415 -2.702 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.561 -175.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.9 m -115.95 151.05 17.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-O 120.977 0.418 . . . . 0.0 111.893 -173.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -151.98 150.04 24.93 Favored Pre-proline 0 N--CA 1.434 -1.23 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.248 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.419 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 7.1 Cg_exo -74.5 128.77 12.18 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 121.831 1.688 . . . . 0.0 109.463 175.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -62.23 -20.17 63.94 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -171.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -71.77 -10.44 59.77 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.17 -1.32 57.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.248 0.546 . . . . 0.0 110.59 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -139.85 174.98 9.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.436 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.35 146.83 26.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.495 HE22 ' HB3' ' A' ' 7' ' ' GLU . 53.6 tp60 -74.62 147.87 41.23 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.9 mm -95.69 -55.63 5.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.9 p . . . . . 0 N--CA 1.414 -2.24 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.68 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.588 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.64 -5.78 59.33 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 122.681 -0.305 . . . . 0.0 111.446 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.6 ttt -71.17 140.78 50.65 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.9 133.58 17.27 Favored Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 114.811 0.684 . . . . 0.0 114.811 -173.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.02 -68.64 0.78 Allowed 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HA ' ' NE2' ' A' ' 32' ' ' HIS . 48.8 mtpt -144.06 76.83 1.52 Allowed 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 170.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 19.2 mm-40 -101.56 118.14 36.34 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.09 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 90.9 m-85 -120.16 132.51 55.42 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.821 0.82 . . . . 0.0 112.073 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.2 m -123.83 143.15 50.51 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.551 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -99.36 130.93 45.68 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.9 p -70.51 128.74 37.19 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 123.549 0.53 . . . . 0.0 109.917 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.0 mt -99.77 -18.57 17.14 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.591 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -140.64 145.35 39.92 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.66 141.11 40.82 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.115 1.876 . . . . 0.0 109.929 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -142.86 142.35 31.77 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 m -107.53 117.79 35.04 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.638 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.15 116.34 8.37 Favored Glycine 0 N--CA 1.425 -2.079 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 m -83.06 -20.15 35.51 Favored 'General case' 0 N--CA 1.388 -3.527 0 CA-C-O 122.438 1.113 . . . . 0.0 108.044 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -114.35 155.53 26.09 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -73.19 -29.86 63.13 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.332 0.587 . . . . 0.0 110.138 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -84.87 9.07 15.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.861 0.838 . . . . 0.0 110.533 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -112.09 133.37 54.29 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mt -78.62 133.43 37.27 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -173.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.1 m -98.08 120.14 37.96 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 173.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -134.23 155.09 50.78 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.49 169.35 8.7 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -79.39 130.33 35.32 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -175.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.14 23.38 13.12 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.999 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -107.73 138.09 44.59 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.5 mm -94.31 125.04 46.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 8' ' ' TYR . 55.5 mt -109.17 135.45 48.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.519 ' NE2' ' HA ' ' A' ' 6' ' ' LYS . 19.2 t-80 -90.52 104.68 17.23 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 4.7 tt -69.39 129.02 38.6 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.508 -177.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.7 mm -100.07 -37.85 6.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.443 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.9 m -148.87 122.16 8.99 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 121.522 -0.736 . . . . 0.0 111.589 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -80.77 -2.95 49.2 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.526 0.679 . . . . 0.0 111.651 175.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -136.32 124.68 23.34 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.495 0.664 . . . . 0.0 109.665 173.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.1 p -113.18 17.07 18.95 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 122.015 0.912 . . . . 0.0 109.217 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.97 -12.79 62.35 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 107.918 -2.073 . . . . 0.0 107.918 -170.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -131.65 149.55 52.45 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.82 104.29 13.94 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.71 -27.66 1.32 Allowed Glycine 0 C--N 1.297 -1.625 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -112.97 121.83 45.83 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -107.98 147.9 30.45 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.971 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -105.83 130.01 53.89 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -146.99 163.89 28.61 Favored Glycine 0 N--CA 1.417 -2.572 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -109.43 123.39 49.27 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.4 tp -136.77 121.07 18.01 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.617 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 63.94 23.08 13.21 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 124.154 0.909 . . . . 0.0 111.437 174.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.08 -19.79 37.03 Favored Glycine 0 N--CA 1.427 -1.911 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.748 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -100.23 126.4 46.52 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 117.717 0.758 . . . . 0.0 111.2 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 6.7 pt-20 -102.04 100.89 11.19 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.991 175.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -131.57 -163.92 10.97 Favored Glycine 0 C--N 1.286 -2.235 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.638 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.5 m -114.47 150.99 16.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 116.871 0.335 . . . . 0.0 110.812 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -147.61 155.16 45.26 Favored Pre-proline 0 N--CA 1.433 -1.296 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.438 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.53 133.79 38.57 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.153 1.902 . . . . 0.0 110.851 176.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -62.72 -15.12 51.56 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.249 1.02 . . . . 0.0 112.842 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -101.77 -13.19 17.82 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -80.8 -7.5 59.43 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.176 0.512 . . . . 0.0 111.964 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -136.88 139.54 41.71 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.03 125.47 57.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -78.35 113.99 16.84 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.426 0.632 . . . . 0.0 111.047 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.0 pt -85.36 -48.32 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.946 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.2 m . . . . . 0 N--CA 1.408 -2.564 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.456 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.692 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.74 105.15 17.51 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 88.1 mmm -95.05 122.94 38.23 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.387 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.92 -29.95 1.52 Allowed Glycine 0 N--CA 1.429 -1.815 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -174.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 68.41 -61.58 0.4 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.753 1.621 . . . . 0.0 112.414 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -110.98 96.72 6.33 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.624 0.726 . . . . 0.0 109.445 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.48 ' HB3' ' NE2' ' A' ' 62' ' ' GLN . 41.6 mt-10 -119.45 140.24 50.76 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -122.87 138.4 54.67 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.278 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.8 m -128.26 137.23 51.9 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.689 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -101.48 136.89 40.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.1 p -72.93 133.63 44.43 Favored 'General case' 0 N--CA 1.417 -2.077 0 O-C-N 123.519 0.512 . . . . 0.0 109.944 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.2 mt -99.13 -18.17 17.83 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -144.87 150.72 47.23 Favored Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.38 154.21 21.36 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 121.807 1.671 . . . . 0.0 110.383 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -150.97 136.11 17.56 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.403 ' HA ' HG21 ' A' ' 24' ' ' THR . 26.0 m -103.11 128.75 49.92 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.9 137.15 16.17 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 t -89.48 -15.42 33.1 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 122.345 1.069 . . . . 0.0 108.331 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -115.42 157.25 24.21 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.778 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.75 -30.6 71.29 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.937 0.875 . . . . 0.0 110.351 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.01 12.22 27.0 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.8 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -114.37 115.0 26.65 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tt -70.78 120.03 15.79 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.479 -166.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.403 HG21 ' HA ' ' A' ' 16' ' ' THR . 87.0 m -89.76 120.1 30.73 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.018 175.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -135.13 161.8 34.3 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -105.17 174.98 5.65 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -87.8 123.25 32.4 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.25 8.05 15.54 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -92.81 137.11 32.65 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.763 0.316 . . . . 0.0 110.401 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mm -99.05 117.28 43.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.2 mt -102.99 141.72 18.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -174.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -90.09 114.72 26.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.7 tt -74.07 127.53 33.16 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.6 mm -102.95 -52.48 8.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.216 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.0 m -143.96 130.98 20.51 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.958 -0.11 . . . . 0.0 110.799 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -88.29 -15.98 34.33 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.823 0.821 . . . . 0.0 110.379 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -114.07 121.67 44.55 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.79 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.0 p -123.64 17.48 9.57 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.05 -47.85 1.0 Allowed Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -100.63 161.3 13.69 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.687 -0.757 . . . . 0.0 109.812 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.03 85.52 2.22 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 176.15 -47.96 0.12 Allowed Glycine 0 CA--C 1.49 -1.486 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -82.85 121.3 26.76 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.9 m0 -107.9 144.19 35.48 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -103.31 129.33 50.29 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.19 168.23 27.15 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -123.28 129.11 50.89 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.4 tp -138.79 115.77 10.89 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.796 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 62.97 23.93 14.28 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 123.907 0.883 . . . . 0.0 111.672 173.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.28 -14.28 39.82 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.885 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.475 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 9.6 mptt -103.27 136.37 43.17 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.0 146.68 46.44 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.67 -160.99 26.21 Favored Glycine 0 N--CA 1.422 -2.276 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.03 152.36 16.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 116.947 0.374 . . . . 0.0 110.122 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -149.76 152.05 33.9 Favored Pre-proline 0 N--CA 1.425 -1.684 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.06 129.29 11.29 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.678 1.586 . . . . 0.0 111.611 177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -49.93 -29.7 8.83 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.509 1.524 . . . . 0.0 113.507 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -68.08 -10.58 55.02 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -96.31 -9.55 29.92 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.79 160.84 38.71 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.967 -175.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 p -128.3 133.51 66.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.48 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 51.5 tt0 -73.9 116.86 15.01 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.334 0.588 . . . . 0.0 110.007 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.4 pt -91.3 -23.76 5.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.57 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.419 -1.98 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.785 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.612 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.93 145.96 33.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 117.064 0.432 . . . . 0.0 110.09 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.8 ptm -137.81 -165.7 1.83 Allowed 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.21 80.92 0.23 Allowed Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.36 -60.16 2.49 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.446 0.641 . . . . 0.0 110.864 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -144.05 25.17 1.6 Allowed 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -86.36 137.06 32.87 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.787 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -123.38 158.29 31.43 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.2 p -135.84 134.12 38.52 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.146 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -100.24 135.73 41.21 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.4 p -60.85 135.68 57.85 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 124.856 1.262 . . . . 0.0 110.867 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.406 HD11 ' HB ' ' A' ' 61' ' ' VAL . 92.4 mt -108.13 -19.08 13.61 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.232 0.539 . . . . 0.0 109.904 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -148.05 152.38 39.85 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.53 148.37 42.38 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.587 1.525 . . . . 0.0 109.538 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -139.11 132.78 30.57 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.5 m -107.38 129.87 54.87 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.68 138.9 15.12 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -91.8 -16.49 26.73 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -125.63 169.92 12.02 Favored 'General case' 0 N--CA 1.402 -2.852 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.905 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -77.32 -28.11 53.08 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -174.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.27 -12.15 57.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.255 1.026 . . . . 0.0 110.154 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.03 107.58 18.49 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -71.96 133.41 45.34 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.24 -169.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.3 m -102.5 120.85 41.23 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.162 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -133.85 161.75 33.89 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -111.28 171.39 7.51 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -84.58 113.3 21.15 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.47 24.01 2.48 Favored Glycine 0 N--CA 1.425 -2.074 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.879 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -119.94 147.47 44.71 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.7 mm -100.36 119.85 49.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.503 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 61.7 mt -103.07 138.1 28.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -88.63 112.87 23.59 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.405 HD22 ' HG3' ' A' ' 36' ' ' LYS . 5.0 tt -76.1 122.45 24.3 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -174.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.1 mt -97.01 -39.14 8.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.335 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.2 t -160.56 138.77 9.92 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.285 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.405 ' HG3' HD22 ' A' ' 33' ' ' LEU . 89.9 mttt -89.75 -8.4 52.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.283 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.35 129.99 49.9 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.357 0.598 . . . . 0.0 110.269 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.9 p -125.42 23.9 7.43 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.79 0.805 . . . . 0.0 109.722 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.0 -39.39 2.86 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -174.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -104.43 139.85 38.78 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.16 102.1 14.63 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.17 -26.69 1.87 Allowed Glycine 0 C--N 1.303 -1.275 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -98.9 126.24 44.51 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.417 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 36.6 m0 -107.27 154.24 21.54 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.561 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -115.33 128.74 56.3 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.37 160.98 28.53 Favored Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.211 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.2 tm-20 -117.52 131.34 56.72 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.504 0.668 . . . . 0.0 110.748 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 68.7 tp -141.34 127.68 19.86 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 67.89 15.36 9.55 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.466 1.106 . . . . 0.0 111.395 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.74 0.77 62.19 Favored Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.353 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 4.4 mptp? -105.92 129.52 54.05 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.36 121.86 46.31 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -143.58 -174.09 15.6 Favored Glycine 0 N--CA 1.412 -2.904 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.361 -178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 35.4 m -115.31 150.93 17.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 O-C-N 123.884 0.403 . . . . 0.0 109.988 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -160.71 151.2 15.06 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.616 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.96 138.05 36.3 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 122.158 1.905 . . . . 0.0 110.768 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.78 -16.76 63.47 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -173.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -72.91 -1.46 16.97 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 120.987 0.423 . . . . 0.0 111.576 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -102.42 -3.09 27.54 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.78 156.02 44.92 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.89 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.406 ' HB ' HD11 ' A' ' 12' ' ' LEU . 14.4 p -118.91 136.05 57.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -78.81 117.71 20.18 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.2 pt -87.65 -9.4 10.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.433 0.635 . . . . 0.0 111.678 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--N 1.283 -2.321 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.672 177.315 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.957 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.43 87.15 2.27 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.1 mtt 60.13 80.92 0.19 Allowed 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 125.248 1.592 . . . . 0.0 111.071 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -151.98 63.38 0.38 Allowed Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.546 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.88 -43.58 1.35 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.55 0.69 . . . . 0.0 110.57 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -121.85 11.37 10.37 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 122.404 1.097 . . . . 0.0 108.25 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.537 ' HA ' ' OXT' ' A' ' 64' ' ' SER . 14.5 mp0 -95.61 114.96 26.76 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 112.929 -1.941 . . . . 0.0 109.437 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -131.92 145.37 51.47 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.9 m -127.96 142.91 51.11 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.539 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -104.05 132.31 50.43 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.0 p -76.49 134.84 39.39 Favored 'General case' 0 C--N 1.288 -2.109 0 CA-C-O 121.155 0.502 . . . . 0.0 111.724 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.6 mt -95.5 -17.97 21.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.873 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -141.44 154.32 66.76 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.571 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.79 134.71 8.6 Favored 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 122.011 1.808 . . . . 0.0 109.375 169.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -135.25 138.15 43.25 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.0 m -107.5 122.42 46.62 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.039 -177.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.09 106.81 2.72 Favored Glycine 0 N--CA 1.413 -2.838 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.77 176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.7 -33.28 21.55 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.401 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 90.5 m-20 -88.8 153.95 20.66 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.892 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -62.11 -37.45 85.15 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.793 0.33 . . . . 0.0 111.661 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -90.91 10.67 25.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.629 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.401 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 46.8 tt0 -110.44 125.55 53.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 mt -82.86 139.51 33.43 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -175.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 51.4 m -99.32 119.44 37.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -134.88 159.78 40.35 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -101.11 -179.7 4.12 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -85.51 133.55 34.07 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.54 17.4 39.2 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.101 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -92.42 142.57 27.28 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.8 mm -99.99 123.55 52.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.9 mt -114.31 142.34 27.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -89.17 115.27 26.56 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 tt -66.11 133.82 51.51 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.454 ' C ' ' HG ' ' A' ' 35' ' ' SER . 48.4 mm -112.48 -49.41 5.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.427 0.632 . . . . 0.0 109.436 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.454 ' HG ' ' C ' ' A' ' 34' ' ' ILE . 28.3 m -149.94 118.5 6.52 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.631 -0.668 . . . . 0.0 111.596 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.422 ' HB2' ' HZ1' ' A' ' 36' ' ' LYS . 9.2 mtmp? -73.45 -26.08 60.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.505 0.669 . . . . 0.0 109.833 173.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -101.98 111.97 24.44 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.2 p -110.12 -2.29 17.02 Favored 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.43 -10.88 33.28 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -125.8 143.78 50.92 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.17 86.72 5.04 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.199 0.523 . . . . 0.0 109.614 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.91 -30.27 0.39 Allowed Glycine 0 CA--C 1.489 -1.591 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -89.63 123.22 33.49 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -108.99 134.21 51.94 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -99.12 129.61 45.39 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 177.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.54 165.18 26.85 Favored Glycine 0 N--CA 1.423 -2.195 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 -178.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 41.7 tt0 -110.77 131.95 54.61 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 123.772 0.337 . . . . 0.0 110.346 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.9 tp -148.27 119.72 7.92 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.098 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 62.06 34.08 16.73 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.965 0.906 . . . . 0.0 112.212 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.9 -10.99 68.2 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.651 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 4.6 mptp? -105.82 129.7 53.95 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-N 117.482 0.641 . . . . 0.0 111.083 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . 0.383 0.0 OUTLIER -111.99 106.29 14.93 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 122.662 1.22 . . . . 0.0 111.002 170.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -134.61 -171.57 12.55 Favored Glycine 0 N--CA 1.425 -2.084 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.354 -174.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.0 m -114.63 150.82 16.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-O 121.303 0.573 . . . . 0.0 111.403 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -152.42 148.76 21.43 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.956 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.67 129.76 21.85 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 121.569 1.512 . . . . 0.0 109.498 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.75 -22.6 58.24 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -172.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -69.19 -8.2 43.46 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -91.96 -0.7 57.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.641 0.257 . . . . 0.0 110.907 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -144.73 165.95 26.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.719 0.295 . . . . 0.0 110.861 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 p -131.57 134.37 60.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -71.27 118.2 13.77 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.3 pt -96.51 -23.78 4.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-O 121.953 0.882 . . . . 0.0 110.522 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.537 ' OXT' ' HA ' ' A' ' 7' ' ' GLU . 44.9 m . . . . . 0 N--CA 1.4 -2.938 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.53 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.0 148.69 48.54 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.2 ttp -99.49 94.2 6.29 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.729 0.776 . . . . 0.0 112.573 -172.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 6' ' ' LYS . . . 80.72 -4.6 68.66 Favored Glycine 0 N--CA 1.437 -1.233 0 CA-C-N 115.058 -0.974 . . . . 0.0 114.827 174.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.42 24.1 13.67 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.95 0.881 . . . . 0.0 110.543 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 4' ' ' GLY . 58.5 mttp -109.14 26.45 10.61 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.53 137.56 40.61 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -130.23 139.45 50.79 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.49 -175.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 13.8 p -124.01 147.62 47.67 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.342 -178.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -108.15 135.61 49.21 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.4 HG23 ' CD1' ' A' ' 25' ' ' PHE . 43.2 p -79.44 136.65 37.0 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.399 0.619 . . . . 0.0 112.268 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.0 mt -99.96 -18.01 17.28 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.672 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -145.55 156.37 52.95 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -84.2 151.2 12.23 Favored 'Trans proline' 0 C--O 1.253 1.265 0 C-N-CA 122.142 1.895 . . . . 0.0 111.323 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -137.55 125.8 23.16 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 m -112.99 110.88 21.23 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.47 144.49 44.2 Favored Glycine 0 N--CA 1.412 -2.958 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.992 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.1 p -89.93 -21.44 22.47 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -121.11 157.2 30.64 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -87.87 12.01 14.2 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.471 1.129 . . . . 0.0 109.853 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -78.65 -31.35 46.76 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 170.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -82.32 150.03 27.43 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 113.333 -1.758 . . . . 0.0 107.148 173.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -103.58 126.33 50.66 Favored 'General case' 0 C--N 1.281 -2.396 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.625 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.3 m -94.53 120.43 34.75 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.204 -176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.4 ' CD1' HG23 ' A' ' 11' ' ' THR . 23.4 p90 -134.77 158.88 43.02 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.411 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -99.63 -179.3 4.15 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -81.1 133.77 35.53 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.2 27.29 28.52 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.118 176.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -105.97 151.47 24.57 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mm -101.26 124.48 55.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.7 mt -110.02 143.88 19.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -89.33 104.97 17.48 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.447 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.4 tt -71.62 128.23 35.13 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.215 0.531 . . . . 0.0 109.758 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.35 -50.51 9.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.957 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.8 m -144.21 131.24 20.5 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.944 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HG3' HD21 ' A' ' 33' ' ' LEU . 44.5 mtmt -97.98 -22.52 16.25 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.598 0.713 . . . . 0.0 110.476 174.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -109.8 86.44 2.3 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 p -87.4 -18.23 30.48 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.703 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.81 -43.0 1.02 Allowed Glycine 0 C--N 1.28 -2.571 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -120.36 111.14 17.38 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.85 109.25 1.69 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 152.14 -33.0 0.87 Allowed Glycine 0 C--N 1.287 -2.183 0 N-CA-C 107.545 -2.222 . . . . 0.0 107.545 -174.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -100.34 124.6 46.03 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 35.6 m0 -107.86 146.09 32.78 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.21 129.09 55.78 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.22 159.65 27.93 Favored Glycine 0 N--CA 1.41 -3.082 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.2 tm-20 -110.73 130.55 55.54 Favored 'General case' 0 N--CA 1.414 -2.244 0 O-C-N 124.402 0.707 . . . . 0.0 109.358 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.509 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 43.0 tp -144.66 127.42 16.26 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.254 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.509 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 51.9 m-80 65.26 17.98 11.22 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.754 1.221 . . . . 0.0 111.484 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.01 -15.4 55.28 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.36 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 12.1 mptt -100.52 133.54 44.81 Favored 'General case' 0 CA--C 1.489 -1.379 0 CA-C-N 117.013 0.406 . . . . 0.0 110.31 -175.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -111.38 121.61 45.69 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.041 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.22 -170.01 13.93 Favored Glycine 0 C--N 1.287 -2.168 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.1 m -115.22 150.88 17.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 120.796 0.332 . . . . 0.0 110.591 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -156.13 149.06 18.23 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.134 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 34.8 Cg_exo -66.72 136.99 44.11 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.072 1.848 . . . . 0.0 111.398 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -63.2 -13.36 36.59 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.108 0.963 . . . . 0.0 112.743 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -71.91 -10.6 60.01 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.165 0.586 . . . . 0.0 111.922 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -107.61 8.62 29.24 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.666 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.13 154.33 43.79 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.427 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.16 131.6 72.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -76.53 127.54 33.02 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.8 mm -90.51 -49.79 13.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.41 -2.475 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -179.709 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.266 0 N-CA-C 112.81 -0.116 . . . . 0.0 112.81 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.91 81.07 6.97 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.658 0.742 . . . . 0.0 111.684 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.6 ttp -149.96 134.67 17.62 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.1 -164.92 16.87 Favored Glycine 0 C--N 1.297 -1.603 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.37 -34.9 2.44 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.258 0.551 . . . . 0.0 110.296 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -98.12 75.65 2.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.538 0.685 . . . . 0.0 110.414 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -146.69 111.76 5.41 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 172.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -110.8 134.42 52.52 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.594 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.466 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 12.9 p -120.03 146.32 45.99 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-O 121.173 0.511 . . . . 0.0 110.233 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -106.0 134.66 48.77 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.0 p -66.74 140.12 57.85 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 123.823 0.849 . . . . 0.0 110.25 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.5 mt -107.04 -20.22 13.38 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.818 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -153.4 152.27 27.23 Favored Pre-proline 0 C--N 1.316 -0.853 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.28 110.85 3.15 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 121.626 1.551 . . . . 0.0 111.29 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -109.4 131.4 55.1 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.435 ' HA ' HG21 ' A' ' 24' ' ' THR . 24.2 m -110.6 129.6 55.77 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.94 150.28 39.1 Favored Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.0 t -98.74 5.66 47.44 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.734 1.254 . . . . 0.0 108.284 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -156.0 173.25 17.07 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.504 -1.68 . . . . 0.0 106.658 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -79.62 -30.35 41.39 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -174.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.13 -21.77 60.66 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.182 0.992 . . . . 0.0 109.313 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -87.99 110.45 20.6 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.1 135.13 38.57 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.581 0.705 . . . . 0.0 111.6 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.435 HG21 ' HA ' ' A' ' 16' ' ' THR . 94.7 m -98.92 122.54 42.3 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.569 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -133.39 157.77 44.71 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.529 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -109.84 -167.41 1.2 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 122.745 0.418 . . . . 0.0 110.568 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -89.22 141.71 28.29 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.85 29.97 49.61 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.272 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.03 157.53 23.35 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 122.154 -0.615 . . . . 0.0 112.272 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.6 mm -111.73 124.78 68.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.466 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 65.3 mt -114.48 143.62 23.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -89.49 116.01 27.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.5 tt -79.73 118.99 22.04 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 34' ' ' ILE . 61.3 mt -89.52 -47.99 14.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.52 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.1 m -155.88 140.77 17.2 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 122.149 -0.344 . . . . 0.0 110.621 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -90.86 -16.56 28.02 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -106.9 103.03 12.35 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.063 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.0 p -107.18 3.02 25.19 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.784 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.86 -14.91 41.1 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -130.54 116.38 18.08 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.31 118.59 10.21 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.48 -22.76 7.32 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -105.3 122.37 45.81 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.7 m0 -108.18 155.06 20.86 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -110.56 129.85 55.7 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.85 164.23 25.51 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.431 ' HB2' HD13 ' A' ' 34' ' ' ILE . 25.2 tt0 -124.94 123.93 40.95 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.4 tp -125.2 117.45 23.88 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 m120 66.14 21.85 11.12 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.193 0.997 . . . . 0.0 110.82 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.16 -10.02 58.1 Favored Glycine 0 N--CA 1.435 -1.393 0 CA-C-N 115.661 -0.699 . . . . 0.0 113.712 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 3.3 mptp? -97.84 132.3 43.57 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 117.852 0.826 . . . . 0.0 109.405 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.85 148.05 29.0 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 123.673 0.608 . . . . 0.0 111.917 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.49 -172.06 40.81 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.21 156.58 16.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 116.809 0.304 . . . . 0.0 110.809 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -158.35 156.05 26.82 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.114 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -74.48 136.21 21.24 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.116 1.877 . . . . 0.0 110.913 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -61.33 -21.97 64.49 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -174.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -73.16 -4.65 34.13 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -102.45 4.52 38.85 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.933 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.92 164.38 33.92 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.1 p -134.64 140.64 45.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 52.6 tt0 -85.28 133.01 34.17 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.255 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.6 mt -79.3 -67.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 N--CA 1.403 -2.822 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 177.763 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.038 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.455 ' HB1' ' OE2' ' A' ' 7' ' ' GLU . . . 51.85 -163.11 0.07 Allowed 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.466 1.106 . . . . 0.0 111.066 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -102.31 -6.54 22.97 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.396 172.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.79 -131.15 10.31 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 117.06 1.584 . . . . 0.0 117.06 164.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.0 -29.83 3.8 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 116.448 2.018 . . . . 0.0 116.448 -168.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.251 27.3 mtpp -98.85 19.98 13.96 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.455 ' OE2' ' HB1' ' A' ' 2' ' ' ALA . 43.8 mt-10 -99.18 125.95 44.87 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 170.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -120.22 133.5 55.47 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.578 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.558 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 3.4 p -122.3 149.3 43.93 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.993 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.411 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 51.2 ttt180 -118.79 133.92 55.51 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.3 p -74.92 135.66 41.45 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.4 mt -103.01 -17.6 15.36 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -138.44 150.86 67.85 Favored Pre-proline 0 N--CA 1.438 -1.07 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.304 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -76.7 161.03 34.16 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.09 1.86 . . . . 0.0 110.643 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -149.19 124.59 10.27 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.7 m -101.92 124.85 48.24 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.98 134.07 12.52 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.1 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -95.31 -15.16 23.33 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 122.304 1.05 . . . . 0.0 108.493 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -112.38 168.41 9.66 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -86.43 -27.5 24.1 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.729 0.776 . . . . 0.0 109.647 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.86 -28.03 60.5 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.863 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -82.36 116.78 22.0 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.539 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -89.72 143.22 26.98 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.046 0.45 . . . . 0.0 110.481 -169.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.2 m -92.66 128.38 38.5 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.177 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.539 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 98.8 m-85 -129.03 147.08 50.86 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.143 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -104.62 171.61 7.23 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 172.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -78.71 133.95 37.12 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 122.557 0.343 . . . . 0.0 110.871 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.56 16.88 57.93 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.995 -0.621 . . . . 0.0 113.388 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 27.5 mm-40 -92.72 147.38 22.92 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.1 mm -98.72 118.31 45.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.558 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 53.4 mt -99.13 135.22 35.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.075 -175.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -89.65 107.1 18.89 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.402 HD21 ' HG3' ' A' ' 36' ' ' LYS . 8.0 tt -70.5 140.22 51.81 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 121.11 0.481 . . . . 0.0 110.706 -173.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mm -108.72 -44.92 6.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.311 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.3 t -157.44 145.23 18.89 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.519 ' HE3' ' CZ2' ' A' ' 44' ' ' TRP . 51.1 mtpt -102.86 1.23 33.71 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-O 121.746 0.784 . . . . 0.0 109.645 175.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -121.63 115.76 23.34 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.609 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -124.63 3.76 8.25 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.806 0.812 . . . . 0.0 109.847 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.23 -21.62 39.04 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -114.8 135.46 54.16 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.764 -0.718 . . . . 0.0 109.195 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.65 99.8 11.54 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 134.25 -14.2 4.57 Favored Glycine 0 N--CA 1.421 -2.327 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.187 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -107.45 125.74 51.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.287 0.565 . . . . 0.0 110.329 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.519 ' CZ2' ' HE3' ' A' ' 36' ' ' LYS . 43.3 m0 -113.71 164.9 13.11 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.235 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -118.31 129.97 55.76 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.54 158.02 27.4 Favored Glycine 0 N--CA 1.421 -2.358 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 1.1 tm-20 -112.1 131.52 55.39 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 123.239 0.616 . . . . 0.0 109.831 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 51.0 tp -144.56 132.62 21.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 68.76 13.79 8.91 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.407 1.083 . . . . 0.0 111.838 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.14 9.47 56.99 Favored Glycine 0 N--CA 1.427 -1.903 0 C-N-CA 121.151 -0.547 . . . . 0.0 111.776 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -123.75 126.75 47.07 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.073 0.463 . . . . 0.0 110.849 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -99.69 125.87 45.63 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.297 177.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.26 -172.47 17.48 Favored Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.3 m -115.13 158.19 15.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 117.215 0.507 . . . . 0.0 110.871 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -162.03 156.46 19.01 Favored Pre-proline 0 C--N 1.319 -0.726 0 O-C-N 124.004 0.815 . . . . 0.0 109.595 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 6.6 Cg_exo -75.8 127.58 10.25 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.206 1.937 . . . . 0.0 109.428 172.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -65.6 -17.54 64.66 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.627 0.371 . . . . 0.0 111.941 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -65.7 -14.03 60.45 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -87.32 -2.9 58.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.179 0.514 . . . . 0.0 110.818 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.94 177.82 7.61 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.431 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.49 135.54 43.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -81.65 129.48 34.71 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.85 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.2 mm -77.38 -68.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.399 -3.004 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.341 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.691 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.47 79.94 1.76 Allowed 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 121.063 0.458 . . . . 0.0 110.488 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 mmt -101.91 152.01 21.43 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.951 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.2 148.28 18.5 Favored Glycine 0 N--CA 1.419 -2.445 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.969 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.42 -55.1 1.02 Allowed 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.7 16.52 13.75 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.357 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.462 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 9.3 mm-40 -90.54 108.19 19.64 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -175.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -121.85 138.85 54.23 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.581 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 8.0 p -125.47 142.25 51.61 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.75 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -101.61 135.79 42.53 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 64.2 p -77.5 128.63 34.51 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-O 121.258 0.551 . . . . 0.0 111.65 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.1 mt -98.9 -18.14 18.02 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.138 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -142.52 143.95 28.59 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -74.24 141.75 29.51 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.9 1.733 . . . . 0.0 109.853 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -137.37 128.43 27.6 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.455 ' HA ' HG21 ' A' ' 24' ' ' THR . 24.3 m -100.84 118.0 36.03 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.702 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.7 125.71 17.07 Favored Glycine 0 N--CA 1.427 -1.957 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.3 p -82.26 -20.51 37.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.746 1.26 . . . . 0.0 108.633 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.409 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 44.0 m-80 -115.42 161.9 17.9 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.99 -19.81 29.81 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.582 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -79.91 -3.39 47.88 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.3 1.047 . . . . 0.0 108.9 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 36.7 tt0 -107.19 126.12 51.99 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -86.8 135.13 33.46 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.571 -167.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.455 HG21 ' HA ' ' A' ' 16' ' ' THR . 90.0 m -100.3 119.85 39.04 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.29 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -134.85 151.92 51.31 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.738 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -99.71 179.49 4.52 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 173.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.3 139.85 36.43 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.63 10.34 55.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.222 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -95.49 156.8 16.17 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 122.589 -0.359 . . . . 0.0 110.256 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.9 mm -110.33 116.25 51.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.581 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 62.5 mt -101.75 131.51 49.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -90.77 102.67 15.42 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 6.0 tt -69.03 134.47 49.47 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.656 -173.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.0 mm -101.2 -51.2 9.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.411 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.9 m -146.62 141.64 27.11 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.739 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -91.58 -22.65 20.21 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 172.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -101.78 112.57 25.21 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.462 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.8 p -106.39 2.23 26.33 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.92 0.867 . . . . 0.0 109.069 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.45 -44.1 1.54 Allowed Glycine 0 N--CA 1.427 -1.925 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -99.02 134.24 42.15 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.85 102.11 7.09 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.54 -27.34 1.66 Allowed Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -99.06 128.7 45.24 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 24.5 m0 -108.06 159.92 16.2 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 53.0 tttm -128.32 128.37 44.47 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -150.12 160.08 28.38 Favored Glycine 0 N--CA 1.425 -2.094 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -175.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.19 127.12 53.23 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 68.7 tp -133.22 111.14 10.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.7 179.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.5 m120 63.82 18.94 11.48 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 124.712 1.205 . . . . 0.0 113.099 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.81 -25.24 5.9 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.136 -1.03 . . . . 0.0 113.846 177.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -106.09 142.32 35.98 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 117.697 0.748 . . . . 0.0 110.888 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 14.1 pt-20 -118.76 114.22 22.34 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -132.46 -166.85 11.64 Favored Glycine 0 N--CA 1.42 -2.383 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.66 153.16 16.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -161.73 147.74 10.84 Favored Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 123.88 0.737 . . . . 0.0 109.482 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.43 134.88 29.79 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 121.833 1.688 . . . . 0.0 109.937 174.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.26 1.43 2.91 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -76.37 -22.31 54.99 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 122.942 0.497 . . . . 0.0 110.635 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -91.38 2.09 56.65 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -174.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.12 171.29 15.55 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 122.363 -0.21 . . . . 0.0 110.529 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.47 132.04 40.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -70.18 117.34 11.62 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.031 0.443 . . . . 0.0 110.736 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.6 mt -67.81 -50.16 62.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.426 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 N--CA 1.411 -2.405 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.914 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.38 127.17 6.15 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 mmt -114.43 21.74 14.32 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.008 0.432 . . . . 0.0 110.541 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 33' ' ' LEU . . . 67.81 52.07 31.33 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.215 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.99 -78.45 0.21 Allowed 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -149.78 78.05 1.34 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.371 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -135.57 121.92 20.47 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -121.45 144.48 48.66 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.593 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.5 p -131.12 150.49 52.12 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.526 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -110.14 133.99 52.65 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -75.92 125.99 30.15 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-O 121.011 0.434 . . . . 0.0 111.313 175.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.1 mt -96.41 -9.58 29.57 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.936 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -142.27 141.14 20.37 Favored Pre-proline 0 N--CA 1.431 -1.379 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.708 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.33 132.1 18.75 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.065 1.843 . . . . 0.0 109.648 171.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.517 ' O ' ' HA ' ' A' ' 24' ' ' THR . 87.1 t80 -124.94 122.28 36.88 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.0 m -101.44 120.54 40.44 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.34 143.28 38.82 Favored Glycine 0 N--CA 1.423 -2.192 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.276 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 p -85.18 -33.63 22.25 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 122.605 1.193 . . . . 0.0 108.309 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 40.8 m-80 -103.67 158.4 16.4 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 173.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.39 5.67 49.81 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.737 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.94 -20.23 42.5 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 170.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 19' ' ' ASN . 17.6 mt-10 -81.61 159.3 24.07 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 113.548 -1.66 . . . . 0.0 106.992 171.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -121.06 136.32 55.01 Favored 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 118.932 -1.107 . . . . 0.0 108.593 -178.75 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 88.7 m -89.53 121.04 31.36 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.304 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 89.1 m-85 -121.91 159.16 27.44 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.561 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -117.29 165.59 13.28 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.39 125.33 23.38 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 123.416 0.686 . . . . 0.0 110.028 174.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.97 13.06 57.03 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.512 -0.851 . . . . 0.0 114.028 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -92.41 144.68 25.12 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.8 mm -99.07 123.96 52.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.593 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 50.6 mt -106.93 135.28 45.97 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.588 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -89.86 117.75 28.93 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 171.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.422 ' O ' ' HA2' ' A' ' 4' ' ' GLY . 6.4 tt -73.94 119.82 18.67 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.749 -175.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.1 mm -92.82 -40.35 11.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.392 -176.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.6 t -161.17 144.48 12.86 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.043 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.419 ' HG3' HD21 ' A' ' 33' ' ' LEU . 94.6 mttt -100.46 4.21 43.54 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -120.84 102.39 8.34 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.456 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.2 p -115.96 7.44 14.38 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.38 -17.44 53.59 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 108.671 -1.771 . . . . 0.0 108.671 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -121.62 151.04 40.84 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.885 -0.657 . . . . 0.0 110.253 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.42 99.29 9.33 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.26 -38.9 1.01 Allowed Glycine 0 CA--C 1.49 -1.476 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -176.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -95.79 119.9 35.11 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -109.08 159.18 17.07 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -108.22 129.84 55.18 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.42 159.4 25.26 Favored Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.37 135.29 54.08 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.001 0.429 . . . . 0.0 110.654 -177.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.4 tp -138.88 122.31 17.22 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 124.039 0.935 . . . . 0.0 108.882 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.8 m120 68.87 11.56 8.38 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.307 1.043 . . . . 0.0 112.513 175.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.56 -8.17 43.47 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 3.5 mptp? -102.76 130.93 49.88 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -120.9 135.05 55.28 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-O 121.333 0.587 . . . . 0.0 111.183 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -153.22 -167.22 15.41 Favored Glycine 0 N--CA 1.416 -2.692 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.3 m -115.32 153.51 16.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 120.772 0.32 . . . . 0.0 111.091 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -157.12 150.95 19.33 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.49 136.74 19.79 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 121.559 1.506 . . . . 0.0 109.758 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.66 -16.19 62.44 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.068 0.461 . . . . 0.0 110.795 -176.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -53.39 -29.27 33.8 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 124.481 1.113 . . . . 0.0 111.687 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -94.02 -1.1 55.0 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.32 148.54 36.45 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -174.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.67 134.0 61.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -78.81 128.15 32.99 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.113 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.42 -58.25 3.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.404 -2.754 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 177.654 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.541 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.62 157.49 3.17 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -130.9 16.63 5.18 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.513 0.673 . . . . 0.0 111.881 -171.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.94 141.66 8.47 Favored Glycine 0 N--CA 1.414 -2.822 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.09 -33.54 59.51 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -110.98 76.37 0.97 Allowed 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.062 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -107.78 124.62 50.31 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 172.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -114.17 138.98 49.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.519 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 7.8 p -122.56 133.17 54.57 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.904 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -99.69 135.21 41.44 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.8 p -81.05 129.3 34.48 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.258 0.552 . . . . 0.0 111.135 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.1 mt -97.69 -16.65 19.85 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.571 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -142.84 153.27 60.82 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -81.79 142.59 12.76 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.927 1.751 . . . . 0.0 110.079 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -126.89 130.48 50.24 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.486 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.402 ' HA ' HG21 ' A' ' 24' ' ' THR . 49.7 m -100.32 113.38 26.05 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.16 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.97 145.37 29.71 Favored Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 176.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.9 p -92.19 -35.53 13.78 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.01 0.91 . . . . 0.0 108.701 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -107.28 -179.04 3.81 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.737 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -93.93 8.27 41.93 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.905 0.86 . . . . 0.0 109.472 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -91.22 -32.15 15.89 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.93 156.27 32.16 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.874 172.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.0 tt -102.44 115.18 30.04 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.402 HG21 ' HA ' ' A' ' 16' ' ' THR . 63.8 m -83.59 120.04 25.47 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -134.36 161.83 33.89 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -96.66 170.04 9.47 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -82.99 137.08 34.29 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.55 26.15 21.24 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.481 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -102.65 148.81 25.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mm -105.27 112.5 39.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.519 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 58.9 mt -100.94 139.0 23.3 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -88.24 106.75 18.41 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.461 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.5 tt -68.66 122.64 18.94 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.491 -174.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.7 mt -97.42 -44.71 12.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.378 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.0 m -150.12 138.86 20.8 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.795 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.461 ' HG3' HD21 ' A' ' 33' ' ' LEU . 50.3 mtmt -97.75 5.14 49.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.4 118.81 32.15 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 113.638 -1.619 . . . . 0.0 108.656 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.9 p -133.57 -0.29 3.22 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.37 0.605 . . . . 0.0 110.273 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.25 -41.41 2.14 Favored Glycine 0 C--N 1.306 -1.126 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -174.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -97.79 116.45 30.03 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.39 114.05 6.49 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 128.3 -17.71 5.88 Favored Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -174.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -113.94 128.96 56.62 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.847 0.356 . . . . 0.0 111.118 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.402 ' CE2' ' HG2' ' A' ' 36' ' ' LYS . 34.0 m0 -108.87 169.67 8.53 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 58.9 tttm -137.54 128.92 28.04 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -152.49 173.07 31.61 Favored Glycine 0 C--N 1.297 -1.605 0 C-N-CA 120.285 -0.96 . . . . 0.0 112.121 -175.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -108.91 134.22 51.88 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 123.67 0.788 . . . . 0.0 109.814 -178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.7 tp -153.47 129.71 10.47 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 64.3 20.03 12.01 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.714 0.806 . . . . 0.0 112.403 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.46 3.66 64.67 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 116.13 -0.487 . . . . 0.0 113.039 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -117.4 150.67 38.48 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -121.87 140.81 51.94 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -160.54 -169.31 23.65 Favored Glycine 0 C--N 1.288 -2.086 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.53 152.14 16.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.064 0.459 . . . . 0.0 110.307 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -157.45 148.68 16.69 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.283 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.484 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 20.3 Cg_exo -65.69 125.89 15.11 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.487 1.458 . . . . 0.0 109.245 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -61.29 -18.68 59.67 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -171.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -72.57 -14.36 61.61 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.936 0.335 . . . . 0.0 111.239 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -80.35 -14.74 58.1 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.597 0.237 . . . . 0.0 111.192 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.06 166.55 20.81 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.57 142.3 35.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -70.3 140.87 52.38 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.9 pt -91.17 -42.14 13.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-O 121.255 0.55 . . . . 0.0 111.316 -173.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.411 -2.377 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.555 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.298 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.37 63.83 2.03 Favored 'General case' 0 C--O 1.246 0.891 0 C-N-CA 124.263 1.025 . . . . 0.0 112.309 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 44.2 tpp -145.98 106.77 4.11 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.049 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.98 61.92 1.55 Allowed Glycine 0 C--N 1.312 -0.767 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.638 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -169.49 174.01 6.16 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -118.35 93.7 4.22 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-O 121.625 0.726 . . . . 0.0 109.307 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 35.8 mt-10 -101.89 142.16 33.63 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 120.146 -0.621 . . . . 0.0 109.352 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -128.45 137.96 52.07 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.97 0.414 . . . . 0.0 110.138 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.426 ' SG ' HD13 ' A' ' 33' ' ' LEU . 59.8 m -124.47 153.81 41.44 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.986 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -117.46 132.17 56.61 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 p -72.46 128.51 35.82 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 120.811 0.339 . . . . 0.0 111.235 178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.8 mt -89.16 -18.03 27.98 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.99 157.21 64.54 Favored Pre-proline 0 C--N 1.309 -1.181 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.43 138.63 15.77 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.297 1.332 . . . . 0.0 109.462 173.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 24' ' ' THR . 68.8 t80 -122.6 117.94 27.02 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.792 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 m -109.98 127.54 54.85 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.91 153.37 28.14 Favored Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.57 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -98.15 -20.71 17.15 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -105.16 166.57 10.31 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -82.72 -9.58 59.29 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.654 0.74 . . . . 0.0 109.538 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -78.32 -30.05 48.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.699 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -78.86 151.49 31.8 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.181 173.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.44 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -112.91 139.2 48.75 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 96.2 m -95.13 120.67 35.75 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.668 0.747 . . . . 0.0 111.121 -177.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.44 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 91.7 m-85 -122.55 147.17 46.7 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.829 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -90.29 172.55 8.69 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 176.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -75.41 129.94 38.15 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.3 39.03 20.2 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.793 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -117.97 154.9 31.18 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.0 mm -96.21 128.61 47.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 O-C-N 123.556 0.535 . . . . 0.0 109.994 -175.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 52.7 mt -112.23 134.54 54.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -90.04 110.23 21.23 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 171.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.5 tt -74.45 123.84 25.46 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mm -96.94 -43.66 12.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.387 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.9 m -156.39 135.23 11.81 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.267 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -85.54 -27.01 25.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 170.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -95.35 102.71 14.54 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.639 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.3 p -109.2 -0.91 19.03 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.802 0.811 . . . . 0.0 109.98 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.12 -41.25 1.58 Allowed Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 107.746 -2.141 . . . . 0.0 107.746 -173.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -115.32 166.32 11.99 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.436 -0.882 . . . . 0.0 109.639 175.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.81 149.13 23.69 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 171.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 100.38 -25.86 26.71 Favored Glycine 0 C--N 1.301 -1.39 0 C-N-CA 120.369 -0.919 . . . . 0.0 110.88 -176.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -111.56 116.9 31.61 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -108.89 157.26 18.79 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.577 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -105.06 130.02 53.35 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.34 147.55 19.26 Favored Glycine 0 N--CA 1.417 -2.569 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.96 136.28 44.74 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.459 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 27.4 tp -145.47 128.19 16.24 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.459 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 38.3 m-80 62.91 20.31 12.14 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.938 0.895 . . . . 0.0 112.067 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.42 -3.42 75.55 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.321 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -102.41 133.71 46.92 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.34 120.85 43.13 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -136.67 -172.09 12.45 Favored Glycine 0 C--N 1.286 -2.216 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.76 151.13 16.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.162 0.506 . . . . 0.0 110.848 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -151.4 150.86 27.86 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.586 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.3 Cg_exo -76.75 135.92 16.43 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 121.872 1.715 . . . . 0.0 110.748 175.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -64.72 -14.87 60.35 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.893 0.377 . . . . 0.0 111.432 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -63.42 -19.87 65.06 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.436 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -98.78 0.86 45.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -144.52 167.85 21.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.173 0.511 . . . . 0.0 111.759 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.3 p -132.88 139.17 50.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -83.18 128.34 34.4 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.8 pt -101.77 -30.71 3.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.058 0.456 . . . . 0.0 110.719 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.416 -2.17 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.717 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.891 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.99 -28.89 16.91 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.4 ttm -166.85 89.99 0.37 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -128.89 -38.1 0.37 Allowed Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 119.703 -1.237 . . . . 0.0 112.298 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.03 25.74 4.25 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.4 mptt 66.55 97.56 0.05 Allowed 'General case' 0 C--O 1.246 0.916 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.493 -173.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 3.4 mm-40 -91.58 137.12 32.62 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -174.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -130.96 138.22 49.61 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.1 p -123.57 138.85 54.48 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 65.3 ttt180 -107.86 134.26 51.05 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.406 HG23 ' CD1' ' A' ' 25' ' ' PHE . 45.4 p -77.81 133.97 38.1 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-O 121.504 0.669 . . . . 0.0 111.59 -176.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.22 -7.77 24.31 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.783 0.801 . . . . 0.0 109.515 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -147.17 156.03 46.7 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -85.59 155.63 10.48 Favored 'Trans proline' 0 N--CA 1.436 -1.876 0 C-N-CA 121.852 1.702 . . . . 0.0 109.008 170.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -149.19 129.61 13.86 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.464 ' HA ' HG21 ' A' ' 24' ' ' THR . 19.0 m -115.69 125.81 53.31 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.048 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.93 151.84 24.18 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.0 t -94.73 1.52 55.48 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 122.629 1.204 . . . . 0.0 108.256 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -141.69 165.16 28.23 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.67 -6.73 58.11 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -83.27 -24.28 32.32 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 122.168 0.985 . . . . 0.0 109.103 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -94.44 131.09 40.49 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -87.41 129.39 35.06 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.972 0.891 . . . . 0.0 112.512 -169.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.464 HG21 ' HA ' ' A' ' 16' ' ' THR . 91.1 m -97.1 121.37 38.91 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.205 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.406 ' CD1' HG23 ' A' ' 11' ' ' THR . 10.5 p90 -133.69 160.09 38.6 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.045 0.45 . . . . 0.0 112.175 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -94.23 171.32 8.9 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.62 145.66 31.58 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.33 16.23 78.61 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.419 -0.42 . . . . 0.0 113.263 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 8.9 tp10 -97.98 148.29 23.63 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.849 0.357 . . . . 0.0 110.732 -175.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.3 mm -96.86 121.17 47.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.4 mt -113.84 140.85 32.21 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -89.43 121.9 32.11 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.483 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.0 tt -79.01 133.2 36.83 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -174.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 36.4 mt -106.84 -44.0 7.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-O 121.128 0.489 . . . . 0.0 110.232 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -150.17 130.77 13.97 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 121.973 -0.455 . . . . 0.0 111.839 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -88.36 -23.71 23.31 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -97.87 109.5 22.24 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.556 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.7 p -111.61 -5.64 14.48 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.776 0.798 . . . . 0.0 110.126 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.94 -17.16 30.09 Favored Glycine 0 C--N 1.309 -0.967 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -128.36 128.94 45.49 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.39 115.04 16.83 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.66 -15.59 6.29 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -110.34 124.1 51.07 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -108.77 155.51 20.68 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.775 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 38.3 ttmt -117.2 129.46 55.96 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.61 173.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.64 168.13 26.0 Favored Glycine 0 N--CA 1.416 -2.68 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 1.8 tm-20 -115.34 129.9 56.74 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.097 0.475 . . . . 0.0 110.365 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.8 tp -156.64 138.82 14.62 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 73.02 12.24 5.07 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.659 1.184 . . . . 0.0 110.921 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.44 14.76 59.58 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 27.3 mmmt -126.06 154.98 42.26 Favored 'General case' 0 CA--C 1.468 -2.21 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -175.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.29 126.23 34.85 Favored 'General case' 0 C--N 1.257 -3.427 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.117 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -156.75 -161.66 10.92 Favored Glycine 0 CA--C 1.469 -2.832 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -176.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.5 147.51 17.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.793 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -150.51 154.87 36.07 Favored Pre-proline 0 N--CA 1.426 -1.626 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.679 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.06 128.05 13.51 Favored 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 122.14 1.893 . . . . 0.0 111.372 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.26 -19.38 64.5 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.031 0.933 . . . . 0.0 112.264 -175.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.39 -4.78 44.13 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -102.31 -0.33 33.0 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 121.127 0.489 . . . . 0.0 112.104 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -141.42 155.58 45.87 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.209 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 p -120.75 139.3 48.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.434 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 50.0 tt0 -79.83 122.06 26.17 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.679 0.752 . . . . 0.0 111.613 -177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.6 mm -93.7 -31.06 4.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.541 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.42 -1.967 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 -178.691 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.04 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.15 106.31 17.54 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.0 -8.42 55.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.601 0.715 . . . . 0.0 111.823 -175.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.98 148.92 20.82 Favored Glycine 0 N--CA 1.412 -2.947 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.59 11.09 15.75 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.013 0.435 . . . . 0.0 110.326 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -137.34 37.18 2.5 Favored 'General case' 0 C--O 1.252 1.222 0 CA-C-O 122.199 1.0 . . . . 0.0 109.183 -178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -94.69 131.26 40.68 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.492 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -113.11 153.19 28.62 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.591 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.6 p -133.99 138.36 45.38 Favored 'General case' 0 C--N 1.267 -2.983 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.205 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -99.7 138.23 37.08 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 42.4 p -63.09 142.93 58.19 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 124.332 1.053 . . . . 0.0 110.406 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.7 mt -113.08 -18.78 12.08 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.322 0.582 . . . . 0.0 110.165 175.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -149.4 147.66 23.96 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.38 123.64 8.84 Favored 'Trans proline' 0 C--O 1.253 1.264 0 C-N-CA 122.052 1.835 . . . . 0.0 110.51 173.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -129.98 134.0 47.16 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.429 ' HA ' HG22 ' A' ' 24' ' ' THR . 46.8 m -116.28 131.69 56.87 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 120.933 0.397 . . . . 0.0 110.544 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.04 134.68 11.86 Favored Glycine 0 N--CA 1.413 -2.887 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.5 p -91.15 -34.71 14.92 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -79.27 145.93 33.26 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 113.377 -1.738 . . . . 0.0 108.692 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.41 -35.86 80.55 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.775 0.672 . . . . 0.0 110.631 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.417 ' O ' HG21 ' A' ' 54' ' ' VAL . 31.0 t70 -86.42 4.96 37.29 Favored 'General case' 0 C--O 1.203 -1.371 0 CA-C-O 121.62 0.724 . . . . 0.0 110.213 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -104.35 134.7 47.11 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.19 135.42 33.8 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.73 0.3 . . . . 0.0 111.564 -170.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 16' ' ' THR . 94.1 m -103.24 120.06 40.04 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -135.02 154.42 51.73 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -104.94 -176.69 3.15 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.94 122.96 35.84 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 176.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.39 8.73 8.29 Favored Glycine 0 C--N 1.294 -1.796 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.244 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -110.41 154.33 23.72 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.1 mm -108.13 122.48 62.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.114 0.483 . . . . 0.0 109.762 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.591 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 58.6 mt -105.79 130.15 57.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.95 127.51 36.04 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.99 121.75 20.62 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mm -100.59 -41.33 8.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.603 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.4 m -151.68 139.55 19.94 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.272 -0.268 . . . . 0.0 111.524 -179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -103.4 -14.32 16.31 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.89 0.476 . . . . 0.0 110.366 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -110.47 97.42 6.87 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-O 121.986 0.898 . . . . 0.0 109.375 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 p -105.18 0.5 27.38 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.058 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.52 -25.83 18.3 Favored Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -174.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -117.78 174.73 6.01 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.885 -0.657 . . . . 0.0 109.557 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.39 141.28 37.18 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.73 -30.23 5.47 Favored Glycine 0 C--N 1.312 -0.774 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.411 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -81.98 115.35 21.1 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.135 0.493 . . . . 0.0 110.166 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.469 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 44.9 m0 -108.57 154.19 22.31 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.897 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -116.29 129.64 56.38 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.07 176.51 23.3 Favored Glycine 0 N--CA 1.413 -2.876 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -123.04 133.87 54.31 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.3 tp -149.97 139.7 21.74 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.429 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.8 m120 67.66 10.07 7.51 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.794 1.237 . . . . 0.0 111.35 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.47 -2.97 49.97 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.21 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.38 138.43 51.36 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 122.375 -0.485 . . . . 0.0 110.203 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -93.5 144.06 25.71 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -160.36 177.93 36.6 Favored Glycine 0 N--CA 1.413 -2.836 0 C-N-CA 119.851 -1.166 . . . . 0.0 111.186 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 34.3 m -114.51 152.01 16.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -160.19 147.69 12.69 Favored Pre-proline 0 N--CA 1.419 -1.983 0 O-C-N 124.184 0.928 . . . . 0.0 108.824 -177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -69.05 129.31 18.11 Favored 'Trans proline' 0 C--O 1.251 1.159 0 C-N-CA 121.736 1.624 . . . . 0.0 108.954 172.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -57.83 -20.7 37.96 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 123.974 0.91 . . . . 0.0 113.091 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -69.04 -13.21 62.31 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -91.69 2.46 56.46 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.256 0.55 . . . . 0.0 111.315 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -140.37 169.86 16.89 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.541 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 p -128.93 122.2 56.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -73.07 121.59 20.43 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.5 pt -85.77 -6.81 10.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -173.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 C--N 1.298 -1.663 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.559 174.837 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.823 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.95 -32.49 5.74 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 122.968 0.507 . . . . 0.0 110.218 -176.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 93.1 mmm -102.19 6.39 40.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.149 0.5 . . . . 0.0 110.157 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.2 -168.17 30.17 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -110.32 18.14 20.17 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.477 0.656 . . . . 0.0 110.318 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -120.67 25.0 10.0 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.006 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 64' ' ' SER . 44.7 mt-10 -93.8 123.0 36.86 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.897 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -139.93 151.1 45.3 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 121.4 0.619 . . . . 0.0 111.233 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.6 p -130.19 153.38 48.62 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.051 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.51 HH11 ' HA2' ' A' ' 28' ' ' GLY . 59.5 ttp85 -113.41 134.41 54.66 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.6 p -79.36 131.56 36.15 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.01 -177.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.5 mt -95.18 -12.07 27.0 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.672 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -133.17 149.86 73.82 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.632 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -85.98 120.65 1.97 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.282 1.988 . . . . 0.0 108.925 168.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 89.1 t80 -146.45 123.11 11.17 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.381 0.61 . . . . 0.0 111.328 -173.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.496 ' HA ' HG22 ' A' ' 24' ' ' THR . 87.9 m -91.93 135.33 34.03 Favored 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.87 125.8 33.33 Favored Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -36.75 67.24 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -101.19 148.08 25.51 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 112.791 -2.004 . . . . 0.0 105.956 176.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -15.54 57.17 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.138 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -73.66 -20.51 60.54 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.722 172.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -89.06 143.31 26.94 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 tt -84.7 125.11 32.23 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.093 0.473 . . . . 0.0 111.132 -171.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.496 HG22 ' HA ' ' A' ' 16' ' ' THR . 91.1 m -87.65 121.02 29.54 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.039 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 15' ' ' TYR . 36.1 p90 -133.89 161.43 34.79 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.246 0.546 . . . . 0.0 111.945 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -112.99 173.64 6.28 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -78.69 123.86 27.59 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.51 ' HA2' HH11 ' A' ' 10' ' ' ARG . . . 102.09 13.48 31.25 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.525 -0.845 . . . . 0.0 114.16 177.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -93.58 143.98 25.8 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 117.079 0.44 . . . . 0.0 110.165 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.9 mm -99.33 113.04 33.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.9 mt -107.43 134.06 50.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -88.58 127.88 35.56 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.401 HD21 ' HG3' ' A' ' 36' ' ' LYS . 3.8 tt -74.15 126.26 30.18 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.055 -174.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.413 HD12 ' HB2' ' A' ' 47' ' ' GLU . 59.7 mt -101.39 -52.81 8.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.3 m -143.26 128.54 18.81 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.697 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.401 ' HG3' HD21 ' A' ' 33' ' ' LEU . 58.2 mtpt -85.5 -33.41 21.81 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -97.68 108.19 20.85 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.575 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.1 p -119.33 6.43 11.17 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.435 0.636 . . . . 0.0 110.635 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.06 -22.15 7.65 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -141.28 139.31 33.65 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.16 89.63 7.34 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.42 -30.74 0.16 Allowed Glycine 0 CA--C 1.483 -1.914 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -176.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -99.69 121.88 41.88 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.473 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 25.8 m0 -107.94 141.64 39.26 Favored 'General case' 0 C--N 1.273 -2.737 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 23.0 ttmm -102.54 129.47 49.09 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 175.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.94 175.16 25.58 Favored Glycine 0 N--CA 1.417 -2.619 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.413 ' HB2' HD12 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -123.95 129.69 51.36 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.187 0.494 . . . . 0.0 109.79 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.429 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 47.4 tp -137.96 119.6 15.05 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.959 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.429 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 59.3 m-80 64.82 21.6 12.39 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.742 1.217 . . . . 0.0 112.543 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.74 -11.58 49.78 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.728 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -103.57 134.82 46.27 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 116.884 0.342 . . . . 0.0 110.48 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -112.39 141.48 46.07 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -167.16 -165.19 24.15 Favored Glycine 0 CA--C 1.467 -2.946 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 26.0 m -114.4 147.03 18.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 120.99 0.424 . . . . 0.0 110.56 -178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -147.95 150.6 36.12 Favored Pre-proline 0 C--N 1.296 -1.738 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.201 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -71.58 136.77 29.0 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 121.798 1.665 . . . . 0.0 112.202 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -69.02 -8.16 42.34 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.659 0.784 . . . . 0.0 112.488 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -96.49 0.22 49.96 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 120.817 0.341 . . . . 0.0 111.487 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -99.92 -11.43 20.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.197 0.522 . . . . 0.0 110.996 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.12 145.08 41.2 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.598 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.02 125.76 66.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -68.99 121.52 16.79 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.476 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.4 mm -85.34 -45.79 17.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 43.9 m . . . . . 0 N--CA 1.41 -2.467 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.77 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.78 92.4 1.11 Allowed 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.33 142.18 5.67 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.376 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.16 -72.58 1.0 Allowed Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.18 -73.23 0.15 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.332 0.587 . . . . 0.0 110.344 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -114.64 94.14 4.64 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 64' ' ' SER . 4.7 mm-40 -104.03 127.33 51.58 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.642 -171.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -146.24 144.67 30.03 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.995 0.426 . . . . 0.0 111.187 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.45 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 8.0 p -126.71 147.85 49.92 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.655 -172.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -101.9 136.0 42.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.0 p -69.17 139.47 54.62 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.66 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.0 mt -107.75 -18.87 13.71 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.482 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -147.37 151.05 39.31 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.18 141.12 23.02 Favored 'Trans proline' 0 C--O 1.25 1.101 0 C-N-CA 121.977 1.784 . . . . 0.0 111.091 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -147.41 139.14 24.09 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.1 m -112.79 131.34 55.73 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 120.978 0.418 . . . . 0.0 110.622 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.76 119.9 5.22 Favored Glycine 0 N--CA 1.409 -3.139 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.9 m -82.08 -28.62 32.26 Favored 'General case' 0 N--CA 1.383 -3.807 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -94.31 165.93 12.34 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.788 -1.551 . . . . 0.0 107.85 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -26.62 33.07 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-O 121.425 0.631 . . . . 0.0 109.856 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -92.61 9.75 33.39 Favored 'General case' 0 C--O 1.212 -0.886 0 CA-C-O 121.643 0.735 . . . . 0.0 110.712 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -109.85 131.43 55.07 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.19 130.97 35.52 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.513 -169.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.3 m -93.79 119.7 33.09 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -134.39 145.63 49.12 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.321 0.581 . . . . 0.0 112.366 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -96.47 161.69 13.8 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.391 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.64 123.13 24.3 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.39 11.41 21.8 Favored Glycine 0 C--N 1.294 -1.772 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -100.06 152.74 19.87 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-O 120.93 0.395 . . . . 0.0 110.625 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.3 mm -109.35 111.82 37.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.45 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 67.8 mt -96.42 135.54 30.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -88.31 117.49 27.27 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.3 tt -76.78 124.7 28.08 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.412 ' C ' ' HG ' ' A' ' 35' ' ' SER . 48.8 mm -94.35 -50.15 12.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.258 -178.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 34' ' ' ILE . 52.5 m -156.3 133.24 10.45 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.083 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -84.45 -16.5 42.36 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.882 0.848 . . . . 0.0 108.972 172.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -98.03 99.21 10.47 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.257 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.4 p -105.98 -3.38 21.76 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.89 0.852 . . . . 0.0 109.836 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.96 -42.46 1.49 Allowed Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -176.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -121.61 128.09 51.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.18 121.32 14.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.489 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.95 -25.58 4.12 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -106.57 123.53 48.24 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 177.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.432 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 43.6 m0 -108.7 153.4 23.5 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -114.82 129.45 56.7 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -141.49 160.74 26.95 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.8 125.17 50.07 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.9 tp -147.62 119.01 7.86 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.459 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 72.12 21.81 3.85 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.193 0.997 . . . . 0.0 113.036 174.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.37 0.29 35.1 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.664 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 8.5 mptt -127.22 132.66 50.37 Favored 'General case' 0 CA--C 1.488 -1.423 0 O-C-N 122.419 -0.459 . . . . 0.0 110.073 -177.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.453 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 10.5 pt-20 -107.65 95.85 5.98 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 122.502 1.144 . . . . 0.0 109.433 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.94 -175.45 18.98 Favored Glycine 0 C--N 1.274 -2.9 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.495 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 33.0 m -114.14 152.56 15.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -152.89 155.43 32.2 Favored Pre-proline 0 N--CA 1.418 -2.041 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.662 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.28 134.46 12.78 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.746 1.631 . . . . 0.0 111.284 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -44.86 -37.34 3.82 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 125.458 1.503 . . . . 0.0 113.21 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -63.09 -16.97 61.71 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -96.24 1.56 52.23 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.86 170.38 16.0 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.038 0.446 . . . . 0.0 111.696 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.22 131.42 40.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -83.32 125.69 31.9 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.194 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.1 mm -89.95 -52.5 10.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.562 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 23.2 t . . . . . 0 N--CA 1.413 -2.305 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.98 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.06 80.13 7.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 117.232 0.516 . . . . 0.0 110.63 -177.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 40.5 tpp -114.94 97.09 6.03 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.51 -58.96 0.8 Allowed Glycine 0 N--CA 1.425 -2.089 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.577 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.43 -171.98 3.9 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -92.48 91.57 7.68 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -101.68 147.76 26.06 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.565 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -124.8 139.37 53.91 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.587 0.708 . . . . 0.0 110.597 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.691 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 5.6 p -129.59 162.28 28.61 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 29.8 ttp180 -121.11 145.8 47.42 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.419 HG23 ' HB3' ' A' ' 25' ' ' PHE . 72.0 p -71.31 141.41 50.48 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.794 0.683 . . . . 0.0 109.631 177.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -105.13 -18.79 14.03 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -141.71 156.29 66.17 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -177.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -76.73 120.9 5.68 Favored 'Trans proline' 0 N--CA 1.429 -2.275 0 N-CA-C 108.065 -1.552 . . . . 0.0 108.065 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -111.4 115.37 29.14 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.0 m -98.38 111.3 23.69 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.715 -176.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.43 135.63 18.73 Favored Glycine 0 N--CA 1.425 -2.05 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 176.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -113.6 5.55 16.6 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -127.15 156.24 42.1 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.54 -1.664 . . . . 0.0 107.324 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.15 -24.77 43.05 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -95.16 -4.4 46.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.806 0.812 . . . . 0.0 110.42 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -93.07 115.82 28.46 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 24' ' ' THR . 0.5 OUTLIER -83.78 144.58 29.22 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.874 0.369 . . . . 0.0 110.023 -170.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.408 ' N ' HD12 ' A' ' 23' ' ' LEU . 88.6 m -98.88 129.41 45.23 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.35 0.595 . . . . 0.0 111.492 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.419 ' HB3' HG23 ' A' ' 11' ' ' THR . 90.9 m-85 -127.74 151.84 48.49 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.221 -176.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.424 ' HD2' ' N ' ' A' ' 26' ' ' ARG . 3.5 mpt_? -108.82 174.5 5.84 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -81.75 116.37 21.42 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 117.914 0.324 . . . . 0.0 111.864 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.12 38.12 4.42 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.527 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.428 ' OE2' HD21 ' A' ' 48' ' ' LEU . 9.5 pt-20 -131.56 156.85 45.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 117.942 0.871 . . . . 0.0 111.871 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.9 mm -87.92 137.24 21.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.463 -173.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.691 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 40.1 mt -114.12 136.9 49.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.89 116.96 28.36 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.7 tt -77.93 123.78 27.2 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.8 mm -103.53 -40.69 6.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.319 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.0 m -153.04 134.96 14.69 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.007 -0.433 . . . . 0.0 111.892 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -91.9 -9.93 41.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.683 0.754 . . . . 0.0 109.539 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -117.78 119.52 35.17 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.96 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 p -115.34 0.1 13.34 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-O 121.576 0.703 . . . . 0.0 109.415 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.54 1.46 53.25 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -148.66 132.11 16.66 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.57 106.06 6.93 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 149.12 -31.12 1.19 Allowed Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -105.81 131.16 53.49 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.966 0.412 . . . . 0.0 110.724 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 17.4 m0 -113.24 151.26 31.27 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 84.5 tttt -109.2 129.03 55.5 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.29 157.94 22.73 Favored Glycine 0 N--CA 1.412 -2.914 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.221 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -116.67 129.29 56.05 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.428 HD21 ' OE2' ' A' ' 29' ' ' GLU . 55.4 tp -162.92 149.48 12.61 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 72.4 0.58 3.65 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.603 1.161 . . . . 0.0 111.216 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.79 0.53 42.44 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.83 169.88 10.33 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -175.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -130.25 142.03 50.58 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.475 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 45' ' ' LYS . . . -163.53 -173.13 31.86 Favored Glycine 0 C--N 1.291 -1.951 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -114.71 152.83 16.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 120.843 0.354 . . . . 0.0 110.706 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -153.87 150.94 23.83 Favored Pre-proline 0 N--CA 1.439 -1.022 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.671 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.53 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 17.1 Cg_exo -70.16 132.12 22.05 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.723 1.616 . . . . 0.0 109.692 173.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.6 -10.75 20.07 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -62.59 -31.95 72.86 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 124.41 1.084 . . . . 0.0 111.211 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -88.97 4.02 49.56 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -173.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.2 171.09 14.91 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -138.31 136.3 44.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -80.99 127.75 32.93 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.141 0.496 . . . . 0.0 111.528 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.405 ' C ' ' HG ' ' A' ' 64' ' ' SER . 33.1 mm -86.37 -62.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.405 ' HG ' ' C ' ' A' ' 63' ' ' ILE . 68.4 m . . . . . 0 N--CA 1.405 -2.68 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.38 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.1 -176.55 3.39 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.2 mmt -104.03 -178.71 3.74 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.346 0.593 . . . . 0.0 111.886 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.08 46.94 0.18 Allowed Glycine 0 C--N 1.299 -1.509 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.84 52.99 2.67 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.492 -0.854 . . . . 0.0 112.502 -169.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.1 mttp 55.1 57.08 5.85 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 122.742 1.258 . . . . 0.0 109.173 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -101.12 151.28 22.02 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 113.222 -1.808 . . . . 0.0 106.786 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -125.51 143.83 50.83 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.904 -1.118 . . . . 0.0 111.188 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.661 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 7.2 p -125.48 153.08 44.09 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.255 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -116.18 134.09 55.31 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.8 p -62.77 149.1 44.88 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 122.8 0.44 . . . . 0.0 112.037 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.54 -19.17 10.15 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -151.86 153.93 32.22 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.49 143.41 38.46 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.859 1.706 . . . . 0.0 109.224 169.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -135.0 127.86 31.28 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.4 m -93.27 115.85 28.44 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.306 -177.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.87 118.47 5.04 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.2 p -106.63 -7.32 17.43 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.983 0.897 . . . . 0.0 109.742 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -108.87 149.96 28.37 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -69.54 -22.95 63.52 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.094 0.474 . . . . 0.0 112.276 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -94.17 -2.44 52.59 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.296 1.046 . . . . 0.0 109.972 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -103.83 127.37 51.33 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.689 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.55 ' CD1' ' HA3' ' A' ' 53' ' ' GLY . 3.0 mp -84.89 135.66 33.97 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -177.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.2 m -96.2 123.26 39.76 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.94 176.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -133.75 159.59 40.13 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.202 0.525 . . . . 0.0 111.867 177.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -117.67 173.64 6.62 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -78.46 141.89 37.92 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.89 11.69 42.54 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.555 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -105.85 147.26 28.9 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.575 0.703 . . . . 0.0 112.317 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.9 mm -102.86 127.68 56.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.661 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 62.0 mt -114.39 135.01 55.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -89.39 118.52 29.11 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.5 tt -81.27 124.24 29.16 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mm -98.66 -47.23 12.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.905 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.0 m -153.46 124.55 7.42 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -75.69 -25.48 56.74 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.163 0.506 . . . . 0.0 109.843 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -90.71 121.39 32.56 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.173 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -122.77 -2.39 8.82 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.253 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.84 -7.41 41.71 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -145.66 131.86 19.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.36 126.86 30.84 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.38 -38.22 2.18 Favored Glycine 0 C--N 1.304 -1.234 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.649 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -98.82 127.58 44.79 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 120.798 0.333 . . . . 0.0 110.483 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 31.6 m0 -108.95 153.75 23.13 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.039 176.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 65.0 tttm -114.21 128.48 56.39 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.07 173.68 28.89 Favored Glycine 0 N--CA 1.424 -2.152 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.15 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -115.52 130.35 56.85 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 124.616 1.166 . . . . 0.0 109.626 -177.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.412 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 39.3 tp -154.66 135.7 13.85 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.412 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 56.4 m-80 65.59 16.26 10.42 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.397 1.079 . . . . 0.0 111.84 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.33 6.83 77.45 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.837 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.86 155.1 27.43 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -133.6 138.09 45.8 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.612 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.55 ' HA3' ' CD1' ' A' ' 23' ' ' LEU . . . -164.65 -156.71 9.12 Favored Glycine 0 CA--C 1.483 -1.945 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.054 -175.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.76 154.09 17.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 120.943 0.401 . . . . 0.0 111.506 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -158.53 148.85 15.63 Favored Pre-proline 0 N--CA 1.434 -1.228 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.125 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -74.35 135.76 20.86 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 121.77 1.647 . . . . 0.0 110.21 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -69.55 -7.25 36.81 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 120.821 0.343 . . . . 0.0 111.794 -176.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.6 -21.09 65.37 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.464 0.706 . . . . 0.0 112.035 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -107.11 9.77 30.31 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -173.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.93 164.3 34.15 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.9 p -131.34 135.25 59.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -78.26 133.11 37.73 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.1 mm -86.83 -67.22 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.398 -3.067 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.964 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 N--CA 1.429 -1.497 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -138.99 149.44 44.7 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.419 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.0 p -137.56 157.67 46.02 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 123.041 0.213 . . . . 0.0 110.874 -177.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.438 ' NE ' ' HA2' ' A' ' 28' ' ' GLY . 45.3 ttt180 -119.31 138.08 53.27 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.6 p -78.22 134.34 37.6 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.883 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.5 mt -98.29 -18.08 18.56 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.587 0.708 . . . . 0.0 109.566 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -142.56 150.14 53.22 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -78.5 157.75 28.85 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.875 1.716 . . . . 0.0 110.015 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -150.73 132.93 15.38 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.431 ' HA ' HG23 ' A' ' 24' ' ' THR . 82.1 m -96.14 122.38 38.93 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.967 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.77 125.97 7.21 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.1 p -90.55 -36.43 14.47 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 122.549 1.166 . . . . 0.0 108.376 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 57.3 m-80 -89.09 166.12 14.07 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.261 175.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -81.77 -33.21 31.04 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.7 3.34 14.25 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.408 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 34.7 tt0 -110.84 128.44 55.78 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tt -85.67 125.38 33.13 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.215 -170.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.431 HG23 ' HA ' ' A' ' 16' ' ' THR . 91.6 m -90.26 119.41 30.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 174.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -135.37 159.11 42.59 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -100.1 -178.37 3.82 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -91.85 137.73 32.13 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.438 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 95.83 15.66 41.85 Favored Glycine 0 CA--C 1.496 -1.103 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.858 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 20.0 mm-40 -95.94 127.25 41.8 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.9 mm -87.66 116.64 30.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 174.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.419 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 57.9 mt -105.98 144.12 15.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -88.51 109.26 19.9 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.553 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.2 tt -73.09 124.83 26.33 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -175.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.7 mm -97.37 -51.43 10.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.338 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -152.07 134.59 15.33 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.89 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.553 ' HG3' HD21 ' A' ' 33' ' ' LEU . 50.6 mtmt -90.33 -25.84 20.27 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.555 0.693 . . . . 0.0 109.169 175.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -96.44 103.05 14.93 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.19 -0.913 . . . . 0.0 108.551 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.7 p -104.11 8.81 36.48 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.132 0.968 . . . . 0.0 108.94 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.03 -22.3 38.63 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -119.06 146.92 44.68 Favored 'General case' 0 N--CA 1.413 -2.286 0 CA-C-N 114.806 -0.697 . . . . 0.0 109.529 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.86 109.97 21.18 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 132.71 -23.47 3.98 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.723 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -107.14 126.92 53.0 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.41 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 35.5 m0 -108.88 150.65 27.38 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 88.5 tttt -108.59 129.1 55.32 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -140.8 160.51 26.63 Favored Glycine 0 N--CA 1.408 -3.233 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.7 tm-20 -117.78 123.75 46.75 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.6 tp -142.77 133.73 25.65 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 67.7 17.46 9.84 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 124.079 0.862 . . . . 0.0 111.169 171.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.01 3.1 62.12 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.677 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 9.5 mptt -115.84 125.75 53.07 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 122.394 -0.474 . . . . 0.0 110.417 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 10.6 pt-20 -112.42 112.92 24.83 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.014 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -145.84 -166.66 12.08 Favored Glycine 0 N--CA 1.423 -2.229 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -177.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 34.6 m -114.21 151.09 16.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-O 120.97 0.414 . . . . 0.0 110.163 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -154.48 150.55 22.16 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.862 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 23.6 Cg_exo -66.85 130.74 23.85 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 121.953 1.769 . . . . 0.0 110.544 175.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -67.79 -9.53 45.03 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -68.87 -16.66 63.83 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.074 0.549 . . . . 0.0 111.745 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -91.45 -3.93 56.1 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.09 163.16 30.54 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.63 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.23 142.57 42.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -86.84 144.5 26.99 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.922 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.4 mm -102.98 -44.33 9.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.651 0.738 . . . . 0.0 109.355 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.413 -2.289 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -178.015 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.503 ' HA ' ' OXT' ' A' ' 64' ' ' SER . 45.6 mt-10 . . . . . 0 N--CA 1.424 -1.729 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -132.42 137.1 47.18 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.53 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 5.6 p -120.82 133.34 55.32 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.083 0.468 . . . . 0.0 109.946 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -99.55 129.84 45.75 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.3 p -62.92 128.78 37.46 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.158 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -97.35 -19.32 18.58 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -151.5 162.78 25.75 Favored Pre-proline 0 C--N 1.31 -1.141 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.7 165.68 11.94 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 121.729 1.619 . . . . 0.0 110.412 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -150.59 130.37 13.24 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.5 m -98.37 118.62 35.43 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.821 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.35 126.81 7.65 Favored Glycine 0 N--CA 1.417 -2.625 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.0 t -102.32 7.92 40.46 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 38.1 m-80 -127.6 152.36 47.74 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.77 -40.51 96.87 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -98.25 14.35 28.12 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.726 0.774 . . . . 0.0 111.602 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 44.8 tt0 -97.61 129.04 44.75 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 172.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.423 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -74.7 119.71 19.26 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.291 0.567 . . . . 0.0 111.821 -168.609 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.2 m -95.0 119.65 33.87 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -133.62 161.73 33.84 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -101.94 173.5 6.36 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.272 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -92.38 109.63 21.02 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.86 27.81 1.83 Allowed Glycine 0 C--N 1.304 -1.233 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.954 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -119.68 158.67 25.98 Favored 'General case' 0 C--O 1.251 1.164 0 CA-C-O 121.038 0.447 . . . . 0.0 111.146 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.6 mm -101.44 117.13 46.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 67.9 mt -94.53 134.3 32.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -89.3 109.59 20.47 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.519 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.6 tt -70.41 118.15 12.86 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.3 mm -93.27 -41.36 12.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.262 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.3 t -154.48 146.34 23.46 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.473 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.519 ' HG3' HD21 ' A' ' 33' ' ' LEU . 86.9 mttt -103.15 -3.55 25.66 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.964 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -115.1 103.14 10.59 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.603 0.716 . . . . 0.0 111.668 -176.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.5 p -118.46 9.88 12.49 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-O 122.111 0.957 . . . . 0.0 109.209 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.36 -21.28 46.36 Favored Glycine 0 N--CA 1.435 -1.402 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.044 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -125.98 142.17 51.64 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.3 125.94 30.15 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.372 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 114.38 -21.1 15.31 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.74 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -101.42 116.81 33.62 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 121.049 0.452 . . . . 0.0 110.416 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.434 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 40.6 m0 -108.77 155.54 20.65 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.589 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 16.8 ttmm -113.88 129.73 56.56 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -144.7 158.96 27.73 Favored Glycine 0 N--CA 1.414 -2.832 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 1.1 tm-20 -112.63 123.6 50.66 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.603 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 49.4 tp -147.05 130.44 16.67 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.945 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.603 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 59.3 m-80 66.05 18.65 11.07 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.716 1.206 . . . . 0.0 112.847 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.31 -18.72 20.61 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.012 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.26 144.37 44.91 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.528 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 10.1 pt-20 -102.03 116.36 32.51 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -125.63 -177.89 15.08 Favored Glycine 0 N--CA 1.409 -3.146 0 C-N-CA 119.962 -1.113 . . . . 0.0 111.067 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 27.4 m -114.23 146.69 18.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 52.7 p90 -154.38 153.85 28.68 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.814 -175.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 16.5 Cg_exo -71.08 129.34 16.06 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.303 2.002 . . . . 0.0 110.334 174.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.64 -20.87 63.87 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 124.284 1.033 . . . . 0.0 113.296 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -73.82 0.83 11.99 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -104.74 -0.86 26.92 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 122.264 -0.273 . . . . 0.0 111.529 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -141.19 146.72 37.31 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.977 -176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 p -108.22 132.43 56.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -78.76 126.81 31.22 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.373 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.1 mm -91.51 -54.12 7.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.227 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.503 ' OXT' ' HA ' ' A' ' 7' ' ' GLU . 19.4 m . . . . . 0 N--CA 1.421 -1.91 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.579 ' HB3' HE22 ' A' ' 62' ' ' GLN . 45.9 mt-10 . . . . . 0 N--CA 1.433 -1.307 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -126.47 135.3 51.18 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.496 ' SG ' HD12 ' A' ' 33' ' ' LEU . 12.9 m -126.03 164.81 20.04 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.524 HH11 ' HA2' ' A' ' 28' ' ' GLY . 65.7 ttp85 -129.96 134.35 47.4 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.414 HG21 ' HB3' ' A' ' 25' ' ' PHE . 16.8 p -74.34 136.53 42.52 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.9 mt -98.7 -18.37 18.07 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.647 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -144.7 150.31 46.39 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.74 143.49 41.85 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 121.97 1.78 . . . . 0.0 110.046 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -138.05 135.45 35.88 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.427 ' HA ' HG23 ' A' ' 24' ' ' THR . 18.9 m -111.89 128.77 56.24 Favored 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.239 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . -82.13 126.56 7.49 Favored Glycine 0 N--CA 1.421 -2.323 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.5 p -96.18 -5.96 39.33 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.326 1.06 . . . . 0.0 109.85 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -142.18 153.75 44.28 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 113.503 -1.681 . . . . 0.0 106.599 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.21 -28.99 70.07 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -171.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -82.68 -7.36 59.65 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.286 0.565 . . . . 0.0 111.235 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.512 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 42.9 tt0 -102.46 114.14 28.09 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.644 HD13 ' HA3' ' A' ' 53' ' ' GLY . 3.9 mp -83.34 145.33 29.11 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -172.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.427 HG23 ' HA ' ' A' ' 16' ' ' THR . 86.4 m -94.82 131.55 40.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.832 -1.077 . . . . 0.0 108.962 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.467 ' CD2' HD22 ' A' ' 48' ' ' LEU . 97.1 m-85 -132.07 152.87 50.95 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 123.068 0.547 . . . . 0.0 110.299 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.43 ' H ' ' HG3' ' A' ' 29' ' ' GLU . 30.6 mtm180 -100.26 -176.07 3.12 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 171.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.3 122.04 34.39 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.524 ' HA2' HH11 ' A' ' 10' ' ' ARG . . . 100.57 21.57 12.53 Favored Glycine 0 C--N 1.313 -0.712 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.617 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 26' ' ' ARG . 20.7 mm-40 -94.88 137.18 34.28 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.5 mm -89.56 124.55 42.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 108.093 -1.076 . . . . 0.0 108.093 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.5 mt -99.87 134.74 38.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -89.29 102.37 15.03 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 172.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.496 HD12 ' SG ' ' A' ' 9' ' ' CYS . 6.8 tt -72.56 125.3 27.11 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 -175.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.6 mm -98.99 -42.37 10.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.951 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.3 m -153.35 131.45 11.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.747 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -87.16 -41.02 14.08 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -87.49 105.14 17.1 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.246 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.5 p -112.04 0.02 15.83 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.77 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.92 -40.17 2.52 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.9 115.24 28.41 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.127 0.489 . . . . 0.0 109.765 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.43 124.68 22.41 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.243 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 109.52 -16.56 31.58 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.549 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -106.87 124.78 50.11 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 120.951 0.405 . . . . 0.0 110.51 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -110.82 153.07 25.91 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 86.6 tttt -106.24 129.4 54.29 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.75 166.18 25.68 Favored Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.7 tm-20 -118.8 130.42 55.77 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.467 HD22 ' CD2' ' A' ' 25' ' ' PHE . 38.6 tp -144.95 127.01 15.57 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 63.39 21.41 12.77 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.179 0.992 . . . . 0.0 111.884 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.24 4.93 62.47 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.274 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 10.3 mptt -114.73 136.98 52.47 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -125.25 127.17 46.32 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.78 0.8 . . . . 0.0 110.188 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.644 ' HA3' HD13 ' A' ' 23' ' ' LEU . . . -163.18 -157.03 8.9 Favored Glycine 0 N--CA 1.415 -2.702 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.561 -175.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.9 m -115.95 151.05 17.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-O 120.977 0.418 . . . . 0.0 111.893 -173.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -151.98 150.04 24.93 Favored Pre-proline 0 N--CA 1.434 -1.23 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.248 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 7.1 Cg_exo -74.5 128.77 12.18 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 121.831 1.688 . . . . 0.0 109.463 175.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -62.23 -20.17 63.94 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -171.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -71.77 -10.44 59.77 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.17 -1.32 57.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.248 0.546 . . . . 0.0 110.59 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -139.85 174.98 9.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.436 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.35 146.83 26.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.579 HE22 ' HB3' ' A' ' 7' ' ' GLU . 53.6 tp60 -74.62 147.87 41.23 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' A' ' 10' ' ' ARG . 45.9 mm -95.69 -55.63 5.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.9 p . . . . . 0 N--CA 1.414 -2.24 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.68 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.634 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 19.2 mm-40 . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -120.16 132.51 55.42 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.821 0.82 . . . . 0.0 112.073 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.2 m -123.83 143.15 50.51 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.551 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -99.36 130.93 45.68 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.9 p -70.51 128.74 37.19 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 123.549 0.53 . . . . 0.0 109.917 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.0 mt -99.77 -18.57 17.14 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.591 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -140.64 145.35 39.92 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.66 141.11 40.82 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.115 1.876 . . . . 0.0 109.929 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -142.86 142.35 31.77 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 m -107.53 117.79 35.04 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.638 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.15 116.34 8.37 Favored Glycine 0 N--CA 1.425 -2.079 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 m -83.06 -20.15 35.51 Favored 'General case' 0 N--CA 1.388 -3.527 0 CA-C-O 122.438 1.113 . . . . 0.0 108.044 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -114.35 155.53 26.09 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -73.19 -29.86 63.13 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.332 0.587 . . . . 0.0 110.138 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -84.87 9.07 15.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.861 0.838 . . . . 0.0 110.533 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -112.09 133.37 54.29 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mt -78.62 133.43 37.27 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -173.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.1 m -98.08 120.14 37.96 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 173.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -134.23 155.09 50.78 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.49 169.35 8.7 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -79.39 130.33 35.32 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -175.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.14 23.38 13.12 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.999 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -107.73 138.09 44.59 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.5 mm -94.31 125.04 46.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 55.5 mt -109.17 135.45 48.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -90.52 104.68 17.23 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.634 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 4.7 tt -69.39 129.02 38.6 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.508 -177.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.7 mm -100.07 -37.85 6.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.443 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.9 m -148.87 122.16 8.99 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 121.522 -0.736 . . . . 0.0 111.589 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.562 ' HG3' HD21 ' A' ' 33' ' ' LEU . 37.6 mtmt -80.77 -2.95 49.2 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.526 0.679 . . . . 0.0 111.651 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -136.32 124.68 23.34 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.495 0.664 . . . . 0.0 109.665 173.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.1 p -113.18 17.07 18.95 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 122.015 0.912 . . . . 0.0 109.217 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.97 -12.79 62.35 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 107.918 -2.073 . . . . 0.0 107.918 -170.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -131.65 149.55 52.45 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.82 104.29 13.94 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.71 -27.66 1.32 Allowed Glycine 0 C--N 1.297 -1.625 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -112.97 121.83 45.83 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -107.98 147.9 30.45 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.971 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -105.83 130.01 53.89 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -146.99 163.89 28.61 Favored Glycine 0 N--CA 1.417 -2.572 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -109.43 123.39 49.27 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.4 tp -136.77 121.07 18.01 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.617 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 63.94 23.08 13.21 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 124.154 0.909 . . . . 0.0 111.437 174.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.08 -19.79 37.03 Favored Glycine 0 N--CA 1.427 -1.911 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.748 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -100.23 126.4 46.52 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 117.717 0.758 . . . . 0.0 111.2 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 6.7 pt-20 -102.04 100.89 11.19 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.991 175.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -131.57 -163.92 10.97 Favored Glycine 0 C--N 1.286 -2.235 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.638 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.5 m -114.47 150.99 16.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 116.871 0.335 . . . . 0.0 110.812 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -147.61 155.16 45.26 Favored Pre-proline 0 N--CA 1.433 -1.296 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.438 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.53 133.79 38.57 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.153 1.902 . . . . 0.0 110.851 176.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -62.72 -15.12 51.56 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.249 1.02 . . . . 0.0 112.842 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -101.77 -13.19 17.82 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -80.8 -7.5 59.43 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.176 0.512 . . . . 0.0 111.964 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -136.88 139.54 41.71 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.03 125.47 57.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -78.35 113.99 16.84 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.426 0.632 . . . . 0.0 111.047 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.0 pt -85.36 -48.32 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.946 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.2 m . . . . . 0 N--CA 1.408 -2.564 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.456 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 41.6 mt-10 . . . . . 0 N--CA 1.432 -1.336 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -122.87 138.4 54.67 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.278 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.8 m -128.26 137.23 51.9 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.689 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -101.48 136.89 40.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.1 p -72.93 133.63 44.43 Favored 'General case' 0 N--CA 1.417 -2.077 0 O-C-N 123.519 0.512 . . . . 0.0 109.944 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.2 mt -99.13 -18.17 17.83 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -144.87 150.72 47.23 Favored Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.38 154.21 21.36 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 121.807 1.671 . . . . 0.0 110.383 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -150.97 136.11 17.56 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.463 ' HA ' HG23 ' A' ' 24' ' ' THR . 26.0 m -103.11 128.75 49.92 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.9 137.15 16.17 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 t -89.48 -15.42 33.1 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 122.345 1.069 . . . . 0.0 108.331 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 87.7 m-20 -115.42 157.25 24.21 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.778 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.75 -30.6 71.29 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.937 0.875 . . . . 0.0 110.351 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.01 12.22 27.0 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.8 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 33.8 tt0 -114.37 115.0 26.65 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 174.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.4 HD21 ' HB3' ' A' ' 48' ' ' LEU . 1.1 tt -70.78 120.03 15.79 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.479 -166.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 16' ' ' THR . 87.0 m -89.76 120.1 30.73 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.018 175.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -135.13 161.8 34.3 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -105.17 174.98 5.65 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -87.8 123.25 32.4 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.25 8.05 15.54 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -92.81 137.11 32.65 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.763 0.316 . . . . 0.0 110.401 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mm -99.05 117.28 43.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.2 mt -102.99 141.72 18.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -174.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -90.09 114.72 26.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.7 tt -74.07 127.53 33.16 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.6 mm -102.95 -52.48 8.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.216 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 45' ' ' LYS . 20.0 m -143.96 130.98 20.51 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.958 -0.11 . . . . 0.0 110.799 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.474 ' HG3' HD21 ' A' ' 33' ' ' LEU . 97.8 mttt -88.29 -15.98 34.33 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.823 0.821 . . . . 0.0 110.379 177.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -114.07 121.67 44.55 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.79 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.0 p -123.64 17.48 9.57 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.05 -47.85 1.0 Allowed Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -100.63 161.3 13.69 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.687 -0.757 . . . . 0.0 109.812 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.03 85.52 2.22 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 176.15 -47.96 0.12 Allowed Glycine 0 CA--C 1.49 -1.486 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -82.85 121.3 26.76 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.9 m0 -107.9 144.19 35.48 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 64.0 tttp -103.31 129.33 50.29 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.19 168.23 27.15 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -123.28 129.11 50.89 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HB3' HD21 ' A' ' 23' ' ' LEU . 64.4 tp -138.79 115.77 10.89 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.796 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 62.97 23.93 14.28 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 123.907 0.883 . . . . 0.0 111.672 173.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.28 -14.28 39.82 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.885 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 9.6 mptt -103.27 136.37 43.17 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.0 146.68 46.44 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.67 -160.99 26.21 Favored Glycine 0 N--CA 1.422 -2.276 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.03 152.36 16.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 116.947 0.374 . . . . 0.0 110.122 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 53.2 p90 -149.76 152.05 33.9 Favored Pre-proline 0 N--CA 1.425 -1.684 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 55' ' ' PHE . 6.2 Cg_exo -76.06 129.29 11.29 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.678 1.586 . . . . 0.0 111.611 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -49.93 -29.7 8.83 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.509 1.524 . . . . 0.0 113.507 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -68.08 -10.58 55.02 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -96.31 -9.55 29.92 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.79 160.84 38.71 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.967 -175.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 p -128.3 133.51 66.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.484 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 51.5 tt0 -73.9 116.86 15.01 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.334 0.588 . . . . 0.0 110.007 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.4 pt -91.3 -23.76 5.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.57 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.419 -1.98 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.785 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.429 -1.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -123.38 158.29 31.43 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.508 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.2 p -135.84 134.12 38.52 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.146 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -100.24 135.73 41.21 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.4 p -60.85 135.68 57.85 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 124.856 1.262 . . . . 0.0 110.867 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.445 HD11 ' HB ' ' A' ' 61' ' ' VAL . 92.4 mt -108.13 -19.08 13.61 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.232 0.539 . . . . 0.0 109.904 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -148.05 152.38 39.85 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.53 148.37 42.38 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.587 1.525 . . . . 0.0 109.538 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -139.11 132.78 30.57 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.5 m -107.38 129.87 54.87 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.68 138.9 15.12 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -91.8 -16.49 26.73 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -125.63 169.92 12.02 Favored 'General case' 0 N--CA 1.402 -2.852 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.905 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -77.32 -28.11 53.08 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -174.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.27 -12.15 57.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.255 1.026 . . . . 0.0 110.154 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.03 107.58 18.49 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.419 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 2.7 tm? -71.96 133.41 45.34 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.24 -169.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.3 m -102.5 120.85 41.23 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.162 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -133.85 161.75 33.89 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -111.28 171.39 7.51 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -84.58 113.3 21.15 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.47 24.01 2.48 Favored Glycine 0 N--CA 1.425 -2.074 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.879 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -119.94 147.47 44.71 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.7 mm -100.36 119.85 49.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.508 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 61.7 mt -103.07 138.1 28.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -88.63 112.87 23.59 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.522 HD21 ' HG3' ' A' ' 36' ' ' LYS . 5.0 tt -76.1 122.45 24.3 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -174.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.522 HD11 ' HB2' ' A' ' 47' ' ' GLU . 41.1 mt -97.01 -39.14 8.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.335 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.2 t -160.56 138.77 9.92 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.285 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.522 ' HG3' HD21 ' A' ' 33' ' ' LEU . 89.9 mttt -89.75 -8.4 52.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.283 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.35 129.99 49.9 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.357 0.598 . . . . 0.0 110.269 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.9 p -125.42 23.9 7.43 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.79 0.805 . . . . 0.0 109.722 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.0 -39.39 2.86 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -174.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -104.43 139.85 38.78 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.16 102.1 14.63 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.17 -26.69 1.87 Allowed Glycine 0 C--N 1.303 -1.275 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -98.9 126.24 44.51 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.412 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 36.6 m0 -107.27 154.24 21.54 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.561 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 61.4 tttp -115.33 128.74 56.3 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.37 160.98 28.53 Favored Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.211 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.2 tm-20 -117.52 131.34 56.72 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.504 0.668 . . . . 0.0 110.748 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 68.7 tp -141.34 127.68 19.86 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 67.89 15.36 9.55 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.466 1.106 . . . . 0.0 111.395 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.74 0.77 62.19 Favored Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.353 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 4.4 mptp? -105.92 129.52 54.05 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.36 121.86 46.31 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -143.58 -174.09 15.6 Favored Glycine 0 N--CA 1.412 -2.904 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.361 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 35.4 m -115.31 150.93 17.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 O-C-N 123.884 0.403 . . . . 0.0 109.988 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -160.71 151.2 15.06 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.616 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.96 138.05 36.3 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 122.158 1.905 . . . . 0.0 110.768 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.78 -16.76 63.47 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -173.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -72.91 -1.46 16.97 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 120.987 0.423 . . . . 0.0 111.576 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -102.42 -3.09 27.54 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.78 156.02 44.92 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.89 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.445 ' HB ' HD11 ' A' ' 12' ' ' LEU . 14.4 p -118.91 136.05 57.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -78.81 117.71 20.18 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.2 pt -87.65 -9.4 10.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.433 0.635 . . . . 0.0 111.678 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--N 1.283 -2.321 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.672 177.315 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.547 ' HA ' ' OXT' ' A' ' 64' ' ' SER . 14.5 mp0 . . . . . 0 N--CA 1.426 -1.662 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -131.92 145.37 51.47 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.9 m -127.96 142.91 51.11 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.539 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -104.05 132.31 50.43 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.0 p -76.49 134.84 39.39 Favored 'General case' 0 C--N 1.288 -2.109 0 CA-C-O 121.155 0.502 . . . . 0.0 111.724 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.6 mt -95.5 -17.97 21.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.873 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -141.44 154.32 66.76 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.571 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.79 134.71 8.6 Favored 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 122.011 1.808 . . . . 0.0 109.375 169.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -135.25 138.15 43.25 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.422 ' HA ' HG23 ' A' ' 24' ' ' THR . 23.0 m -107.5 122.42 46.62 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.039 -177.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.445 ' HA2' ' HG2' ' A' ' 22' ' ' GLU . . . -82.09 106.81 2.72 Favored Glycine 0 N--CA 1.413 -2.838 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.77 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.7 -33.28 21.55 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 90.5 m-20 -88.8 153.95 20.66 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.892 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -62.11 -37.45 85.15 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.793 0.33 . . . . 0.0 111.661 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -90.91 10.67 25.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.629 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 46.8 tt0 -110.44 125.55 53.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 mt -82.86 139.51 33.43 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -175.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 16' ' ' THR . 51.4 m -99.32 119.44 37.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -134.88 159.78 40.35 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -101.11 -179.7 4.12 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -85.51 133.55 34.07 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.54 17.4 39.2 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.101 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -92.42 142.57 27.28 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.8 mm -99.99 123.55 52.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.9 mt -114.31 142.34 27.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -89.17 115.27 26.56 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 tt -66.11 133.82 51.51 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.4 mm -112.48 -49.41 5.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.427 0.632 . . . . 0.0 109.436 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.3 m -149.94 118.5 6.52 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.631 -0.668 . . . . 0.0 111.596 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -73.45 -26.08 60.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.505 0.669 . . . . 0.0 109.833 173.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -101.98 111.97 24.44 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.2 p -110.12 -2.29 17.02 Favored 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.43 -10.88 33.28 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -125.8 143.78 50.92 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.17 86.72 5.04 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.199 0.523 . . . . 0.0 109.614 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.91 -30.27 0.39 Allowed Glycine 0 CA--C 1.489 -1.591 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -89.63 123.22 33.49 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -108.99 134.21 51.94 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 84.6 tttt -99.12 129.61 45.39 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -142.54 165.18 26.85 Favored Glycine 0 N--CA 1.423 -2.195 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 41.7 tt0 -110.77 131.95 54.61 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 123.772 0.337 . . . . 0.0 110.346 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.9 tp -148.27 119.72 7.92 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.098 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 62.06 34.08 16.73 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.965 0.906 . . . . 0.0 112.212 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.9 -10.99 68.2 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.651 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 4.6 mptp? -105.82 129.7 53.95 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-N 117.482 0.641 . . . . 0.0 111.083 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 46' ' ' GLY 0.383 0.0 OUTLIER -111.99 106.29 14.93 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 122.662 1.22 . . . . 0.0 111.002 170.831 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -134.61 -171.57 12.55 Favored Glycine 0 N--CA 1.425 -2.084 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.354 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.0 m -114.63 150.82 16.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-O 121.303 0.573 . . . . 0.0 111.403 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -152.42 148.76 21.43 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.956 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.67 129.76 21.85 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 121.569 1.512 . . . . 0.0 109.498 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.75 -22.6 58.24 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -172.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -69.19 -8.2 43.46 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -91.96 -0.7 57.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.641 0.257 . . . . 0.0 110.907 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -144.73 165.95 26.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.719 0.295 . . . . 0.0 110.861 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 p -131.57 134.37 60.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -71.27 118.2 13.77 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.3 pt -96.51 -23.78 4.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-O 121.953 0.882 . . . . 0.0 110.522 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.547 ' OXT' ' HA ' ' A' ' 7' ' ' GLU . 44.9 m . . . . . 0 N--CA 1.4 -2.938 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 . . . . . 0 N--CA 1.418 -2.038 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -130.23 139.45 50.79 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.49 -175.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.405 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 13.8 p -124.01 147.62 47.67 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.342 -178.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -108.15 135.61 49.21 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.411 HG21 ' CD1' ' A' ' 25' ' ' PHE . 43.2 p -79.44 136.65 37.0 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.399 0.619 . . . . 0.0 112.268 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.0 mt -99.96 -18.01 17.28 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.672 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -145.55 156.37 52.95 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -84.2 151.2 12.23 Favored 'Trans proline' 0 C--O 1.253 1.265 0 C-N-CA 122.142 1.895 . . . . 0.0 111.323 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -137.55 125.8 23.16 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.446 ' HA ' HG23 ' A' ' 24' ' ' THR . 23.5 m -112.99 110.88 21.23 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.47 144.49 44.2 Favored Glycine 0 N--CA 1.412 -2.958 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.992 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.1 p -89.93 -21.44 22.47 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -121.11 157.2 30.64 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -87.87 12.01 14.2 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.471 1.129 . . . . 0.0 109.853 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -78.65 -31.35 46.76 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 170.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -82.32 150.03 27.43 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 113.333 -1.758 . . . . 0.0 107.148 173.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 48' ' ' LEU . 3.2 tm? -103.58 126.33 50.66 Favored 'General case' 0 C--N 1.281 -2.396 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.625 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.446 HG23 ' HA ' ' A' ' 16' ' ' THR . 94.3 m -94.53 120.43 34.75 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.204 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 11' ' ' THR . 23.4 p90 -134.77 158.88 43.02 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.411 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -99.63 -179.3 4.15 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -81.1 133.77 35.53 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.2 27.29 28.52 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.118 176.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -105.97 151.47 24.57 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mm -101.26 124.48 55.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.405 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 62.7 mt -110.02 143.88 19.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -89.33 104.97 17.48 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.578 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.4 tt -71.62 128.23 35.13 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.215 0.531 . . . . 0.0 109.758 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.35 -50.51 9.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.957 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.8 m -144.21 131.24 20.5 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.944 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.578 ' HG3' HD21 ' A' ' 33' ' ' LEU . 44.5 mtmt -97.98 -22.52 16.25 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.598 0.713 . . . . 0.0 110.476 174.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -109.8 86.44 2.3 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 p -87.4 -18.23 30.48 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.703 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.81 -43.0 1.02 Allowed Glycine 0 C--N 1.28 -2.571 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -120.36 111.14 17.38 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.85 109.25 1.69 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 152.14 -33.0 0.87 Allowed Glycine 0 C--N 1.287 -2.183 0 N-CA-C 107.545 -2.222 . . . . 0.0 107.545 -174.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -100.34 124.6 46.03 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 35.6 m0 -107.86 146.09 32.78 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.21 129.09 55.78 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.22 159.65 27.93 Favored Glycine 0 N--CA 1.41 -3.082 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.2 tm-20 -110.73 130.55 55.54 Favored 'General case' 0 N--CA 1.414 -2.244 0 O-C-N 124.402 0.707 . . . . 0.0 109.358 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.459 ' HB3' HD11 ' A' ' 23' ' ' LEU . 43.0 tp -144.66 127.42 16.26 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.254 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.4 m120 65.26 17.98 11.22 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.754 1.221 . . . . 0.0 111.484 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.01 -15.4 55.28 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.36 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 12.1 mptt -100.52 133.54 44.81 Favored 'General case' 0 CA--C 1.489 -1.379 0 CA-C-N 117.013 0.406 . . . . 0.0 110.31 -175.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -111.38 121.61 45.69 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.041 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.22 -170.01 13.93 Favored Glycine 0 C--N 1.287 -2.168 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.1 m -115.22 150.88 17.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 120.796 0.332 . . . . 0.0 110.591 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -156.13 149.06 18.23 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.134 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 34.8 Cg_exo -66.72 136.99 44.11 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.072 1.848 . . . . 0.0 111.398 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -63.2 -13.36 36.59 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.108 0.963 . . . . 0.0 112.743 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -71.91 -10.6 60.01 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.165 0.586 . . . . 0.0 111.922 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -107.61 8.62 29.24 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.666 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.13 154.33 43.79 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.427 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.16 131.6 72.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -76.53 127.54 33.02 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.8 mm -90.51 -49.79 13.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.41 -2.475 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -179.709 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -110.8 134.42 52.52 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.594 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.473 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 12.9 p -120.03 146.32 45.99 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-O 121.173 0.511 . . . . 0.0 110.233 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -106.0 134.66 48.77 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.0 p -66.74 140.12 57.85 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 123.823 0.849 . . . . 0.0 110.25 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.5 mt -107.04 -20.22 13.38 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.818 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -153.4 152.27 27.23 Favored Pre-proline 0 C--N 1.316 -0.853 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -177.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.28 110.85 3.15 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 121.626 1.551 . . . . 0.0 111.29 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -109.4 131.4 55.1 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.509 ' HA ' HG23 ' A' ' 24' ' ' THR . 24.2 m -110.6 129.6 55.77 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.94 150.28 39.1 Favored Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.0 t -98.74 5.66 47.44 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.734 1.254 . . . . 0.0 108.284 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -156.0 173.25 17.07 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.504 -1.68 . . . . 0.0 106.658 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -79.62 -30.35 41.39 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -174.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.13 -21.77 60.66 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.182 0.992 . . . . 0.0 109.313 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -87.99 110.45 20.6 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.1 135.13 38.57 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.581 0.705 . . . . 0.0 111.6 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 16' ' ' THR . 94.7 m -98.92 122.54 42.3 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.569 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -133.39 157.77 44.71 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.529 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -109.84 -167.41 1.2 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 122.745 0.418 . . . . 0.0 110.568 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -89.22 141.71 28.29 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.85 29.97 49.61 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.272 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.03 157.53 23.35 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 122.154 -0.615 . . . . 0.0 112.272 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.6 mm -111.73 124.78 68.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.473 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 65.3 mt -114.48 143.62 23.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -89.49 116.01 27.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.5 tt -79.73 118.99 22.04 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 47' ' ' GLU . 61.3 mt -89.52 -47.99 14.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.52 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.1 m -155.88 140.77 17.2 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 122.149 -0.344 . . . . 0.0 110.621 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -90.86 -16.56 28.02 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -106.9 103.03 12.35 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.063 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.0 p -107.18 3.02 25.19 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.784 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.86 -14.91 41.1 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -130.54 116.38 18.08 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.31 118.59 10.21 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.48 -22.76 7.32 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -105.3 122.37 45.81 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.7 m0 -108.18 155.06 20.86 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -110.56 129.85 55.7 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.85 164.23 25.51 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.526 ' HB2' HD11 ' A' ' 34' ' ' ILE . 25.2 tt0 -124.94 123.93 40.95 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.4 tp -125.2 117.45 23.88 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 66.14 21.85 11.12 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.193 0.997 . . . . 0.0 110.82 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.16 -10.02 58.1 Favored Glycine 0 N--CA 1.435 -1.393 0 CA-C-N 115.661 -0.699 . . . . 0.0 113.712 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 3.3 mptp? -97.84 132.3 43.57 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 117.852 0.826 . . . . 0.0 109.405 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.85 148.05 29.0 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 123.673 0.608 . . . . 0.0 111.917 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.49 -172.06 40.81 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.21 156.58 16.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 116.809 0.304 . . . . 0.0 110.809 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -158.35 156.05 26.82 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.114 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -74.48 136.21 21.24 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.116 1.877 . . . . 0.0 110.913 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -61.33 -21.97 64.49 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -174.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -73.16 -4.65 34.13 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -102.45 4.52 38.85 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.933 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.92 164.38 33.92 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.1 p -134.64 140.64 45.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 52.6 tt0 -85.28 133.01 34.17 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.255 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.6 mt -79.3 -67.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 N--CA 1.403 -2.822 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 177.763 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -120.22 133.5 55.47 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.578 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.564 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 3.4 p -122.3 149.3 43.93 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.993 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 51.2 ttt180 -118.79 133.92 55.51 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.507 HG23 HD11 ' A' ' 31' ' ' ILE . 4.3 p -74.92 135.66 41.45 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.4 mt -103.01 -17.6 15.36 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -138.44 150.86 67.85 Favored Pre-proline 0 N--CA 1.438 -1.07 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.304 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -76.7 161.03 34.16 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.09 1.86 . . . . 0.0 110.643 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -149.19 124.59 10.27 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.7 m -101.92 124.85 48.24 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.98 134.07 12.52 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.1 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -95.31 -15.16 23.33 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 122.304 1.05 . . . . 0.0 108.493 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -112.38 168.41 9.66 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -86.43 -27.5 24.1 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.729 0.776 . . . . 0.0 109.647 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.86 -28.03 60.5 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.863 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -82.36 116.78 22.0 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.55 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -89.72 143.22 26.98 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.046 0.45 . . . . 0.0 110.481 -169.535 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.2 m -92.66 128.38 38.5 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.177 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 98.8 m-85 -129.03 147.08 50.86 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.143 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 26' ' ' ARG . 37.2 mmt180 -104.62 171.61 7.23 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 172.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -78.71 133.95 37.12 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 122.557 0.343 . . . . 0.0 110.871 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.56 16.88 57.93 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.995 -0.621 . . . . 0.0 113.388 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 27.5 mm-40 -92.72 147.38 22.92 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.1 mm -98.72 118.31 45.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.564 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 53.4 mt -99.13 135.22 35.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.075 -175.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -89.65 107.1 18.89 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.525 HD21 ' HG3' ' A' ' 36' ' ' LYS . 8.0 tt -70.5 140.22 51.81 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 121.11 0.481 . . . . 0.0 110.706 -173.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mm -108.72 -44.92 6.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.311 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.3 t -157.44 145.23 18.89 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.525 ' HG3' HD21 ' A' ' 33' ' ' LEU . 51.1 mtpt -102.86 1.23 33.71 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-O 121.746 0.784 . . . . 0.0 109.645 175.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -121.63 115.76 23.34 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.609 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -124.63 3.76 8.25 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.806 0.812 . . . . 0.0 109.847 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.23 -21.62 39.04 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -114.8 135.46 54.16 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.764 -0.718 . . . . 0.0 109.195 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.65 99.8 11.54 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 134.25 -14.2 4.57 Favored Glycine 0 N--CA 1.421 -2.327 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.187 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -107.45 125.74 51.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.287 0.565 . . . . 0.0 110.329 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.518 ' CZ2' ' HE3' ' A' ' 36' ' ' LYS . 43.3 m0 -113.71 164.9 13.11 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.235 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -118.31 129.97 55.76 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.54 158.02 27.4 Favored Glycine 0 N--CA 1.421 -2.358 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 1.1 tm-20 -112.1 131.52 55.39 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 123.239 0.616 . . . . 0.0 109.831 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 51.0 tp -144.56 132.62 21.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 68.76 13.79 8.91 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.407 1.083 . . . . 0.0 111.838 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.14 9.47 56.99 Favored Glycine 0 N--CA 1.427 -1.903 0 C-N-CA 121.151 -0.547 . . . . 0.0 111.776 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -123.75 126.75 47.07 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.073 0.463 . . . . 0.0 110.849 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -99.69 125.87 45.63 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.297 177.595 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.26 -172.47 17.48 Favored Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.3 m -115.13 158.19 15.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 117.215 0.507 . . . . 0.0 110.871 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -162.03 156.46 19.01 Favored Pre-proline 0 C--N 1.319 -0.726 0 O-C-N 124.004 0.815 . . . . 0.0 109.595 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 6.6 Cg_exo -75.8 127.58 10.25 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.206 1.937 . . . . 0.0 109.428 172.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -65.6 -17.54 64.66 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.627 0.371 . . . . 0.0 111.941 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -65.7 -14.03 60.45 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -87.32 -2.9 58.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.179 0.514 . . . . 0.0 110.818 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.94 177.82 7.61 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.431 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.49 135.54 43.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -81.65 129.48 34.71 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.85 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.2 mm -77.38 -68.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.399 -3.004 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.341 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 9.3 mm-40 . . . . . 0 N--CA 1.426 -1.661 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -121.85 138.85 54.23 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.592 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 8.0 p -125.47 142.25 51.61 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.75 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -101.61 135.79 42.53 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 64.2 p -77.5 128.63 34.51 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-O 121.258 0.551 . . . . 0.0 111.65 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.1 mt -98.9 -18.14 18.02 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.138 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -142.52 143.95 28.59 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -74.24 141.75 29.51 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.9 1.733 . . . . 0.0 109.853 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -137.37 128.43 27.6 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.521 ' HA ' HG23 ' A' ' 24' ' ' THR . 24.3 m -100.84 118.0 36.03 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.702 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.7 125.71 17.07 Favored Glycine 0 N--CA 1.427 -1.957 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.3 p -82.26 -20.51 37.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.746 1.26 . . . . 0.0 108.633 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 44.0 m-80 -115.42 161.9 17.9 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.99 -19.81 29.81 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.582 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -79.91 -3.39 47.88 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.3 1.047 . . . . 0.0 108.9 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 36.7 tt0 -107.19 126.12 51.99 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' A' ' 48' ' ' LEU . 2.3 tm? -86.8 135.13 33.46 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.571 -167.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.521 HG23 ' HA ' ' A' ' 16' ' ' THR . 90.0 m -100.3 119.85 39.04 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.29 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -134.85 151.92 51.31 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.738 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -99.71 179.49 4.52 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 173.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.3 139.85 36.43 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.63 10.34 55.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.222 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -95.49 156.8 16.17 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 122.589 -0.359 . . . . 0.0 110.256 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.9 mm -110.33 116.25 51.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.592 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 62.5 mt -101.75 131.51 49.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -90.77 102.67 15.42 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 6.0 tt -69.03 134.47 49.47 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.656 -173.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.0 mm -101.2 -51.2 9.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.411 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.9 m -146.62 141.64 27.11 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.739 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.446 ' HG2' HD11 ' A' ' 33' ' ' LEU . 47.1 mtmt -91.58 -22.65 20.21 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 172.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -101.78 112.57 25.21 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.462 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.8 p -106.39 2.23 26.33 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.92 0.867 . . . . 0.0 109.069 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.45 -44.1 1.54 Allowed Glycine 0 N--CA 1.427 -1.925 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -99.02 134.24 42.15 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.85 102.11 7.09 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.54 -27.34 1.66 Allowed Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -99.06 128.7 45.24 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 24.5 m0 -108.06 159.92 16.2 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 53.0 tttm -128.32 128.37 44.47 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -150.12 160.08 28.38 Favored Glycine 0 N--CA 1.425 -2.094 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -175.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -107.19 127.12 53.23 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.257 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.496 ' HB3' HD11 ' A' ' 23' ' ' LEU . 68.7 tp -133.22 111.14 10.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.7 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 63.82 18.94 11.48 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 124.712 1.205 . . . . 0.0 113.099 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.81 -25.24 5.9 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.136 -1.03 . . . . 0.0 113.846 177.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 1.5 mptm? -106.09 142.32 35.98 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 117.697 0.748 . . . . 0.0 110.888 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 14.1 pt-20 -118.76 114.22 22.34 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -132.46 -166.85 11.64 Favored Glycine 0 N--CA 1.42 -2.383 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.66 153.16 16.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -161.73 147.74 10.84 Favored Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 123.88 0.737 . . . . 0.0 109.482 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.43 134.88 29.79 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 121.833 1.688 . . . . 0.0 109.937 174.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.26 1.43 2.91 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -76.37 -22.31 54.99 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 122.942 0.497 . . . . 0.0 110.635 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -91.38 2.09 56.65 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -174.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.12 171.29 15.55 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 122.363 -0.21 . . . . 0.0 110.529 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.47 132.04 40.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -70.18 117.34 11.62 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.031 0.443 . . . . 0.0 110.736 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.6 mt -67.81 -50.16 62.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.426 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 N--CA 1.411 -2.405 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 N--CA 1.445 -0.693 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -121.45 144.48 48.66 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.598 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.5 p -131.12 150.49 52.12 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.526 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -110.14 133.99 52.65 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.602 HG23 HD11 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -75.92 125.99 30.15 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-O 121.011 0.434 . . . . 0.0 111.313 175.416 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.1 mt -96.41 -9.58 29.57 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.936 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -142.27 141.14 20.37 Favored Pre-proline 0 N--CA 1.431 -1.379 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.708 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.33 132.1 18.75 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.065 1.843 . . . . 0.0 109.648 171.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 24' ' ' THR . 87.1 t80 -124.94 122.28 36.88 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.0 m -101.44 120.54 40.44 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.34 143.28 38.82 Favored Glycine 0 N--CA 1.423 -2.192 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.276 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 p -85.18 -33.63 22.25 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 122.605 1.193 . . . . 0.0 108.309 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 40.8 m-80 -103.67 158.4 16.4 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 173.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.39 5.67 49.81 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.737 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.94 -20.23 42.5 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 170.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 19' ' ' ASN . 17.6 mt-10 -81.61 159.3 24.07 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 113.548 -1.66 . . . . 0.0 106.992 171.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.437 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -121.06 136.32 55.01 Favored 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 118.932 -1.107 . . . . 0.0 108.593 -178.75 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 88.7 m -89.53 121.04 31.36 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.304 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 89.1 m-85 -121.91 159.16 27.44 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.561 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -117.29 165.59 13.28 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.39 125.33 23.38 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 123.416 0.686 . . . . 0.0 110.028 174.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.97 13.06 57.03 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.512 -0.851 . . . . 0.0 114.028 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -92.41 144.68 25.12 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.8 mm -99.07 123.96 52.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.602 HD11 HG23 ' A' ' 11' ' ' THR . 50.6 mt -106.93 135.28 45.97 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.588 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -89.86 117.75 28.93 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 171.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.527 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.4 tt -73.94 119.82 18.67 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.749 -175.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.1 mm -92.82 -40.35 11.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.392 -176.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.6 t -161.17 144.48 12.86 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.043 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.527 ' HG3' HD21 ' A' ' 33' ' ' LEU . 94.6 mttt -100.46 4.21 43.54 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -120.84 102.39 8.34 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.456 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.2 p -115.96 7.44 14.38 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.38 -17.44 53.59 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 108.671 -1.771 . . . . 0.0 108.671 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -121.62 151.04 40.84 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.885 -0.657 . . . . 0.0 110.253 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.42 99.29 9.33 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.26 -38.9 1.01 Allowed Glycine 0 CA--C 1.49 -1.476 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -176.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -95.79 119.9 35.11 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -109.08 159.18 17.07 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -108.22 129.84 55.18 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.42 159.4 25.26 Favored Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.37 135.29 54.08 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.001 0.429 . . . . 0.0 110.654 -177.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.4 tp -138.88 122.31 17.22 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 124.039 0.935 . . . . 0.0 108.882 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 68.87 11.56 8.38 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.307 1.043 . . . . 0.0 112.513 175.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.56 -8.17 43.47 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 3.5 mptp? -102.76 130.93 49.88 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -120.9 135.05 55.28 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-O 121.333 0.587 . . . . 0.0 111.183 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -153.22 -167.22 15.41 Favored Glycine 0 N--CA 1.416 -2.692 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.3 m -115.32 153.51 16.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 120.772 0.32 . . . . 0.0 111.091 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -157.12 150.95 19.33 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.49 136.74 19.79 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 121.559 1.506 . . . . 0.0 109.758 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.66 -16.19 62.44 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.068 0.461 . . . . 0.0 110.795 -176.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -53.39 -29.27 33.8 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 124.481 1.113 . . . . 0.0 111.687 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -94.02 -1.1 55.0 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.32 148.54 36.45 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -174.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.67 134.0 61.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -78.81 128.15 32.99 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.113 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.42 -58.25 3.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.404 -2.754 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 177.654 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 N--CA 1.439 -0.975 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -114.17 138.98 49.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.53 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 7.8 p -122.56 133.17 54.57 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.904 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -99.69 135.21 41.44 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.8 p -81.05 129.3 34.48 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.258 0.552 . . . . 0.0 111.135 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.1 mt -97.69 -16.65 19.85 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.571 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -142.84 153.27 60.82 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -81.79 142.59 12.76 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.927 1.751 . . . . 0.0 110.079 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -126.89 130.48 50.24 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.486 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.435 ' HA ' HG23 ' A' ' 24' ' ' THR . 49.7 m -100.32 113.38 26.05 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.16 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.97 145.37 29.71 Favored Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 176.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.9 p -92.19 -35.53 13.78 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.01 0.91 . . . . 0.0 108.701 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -107.28 -179.04 3.81 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.737 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -93.93 8.27 41.93 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.905 0.86 . . . . 0.0 109.472 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -91.22 -32.15 15.89 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.93 156.27 32.16 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.874 172.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.0 tt -102.44 115.18 30.04 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.435 HG23 ' HA ' ' A' ' 16' ' ' THR . 63.8 m -83.59 120.04 25.47 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -134.36 161.83 33.89 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -96.66 170.04 9.47 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -82.99 137.08 34.29 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.55 26.15 21.24 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.481 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -102.65 148.81 25.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mm -105.27 112.5 39.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 58.9 mt -100.94 139.0 23.3 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -88.24 106.75 18.41 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.66 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.5 tt -68.66 122.64 18.94 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.491 -174.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 47' ' ' GLU . 50.7 mt -97.42 -44.71 12.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.378 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.0 m -150.12 138.86 20.8 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.795 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.66 ' HG3' HD21 ' A' ' 33' ' ' LEU . 50.3 mtmt -97.75 5.14 49.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.4 118.81 32.15 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 113.638 -1.619 . . . . 0.0 108.656 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.9 p -133.57 -0.29 3.22 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.37 0.605 . . . . 0.0 110.273 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.25 -41.41 2.14 Favored Glycine 0 C--N 1.306 -1.126 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -174.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -97.79 116.45 30.03 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.39 114.05 6.49 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 128.3 -17.71 5.88 Favored Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -174.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -113.94 128.96 56.62 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.847 0.356 . . . . 0.0 111.118 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.403 ' CE2' ' HG2' ' A' ' 36' ' ' LYS . 34.0 m0 -108.87 169.67 8.53 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 58.9 tttm -137.54 128.92 28.04 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -152.49 173.07 31.61 Favored Glycine 0 C--N 1.297 -1.605 0 C-N-CA 120.285 -0.96 . . . . 0.0 112.121 -175.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.476 ' HB2' HD11 ' A' ' 34' ' ' ILE . 9.0 tt0 -108.91 134.22 51.88 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 123.67 0.788 . . . . 0.0 109.814 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.7 tp -153.47 129.71 10.47 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 64.3 20.03 12.01 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.714 0.806 . . . . 0.0 112.403 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.46 3.66 64.67 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 116.13 -0.487 . . . . 0.0 113.039 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -117.4 150.67 38.48 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 9.1 pt-20 -121.87 140.81 51.94 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 172.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -160.54 -169.31 23.65 Favored Glycine 0 C--N 1.288 -2.086 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.53 152.14 16.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.064 0.459 . . . . 0.0 110.307 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -157.45 148.68 16.69 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.283 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 20.3 Cg_exo -65.69 125.89 15.11 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.487 1.458 . . . . 0.0 109.245 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -61.29 -18.68 59.67 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -171.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -72.57 -14.36 61.61 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.936 0.335 . . . . 0.0 111.239 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -80.35 -14.74 58.1 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.597 0.237 . . . . 0.0 111.192 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.06 166.55 20.81 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.57 142.3 35.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -70.3 140.87 52.38 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.9 pt -91.17 -42.14 13.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-O 121.255 0.55 . . . . 0.0 111.316 -173.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.411 -2.377 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.555 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 35.8 mt-10 . . . . . 0 N--CA 1.43 -1.456 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -128.45 137.96 52.07 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.97 0.414 . . . . 0.0 110.138 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.436 ' SG ' HD12 ' A' ' 33' ' ' LEU . 59.8 m -124.47 153.81 41.44 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.986 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -117.46 132.17 56.61 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.425 HG23 HD11 ' A' ' 31' ' ' ILE . 6.5 p -72.46 128.51 35.82 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 120.811 0.339 . . . . 0.0 111.235 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.8 mt -89.16 -18.03 27.98 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.99 157.21 64.54 Favored Pre-proline 0 C--N 1.309 -1.181 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.43 138.63 15.77 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.297 1.332 . . . . 0.0 109.462 173.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 24' ' ' THR . 68.8 t80 -122.6 117.94 27.02 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.792 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 m -109.98 127.54 54.85 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.91 153.37 28.14 Favored Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.57 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -98.15 -20.71 17.15 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -105.16 166.57 10.31 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -82.72 -9.58 59.29 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.654 0.74 . . . . 0.0 109.538 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -78.32 -30.05 48.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.699 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -78.86 151.49 31.8 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.181 173.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.448 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -112.91 139.2 48.75 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 96.2 m -95.13 120.67 35.75 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.668 0.747 . . . . 0.0 111.121 -177.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 91.7 m-85 -122.55 147.17 46.7 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.829 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -90.29 172.55 8.69 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 176.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -75.41 129.94 38.15 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.3 39.03 20.2 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.793 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -117.97 154.9 31.18 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.0 mm -96.21 128.61 47.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 O-C-N 123.556 0.535 . . . . 0.0 109.994 -175.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 11' ' ' THR . 52.7 mt -112.23 134.54 54.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -90.04 110.23 21.23 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 171.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.5 tt -74.45 123.84 25.46 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mm -96.94 -43.66 12.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.387 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.9 m -156.39 135.23 11.81 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.267 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -85.54 -27.01 25.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 170.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -95.35 102.71 14.54 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.639 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.3 p -109.2 -0.91 19.03 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.802 0.811 . . . . 0.0 109.98 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.12 -41.25 1.58 Allowed Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 107.746 -2.141 . . . . 0.0 107.746 -173.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -115.32 166.32 11.99 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.436 -0.882 . . . . 0.0 109.639 175.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.81 149.13 23.69 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 171.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 100.38 -25.86 26.71 Favored Glycine 0 C--N 1.301 -1.39 0 C-N-CA 120.369 -0.919 . . . . 0.0 110.88 -176.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -111.56 116.9 31.61 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -108.89 157.26 18.79 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.577 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -105.06 130.02 53.35 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.34 147.55 19.26 Favored Glycine 0 N--CA 1.417 -2.569 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.96 136.28 44.74 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.41 HD22 ' CD1' ' A' ' 25' ' ' PHE . 27.4 tp -145.47 128.19 16.24 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.9 m120 62.91 20.31 12.14 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.938 0.895 . . . . 0.0 112.067 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.42 -3.42 75.55 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.321 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -102.41 133.71 46.92 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.34 120.85 43.13 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -136.67 -172.09 12.45 Favored Glycine 0 C--N 1.286 -2.216 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.76 151.13 16.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.162 0.506 . . . . 0.0 110.848 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -151.4 150.86 27.86 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.3 Cg_exo -76.75 135.92 16.43 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 121.872 1.715 . . . . 0.0 110.748 175.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -64.72 -14.87 60.35 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.893 0.377 . . . . 0.0 111.432 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -63.42 -19.87 65.06 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.436 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -98.78 0.86 45.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -144.52 167.85 21.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.173 0.511 . . . . 0.0 111.759 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.3 p -132.88 139.17 50.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -83.18 128.34 34.4 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.8 pt -101.77 -30.71 3.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.058 0.456 . . . . 0.0 110.719 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.416 -2.17 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.717 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 3.4 mm-40 . . . . . 0 N--CA 1.42 -1.943 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -130.96 138.22 49.61 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.1 p -123.57 138.85 54.48 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 65.3 ttt180 -107.86 134.26 51.05 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.411 HG21 ' CD1' ' A' ' 25' ' ' PHE . 45.4 p -77.81 133.97 38.1 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-O 121.504 0.669 . . . . 0.0 111.59 -176.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.22 -7.77 24.31 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.783 0.801 . . . . 0.0 109.515 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -147.17 156.03 46.7 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -85.59 155.63 10.48 Favored 'Trans proline' 0 N--CA 1.436 -1.876 0 C-N-CA 121.852 1.702 . . . . 0.0 109.008 170.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -149.19 129.61 13.86 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.509 ' HA ' HG23 ' A' ' 24' ' ' THR . 19.0 m -115.69 125.81 53.31 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.048 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.93 151.84 24.18 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.0 t -94.73 1.52 55.48 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 122.629 1.204 . . . . 0.0 108.256 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -141.69 165.16 28.23 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.67 -6.73 58.11 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -83.27 -24.28 32.32 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 122.168 0.985 . . . . 0.0 109.103 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -94.44 131.09 40.49 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -87.41 129.39 35.06 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.972 0.891 . . . . 0.0 112.512 -169.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 16' ' ' THR . 91.1 m -97.1 121.37 38.91 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.205 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 11' ' ' THR . 10.5 p90 -133.69 160.09 38.6 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.045 0.45 . . . . 0.0 112.175 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -94.23 171.32 8.9 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.62 145.66 31.58 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.33 16.23 78.61 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.419 -0.42 . . . . 0.0 113.263 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 8.9 tp10 -97.98 148.29 23.63 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.849 0.357 . . . . 0.0 110.732 -175.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.3 mm -96.86 121.17 47.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.4 mt -113.84 140.85 32.21 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -89.43 121.9 32.11 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.0 tt -79.01 133.2 36.83 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -174.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 47' ' ' GLU . 36.4 mt -106.84 -44.0 7.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-O 121.128 0.489 . . . . 0.0 110.232 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -150.17 130.77 13.97 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 121.973 -0.455 . . . . 0.0 111.839 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -88.36 -23.71 23.31 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -97.87 109.5 22.24 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.556 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.7 p -111.61 -5.64 14.48 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.776 0.798 . . . . 0.0 110.126 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.94 -17.16 30.09 Favored Glycine 0 C--N 1.309 -0.967 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -128.36 128.94 45.49 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.39 115.04 16.83 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.66 -15.59 6.29 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -110.34 124.1 51.07 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -108.77 155.51 20.68 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.775 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 38.3 ttmt -117.2 129.46 55.96 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.61 173.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.64 168.13 26.0 Favored Glycine 0 N--CA 1.416 -2.68 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.511 ' HB2' HD11 ' A' ' 34' ' ' ILE . 1.8 tm-20 -115.34 129.9 56.74 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.097 0.475 . . . . 0.0 110.365 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.8 tp -156.64 138.82 14.62 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.1 m120 73.02 12.24 5.07 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.659 1.184 . . . . 0.0 110.921 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.44 14.76 59.58 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 27.3 mmmt -126.06 154.98 42.26 Favored 'General case' 0 CA--C 1.468 -2.21 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -175.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.29 126.23 34.85 Favored 'General case' 0 C--N 1.257 -3.427 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.117 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -156.75 -161.66 10.92 Favored Glycine 0 CA--C 1.469 -2.832 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -176.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.5 147.51 17.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.793 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -150.51 154.87 36.07 Favored Pre-proline 0 N--CA 1.426 -1.626 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.679 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.06 128.05 13.51 Favored 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 122.14 1.893 . . . . 0.0 111.372 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.26 -19.38 64.5 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.031 0.933 . . . . 0.0 112.264 -175.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -76.39 -4.78 44.13 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -102.31 -0.33 33.0 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 121.127 0.489 . . . . 0.0 112.104 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -141.42 155.58 45.87 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.209 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 p -120.75 139.3 48.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.445 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 50.0 tt0 -79.83 122.06 26.17 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.679 0.752 . . . . 0.0 111.613 -177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.6 mm -93.7 -31.06 4.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.541 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.42 -1.967 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 -178.691 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 . . . . . 0 N--CA 1.431 -1.407 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -113.11 153.19 28.62 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.592 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.6 p -133.99 138.36 45.38 Favored 'General case' 0 C--N 1.267 -2.983 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.205 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -99.7 138.23 37.08 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 42.4 p -63.09 142.93 58.19 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 124.332 1.053 . . . . 0.0 110.406 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.7 mt -113.08 -18.78 12.08 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.322 0.582 . . . . 0.0 110.165 175.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -149.4 147.66 23.96 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.38 123.64 8.84 Favored 'Trans proline' 0 C--O 1.253 1.264 0 C-N-CA 122.052 1.835 . . . . 0.0 110.51 173.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -129.98 134.0 47.16 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.483 ' HA ' HG23 ' A' ' 24' ' ' THR . 46.8 m -116.28 131.69 56.87 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 120.933 0.397 . . . . 0.0 110.544 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.04 134.68 11.86 Favored Glycine 0 N--CA 1.413 -2.887 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.5 p -91.15 -34.71 14.92 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -79.27 145.93 33.26 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 113.377 -1.738 . . . . 0.0 108.692 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.41 -35.86 80.55 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.775 0.672 . . . . 0.0 110.631 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.426 ' O ' HG22 ' A' ' 54' ' ' VAL . 31.0 t70 -86.42 4.96 37.29 Favored 'General case' 0 C--O 1.203 -1.371 0 CA-C-O 121.62 0.724 . . . . 0.0 110.213 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -104.35 134.7 47.11 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.19 135.42 33.8 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.73 0.3 . . . . 0.0 111.564 -170.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.483 HG23 ' HA ' ' A' ' 16' ' ' THR . 94.1 m -103.24 120.06 40.04 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -135.02 154.42 51.73 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -104.94 -176.69 3.15 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.94 122.96 35.84 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 176.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.39 8.73 8.29 Favored Glycine 0 C--N 1.294 -1.796 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.244 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -110.41 154.33 23.72 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.1 mm -108.13 122.48 62.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.114 0.483 . . . . 0.0 109.762 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.592 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 58.6 mt -105.79 130.15 57.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.95 127.51 36.04 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.99 121.75 20.62 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mm -100.59 -41.33 8.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.603 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 45' ' ' LYS . 25.4 m -151.68 139.55 19.94 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.272 -0.268 . . . . 0.0 111.524 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -103.4 -14.32 16.31 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.89 0.476 . . . . 0.0 110.366 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -110.47 97.42 6.87 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-O 121.986 0.898 . . . . 0.0 109.375 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 p -105.18 0.5 27.38 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.058 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.52 -25.83 18.3 Favored Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -174.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -117.78 174.73 6.01 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.885 -0.657 . . . . 0.0 109.557 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.39 141.28 37.18 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.73 -30.23 5.47 Favored Glycine 0 C--N 1.312 -0.774 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.411 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -81.98 115.35 21.1 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.135 0.493 . . . . 0.0 110.166 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 44.9 m0 -108.57 154.19 22.31 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.897 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 19.3 ttmm -116.29 129.64 56.38 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 176.142 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.07 176.51 23.3 Favored Glycine 0 N--CA 1.413 -2.876 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -123.04 133.87 54.31 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.3 tp -149.97 139.7 21.74 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.429 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.8 m120 67.66 10.07 7.51 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.794 1.237 . . . . 0.0 111.35 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.47 -2.97 49.97 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.21 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.38 138.43 51.36 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 122.375 -0.485 . . . . 0.0 110.203 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -93.5 144.06 25.71 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -160.36 177.93 36.6 Favored Glycine 0 N--CA 1.413 -2.836 0 C-N-CA 119.851 -1.166 . . . . 0.0 111.186 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 34.3 m -114.51 152.01 16.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -160.19 147.69 12.69 Favored Pre-proline 0 N--CA 1.419 -1.983 0 O-C-N 124.184 0.928 . . . . 0.0 108.824 -177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -69.05 129.31 18.11 Favored 'Trans proline' 0 C--O 1.251 1.159 0 C-N-CA 121.736 1.624 . . . . 0.0 108.954 172.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -57.83 -20.7 37.96 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 123.974 0.91 . . . . 0.0 113.091 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -69.04 -13.21 62.31 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -91.69 2.46 56.46 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.256 0.55 . . . . 0.0 111.315 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -140.37 169.86 16.89 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.541 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 p -128.93 122.2 56.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -73.07 121.59 20.43 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.5 pt -85.77 -6.81 10.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -173.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 C--N 1.298 -1.663 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.559 174.837 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 64' ' ' SER . 44.7 mt-10 . . . . . 0 N--CA 1.437 -1.093 0 CA-C-O 120.97 0.414 . . . . 0.0 109.897 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -139.93 151.1 45.3 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 121.4 0.619 . . . . 0.0 111.233 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.6 p -130.19 153.38 48.62 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.051 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.553 HH11 ' HA2' ' A' ' 28' ' ' GLY . 59.5 ttp85 -113.41 134.41 54.66 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.6 p -79.36 131.56 36.15 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.01 -177.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.5 mt -95.18 -12.07 27.0 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.672 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -133.17 149.86 73.82 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.632 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -85.98 120.65 1.97 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.282 1.988 . . . . 0.0 108.925 168.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 89.1 t80 -146.45 123.11 11.17 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.381 0.61 . . . . 0.0 111.328 -173.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.575 ' HA ' HG23 ' A' ' 24' ' ' THR . 87.9 m -91.93 135.33 34.03 Favored 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.87 125.8 33.33 Favored Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -36.75 67.24 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 22' ' ' GLU . 93.4 m-20 -101.19 148.08 25.51 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 112.791 -2.004 . . . . 0.0 105.956 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -15.54 57.17 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.138 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -73.66 -20.51 60.54 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.722 172.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 19' ' ' ASN . 38.4 tt0 -89.06 143.31 26.94 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 tt -84.7 125.11 32.23 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.093 0.473 . . . . 0.0 111.132 -171.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.575 HG23 ' HA ' ' A' ' 16' ' ' THR . 91.1 m -87.65 121.02 29.54 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.039 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 15' ' ' TYR . 36.1 p90 -133.89 161.43 34.79 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.246 0.546 . . . . 0.0 111.945 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -112.99 173.64 6.28 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -78.69 123.86 27.59 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.553 ' HA2' HH11 ' A' ' 10' ' ' ARG . . . 102.09 13.48 31.25 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.525 -0.845 . . . . 0.0 114.16 177.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -93.58 143.98 25.8 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 117.079 0.44 . . . . 0.0 110.165 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.9 mm -99.33 113.04 33.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.9 mt -107.43 134.06 50.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -88.58 127.88 35.56 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.58 HD21 ' HG3' ' A' ' 36' ' ' LYS . 3.8 tt -74.15 126.26 30.18 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.055 -174.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 47' ' ' GLU . 59.7 mt -101.39 -52.81 8.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.3 m -143.26 128.54 18.81 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.697 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.58 ' HG3' HD21 ' A' ' 33' ' ' LEU . 58.2 mtpt -85.5 -33.41 21.81 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -97.68 108.19 20.85 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.575 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.1 p -119.33 6.43 11.17 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.435 0.636 . . . . 0.0 110.635 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.06 -22.15 7.65 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -141.28 139.31 33.65 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.16 89.63 7.34 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 169.42 -30.74 0.16 Allowed Glycine 0 CA--C 1.483 -1.914 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -99.69 121.88 41.88 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.465 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 25.8 m0 -107.94 141.64 39.26 Favored 'General case' 0 C--N 1.273 -2.737 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 23.0 ttmm -102.54 129.47 49.09 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 175.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -145.94 175.16 25.58 Favored Glycine 0 N--CA 1.417 -2.619 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.546 ' HB2' HD11 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -123.95 129.69 51.36 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.187 0.494 . . . . 0.0 109.79 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 47.4 tp -137.96 119.6 15.05 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.959 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.2 m120 64.82 21.6 12.39 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.742 1.217 . . . . 0.0 112.543 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.74 -11.58 49.78 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.728 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 4.0 mptp? -103.57 134.82 46.27 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 116.884 0.342 . . . . 0.0 110.48 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -112.39 141.48 46.07 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -167.16 -165.19 24.15 Favored Glycine 0 CA--C 1.467 -2.946 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 26.0 m -114.4 147.03 18.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 120.99 0.424 . . . . 0.0 110.56 -178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -147.95 150.6 36.12 Favored Pre-proline 0 C--N 1.296 -1.738 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.201 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 8.2 Cg_exo -71.58 136.77 29.0 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 121.798 1.665 . . . . 0.0 112.202 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -69.02 -8.16 42.34 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.659 0.784 . . . . 0.0 112.488 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -96.49 0.22 49.96 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 120.817 0.341 . . . . 0.0 111.487 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -99.92 -11.43 20.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.197 0.522 . . . . 0.0 110.996 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.12 145.08 41.2 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.598 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.02 125.76 66.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -68.99 121.52 16.79 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.476 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.4 mm -85.34 -45.79 17.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 43.9 m . . . . . 0 N--CA 1.41 -2.467 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 64' ' ' SER . 4.7 mm-40 . . . . . 0 N--CA 1.42 -1.928 0 CA-C-O 120.77 0.319 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -146.24 144.67 30.03 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.995 0.426 . . . . 0.0 111.187 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 8.0 p -126.71 147.85 49.92 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.655 -172.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -101.9 136.0 42.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.0 p -69.17 139.47 54.62 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.66 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.0 mt -107.75 -18.87 13.71 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.482 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -147.37 151.05 39.31 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.18 141.12 23.02 Favored 'Trans proline' 0 C--O 1.25 1.101 0 C-N-CA 121.977 1.784 . . . . 0.0 111.091 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -147.41 139.14 24.09 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.1 m -112.79 131.34 55.73 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 120.978 0.418 . . . . 0.0 110.622 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.76 119.9 5.22 Favored Glycine 0 N--CA 1.409 -3.139 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.9 m -82.08 -28.62 32.26 Favored 'General case' 0 N--CA 1.383 -3.807 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -94.31 165.93 12.34 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.788 -1.551 . . . . 0.0 107.85 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -26.62 33.07 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-O 121.425 0.631 . . . . 0.0 109.856 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -92.61 9.75 33.39 Favored 'General case' 0 C--O 1.212 -0.886 0 CA-C-O 121.643 0.735 . . . . 0.0 110.712 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -109.85 131.43 55.07 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.19 130.97 35.52 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.513 -169.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.3 m -93.79 119.7 33.09 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -134.39 145.63 49.12 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.321 0.581 . . . . 0.0 112.366 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -96.47 161.69 13.8 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.391 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.64 123.13 24.3 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.39 11.41 21.8 Favored Glycine 0 C--N 1.294 -1.772 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -100.06 152.74 19.87 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-O 120.93 0.395 . . . . 0.0 110.625 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.3 mm -109.35 111.82 37.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.457 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 67.8 mt -96.42 135.54 30.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -88.31 117.49 27.27 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 6.3 tt -76.78 124.7 28.08 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.35 -50.15 12.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.258 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.5 m -156.3 133.24 10.45 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.083 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -84.45 -16.5 42.36 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.882 0.848 . . . . 0.0 108.972 172.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -98.03 99.21 10.47 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.257 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.4 p -105.98 -3.38 21.76 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.89 0.852 . . . . 0.0 109.836 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.96 -42.46 1.49 Allowed Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -176.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -121.61 128.09 51.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.18 121.32 14.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.489 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.95 -25.58 4.12 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -106.57 123.53 48.24 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 177.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.426 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 43.6 m0 -108.7 153.4 23.5 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 60.0 tttp -114.82 129.45 56.7 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -141.49 160.74 26.95 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -117.8 125.17 50.07 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -178.736 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.9 tp -147.62 119.01 7.86 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.459 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 72.12 21.81 3.85 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.193 0.997 . . . . 0.0 113.036 174.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.37 0.29 35.1 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.664 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 8.5 mptt -127.22 132.66 50.37 Favored 'General case' 0 CA--C 1.488 -1.423 0 O-C-N 122.419 -0.459 . . . . 0.0 110.073 -177.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 10.5 pt-20 -107.65 95.85 5.98 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 122.502 1.144 . . . . 0.0 109.433 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -113.94 -175.45 18.98 Favored Glycine 0 C--N 1.274 -2.9 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.495 -173.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 33.0 m -114.14 152.56 15.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -152.89 155.43 32.2 Favored Pre-proline 0 N--CA 1.418 -2.041 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.662 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.28 134.46 12.78 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.746 1.631 . . . . 0.0 111.284 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -44.86 -37.34 3.82 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 125.458 1.503 . . . . 0.0 113.21 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -63.09 -16.97 61.71 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -96.24 1.56 52.23 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.86 170.38 16.0 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.038 0.446 . . . . 0.0 111.696 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.22 131.42 40.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -83.32 125.69 31.9 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.194 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.1 mm -89.95 -52.5 10.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 23.2 t . . . . . 0 N--CA 1.413 -2.305 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.44 -0.931 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -124.8 139.37 53.91 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.587 0.708 . . . . 0.0 110.597 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.695 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 5.6 p -129.59 162.28 28.61 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HB2' HD11 ' A' ' 63' ' ' ILE . 29.8 ttp180 -121.11 145.8 47.42 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.649 HG21 ' HB3' ' A' ' 25' ' ' PHE . 72.0 p -71.31 141.41 50.48 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.794 0.683 . . . . 0.0 109.631 177.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -105.13 -18.79 14.03 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -141.71 156.29 66.17 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -177.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -76.73 120.9 5.68 Favored 'Trans proline' 0 N--CA 1.429 -2.275 0 N-CA-C 108.065 -1.552 . . . . 0.0 108.065 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -111.4 115.37 29.14 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.407 ' HA ' HG23 ' A' ' 24' ' ' THR . 36.0 m -98.38 111.3 23.69 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.715 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.43 135.63 18.73 Favored Glycine 0 N--CA 1.425 -2.05 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 176.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -113.6 5.55 16.6 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -127.15 156.24 42.1 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.54 -1.664 . . . . 0.0 107.324 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.15 -24.77 43.05 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -95.16 -4.4 46.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.806 0.812 . . . . 0.0 110.42 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -93.07 115.82 28.46 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 24' ' ' THR . 0.5 OUTLIER -83.78 144.58 29.22 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.874 0.369 . . . . 0.0 110.023 -170.884 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.409 ' N ' HD13 ' A' ' 23' ' ' LEU . 88.6 m -98.88 129.41 45.23 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.35 0.595 . . . . 0.0 111.492 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.649 ' HB3' HG21 ' A' ' 11' ' ' THR . 90.9 m-85 -127.74 151.84 48.49 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.221 -176.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.439 ' N ' ' HD2' ' A' ' 26' ' ' ARG . 3.5 mpt_? -108.82 174.5 5.84 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -81.75 116.37 21.42 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 117.914 0.324 . . . . 0.0 111.864 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.12 38.12 4.42 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.527 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.432 ' OE2' HD21 ' A' ' 48' ' ' LEU . 9.5 pt-20 -131.56 156.85 45.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 117.942 0.871 . . . . 0.0 111.871 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.9 mm -87.92 137.24 21.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.463 -173.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.695 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 40.1 mt -114.12 136.9 49.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.89 116.96 28.36 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.7 tt -77.93 123.78 27.2 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.8 mm -103.53 -40.69 6.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.319 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.0 m -153.04 134.96 14.69 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.007 -0.433 . . . . 0.0 111.892 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 94.8 mttt -91.9 -9.93 41.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.683 0.754 . . . . 0.0 109.539 173.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -117.78 119.52 35.17 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.96 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 p -115.34 0.1 13.34 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-O 121.576 0.703 . . . . 0.0 109.415 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.54 1.46 53.25 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -148.66 132.11 16.66 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.57 106.06 6.93 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 149.12 -31.12 1.19 Allowed Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -105.81 131.16 53.49 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.966 0.412 . . . . 0.0 110.724 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.4 ' CD1' ' HA ' ' A' ' 36' ' ' LYS . 17.4 m0 -113.24 151.26 31.27 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 172.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 84.5 tttt -109.2 129.03 55.5 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.29 157.94 22.73 Favored Glycine 0 N--CA 1.412 -2.914 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.221 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -116.67 129.29 56.05 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.432 HD21 ' OE2' ' A' ' 29' ' ' GLU . 55.4 tp -162.92 149.48 12.61 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 72.4 0.58 3.65 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.603 1.161 . . . . 0.0 111.216 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.79 0.53 42.44 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.83 169.88 10.33 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -175.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -130.25 142.03 50.58 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.475 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 45' ' ' LYS . . . -163.53 -173.13 31.86 Favored Glycine 0 C--N 1.291 -1.951 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -114.71 152.83 16.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 120.843 0.354 . . . . 0.0 110.706 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -153.87 150.94 23.83 Favored Pre-proline 0 N--CA 1.439 -1.022 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.671 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 17.1 Cg_exo -70.16 132.12 22.05 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.723 1.616 . . . . 0.0 109.692 173.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.6 -10.75 20.07 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -62.59 -31.95 72.86 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 124.41 1.084 . . . . 0.0 111.211 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -88.97 4.02 49.56 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -173.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.2 171.09 14.91 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -138.31 136.3 44.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -80.99 127.75 32.93 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.141 0.496 . . . . 0.0 111.528 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' A' ' 10' ' ' ARG . 33.1 mm -86.37 -62.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 N--CA 1.405 -2.68 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.878 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 N--CA 1.424 -1.758 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -125.51 143.83 50.83 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.904 -1.118 . . . . 0.0 111.188 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.668 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 7.2 p -125.48 153.08 44.09 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.255 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -116.18 134.09 55.31 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.8 p -62.77 149.1 44.88 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 122.8 0.44 . . . . 0.0 112.037 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.54 -19.17 10.15 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -151.86 153.93 32.22 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.49 143.41 38.46 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.859 1.706 . . . . 0.0 109.224 169.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -135.0 127.86 31.28 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.4 m -93.27 115.85 28.44 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.306 -177.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.87 118.47 5.04 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.2 p -106.63 -7.32 17.43 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.983 0.897 . . . . 0.0 109.742 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -108.87 149.96 28.37 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -69.54 -22.95 63.52 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.094 0.474 . . . . 0.0 112.276 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -94.17 -2.44 52.59 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.296 1.046 . . . . 0.0 109.972 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -103.83 127.37 51.33 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.689 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.627 HD13 ' HA3' ' A' ' 53' ' ' GLY . 3.0 mp -84.89 135.66 33.97 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -177.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.2 m -96.2 123.26 39.76 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.94 176.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -133.75 159.59 40.13 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.202 0.525 . . . . 0.0 111.867 177.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -117.67 173.64 6.62 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -78.46 141.89 37.92 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.89 11.69 42.54 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.555 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -105.85 147.26 28.9 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.575 0.703 . . . . 0.0 112.317 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.9 mm -102.86 127.68 56.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.668 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 62.0 mt -114.39 135.01 55.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -89.39 118.52 29.11 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.465 HD21 ' HG3' ' A' ' 36' ' ' LYS . 5.5 tt -81.27 124.24 29.16 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -175.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mm -98.66 -47.23 12.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.905 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.0 m -153.46 124.55 7.42 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.465 ' HG3' HD21 ' A' ' 33' ' ' LEU . 97.7 mttt -75.69 -25.48 56.74 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.163 0.506 . . . . 0.0 109.843 174.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -90.71 121.39 32.56 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.173 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -122.77 -2.39 8.82 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.253 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.84 -7.41 41.71 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -145.66 131.86 19.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.36 126.86 30.84 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.38 -38.22 2.18 Favored Glycine 0 C--N 1.304 -1.234 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.649 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -98.82 127.58 44.79 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 120.798 0.333 . . . . 0.0 110.483 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 31.6 m0 -108.95 153.75 23.13 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.039 176.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 65.0 tttm -114.21 128.48 56.39 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.07 173.68 28.89 Favored Glycine 0 N--CA 1.424 -2.152 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.15 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -115.52 130.35 56.85 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 124.616 1.166 . . . . 0.0 109.626 -177.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 39.3 tp -154.66 135.7 13.85 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.2 m120 65.59 16.26 10.42 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.397 1.079 . . . . 0.0 111.84 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.33 6.83 77.45 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.837 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.86 155.1 27.43 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -133.6 138.09 45.8 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.612 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.627 ' HA3' HD13 ' A' ' 23' ' ' LEU . . . -164.65 -156.71 9.12 Favored Glycine 0 CA--C 1.483 -1.945 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.054 -175.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.76 154.09 17.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 120.943 0.401 . . . . 0.0 111.506 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -158.53 148.85 15.63 Favored Pre-proline 0 N--CA 1.434 -1.228 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.125 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -74.35 135.76 20.86 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 121.77 1.647 . . . . 0.0 110.21 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -69.55 -7.25 36.81 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 120.821 0.343 . . . . 0.0 111.794 -176.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.6 -21.09 65.37 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.464 0.706 . . . . 0.0 112.035 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -107.11 9.77 30.31 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -173.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.93 164.3 34.15 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.9 p -131.34 135.25 59.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -78.26 133.11 37.73 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.1 mm -86.83 -67.22 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.398 -3.067 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.964 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.675 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.54 156.89 20.57 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 ttt -139.06 99.55 3.79 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.06 95.32 0.16 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.165 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.61 23.47 12.63 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 80.97 75.5 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 125.786 1.634 . . . . 0.0 109.138 -174.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -98.52 151.27 20.81 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.706 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -138.99 149.44 44.7 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.419 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.0 p -137.56 157.67 46.02 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 123.041 0.213 . . . . 0.0 110.874 -177.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.438 ' NE ' ' HA2' ' A' ' 28' ' ' GLY . 45.3 ttt180 -119.31 138.08 53.27 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.6 p -78.22 134.34 37.6 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.883 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.5 mt -98.29 -18.08 18.56 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.587 0.708 . . . . 0.0 109.566 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -142.56 150.14 53.22 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -78.5 157.75 28.85 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.875 1.716 . . . . 0.0 110.015 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -150.73 132.93 15.38 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.431 ' HA ' HG23 ' A' ' 24' ' ' THR . 82.1 m -96.14 122.38 38.93 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.967 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.77 125.97 7.21 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.1 p -90.55 -36.43 14.47 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 122.549 1.166 . . . . 0.0 108.376 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 57.3 m-80 -89.09 166.12 14.07 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.261 175.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -81.77 -33.21 31.04 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.7 3.34 14.25 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.408 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 34.7 tt0 -110.84 128.44 55.78 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tt -85.67 125.38 33.13 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.215 -170.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.431 HG23 ' HA ' ' A' ' 16' ' ' THR . 91.6 m -90.26 119.41 30.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 174.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -135.37 159.11 42.59 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -100.1 -178.37 3.82 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -91.85 137.73 32.13 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.438 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 95.83 15.66 41.85 Favored Glycine 0 CA--C 1.496 -1.103 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.858 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 20.0 mm-40 -95.94 127.25 41.8 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.9 mm -87.66 116.64 30.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 174.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.419 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 57.9 mt -105.98 144.12 15.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -88.51 109.26 19.9 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.553 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.2 tt -73.09 124.83 26.33 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -175.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.7 mm -97.37 -51.43 10.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.338 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -152.07 134.59 15.33 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.89 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.553 ' HG3' HD21 ' A' ' 33' ' ' LEU . 50.6 mtmt -90.33 -25.84 20.27 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.555 0.693 . . . . 0.0 109.169 175.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -96.44 103.05 14.93 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.19 -0.913 . . . . 0.0 108.551 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.7 p -104.11 8.81 36.48 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.132 0.968 . . . . 0.0 108.94 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.03 -22.3 38.63 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -119.06 146.92 44.68 Favored 'General case' 0 N--CA 1.413 -2.286 0 CA-C-N 114.806 -0.697 . . . . 0.0 109.529 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.86 109.97 21.18 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 132.71 -23.47 3.98 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.723 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -107.14 126.92 53.0 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.41 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 35.5 m0 -108.88 150.65 27.38 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 88.5 tttt -108.59 129.1 55.32 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -140.8 160.51 26.63 Favored Glycine 0 N--CA 1.408 -3.233 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.7 tm-20 -117.78 123.75 46.75 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.6 tp -142.77 133.73 25.65 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 67.7 17.46 9.84 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 124.079 0.862 . . . . 0.0 111.169 171.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.01 3.1 62.12 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.677 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 9.5 mptt -115.84 125.75 53.07 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 122.394 -0.474 . . . . 0.0 110.417 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 10.6 pt-20 -112.42 112.92 24.83 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.014 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -145.84 -166.66 12.08 Favored Glycine 0 N--CA 1.423 -2.229 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -177.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 34.6 m -114.21 151.09 16.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-O 120.97 0.414 . . . . 0.0 110.163 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -154.48 150.55 22.16 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.862 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 23.6 Cg_exo -66.85 130.74 23.85 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 121.953 1.769 . . . . 0.0 110.544 175.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -67.79 -9.53 45.03 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -68.87 -16.66 63.83 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.074 0.549 . . . . 0.0 111.745 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -91.45 -3.93 56.1 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.09 163.16 30.54 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.63 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.23 142.57 42.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -86.84 144.5 26.99 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.922 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.4 mm -102.98 -44.33 9.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.651 0.738 . . . . 0.0 109.355 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.413 -2.289 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -178.015 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.349 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.89 -39.05 2.42 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 117.251 0.525 . . . . 0.0 110.218 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 mmt -113.11 2.11 15.55 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.702 0.763 . . . . 0.0 110.02 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.01 167.17 33.74 Favored Glycine 0 N--CA 1.424 -2.114 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.38 -27.57 46.87 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.979 0.419 . . . . 0.0 110.908 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -142.43 93.29 2.51 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.611 0.72 . . . . 0.0 110.324 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.503 ' HA ' ' OXT' ' A' ' 64' ' ' SER . 45.6 mt-10 -108.44 132.52 53.7 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.047 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -132.42 137.1 47.18 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.53 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 5.6 p -120.82 133.34 55.32 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.083 0.468 . . . . 0.0 109.946 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -99.55 129.84 45.75 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.3 p -62.92 128.78 37.46 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.158 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -97.35 -19.32 18.58 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -151.5 162.78 25.75 Favored Pre-proline 0 C--N 1.31 -1.141 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.7 165.68 11.94 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 121.729 1.619 . . . . 0.0 110.412 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -150.59 130.37 13.24 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.5 m -98.37 118.62 35.43 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.821 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.35 126.81 7.65 Favored Glycine 0 N--CA 1.417 -2.625 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.0 t -102.32 7.92 40.46 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 38.1 m-80 -127.6 152.36 47.74 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.77 -40.51 96.87 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -98.25 14.35 28.12 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.726 0.774 . . . . 0.0 111.602 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 44.8 tt0 -97.61 129.04 44.75 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 172.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.423 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -74.7 119.71 19.26 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.291 0.567 . . . . 0.0 111.821 -168.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.2 m -95.0 119.65 33.87 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -133.62 161.73 33.84 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -101.94 173.5 6.36 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.272 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -92.38 109.63 21.02 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.86 27.81 1.83 Allowed Glycine 0 C--N 1.304 -1.233 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.954 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -119.68 158.67 25.98 Favored 'General case' 0 C--O 1.251 1.164 0 CA-C-O 121.038 0.447 . . . . 0.0 111.146 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.6 mm -101.44 117.13 46.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 67.9 mt -94.53 134.3 32.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -89.3 109.59 20.47 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.519 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.6 tt -70.41 118.15 12.86 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.3 mm -93.27 -41.36 12.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.262 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.3 t -154.48 146.34 23.46 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.473 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.519 ' HG3' HD21 ' A' ' 33' ' ' LEU . 86.9 mttt -103.15 -3.55 25.66 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.964 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -115.1 103.14 10.59 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.603 0.716 . . . . 0.0 111.668 -176.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.5 p -118.46 9.88 12.49 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-O 122.111 0.957 . . . . 0.0 109.209 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.36 -21.28 46.36 Favored Glycine 0 N--CA 1.435 -1.402 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.044 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -125.98 142.17 51.64 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.3 125.94 30.15 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.372 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 114.38 -21.1 15.31 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.74 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -101.42 116.81 33.62 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 121.049 0.452 . . . . 0.0 110.416 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.434 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 40.6 m0 -108.77 155.54 20.65 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.589 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 16.8 ttmm -113.88 129.73 56.56 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -144.7 158.96 27.73 Favored Glycine 0 N--CA 1.414 -2.832 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 1.1 tm-20 -112.63 123.6 50.66 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.603 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 49.4 tp -147.05 130.44 16.67 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.945 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.603 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 59.3 m-80 66.05 18.65 11.07 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.716 1.206 . . . . 0.0 112.847 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.31 -18.72 20.61 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.012 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.26 144.37 44.91 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.528 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 10.1 pt-20 -102.03 116.36 32.51 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -125.63 -177.89 15.08 Favored Glycine 0 N--CA 1.409 -3.146 0 C-N-CA 119.962 -1.113 . . . . 0.0 111.067 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 27.4 m -114.23 146.69 18.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 52.7 p90 -154.38 153.85 28.68 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.814 -175.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 16.5 Cg_exo -71.08 129.34 16.06 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.303 2.002 . . . . 0.0 110.334 174.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.64 -20.87 63.87 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 124.284 1.033 . . . . 0.0 113.296 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -73.82 0.83 11.99 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -104.74 -0.86 26.92 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 122.264 -0.273 . . . . 0.0 111.529 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -141.19 146.72 37.31 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.977 -176.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 p -108.22 132.43 56.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -78.76 126.81 31.22 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.373 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.1 mm -91.51 -54.12 7.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.227 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.503 ' OXT' ' HA ' ' A' ' 7' ' ' GLU . 19.4 m . . . . . 0 N--CA 1.421 -1.91 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.477 -2.331 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 42.95 -79.03 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.327 1.851 . . . . 0.0 115.799 171.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.4 mtp -86.89 -4.73 59.21 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 122.969 0.508 . . . . 0.0 112.06 -173.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.98 -119.62 0.84 Allowed Glycine 0 C--N 1.3 -1.462 0 C-N-CA 120.338 -0.934 . . . . 0.0 114.574 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.67 -153.95 0.42 Allowed 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 123.288 0.635 . . . . 0.0 109.831 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -62.4 125.15 22.92 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 123.543 0.527 . . . . 0.0 109.837 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.579 ' HB3' HE22 ' A' ' 62' ' ' GLN . 45.9 mt-10 -106.15 145.31 31.67 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.468 -176.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -126.47 135.3 51.18 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.496 ' SG ' HD12 ' A' ' 33' ' ' LEU . 12.9 m -126.03 164.81 20.04 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.524 HH11 ' HA2' ' A' ' 28' ' ' GLY . 65.7 ttp85 -129.96 134.35 47.4 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.414 HG21 ' HB3' ' A' ' 25' ' ' PHE . 16.8 p -74.34 136.53 42.52 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.9 mt -98.7 -18.37 18.07 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.647 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -144.7 150.31 46.39 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.74 143.49 41.85 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 121.97 1.78 . . . . 0.0 110.046 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -138.05 135.45 35.88 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.427 ' HA ' HG23 ' A' ' 24' ' ' THR . 18.9 m -111.89 128.77 56.24 Favored 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.239 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . -82.13 126.56 7.49 Favored Glycine 0 N--CA 1.421 -2.323 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.5 p -96.18 -5.96 39.33 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.326 1.06 . . . . 0.0 109.85 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -142.18 153.75 44.28 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 113.503 -1.681 . . . . 0.0 106.599 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.21 -28.99 70.07 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -171.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -82.68 -7.36 59.65 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.286 0.565 . . . . 0.0 111.235 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.512 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 42.9 tt0 -102.46 114.14 28.09 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.644 HD13 ' HA3' ' A' ' 53' ' ' GLY . 3.9 mp -83.34 145.33 29.11 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -172.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.427 HG23 ' HA ' ' A' ' 16' ' ' THR . 86.4 m -94.82 131.55 40.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.832 -1.077 . . . . 0.0 108.962 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.467 ' CD2' HD22 ' A' ' 48' ' ' LEU . 97.1 m-85 -132.07 152.87 50.95 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 123.068 0.547 . . . . 0.0 110.299 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.43 ' H ' ' HG3' ' A' ' 29' ' ' GLU . 30.6 mtm180 -100.26 -176.07 3.12 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 171.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.3 122.04 34.39 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.524 ' HA2' HH11 ' A' ' 10' ' ' ARG . . . 100.57 21.57 12.53 Favored Glycine 0 C--N 1.313 -0.712 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.617 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 26' ' ' ARG . 20.7 mm-40 -94.88 137.18 34.28 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.5 mm -89.56 124.55 42.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 108.093 -1.076 . . . . 0.0 108.093 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.5 mt -99.87 134.74 38.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -89.29 102.37 15.03 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 172.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.496 HD12 ' SG ' ' A' ' 9' ' ' CYS . 6.8 tt -72.56 125.3 27.11 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 -175.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.6 mm -98.99 -42.37 10.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.951 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.3 m -153.35 131.45 11.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.747 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -87.16 -41.02 14.08 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -87.49 105.14 17.1 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.246 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.5 p -112.04 0.02 15.83 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.77 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.92 -40.17 2.52 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.9 115.24 28.41 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.127 0.489 . . . . 0.0 109.765 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.43 124.68 22.41 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.243 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 109.52 -16.56 31.58 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.549 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -106.87 124.78 50.11 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 120.951 0.405 . . . . 0.0 110.51 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -110.82 153.07 25.91 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 86.6 tttt -106.24 129.4 54.29 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.75 166.18 25.68 Favored Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.7 tm-20 -118.8 130.42 55.77 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.467 HD22 ' CD2' ' A' ' 25' ' ' PHE . 38.6 tp -144.95 127.01 15.57 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 63.39 21.41 12.77 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.179 0.992 . . . . 0.0 111.884 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.24 4.93 62.47 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.274 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 10.3 mptt -114.73 136.98 52.47 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -125.25 127.17 46.32 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.78 0.8 . . . . 0.0 110.188 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.644 ' HA3' HD13 ' A' ' 23' ' ' LEU . . . -163.18 -157.03 8.9 Favored Glycine 0 N--CA 1.415 -2.702 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.561 -175.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.9 m -115.95 151.05 17.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-O 120.977 0.418 . . . . 0.0 111.893 -173.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -151.98 150.04 24.93 Favored Pre-proline 0 N--CA 1.434 -1.23 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.248 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 7.1 Cg_exo -74.5 128.77 12.18 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 121.831 1.688 . . . . 0.0 109.463 175.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -62.23 -20.17 63.94 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -171.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -71.77 -10.44 59.77 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.17 -1.32 57.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.248 0.546 . . . . 0.0 110.59 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -139.85 174.98 9.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.436 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.35 146.83 26.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.579 HE22 ' HB3' ' A' ' 7' ' ' GLU . 53.6 tp60 -74.62 147.87 41.23 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' A' ' 10' ' ' ARG . 45.9 mm -95.69 -55.63 5.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.9 p . . . . . 0 N--CA 1.414 -2.24 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.68 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.588 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.64 -5.78 59.33 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 122.681 -0.305 . . . . 0.0 111.446 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.6 ttt -71.17 140.78 50.65 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.9 133.58 17.27 Favored Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 114.811 0.684 . . . . 0.0 114.811 -173.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.02 -68.64 0.78 Allowed 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.505 ' HA ' ' NE2' ' A' ' 32' ' ' HIS . 48.8 mtpt -144.06 76.83 1.52 Allowed 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 170.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.634 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 19.2 mm-40 -101.56 118.14 36.34 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.09 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -120.16 132.51 55.42 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.821 0.82 . . . . 0.0 112.073 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.2 m -123.83 143.15 50.51 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.551 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -99.36 130.93 45.68 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.9 p -70.51 128.74 37.19 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 123.549 0.53 . . . . 0.0 109.917 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.0 mt -99.77 -18.57 17.14 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.591 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -140.64 145.35 39.92 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.66 141.11 40.82 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.115 1.876 . . . . 0.0 109.929 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -142.86 142.35 31.77 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 m -107.53 117.79 35.04 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.638 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.15 116.34 8.37 Favored Glycine 0 N--CA 1.425 -2.079 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 m -83.06 -20.15 35.51 Favored 'General case' 0 N--CA 1.388 -3.527 0 CA-C-O 122.438 1.113 . . . . 0.0 108.044 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -114.35 155.53 26.09 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -73.19 -29.86 63.13 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.332 0.587 . . . . 0.0 110.138 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -84.87 9.07 15.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.861 0.838 . . . . 0.0 110.533 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -112.09 133.37 54.29 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mt -78.62 133.43 37.27 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -173.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.1 m -98.08 120.14 37.96 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 173.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -134.23 155.09 50.78 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.49 169.35 8.7 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -79.39 130.33 35.32 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -175.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.14 23.38 13.12 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.999 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -107.73 138.09 44.59 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.5 mm -94.31 125.04 46.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 55.5 mt -109.17 135.45 48.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.505 ' NE2' ' HA ' ' A' ' 6' ' ' LYS . 19.2 t-80 -90.52 104.68 17.23 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.634 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 4.7 tt -69.39 129.02 38.6 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.508 -177.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.7 mm -100.07 -37.85 6.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.443 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.9 m -148.87 122.16 8.99 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 121.522 -0.736 . . . . 0.0 111.589 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.562 ' HG3' HD21 ' A' ' 33' ' ' LEU . 37.6 mtmt -80.77 -2.95 49.2 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.526 0.679 . . . . 0.0 111.651 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -136.32 124.68 23.34 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.495 0.664 . . . . 0.0 109.665 173.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.1 p -113.18 17.07 18.95 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 122.015 0.912 . . . . 0.0 109.217 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.97 -12.79 62.35 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 107.918 -2.073 . . . . 0.0 107.918 -170.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -131.65 149.55 52.45 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.82 104.29 13.94 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.71 -27.66 1.32 Allowed Glycine 0 C--N 1.297 -1.625 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -112.97 121.83 45.83 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -107.98 147.9 30.45 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.971 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -105.83 130.01 53.89 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -146.99 163.89 28.61 Favored Glycine 0 N--CA 1.417 -2.572 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -109.43 123.39 49.27 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.4 tp -136.77 121.07 18.01 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.617 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 63.94 23.08 13.21 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 124.154 0.909 . . . . 0.0 111.437 174.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.08 -19.79 37.03 Favored Glycine 0 N--CA 1.427 -1.911 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.748 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -100.23 126.4 46.52 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 117.717 0.758 . . . . 0.0 111.2 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 6.7 pt-20 -102.04 100.89 11.19 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.991 175.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -131.57 -163.92 10.97 Favored Glycine 0 C--N 1.286 -2.235 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.638 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.5 m -114.47 150.99 16.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 116.871 0.335 . . . . 0.0 110.812 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -147.61 155.16 45.26 Favored Pre-proline 0 N--CA 1.433 -1.296 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.438 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.53 133.79 38.57 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.153 1.902 . . . . 0.0 110.851 176.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -62.72 -15.12 51.56 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.249 1.02 . . . . 0.0 112.842 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -101.77 -13.19 17.82 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -80.8 -7.5 59.43 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.176 0.512 . . . . 0.0 111.964 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -136.88 139.54 41.71 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.03 125.47 57.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -78.35 113.99 16.84 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.426 0.632 . . . . 0.0 111.047 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.0 pt -85.36 -48.32 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.946 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.2 m . . . . . 0 N--CA 1.408 -2.564 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.456 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.692 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.74 105.15 17.51 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 88.1 mmm -95.05 122.94 38.23 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.387 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.92 -29.95 1.52 Allowed Glycine 0 N--CA 1.429 -1.815 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -174.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 68.41 -61.58 0.4 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.753 1.621 . . . . 0.0 112.414 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -110.98 96.72 6.33 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.624 0.726 . . . . 0.0 109.445 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 41.6 mt-10 -119.45 140.24 50.76 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -122.87 138.4 54.67 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.278 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.8 m -128.26 137.23 51.9 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.689 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -101.48 136.89 40.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.1 p -72.93 133.63 44.43 Favored 'General case' 0 N--CA 1.417 -2.077 0 O-C-N 123.519 0.512 . . . . 0.0 109.944 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.2 mt -99.13 -18.17 17.83 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -144.87 150.72 47.23 Favored Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.38 154.21 21.36 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 121.807 1.671 . . . . 0.0 110.383 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -150.97 136.11 17.56 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.463 ' HA ' HG23 ' A' ' 24' ' ' THR . 26.0 m -103.11 128.75 49.92 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.9 137.15 16.17 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 t -89.48 -15.42 33.1 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 122.345 1.069 . . . . 0.0 108.331 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 87.7 m-20 -115.42 157.25 24.21 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.778 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.75 -30.6 71.29 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.937 0.875 . . . . 0.0 110.351 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.01 12.22 27.0 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.8 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 33.8 tt0 -114.37 115.0 26.65 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 174.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.4 HD21 ' HB3' ' A' ' 48' ' ' LEU . 1.1 tt -70.78 120.03 15.79 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.479 -166.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 16' ' ' THR . 87.0 m -89.76 120.1 30.73 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.018 175.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -135.13 161.8 34.3 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -105.17 174.98 5.65 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -87.8 123.25 32.4 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.25 8.05 15.54 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -92.81 137.11 32.65 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.763 0.316 . . . . 0.0 110.401 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mm -99.05 117.28 43.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.2 mt -102.99 141.72 18.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -174.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -90.09 114.72 26.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.7 tt -74.07 127.53 33.16 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.6 mm -102.95 -52.48 8.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.216 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 45' ' ' LYS . 20.0 m -143.96 130.98 20.51 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.958 -0.11 . . . . 0.0 110.799 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.474 ' HG3' HD21 ' A' ' 33' ' ' LEU . 97.8 mttt -88.29 -15.98 34.33 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.823 0.821 . . . . 0.0 110.379 177.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -114.07 121.67 44.55 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.79 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.0 p -123.64 17.48 9.57 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.05 -47.85 1.0 Allowed Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -100.63 161.3 13.69 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.687 -0.757 . . . . 0.0 109.812 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.03 85.52 2.22 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 176.15 -47.96 0.12 Allowed Glycine 0 CA--C 1.49 -1.486 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -82.85 121.3 26.76 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.9 m0 -107.9 144.19 35.48 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 64.0 tttp -103.31 129.33 50.29 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.19 168.23 27.15 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -123.28 129.11 50.89 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HB3' HD21 ' A' ' 23' ' ' LEU . 64.4 tp -138.79 115.77 10.89 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.796 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 62.97 23.93 14.28 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 123.907 0.883 . . . . 0.0 111.672 173.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.28 -14.28 39.82 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.885 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 9.6 mptt -103.27 136.37 43.17 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.0 146.68 46.44 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.67 -160.99 26.21 Favored Glycine 0 N--CA 1.422 -2.276 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.03 152.36 16.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 116.947 0.374 . . . . 0.0 110.122 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 53.2 p90 -149.76 152.05 33.9 Favored Pre-proline 0 N--CA 1.425 -1.684 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 55' ' ' PHE . 6.2 Cg_exo -76.06 129.29 11.29 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.678 1.586 . . . . 0.0 111.611 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -49.93 -29.7 8.83 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.509 1.524 . . . . 0.0 113.507 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -68.08 -10.58 55.02 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -96.31 -9.55 29.92 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.79 160.84 38.71 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.967 -175.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 p -128.3 133.51 66.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.484 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 51.5 tt0 -73.9 116.86 15.01 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.334 0.588 . . . . 0.0 110.007 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.4 pt -91.3 -23.76 5.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.57 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.419 -1.98 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.785 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.612 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.491 ' HB1' ' HB2' ' A' ' 36' ' ' LYS . . . -142.93 145.96 33.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 117.064 0.432 . . . . 0.0 110.09 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.8 ptm -137.81 -165.7 1.83 Allowed 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.21 80.92 0.23 Allowed Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.36 -60.16 2.49 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.446 0.641 . . . . 0.0 110.864 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -144.05 25.17 1.6 Allowed 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -86.36 137.06 32.87 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.787 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -123.38 158.29 31.43 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.508 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.2 p -135.84 134.12 38.52 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.146 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -100.24 135.73 41.21 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.4 p -60.85 135.68 57.85 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 124.856 1.262 . . . . 0.0 110.867 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.445 HD11 ' HB ' ' A' ' 61' ' ' VAL . 92.4 mt -108.13 -19.08 13.61 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.232 0.539 . . . . 0.0 109.904 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -148.05 152.38 39.85 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.53 148.37 42.38 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.587 1.525 . . . . 0.0 109.538 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -139.11 132.78 30.57 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.5 m -107.38 129.87 54.87 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.68 138.9 15.12 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -91.8 -16.49 26.73 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -125.63 169.92 12.02 Favored 'General case' 0 N--CA 1.402 -2.852 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.905 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -77.32 -28.11 53.08 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -174.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.27 -12.15 57.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.255 1.026 . . . . 0.0 110.154 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.03 107.58 18.49 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.419 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 2.7 tm? -71.96 133.41 45.34 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.24 -169.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.3 m -102.5 120.85 41.23 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.162 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -133.85 161.75 33.89 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -111.28 171.39 7.51 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -84.58 113.3 21.15 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.47 24.01 2.48 Favored Glycine 0 N--CA 1.425 -2.074 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.879 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -119.94 147.47 44.71 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.7 mm -100.36 119.85 49.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.508 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 61.7 mt -103.07 138.1 28.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -88.63 112.87 23.59 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.522 HD21 ' HG3' ' A' ' 36' ' ' LYS . 5.0 tt -76.1 122.45 24.3 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -174.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.522 HD11 ' HB2' ' A' ' 47' ' ' GLU . 41.1 mt -97.01 -39.14 8.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.335 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.2 t -160.56 138.77 9.92 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.285 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.522 ' HG3' HD21 ' A' ' 33' ' ' LEU . 89.9 mttt -89.75 -8.4 52.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.283 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.35 129.99 49.9 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.357 0.598 . . . . 0.0 110.269 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.9 p -125.42 23.9 7.43 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.79 0.805 . . . . 0.0 109.722 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.0 -39.39 2.86 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -174.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -104.43 139.85 38.78 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.16 102.1 14.63 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.17 -26.69 1.87 Allowed Glycine 0 C--N 1.303 -1.275 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -98.9 126.24 44.51 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.412 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 36.6 m0 -107.27 154.24 21.54 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.561 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 61.4 tttp -115.33 128.74 56.3 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.37 160.98 28.53 Favored Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.211 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.2 tm-20 -117.52 131.34 56.72 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.504 0.668 . . . . 0.0 110.748 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 68.7 tp -141.34 127.68 19.86 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 67.89 15.36 9.55 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.466 1.106 . . . . 0.0 111.395 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.74 0.77 62.19 Favored Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.353 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 4.4 mptp? -105.92 129.52 54.05 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.36 121.86 46.31 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -143.58 -174.09 15.6 Favored Glycine 0 N--CA 1.412 -2.904 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.361 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 35.4 m -115.31 150.93 17.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 O-C-N 123.884 0.403 . . . . 0.0 109.988 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -160.71 151.2 15.06 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.616 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.96 138.05 36.3 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 122.158 1.905 . . . . 0.0 110.768 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.78 -16.76 63.47 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -173.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -72.91 -1.46 16.97 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 120.987 0.423 . . . . 0.0 111.576 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -102.42 -3.09 27.54 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.78 156.02 44.92 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.89 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.445 ' HB ' HD11 ' A' ' 12' ' ' LEU . 14.4 p -118.91 136.05 57.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -78.81 117.71 20.18 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.2 pt -87.65 -9.4 10.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.433 0.635 . . . . 0.0 111.678 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--N 1.283 -2.321 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.672 177.315 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.957 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.43 87.15 2.27 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.1 mtt 60.13 80.92 0.19 Allowed 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 125.248 1.592 . . . . 0.0 111.071 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -151.98 63.38 0.38 Allowed Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.546 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.88 -43.58 1.35 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.55 0.69 . . . . 0.0 110.57 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -121.85 11.37 10.37 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 122.404 1.097 . . . . 0.0 108.25 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.547 ' HA ' ' OXT' ' A' ' 64' ' ' SER . 14.5 mp0 -95.61 114.96 26.76 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 112.929 -1.941 . . . . 0.0 109.437 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -131.92 145.37 51.47 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.9 m -127.96 142.91 51.11 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.539 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -104.05 132.31 50.43 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.0 p -76.49 134.84 39.39 Favored 'General case' 0 C--N 1.288 -2.109 0 CA-C-O 121.155 0.502 . . . . 0.0 111.724 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.6 mt -95.5 -17.97 21.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.873 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -141.44 154.32 66.76 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.571 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.79 134.71 8.6 Favored 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 122.011 1.808 . . . . 0.0 109.375 169.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -135.25 138.15 43.25 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.422 ' HA ' HG23 ' A' ' 24' ' ' THR . 23.0 m -107.5 122.42 46.62 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.039 -177.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.445 ' HA2' ' HG2' ' A' ' 22' ' ' GLU . . . -82.09 106.81 2.72 Favored Glycine 0 N--CA 1.413 -2.838 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.77 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.7 -33.28 21.55 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 90.5 m-20 -88.8 153.95 20.66 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.892 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -62.11 -37.45 85.15 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.793 0.33 . . . . 0.0 111.661 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -90.91 10.67 25.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.629 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 46.8 tt0 -110.44 125.55 53.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 mt -82.86 139.51 33.43 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -175.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 16' ' ' THR . 51.4 m -99.32 119.44 37.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -134.88 159.78 40.35 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -101.11 -179.7 4.12 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -85.51 133.55 34.07 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.54 17.4 39.2 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.101 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -92.42 142.57 27.28 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.8 mm -99.99 123.55 52.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.9 mt -114.31 142.34 27.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -89.17 115.27 26.56 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 tt -66.11 133.82 51.51 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.4 mm -112.48 -49.41 5.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.427 0.632 . . . . 0.0 109.436 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.3 m -149.94 118.5 6.52 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.631 -0.668 . . . . 0.0 111.596 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -73.45 -26.08 60.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.505 0.669 . . . . 0.0 109.833 173.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -101.98 111.97 24.44 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.2 p -110.12 -2.29 17.02 Favored 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.43 -10.88 33.28 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -125.8 143.78 50.92 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.17 86.72 5.04 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.199 0.523 . . . . 0.0 109.614 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.91 -30.27 0.39 Allowed Glycine 0 CA--C 1.489 -1.591 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -89.63 123.22 33.49 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -108.99 134.21 51.94 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 84.6 tttt -99.12 129.61 45.39 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -142.54 165.18 26.85 Favored Glycine 0 N--CA 1.423 -2.195 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 41.7 tt0 -110.77 131.95 54.61 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 123.772 0.337 . . . . 0.0 110.346 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.9 tp -148.27 119.72 7.92 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.098 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 62.06 34.08 16.73 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.965 0.906 . . . . 0.0 112.212 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.9 -10.99 68.2 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.651 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 4.6 mptp? -105.82 129.7 53.95 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-N 117.482 0.641 . . . . 0.0 111.083 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 46' ' ' GLY 0.383 0.0 OUTLIER -111.99 106.29 14.93 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 122.662 1.22 . . . . 0.0 111.002 170.831 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -134.61 -171.57 12.55 Favored Glycine 0 N--CA 1.425 -2.084 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.354 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.0 m -114.63 150.82 16.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-O 121.303 0.573 . . . . 0.0 111.403 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -152.42 148.76 21.43 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.956 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.67 129.76 21.85 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 121.569 1.512 . . . . 0.0 109.498 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.75 -22.6 58.24 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -172.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -69.19 -8.2 43.46 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -91.96 -0.7 57.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.641 0.257 . . . . 0.0 110.907 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -144.73 165.95 26.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.719 0.295 . . . . 0.0 110.861 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 p -131.57 134.37 60.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -71.27 118.2 13.77 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.3 pt -96.51 -23.78 4.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-O 121.953 0.882 . . . . 0.0 110.522 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.547 ' OXT' ' HA ' ' A' ' 7' ' ' GLU . 44.9 m . . . . . 0 N--CA 1.4 -2.938 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 37' ' ' GLU . . . . . . . . 0 CA--C 1.506 -0.53 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.0 148.69 48.54 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.2 ttp -99.49 94.2 6.29 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.729 0.776 . . . . 0.0 112.573 -172.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 6' ' ' LYS . . . 80.72 -4.6 68.66 Favored Glycine 0 N--CA 1.437 -1.233 0 CA-C-N 115.058 -0.974 . . . . 0.0 114.827 174.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.42 24.1 13.67 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.95 0.881 . . . . 0.0 110.543 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 4' ' ' GLY . 58.5 mttp -109.14 26.45 10.61 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.53 137.56 40.61 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -130.23 139.45 50.79 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.49 -175.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.405 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 13.8 p -124.01 147.62 47.67 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.342 -178.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -108.15 135.61 49.21 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.411 HG21 ' CD1' ' A' ' 25' ' ' PHE . 43.2 p -79.44 136.65 37.0 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.399 0.619 . . . . 0.0 112.268 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.0 mt -99.96 -18.01 17.28 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.672 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -145.55 156.37 52.95 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -84.2 151.2 12.23 Favored 'Trans proline' 0 C--O 1.253 1.265 0 C-N-CA 122.142 1.895 . . . . 0.0 111.323 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -137.55 125.8 23.16 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.446 ' HA ' HG23 ' A' ' 24' ' ' THR . 23.5 m -112.99 110.88 21.23 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.47 144.49 44.2 Favored Glycine 0 N--CA 1.412 -2.958 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.992 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.1 p -89.93 -21.44 22.47 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -121.11 157.2 30.64 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -87.87 12.01 14.2 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.471 1.129 . . . . 0.0 109.853 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -78.65 -31.35 46.76 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 170.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -82.32 150.03 27.43 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 113.333 -1.758 . . . . 0.0 107.148 173.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 48' ' ' LEU . 3.2 tm? -103.58 126.33 50.66 Favored 'General case' 0 C--N 1.281 -2.396 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.625 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.446 HG23 ' HA ' ' A' ' 16' ' ' THR . 94.3 m -94.53 120.43 34.75 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.204 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 11' ' ' THR . 23.4 p90 -134.77 158.88 43.02 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.411 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -99.63 -179.3 4.15 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -81.1 133.77 35.53 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.2 27.29 28.52 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.118 176.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -105.97 151.47 24.57 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mm -101.26 124.48 55.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.405 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 62.7 mt -110.02 143.88 19.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -89.33 104.97 17.48 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.578 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.4 tt -71.62 128.23 35.13 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.215 0.531 . . . . 0.0 109.758 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.35 -50.51 9.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.957 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.8 m -144.21 131.24 20.5 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.944 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.578 ' HG3' HD21 ' A' ' 33' ' ' LEU . 44.5 mtmt -97.98 -22.52 16.25 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.598 0.713 . . . . 0.0 110.476 174.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.425 ' HB3' ' HA2' ' A' ' 1' ' ' GLY . 33.9 tt0 -109.8 86.44 2.3 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 p -87.4 -18.23 30.48 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.703 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.81 -43.0 1.02 Allowed Glycine 0 C--N 1.28 -2.571 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -120.36 111.14 17.38 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.85 109.25 1.69 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 152.14 -33.0 0.87 Allowed Glycine 0 C--N 1.287 -2.183 0 N-CA-C 107.545 -2.222 . . . . 0.0 107.545 -174.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -100.34 124.6 46.03 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 35.6 m0 -107.86 146.09 32.78 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.21 129.09 55.78 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.22 159.65 27.93 Favored Glycine 0 N--CA 1.41 -3.082 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.2 tm-20 -110.73 130.55 55.54 Favored 'General case' 0 N--CA 1.414 -2.244 0 O-C-N 124.402 0.707 . . . . 0.0 109.358 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.459 ' HB3' HD11 ' A' ' 23' ' ' LEU . 43.0 tp -144.66 127.42 16.26 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.254 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.4 m120 65.26 17.98 11.22 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.754 1.221 . . . . 0.0 111.484 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.01 -15.4 55.28 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.36 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 12.1 mptt -100.52 133.54 44.81 Favored 'General case' 0 CA--C 1.489 -1.379 0 CA-C-N 117.013 0.406 . . . . 0.0 110.31 -175.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -111.38 121.61 45.69 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.041 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.22 -170.01 13.93 Favored Glycine 0 C--N 1.287 -2.168 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.1 m -115.22 150.88 17.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 120.796 0.332 . . . . 0.0 110.591 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -156.13 149.06 18.23 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.134 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 34.8 Cg_exo -66.72 136.99 44.11 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.072 1.848 . . . . 0.0 111.398 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -63.2 -13.36 36.59 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.108 0.963 . . . . 0.0 112.743 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -71.91 -10.6 60.01 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.165 0.586 . . . . 0.0 111.922 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -107.61 8.62 29.24 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.666 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.13 154.33 43.79 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.427 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.16 131.6 72.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -76.53 127.54 33.02 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.8 mm -90.51 -49.79 13.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.41 -2.475 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -179.709 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.266 0 N-CA-C 112.81 -0.116 . . . . 0.0 112.81 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.91 81.07 6.97 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.658 0.742 . . . . 0.0 111.684 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.6 ttp -149.96 134.67 17.62 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.1 -164.92 16.87 Favored Glycine 0 C--N 1.297 -1.603 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.37 -34.9 2.44 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.258 0.551 . . . . 0.0 110.296 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -98.12 75.65 2.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.538 0.685 . . . . 0.0 110.414 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -146.69 111.76 5.41 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 172.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -110.8 134.42 52.52 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.594 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.473 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 12.9 p -120.03 146.32 45.99 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-O 121.173 0.511 . . . . 0.0 110.233 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -106.0 134.66 48.77 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.0 p -66.74 140.12 57.85 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 123.823 0.849 . . . . 0.0 110.25 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.5 mt -107.04 -20.22 13.38 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.818 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -153.4 152.27 27.23 Favored Pre-proline 0 C--N 1.316 -0.853 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -177.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.28 110.85 3.15 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 121.626 1.551 . . . . 0.0 111.29 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -109.4 131.4 55.1 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.509 ' HA ' HG23 ' A' ' 24' ' ' THR . 24.2 m -110.6 129.6 55.77 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.94 150.28 39.1 Favored Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.0 t -98.74 5.66 47.44 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.734 1.254 . . . . 0.0 108.284 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -156.0 173.25 17.07 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.504 -1.68 . . . . 0.0 106.658 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -79.62 -30.35 41.39 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -174.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.13 -21.77 60.66 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.182 0.992 . . . . 0.0 109.313 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -87.99 110.45 20.6 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.1 135.13 38.57 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.581 0.705 . . . . 0.0 111.6 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 16' ' ' THR . 94.7 m -98.92 122.54 42.3 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.569 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -133.39 157.77 44.71 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.529 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -109.84 -167.41 1.2 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 122.745 0.418 . . . . 0.0 110.568 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -89.22 141.71 28.29 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.85 29.97 49.61 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.272 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.03 157.53 23.35 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 122.154 -0.615 . . . . 0.0 112.272 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.6 mm -111.73 124.78 68.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.473 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 65.3 mt -114.48 143.62 23.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -89.49 116.01 27.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.5 tt -79.73 118.99 22.04 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 47' ' ' GLU . 61.3 mt -89.52 -47.99 14.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.52 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.1 m -155.88 140.77 17.2 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 122.149 -0.344 . . . . 0.0 110.621 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -90.86 -16.56 28.02 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -106.9 103.03 12.35 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.063 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.0 p -107.18 3.02 25.19 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.784 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.86 -14.91 41.1 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -130.54 116.38 18.08 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.31 118.59 10.21 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.48 -22.76 7.32 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -105.3 122.37 45.81 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.7 m0 -108.18 155.06 20.86 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -110.56 129.85 55.7 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.85 164.23 25.51 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.526 ' HB2' HD11 ' A' ' 34' ' ' ILE . 25.2 tt0 -124.94 123.93 40.95 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.4 tp -125.2 117.45 23.88 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 66.14 21.85 11.12 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.193 0.997 . . . . 0.0 110.82 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.16 -10.02 58.1 Favored Glycine 0 N--CA 1.435 -1.393 0 CA-C-N 115.661 -0.699 . . . . 0.0 113.712 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 3.3 mptp? -97.84 132.3 43.57 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 117.852 0.826 . . . . 0.0 109.405 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.85 148.05 29.0 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 123.673 0.608 . . . . 0.0 111.917 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.49 -172.06 40.81 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.21 156.58 16.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 116.809 0.304 . . . . 0.0 110.809 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -158.35 156.05 26.82 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.114 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -74.48 136.21 21.24 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.116 1.877 . . . . 0.0 110.913 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -61.33 -21.97 64.49 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -174.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -73.16 -4.65 34.13 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -102.45 4.52 38.85 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.933 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.92 164.38 33.92 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.1 p -134.64 140.64 45.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 52.6 tt0 -85.28 133.01 34.17 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.255 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.6 mt -79.3 -67.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 N--CA 1.403 -2.822 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 177.763 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.038 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.483 ' HB1' ' OE2' ' A' ' 7' ' ' GLU . . . 51.85 -163.11 0.07 Allowed 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.466 1.106 . . . . 0.0 111.066 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -102.31 -6.54 22.97 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.396 172.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.79 -131.15 10.31 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 117.06 1.584 . . . . 0.0 117.06 164.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.0 -29.83 3.8 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 116.448 2.018 . . . . 0.0 116.448 -168.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.251 27.3 mtpp -98.85 19.98 13.96 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' OE2' ' HB1' ' A' ' 2' ' ' ALA . 43.8 mt-10 -99.18 125.95 44.87 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 170.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -120.22 133.5 55.47 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.578 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.564 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 3.4 p -122.3 149.3 43.93 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.993 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 51.2 ttt180 -118.79 133.92 55.51 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.507 HG23 HD11 ' A' ' 31' ' ' ILE . 4.3 p -74.92 135.66 41.45 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.4 mt -103.01 -17.6 15.36 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -138.44 150.86 67.85 Favored Pre-proline 0 N--CA 1.438 -1.07 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.304 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -76.7 161.03 34.16 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.09 1.86 . . . . 0.0 110.643 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -149.19 124.59 10.27 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.7 m -101.92 124.85 48.24 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.98 134.07 12.52 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.1 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -95.31 -15.16 23.33 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 122.304 1.05 . . . . 0.0 108.493 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -112.38 168.41 9.66 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -86.43 -27.5 24.1 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.729 0.776 . . . . 0.0 109.647 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.86 -28.03 60.5 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.863 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -82.36 116.78 22.0 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.55 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -89.72 143.22 26.98 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.046 0.45 . . . . 0.0 110.481 -169.535 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.2 m -92.66 128.38 38.5 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.177 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 98.8 m-85 -129.03 147.08 50.86 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.143 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 26' ' ' ARG . 37.2 mmt180 -104.62 171.61 7.23 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 172.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -78.71 133.95 37.12 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 122.557 0.343 . . . . 0.0 110.871 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.56 16.88 57.93 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.995 -0.621 . . . . 0.0 113.388 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 27.5 mm-40 -92.72 147.38 22.92 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.1 mm -98.72 118.31 45.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.564 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 53.4 mt -99.13 135.22 35.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.075 -175.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -89.65 107.1 18.89 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.525 HD21 ' HG3' ' A' ' 36' ' ' LYS . 8.0 tt -70.5 140.22 51.81 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 121.11 0.481 . . . . 0.0 110.706 -173.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mm -108.72 -44.92 6.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.311 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.3 t -157.44 145.23 18.89 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.525 ' HG3' HD21 ' A' ' 33' ' ' LEU . 51.1 mtpt -102.86 1.23 33.71 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-O 121.746 0.784 . . . . 0.0 109.645 175.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -121.63 115.76 23.34 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.609 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -124.63 3.76 8.25 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.806 0.812 . . . . 0.0 109.847 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.23 -21.62 39.04 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -114.8 135.46 54.16 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.764 -0.718 . . . . 0.0 109.195 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.65 99.8 11.54 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 134.25 -14.2 4.57 Favored Glycine 0 N--CA 1.421 -2.327 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.187 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -107.45 125.74 51.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.287 0.565 . . . . 0.0 110.329 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.518 ' CZ2' ' HE3' ' A' ' 36' ' ' LYS . 43.3 m0 -113.71 164.9 13.11 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.235 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -118.31 129.97 55.76 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.54 158.02 27.4 Favored Glycine 0 N--CA 1.421 -2.358 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 1.1 tm-20 -112.1 131.52 55.39 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 123.239 0.616 . . . . 0.0 109.831 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 51.0 tp -144.56 132.62 21.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 68.76 13.79 8.91 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.407 1.083 . . . . 0.0 111.838 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.14 9.47 56.99 Favored Glycine 0 N--CA 1.427 -1.903 0 C-N-CA 121.151 -0.547 . . . . 0.0 111.776 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -123.75 126.75 47.07 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.073 0.463 . . . . 0.0 110.849 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -99.69 125.87 45.63 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.297 177.595 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.26 -172.47 17.48 Favored Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.3 m -115.13 158.19 15.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 117.215 0.507 . . . . 0.0 110.871 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -162.03 156.46 19.01 Favored Pre-proline 0 C--N 1.319 -0.726 0 O-C-N 124.004 0.815 . . . . 0.0 109.595 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 6.6 Cg_exo -75.8 127.58 10.25 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.206 1.937 . . . . 0.0 109.428 172.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -65.6 -17.54 64.66 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.627 0.371 . . . . 0.0 111.941 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -65.7 -14.03 60.45 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -87.32 -2.9 58.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.179 0.514 . . . . 0.0 110.818 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.94 177.82 7.61 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.431 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.49 135.54 43.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -81.65 129.48 34.71 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.85 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.2 mm -77.38 -68.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.399 -3.004 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.341 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.691 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.47 79.94 1.76 Allowed 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 121.063 0.458 . . . . 0.0 110.488 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 mmt -101.91 152.01 21.43 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.951 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.2 148.28 18.5 Favored Glycine 0 N--CA 1.419 -2.445 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.969 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.42 -55.1 1.02 Allowed 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.7 16.52 13.75 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.357 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 9.3 mm-40 -90.54 108.19 19.64 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -175.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -121.85 138.85 54.23 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.592 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 8.0 p -125.47 142.25 51.61 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.75 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -101.61 135.79 42.53 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 64.2 p -77.5 128.63 34.51 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-O 121.258 0.551 . . . . 0.0 111.65 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.1 mt -98.9 -18.14 18.02 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.138 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -142.52 143.95 28.59 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -74.24 141.75 29.51 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.9 1.733 . . . . 0.0 109.853 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -137.37 128.43 27.6 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.521 ' HA ' HG23 ' A' ' 24' ' ' THR . 24.3 m -100.84 118.0 36.03 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.702 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.7 125.71 17.07 Favored Glycine 0 N--CA 1.427 -1.957 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.3 p -82.26 -20.51 37.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.746 1.26 . . . . 0.0 108.633 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 44.0 m-80 -115.42 161.9 17.9 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.99 -19.81 29.81 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.582 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -79.91 -3.39 47.88 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.3 1.047 . . . . 0.0 108.9 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 36.7 tt0 -107.19 126.12 51.99 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' A' ' 48' ' ' LEU . 2.3 tm? -86.8 135.13 33.46 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.571 -167.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.521 HG23 ' HA ' ' A' ' 16' ' ' THR . 90.0 m -100.3 119.85 39.04 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.29 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -134.85 151.92 51.31 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.738 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -99.71 179.49 4.52 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 173.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.3 139.85 36.43 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.63 10.34 55.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.222 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -95.49 156.8 16.17 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 122.589 -0.359 . . . . 0.0 110.256 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.9 mm -110.33 116.25 51.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.592 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 62.5 mt -101.75 131.51 49.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -90.77 102.67 15.42 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 6.0 tt -69.03 134.47 49.47 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.656 -173.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.0 mm -101.2 -51.2 9.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.411 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.9 m -146.62 141.64 27.11 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.739 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.446 ' HG2' HD11 ' A' ' 33' ' ' LEU . 47.1 mtmt -91.58 -22.65 20.21 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 172.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -101.78 112.57 25.21 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.462 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.8 p -106.39 2.23 26.33 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.92 0.867 . . . . 0.0 109.069 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.45 -44.1 1.54 Allowed Glycine 0 N--CA 1.427 -1.925 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -99.02 134.24 42.15 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.85 102.11 7.09 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.54 -27.34 1.66 Allowed Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -99.06 128.7 45.24 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 24.5 m0 -108.06 159.92 16.2 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 53.0 tttm -128.32 128.37 44.47 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -150.12 160.08 28.38 Favored Glycine 0 N--CA 1.425 -2.094 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -175.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -107.19 127.12 53.23 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.257 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.496 ' HB3' HD11 ' A' ' 23' ' ' LEU . 68.7 tp -133.22 111.14 10.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.7 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 63.82 18.94 11.48 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 124.712 1.205 . . . . 0.0 113.099 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.81 -25.24 5.9 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.136 -1.03 . . . . 0.0 113.846 177.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 1.5 mptm? -106.09 142.32 35.98 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 117.697 0.748 . . . . 0.0 110.888 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 14.1 pt-20 -118.76 114.22 22.34 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -132.46 -166.85 11.64 Favored Glycine 0 N--CA 1.42 -2.383 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.66 153.16 16.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -161.73 147.74 10.84 Favored Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 123.88 0.737 . . . . 0.0 109.482 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.43 134.88 29.79 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 121.833 1.688 . . . . 0.0 109.937 174.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.26 1.43 2.91 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -76.37 -22.31 54.99 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 122.942 0.497 . . . . 0.0 110.635 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -91.38 2.09 56.65 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -174.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.12 171.29 15.55 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 122.363 -0.21 . . . . 0.0 110.529 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.47 132.04 40.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -70.18 117.34 11.62 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.031 0.443 . . . . 0.0 110.736 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.6 mt -67.81 -50.16 62.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.426 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 N--CA 1.411 -2.405 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.914 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.38 127.17 6.15 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 mmt -114.43 21.74 14.32 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.008 0.432 . . . . 0.0 110.541 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 33' ' ' LEU . . . 67.81 52.07 31.33 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.215 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.99 -78.45 0.21 Allowed 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -149.78 78.05 1.34 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.371 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -135.57 121.92 20.47 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -121.45 144.48 48.66 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.598 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.5 p -131.12 150.49 52.12 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.526 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -110.14 133.99 52.65 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.602 HG23 HD11 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -75.92 125.99 30.15 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-O 121.011 0.434 . . . . 0.0 111.313 175.416 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.1 mt -96.41 -9.58 29.57 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.936 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -142.27 141.14 20.37 Favored Pre-proline 0 N--CA 1.431 -1.379 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.708 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.33 132.1 18.75 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.065 1.843 . . . . 0.0 109.648 171.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 24' ' ' THR . 87.1 t80 -124.94 122.28 36.88 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.0 m -101.44 120.54 40.44 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.34 143.28 38.82 Favored Glycine 0 N--CA 1.423 -2.192 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.276 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 p -85.18 -33.63 22.25 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 122.605 1.193 . . . . 0.0 108.309 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 40.8 m-80 -103.67 158.4 16.4 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 173.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.39 5.67 49.81 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.737 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.94 -20.23 42.5 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 170.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 19' ' ' ASN . 17.6 mt-10 -81.61 159.3 24.07 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 113.548 -1.66 . . . . 0.0 106.992 171.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.437 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -121.06 136.32 55.01 Favored 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 118.932 -1.107 . . . . 0.0 108.593 -178.75 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 88.7 m -89.53 121.04 31.36 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.304 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 89.1 m-85 -121.91 159.16 27.44 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.561 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -117.29 165.59 13.28 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.39 125.33 23.38 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 123.416 0.686 . . . . 0.0 110.028 174.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.97 13.06 57.03 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.512 -0.851 . . . . 0.0 114.028 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -92.41 144.68 25.12 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.8 mm -99.07 123.96 52.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.602 HD11 HG23 ' A' ' 11' ' ' THR . 50.6 mt -106.93 135.28 45.97 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.588 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -89.86 117.75 28.93 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 171.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.527 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.4 tt -73.94 119.82 18.67 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.749 -175.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.1 mm -92.82 -40.35 11.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.392 -176.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.6 t -161.17 144.48 12.86 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.043 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.527 ' HG3' HD21 ' A' ' 33' ' ' LEU . 94.6 mttt -100.46 4.21 43.54 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -120.84 102.39 8.34 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.456 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.2 p -115.96 7.44 14.38 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.38 -17.44 53.59 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 108.671 -1.771 . . . . 0.0 108.671 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -121.62 151.04 40.84 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.885 -0.657 . . . . 0.0 110.253 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.42 99.29 9.33 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.26 -38.9 1.01 Allowed Glycine 0 CA--C 1.49 -1.476 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -176.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -95.79 119.9 35.11 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -109.08 159.18 17.07 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -108.22 129.84 55.18 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.42 159.4 25.26 Favored Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.37 135.29 54.08 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.001 0.429 . . . . 0.0 110.654 -177.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.4 tp -138.88 122.31 17.22 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 124.039 0.935 . . . . 0.0 108.882 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 68.87 11.56 8.38 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.307 1.043 . . . . 0.0 112.513 175.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.56 -8.17 43.47 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 3.5 mptp? -102.76 130.93 49.88 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -120.9 135.05 55.28 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-O 121.333 0.587 . . . . 0.0 111.183 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -153.22 -167.22 15.41 Favored Glycine 0 N--CA 1.416 -2.692 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.3 m -115.32 153.51 16.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 120.772 0.32 . . . . 0.0 111.091 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -157.12 150.95 19.33 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.49 136.74 19.79 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 121.559 1.506 . . . . 0.0 109.758 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.66 -16.19 62.44 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.068 0.461 . . . . 0.0 110.795 -176.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -53.39 -29.27 33.8 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 124.481 1.113 . . . . 0.0 111.687 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -94.02 -1.1 55.0 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.32 148.54 36.45 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -174.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.67 134.0 61.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -78.81 128.15 32.99 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.113 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.42 -58.25 3.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.404 -2.754 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 177.654 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.541 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.62 157.49 3.17 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -130.9 16.63 5.18 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.513 0.673 . . . . 0.0 111.881 -171.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.94 141.66 8.47 Favored Glycine 0 N--CA 1.414 -2.822 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.09 -33.54 59.51 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -110.98 76.37 0.97 Allowed 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.062 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -107.78 124.62 50.31 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 172.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -114.17 138.98 49.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.53 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 7.8 p -122.56 133.17 54.57 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.904 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -99.69 135.21 41.44 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.8 p -81.05 129.3 34.48 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.258 0.552 . . . . 0.0 111.135 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.1 mt -97.69 -16.65 19.85 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.571 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -142.84 153.27 60.82 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -81.79 142.59 12.76 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.927 1.751 . . . . 0.0 110.079 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -126.89 130.48 50.24 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.486 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.435 ' HA ' HG23 ' A' ' 24' ' ' THR . 49.7 m -100.32 113.38 26.05 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.16 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.97 145.37 29.71 Favored Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 176.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.9 p -92.19 -35.53 13.78 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.01 0.91 . . . . 0.0 108.701 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -107.28 -179.04 3.81 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.737 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -93.93 8.27 41.93 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.905 0.86 . . . . 0.0 109.472 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -91.22 -32.15 15.89 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.93 156.27 32.16 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.874 172.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.0 tt -102.44 115.18 30.04 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.435 HG23 ' HA ' ' A' ' 16' ' ' THR . 63.8 m -83.59 120.04 25.47 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -134.36 161.83 33.89 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -96.66 170.04 9.47 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -82.99 137.08 34.29 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.55 26.15 21.24 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.481 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -102.65 148.81 25.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mm -105.27 112.5 39.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 58.9 mt -100.94 139.0 23.3 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -88.24 106.75 18.41 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.66 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.5 tt -68.66 122.64 18.94 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.491 -174.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 47' ' ' GLU . 50.7 mt -97.42 -44.71 12.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.378 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.0 m -150.12 138.86 20.8 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.795 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.66 ' HG3' HD21 ' A' ' 33' ' ' LEU . 50.3 mtmt -97.75 5.14 49.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.4 118.81 32.15 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 113.638 -1.619 . . . . 0.0 108.656 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.9 p -133.57 -0.29 3.22 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.37 0.605 . . . . 0.0 110.273 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.25 -41.41 2.14 Favored Glycine 0 C--N 1.306 -1.126 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -174.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -97.79 116.45 30.03 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.39 114.05 6.49 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 128.3 -17.71 5.88 Favored Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -174.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -113.94 128.96 56.62 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.847 0.356 . . . . 0.0 111.118 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.403 ' CE2' ' HG2' ' A' ' 36' ' ' LYS . 34.0 m0 -108.87 169.67 8.53 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 58.9 tttm -137.54 128.92 28.04 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -152.49 173.07 31.61 Favored Glycine 0 C--N 1.297 -1.605 0 C-N-CA 120.285 -0.96 . . . . 0.0 112.121 -175.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.476 ' HB2' HD11 ' A' ' 34' ' ' ILE . 9.0 tt0 -108.91 134.22 51.88 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 123.67 0.788 . . . . 0.0 109.814 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.7 tp -153.47 129.71 10.47 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 64.3 20.03 12.01 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.714 0.806 . . . . 0.0 112.403 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.46 3.66 64.67 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 116.13 -0.487 . . . . 0.0 113.039 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -117.4 150.67 38.48 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 9.1 pt-20 -121.87 140.81 51.94 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 172.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -160.54 -169.31 23.65 Favored Glycine 0 C--N 1.288 -2.086 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.53 152.14 16.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.064 0.459 . . . . 0.0 110.307 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -157.45 148.68 16.69 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.283 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 20.3 Cg_exo -65.69 125.89 15.11 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.487 1.458 . . . . 0.0 109.245 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -61.29 -18.68 59.67 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -171.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -72.57 -14.36 61.61 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.936 0.335 . . . . 0.0 111.239 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -80.35 -14.74 58.1 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.597 0.237 . . . . 0.0 111.192 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.06 166.55 20.81 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.57 142.3 35.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -70.3 140.87 52.38 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.9 pt -91.17 -42.14 13.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-O 121.255 0.55 . . . . 0.0 111.316 -173.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.411 -2.377 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.555 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.298 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.37 63.83 2.03 Favored 'General case' 0 C--O 1.246 0.891 0 C-N-CA 124.263 1.025 . . . . 0.0 112.309 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 44.2 tpp -145.98 106.77 4.11 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.049 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.98 61.92 1.55 Allowed Glycine 0 C--N 1.312 -0.767 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.638 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -169.49 174.01 6.16 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -118.35 93.7 4.22 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-O 121.625 0.726 . . . . 0.0 109.307 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 35.8 mt-10 -101.89 142.16 33.63 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 120.146 -0.621 . . . . 0.0 109.352 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -128.45 137.96 52.07 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.97 0.414 . . . . 0.0 110.138 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.436 ' SG ' HD12 ' A' ' 33' ' ' LEU . 59.8 m -124.47 153.81 41.44 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.986 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -117.46 132.17 56.61 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.425 HG23 HD11 ' A' ' 31' ' ' ILE . 6.5 p -72.46 128.51 35.82 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 120.811 0.339 . . . . 0.0 111.235 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.8 mt -89.16 -18.03 27.98 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.99 157.21 64.54 Favored Pre-proline 0 C--N 1.309 -1.181 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.43 138.63 15.77 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.297 1.332 . . . . 0.0 109.462 173.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 24' ' ' THR . 68.8 t80 -122.6 117.94 27.02 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.792 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 m -109.98 127.54 54.85 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.91 153.37 28.14 Favored Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.57 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -98.15 -20.71 17.15 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -105.16 166.57 10.31 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -82.72 -9.58 59.29 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.654 0.74 . . . . 0.0 109.538 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -78.32 -30.05 48.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.699 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -78.86 151.49 31.8 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.181 173.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.448 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -112.91 139.2 48.75 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 96.2 m -95.13 120.67 35.75 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.668 0.747 . . . . 0.0 111.121 -177.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 91.7 m-85 -122.55 147.17 46.7 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.829 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -90.29 172.55 8.69 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 176.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -75.41 129.94 38.15 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.3 39.03 20.2 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.793 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -117.97 154.9 31.18 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.0 mm -96.21 128.61 47.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 O-C-N 123.556 0.535 . . . . 0.0 109.994 -175.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 11' ' ' THR . 52.7 mt -112.23 134.54 54.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -90.04 110.23 21.23 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 171.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.5 tt -74.45 123.84 25.46 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mm -96.94 -43.66 12.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.387 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.9 m -156.39 135.23 11.81 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.267 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -85.54 -27.01 25.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 170.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -95.35 102.71 14.54 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.639 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.3 p -109.2 -0.91 19.03 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.802 0.811 . . . . 0.0 109.98 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.12 -41.25 1.58 Allowed Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 107.746 -2.141 . . . . 0.0 107.746 -173.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -115.32 166.32 11.99 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.436 -0.882 . . . . 0.0 109.639 175.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.81 149.13 23.69 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 171.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 100.38 -25.86 26.71 Favored Glycine 0 C--N 1.301 -1.39 0 C-N-CA 120.369 -0.919 . . . . 0.0 110.88 -176.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -111.56 116.9 31.61 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -108.89 157.26 18.79 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.577 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -105.06 130.02 53.35 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.34 147.55 19.26 Favored Glycine 0 N--CA 1.417 -2.569 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.96 136.28 44.74 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.41 HD22 ' CD1' ' A' ' 25' ' ' PHE . 27.4 tp -145.47 128.19 16.24 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.9 m120 62.91 20.31 12.14 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.938 0.895 . . . . 0.0 112.067 178.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.42 -3.42 75.55 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.321 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -102.41 133.71 46.92 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.34 120.85 43.13 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -136.67 -172.09 12.45 Favored Glycine 0 C--N 1.286 -2.216 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.76 151.13 16.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.162 0.506 . . . . 0.0 110.848 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -151.4 150.86 27.86 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.3 Cg_exo -76.75 135.92 16.43 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 121.872 1.715 . . . . 0.0 110.748 175.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -64.72 -14.87 60.35 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.893 0.377 . . . . 0.0 111.432 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -63.42 -19.87 65.06 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.436 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -98.78 0.86 45.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -144.52 167.85 21.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.173 0.511 . . . . 0.0 111.759 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.3 p -132.88 139.17 50.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -83.18 128.34 34.4 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.8 pt -101.77 -30.71 3.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.058 0.456 . . . . 0.0 110.719 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.416 -2.17 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.717 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.891 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.99 -28.89 16.91 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.4 ttm -166.85 89.99 0.37 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -128.89 -38.1 0.37 Allowed Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 119.703 -1.237 . . . . 0.0 112.298 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.03 25.74 4.25 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.4 mptt 66.55 97.56 0.05 Allowed 'General case' 0 C--O 1.246 0.916 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.493 -173.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 3.4 mm-40 -91.58 137.12 32.62 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -174.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -130.96 138.22 49.61 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.1 p -123.57 138.85 54.48 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 65.3 ttt180 -107.86 134.26 51.05 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.411 HG21 ' CD1' ' A' ' 25' ' ' PHE . 45.4 p -77.81 133.97 38.1 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-O 121.504 0.669 . . . . 0.0 111.59 -176.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.22 -7.77 24.31 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.783 0.801 . . . . 0.0 109.515 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -147.17 156.03 46.7 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -85.59 155.63 10.48 Favored 'Trans proline' 0 N--CA 1.436 -1.876 0 C-N-CA 121.852 1.702 . . . . 0.0 109.008 170.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -149.19 129.61 13.86 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.509 ' HA ' HG23 ' A' ' 24' ' ' THR . 19.0 m -115.69 125.81 53.31 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.048 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.93 151.84 24.18 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.0 t -94.73 1.52 55.48 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 122.629 1.204 . . . . 0.0 108.256 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -141.69 165.16 28.23 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.67 -6.73 58.11 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -83.27 -24.28 32.32 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 122.168 0.985 . . . . 0.0 109.103 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -94.44 131.09 40.49 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -87.41 129.39 35.06 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.972 0.891 . . . . 0.0 112.512 -169.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 16' ' ' THR . 91.1 m -97.1 121.37 38.91 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.205 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 11' ' ' THR . 10.5 p90 -133.69 160.09 38.6 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.045 0.45 . . . . 0.0 112.175 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -94.23 171.32 8.9 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.62 145.66 31.58 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.33 16.23 78.61 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.419 -0.42 . . . . 0.0 113.263 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 8.9 tp10 -97.98 148.29 23.63 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.849 0.357 . . . . 0.0 110.732 -175.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.3 mm -96.86 121.17 47.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.4 mt -113.84 140.85 32.21 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -89.43 121.9 32.11 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.0 tt -79.01 133.2 36.83 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -174.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 47' ' ' GLU . 36.4 mt -106.84 -44.0 7.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-O 121.128 0.489 . . . . 0.0 110.232 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -150.17 130.77 13.97 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 121.973 -0.455 . . . . 0.0 111.839 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -88.36 -23.71 23.31 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -97.87 109.5 22.24 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.556 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.7 p -111.61 -5.64 14.48 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.776 0.798 . . . . 0.0 110.126 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.94 -17.16 30.09 Favored Glycine 0 C--N 1.309 -0.967 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -128.36 128.94 45.49 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.39 115.04 16.83 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.66 -15.59 6.29 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -110.34 124.1 51.07 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -108.77 155.51 20.68 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.775 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 38.3 ttmt -117.2 129.46 55.96 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.61 173.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.64 168.13 26.0 Favored Glycine 0 N--CA 1.416 -2.68 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.511 ' HB2' HD11 ' A' ' 34' ' ' ILE . 1.8 tm-20 -115.34 129.9 56.74 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.097 0.475 . . . . 0.0 110.365 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.8 tp -156.64 138.82 14.62 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 20.1 m120 73.02 12.24 5.07 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.659 1.184 . . . . 0.0 110.921 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.44 14.76 59.58 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 27.3 mmmt -126.06 154.98 42.26 Favored 'General case' 0 CA--C 1.468 -2.21 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -175.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.29 126.23 34.85 Favored 'General case' 0 C--N 1.257 -3.427 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.117 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -156.75 -161.66 10.92 Favored Glycine 0 CA--C 1.469 -2.832 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -176.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.5 147.51 17.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.793 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -150.51 154.87 36.07 Favored Pre-proline 0 N--CA 1.426 -1.626 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.679 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.06 128.05 13.51 Favored 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 122.14 1.893 . . . . 0.0 111.372 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.26 -19.38 64.5 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.031 0.933 . . . . 0.0 112.264 -175.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -76.39 -4.78 44.13 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -102.31 -0.33 33.0 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 121.127 0.489 . . . . 0.0 112.104 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -141.42 155.58 45.87 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.209 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 p -120.75 139.3 48.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.445 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 50.0 tt0 -79.83 122.06 26.17 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.679 0.752 . . . . 0.0 111.613 -177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.6 mm -93.7 -31.06 4.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.541 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.42 -1.967 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 -178.691 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.04 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.15 106.31 17.54 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.0 -8.42 55.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.601 0.715 . . . . 0.0 111.823 -175.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.98 148.92 20.82 Favored Glycine 0 N--CA 1.412 -2.947 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.59 11.09 15.75 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.013 0.435 . . . . 0.0 110.326 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -137.34 37.18 2.5 Favored 'General case' 0 C--O 1.252 1.222 0 CA-C-O 122.199 1.0 . . . . 0.0 109.183 -178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -94.69 131.26 40.68 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.492 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -113.11 153.19 28.62 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.592 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.6 p -133.99 138.36 45.38 Favored 'General case' 0 C--N 1.267 -2.983 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.205 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -99.7 138.23 37.08 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 42.4 p -63.09 142.93 58.19 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 124.332 1.053 . . . . 0.0 110.406 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.7 mt -113.08 -18.78 12.08 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.322 0.582 . . . . 0.0 110.165 175.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -149.4 147.66 23.96 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.38 123.64 8.84 Favored 'Trans proline' 0 C--O 1.253 1.264 0 C-N-CA 122.052 1.835 . . . . 0.0 110.51 173.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -129.98 134.0 47.16 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.483 ' HA ' HG23 ' A' ' 24' ' ' THR . 46.8 m -116.28 131.69 56.87 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 120.933 0.397 . . . . 0.0 110.544 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.04 134.68 11.86 Favored Glycine 0 N--CA 1.413 -2.887 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.5 p -91.15 -34.71 14.92 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -79.27 145.93 33.26 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 113.377 -1.738 . . . . 0.0 108.692 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.41 -35.86 80.55 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.775 0.672 . . . . 0.0 110.631 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.426 ' O ' HG22 ' A' ' 54' ' ' VAL . 31.0 t70 -86.42 4.96 37.29 Favored 'General case' 0 C--O 1.203 -1.371 0 CA-C-O 121.62 0.724 . . . . 0.0 110.213 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -104.35 134.7 47.11 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.19 135.42 33.8 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.73 0.3 . . . . 0.0 111.564 -170.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.483 HG23 ' HA ' ' A' ' 16' ' ' THR . 94.1 m -103.24 120.06 40.04 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -135.02 154.42 51.73 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -104.94 -176.69 3.15 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.94 122.96 35.84 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 176.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.39 8.73 8.29 Favored Glycine 0 C--N 1.294 -1.796 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.244 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -110.41 154.33 23.72 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.1 mm -108.13 122.48 62.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.114 0.483 . . . . 0.0 109.762 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.592 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 58.6 mt -105.79 130.15 57.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.95 127.51 36.04 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.99 121.75 20.62 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mm -100.59 -41.33 8.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.603 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 45' ' ' LYS . 25.4 m -151.68 139.55 19.94 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.272 -0.268 . . . . 0.0 111.524 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -103.4 -14.32 16.31 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.89 0.476 . . . . 0.0 110.366 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -110.47 97.42 6.87 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-O 121.986 0.898 . . . . 0.0 109.375 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 p -105.18 0.5 27.38 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.058 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.52 -25.83 18.3 Favored Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -174.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -117.78 174.73 6.01 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.885 -0.657 . . . . 0.0 109.557 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.39 141.28 37.18 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.73 -30.23 5.47 Favored Glycine 0 C--N 1.312 -0.774 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.411 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -81.98 115.35 21.1 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.135 0.493 . . . . 0.0 110.166 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 44.9 m0 -108.57 154.19 22.31 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.897 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 19.3 ttmm -116.29 129.64 56.38 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 176.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.07 176.51 23.3 Favored Glycine 0 N--CA 1.413 -2.876 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -123.04 133.87 54.31 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.3 tp -149.97 139.7 21.74 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.429 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.8 m120 67.66 10.07 7.51 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.794 1.237 . . . . 0.0 111.35 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.47 -2.97 49.97 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.21 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.38 138.43 51.36 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 122.375 -0.485 . . . . 0.0 110.203 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -93.5 144.06 25.71 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -160.36 177.93 36.6 Favored Glycine 0 N--CA 1.413 -2.836 0 C-N-CA 119.851 -1.166 . . . . 0.0 111.186 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 34.3 m -114.51 152.01 16.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -160.19 147.69 12.69 Favored Pre-proline 0 N--CA 1.419 -1.983 0 O-C-N 124.184 0.928 . . . . 0.0 108.824 -177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -69.05 129.31 18.11 Favored 'Trans proline' 0 C--O 1.251 1.159 0 C-N-CA 121.736 1.624 . . . . 0.0 108.954 172.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -57.83 -20.7 37.96 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 123.974 0.91 . . . . 0.0 113.091 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -69.04 -13.21 62.31 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -91.69 2.46 56.46 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.256 0.55 . . . . 0.0 111.315 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -140.37 169.86 16.89 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.541 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 p -128.93 122.2 56.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -73.07 121.59 20.43 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.5 pt -85.77 -6.81 10.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -173.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 C--N 1.298 -1.663 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.559 174.837 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.823 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.95 -32.49 5.74 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 122.968 0.507 . . . . 0.0 110.218 -176.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 93.1 mmm -102.19 6.39 40.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.149 0.5 . . . . 0.0 110.157 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.2 -168.17 30.17 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -110.32 18.14 20.17 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.477 0.656 . . . . 0.0 110.318 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -120.67 25.0 10.0 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.006 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 64' ' ' SER . 44.7 mt-10 -93.8 123.0 36.86 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.897 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -139.93 151.1 45.3 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 121.4 0.619 . . . . 0.0 111.233 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.6 p -130.19 153.38 48.62 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.051 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.553 HH11 ' HA2' ' A' ' 28' ' ' GLY . 59.5 ttp85 -113.41 134.41 54.66 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.6 p -79.36 131.56 36.15 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.01 -177.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.5 mt -95.18 -12.07 27.0 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.672 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -133.17 149.86 73.82 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.632 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -85.98 120.65 1.97 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.282 1.988 . . . . 0.0 108.925 168.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 89.1 t80 -146.45 123.11 11.17 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.381 0.61 . . . . 0.0 111.328 -173.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.575 ' HA ' HG23 ' A' ' 24' ' ' THR . 87.9 m -91.93 135.33 34.03 Favored 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.87 125.8 33.33 Favored Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -36.75 67.24 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 22' ' ' GLU . 93.4 m-20 -101.19 148.08 25.51 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 112.791 -2.004 . . . . 0.0 105.956 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -15.54 57.17 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.138 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -73.66 -20.51 60.54 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.722 172.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 19' ' ' ASN . 38.4 tt0 -89.06 143.31 26.94 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 tt -84.7 125.11 32.23 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.093 0.473 . . . . 0.0 111.132 -171.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.575 HG23 ' HA ' ' A' ' 16' ' ' THR . 91.1 m -87.65 121.02 29.54 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.039 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 15' ' ' TYR . 36.1 p90 -133.89 161.43 34.79 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.246 0.546 . . . . 0.0 111.945 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -112.99 173.64 6.28 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -78.69 123.86 27.59 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.553 ' HA2' HH11 ' A' ' 10' ' ' ARG . . . 102.09 13.48 31.25 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.525 -0.845 . . . . 0.0 114.16 177.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -93.58 143.98 25.8 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 117.079 0.44 . . . . 0.0 110.165 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.9 mm -99.33 113.04 33.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.9 mt -107.43 134.06 50.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -88.58 127.88 35.56 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.58 HD21 ' HG3' ' A' ' 36' ' ' LYS . 3.8 tt -74.15 126.26 30.18 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.055 -174.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 47' ' ' GLU . 59.7 mt -101.39 -52.81 8.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.3 m -143.26 128.54 18.81 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.697 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.58 ' HG3' HD21 ' A' ' 33' ' ' LEU . 58.2 mtpt -85.5 -33.41 21.81 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -97.68 108.19 20.85 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.575 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.1 p -119.33 6.43 11.17 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.435 0.636 . . . . 0.0 110.635 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.06 -22.15 7.65 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -141.28 139.31 33.65 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.16 89.63 7.34 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 169.42 -30.74 0.16 Allowed Glycine 0 CA--C 1.483 -1.914 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -99.69 121.88 41.88 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.465 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 25.8 m0 -107.94 141.64 39.26 Favored 'General case' 0 C--N 1.273 -2.737 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 23.0 ttmm -102.54 129.47 49.09 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 175.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -145.94 175.16 25.58 Favored Glycine 0 N--CA 1.417 -2.619 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.546 ' HB2' HD11 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -123.95 129.69 51.36 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.187 0.494 . . . . 0.0 109.79 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 47.4 tp -137.96 119.6 15.05 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.959 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.2 m120 64.82 21.6 12.39 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.742 1.217 . . . . 0.0 112.543 178.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.74 -11.58 49.78 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.728 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 4.0 mptp? -103.57 134.82 46.27 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 116.884 0.342 . . . . 0.0 110.48 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -112.39 141.48 46.07 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -167.16 -165.19 24.15 Favored Glycine 0 CA--C 1.467 -2.946 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 26.0 m -114.4 147.03 18.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 120.99 0.424 . . . . 0.0 110.56 -178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -147.95 150.6 36.12 Favored Pre-proline 0 C--N 1.296 -1.738 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.201 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 8.2 Cg_exo -71.58 136.77 29.0 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 121.798 1.665 . . . . 0.0 112.202 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -69.02 -8.16 42.34 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.659 0.784 . . . . 0.0 112.488 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -96.49 0.22 49.96 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 120.817 0.341 . . . . 0.0 111.487 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -99.92 -11.43 20.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.197 0.522 . . . . 0.0 110.996 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.12 145.08 41.2 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.598 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.02 125.76 66.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -68.99 121.52 16.79 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.476 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.4 mm -85.34 -45.79 17.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 43.9 m . . . . . 0 N--CA 1.41 -2.467 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.77 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.78 92.4 1.11 Allowed 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.33 142.18 5.67 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.376 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.419 ' H ' ' CD ' ' A' ' 7' ' ' GLU . . . -74.16 -72.58 1.0 Allowed Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 176.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.18 -73.23 0.15 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.332 0.587 . . . . 0.0 110.344 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -114.64 94.14 4.64 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 64' ' ' SER . 4.7 mm-40 -104.03 127.33 51.58 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.642 -171.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -146.24 144.67 30.03 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.995 0.426 . . . . 0.0 111.187 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 8.0 p -126.71 147.85 49.92 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.655 -172.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -101.9 136.0 42.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.0 p -69.17 139.47 54.62 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.66 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.0 mt -107.75 -18.87 13.71 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.482 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -147.37 151.05 39.31 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.18 141.12 23.02 Favored 'Trans proline' 0 C--O 1.25 1.101 0 C-N-CA 121.977 1.784 . . . . 0.0 111.091 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -147.41 139.14 24.09 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.1 m -112.79 131.34 55.73 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 120.978 0.418 . . . . 0.0 110.622 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.76 119.9 5.22 Favored Glycine 0 N--CA 1.409 -3.139 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.9 m -82.08 -28.62 32.26 Favored 'General case' 0 N--CA 1.383 -3.807 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -94.31 165.93 12.34 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.788 -1.551 . . . . 0.0 107.85 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -26.62 33.07 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-O 121.425 0.631 . . . . 0.0 109.856 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -92.61 9.75 33.39 Favored 'General case' 0 C--O 1.212 -0.886 0 CA-C-O 121.643 0.735 . . . . 0.0 110.712 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -109.85 131.43 55.07 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.19 130.97 35.52 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.513 -169.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.3 m -93.79 119.7 33.09 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -134.39 145.63 49.12 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.321 0.581 . . . . 0.0 112.366 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -96.47 161.69 13.8 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.391 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.64 123.13 24.3 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.39 11.41 21.8 Favored Glycine 0 C--N 1.294 -1.772 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -100.06 152.74 19.87 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-O 120.93 0.395 . . . . 0.0 110.625 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.3 mm -109.35 111.82 37.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.457 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 67.8 mt -96.42 135.54 30.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -88.31 117.49 27.27 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 6.3 tt -76.78 124.7 28.08 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.35 -50.15 12.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.258 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.5 m -156.3 133.24 10.45 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.083 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -84.45 -16.5 42.36 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.882 0.848 . . . . 0.0 108.972 172.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -98.03 99.21 10.47 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.257 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.4 p -105.98 -3.38 21.76 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.89 0.852 . . . . 0.0 109.836 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.96 -42.46 1.49 Allowed Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -176.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -121.61 128.09 51.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.18 121.32 14.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.489 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.95 -25.58 4.12 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -106.57 123.53 48.24 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 177.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.426 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 43.6 m0 -108.7 153.4 23.5 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 60.0 tttp -114.82 129.45 56.7 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -141.49 160.74 26.95 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -117.8 125.17 50.07 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -178.736 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.9 tp -147.62 119.01 7.86 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.459 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 72.12 21.81 3.85 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.193 0.997 . . . . 0.0 113.036 174.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.37 0.29 35.1 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.664 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 8.5 mptt -127.22 132.66 50.37 Favored 'General case' 0 CA--C 1.488 -1.423 0 O-C-N 122.419 -0.459 . . . . 0.0 110.073 -177.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 10.5 pt-20 -107.65 95.85 5.98 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 122.502 1.144 . . . . 0.0 109.433 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -113.94 -175.45 18.98 Favored Glycine 0 C--N 1.274 -2.9 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.495 -173.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 33.0 m -114.14 152.56 15.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -152.89 155.43 32.2 Favored Pre-proline 0 N--CA 1.418 -2.041 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.662 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.28 134.46 12.78 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.746 1.631 . . . . 0.0 111.284 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -44.86 -37.34 3.82 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 125.458 1.503 . . . . 0.0 113.21 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -63.09 -16.97 61.71 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -96.24 1.56 52.23 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.86 170.38 16.0 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.038 0.446 . . . . 0.0 111.696 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.22 131.42 40.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -83.32 125.69 31.9 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.194 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.1 mm -89.95 -52.5 10.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 23.2 t . . . . . 0 N--CA 1.413 -2.305 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.98 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.06 80.13 7.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 117.232 0.516 . . . . 0.0 110.63 -177.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 40.5 tpp -114.94 97.09 6.03 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.51 -58.96 0.8 Allowed Glycine 0 N--CA 1.425 -2.089 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.577 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.43 -171.98 3.9 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -92.48 91.57 7.68 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -101.68 147.76 26.06 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.565 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -124.8 139.37 53.91 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.587 0.708 . . . . 0.0 110.597 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.695 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 5.6 p -129.59 162.28 28.61 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HB2' HD11 ' A' ' 63' ' ' ILE . 29.8 ttp180 -121.11 145.8 47.42 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.649 HG21 ' HB3' ' A' ' 25' ' ' PHE . 72.0 p -71.31 141.41 50.48 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.794 0.683 . . . . 0.0 109.631 177.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -105.13 -18.79 14.03 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -141.71 156.29 66.17 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -177.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -76.73 120.9 5.68 Favored 'Trans proline' 0 N--CA 1.429 -2.275 0 N-CA-C 108.065 -1.552 . . . . 0.0 108.065 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -111.4 115.37 29.14 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.407 ' HA ' HG23 ' A' ' 24' ' ' THR . 36.0 m -98.38 111.3 23.69 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.715 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.43 135.63 18.73 Favored Glycine 0 N--CA 1.425 -2.05 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 176.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -113.6 5.55 16.6 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -127.15 156.24 42.1 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.54 -1.664 . . . . 0.0 107.324 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.15 -24.77 43.05 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -95.16 -4.4 46.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.806 0.812 . . . . 0.0 110.42 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -93.07 115.82 28.46 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 24' ' ' THR . 0.5 OUTLIER -83.78 144.58 29.22 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.874 0.369 . . . . 0.0 110.023 -170.884 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.409 ' N ' HD13 ' A' ' 23' ' ' LEU . 88.6 m -98.88 129.41 45.23 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.35 0.595 . . . . 0.0 111.492 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.649 ' HB3' HG21 ' A' ' 11' ' ' THR . 90.9 m-85 -127.74 151.84 48.49 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.221 -176.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.439 ' N ' ' HD2' ' A' ' 26' ' ' ARG . 3.5 mpt_? -108.82 174.5 5.84 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -81.75 116.37 21.42 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 117.914 0.324 . . . . 0.0 111.864 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.12 38.12 4.42 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.527 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.432 ' OE2' HD21 ' A' ' 48' ' ' LEU . 9.5 pt-20 -131.56 156.85 45.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 117.942 0.871 . . . . 0.0 111.871 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.9 mm -87.92 137.24 21.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.463 -173.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.695 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 40.1 mt -114.12 136.9 49.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.89 116.96 28.36 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.7 tt -77.93 123.78 27.2 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.8 mm -103.53 -40.69 6.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.319 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.0 m -153.04 134.96 14.69 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.007 -0.433 . . . . 0.0 111.892 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 94.8 mttt -91.9 -9.93 41.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.683 0.754 . . . . 0.0 109.539 173.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -117.78 119.52 35.17 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.96 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 p -115.34 0.1 13.34 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-O 121.576 0.703 . . . . 0.0 109.415 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.54 1.46 53.25 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -148.66 132.11 16.66 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.57 106.06 6.93 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 149.12 -31.12 1.19 Allowed Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -105.81 131.16 53.49 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.966 0.412 . . . . 0.0 110.724 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.4 ' CD1' ' HA ' ' A' ' 36' ' ' LYS . 17.4 m0 -113.24 151.26 31.27 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 172.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 84.5 tttt -109.2 129.03 55.5 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.29 157.94 22.73 Favored Glycine 0 N--CA 1.412 -2.914 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.221 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -116.67 129.29 56.05 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.432 HD21 ' OE2' ' A' ' 29' ' ' GLU . 55.4 tp -162.92 149.48 12.61 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 72.4 0.58 3.65 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.603 1.161 . . . . 0.0 111.216 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.79 0.53 42.44 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.83 169.88 10.33 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -175.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -130.25 142.03 50.58 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.475 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 45' ' ' LYS . . . -163.53 -173.13 31.86 Favored Glycine 0 C--N 1.291 -1.951 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -114.71 152.83 16.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 120.843 0.354 . . . . 0.0 110.706 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -153.87 150.94 23.83 Favored Pre-proline 0 N--CA 1.439 -1.022 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.671 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 17.1 Cg_exo -70.16 132.12 22.05 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.723 1.616 . . . . 0.0 109.692 173.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.6 -10.75 20.07 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -62.59 -31.95 72.86 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 124.41 1.084 . . . . 0.0 111.211 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -88.97 4.02 49.56 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -173.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.2 171.09 14.91 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -138.31 136.3 44.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -80.99 127.75 32.93 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.141 0.496 . . . . 0.0 111.528 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' A' ' 10' ' ' ARG . 33.1 mm -86.37 -62.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 N--CA 1.405 -2.68 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.878 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.38 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 36' ' ' LYS . . . -167.1 -176.55 3.39 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.2 mmt -104.03 -178.71 3.74 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.346 0.593 . . . . 0.0 111.886 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.08 46.94 0.18 Allowed Glycine 0 C--N 1.299 -1.509 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.84 52.99 2.67 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.492 -0.854 . . . . 0.0 112.502 -169.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.1 mttp 55.1 57.08 5.85 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 122.742 1.258 . . . . 0.0 109.173 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -101.12 151.28 22.02 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 113.222 -1.808 . . . . 0.0 106.786 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -125.51 143.83 50.83 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.904 -1.118 . . . . 0.0 111.188 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.668 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 7.2 p -125.48 153.08 44.09 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.255 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -116.18 134.09 55.31 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.8 p -62.77 149.1 44.88 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 122.8 0.44 . . . . 0.0 112.037 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.54 -19.17 10.15 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -151.86 153.93 32.22 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.49 143.41 38.46 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.859 1.706 . . . . 0.0 109.224 169.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -135.0 127.86 31.28 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.4 m -93.27 115.85 28.44 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.306 -177.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.87 118.47 5.04 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.2 p -106.63 -7.32 17.43 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.983 0.897 . . . . 0.0 109.742 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -108.87 149.96 28.37 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -69.54 -22.95 63.52 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.094 0.474 . . . . 0.0 112.276 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -94.17 -2.44 52.59 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.296 1.046 . . . . 0.0 109.972 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -103.83 127.37 51.33 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.689 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.627 HD13 ' HA3' ' A' ' 53' ' ' GLY . 3.0 mp -84.89 135.66 33.97 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -177.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.2 m -96.2 123.26 39.76 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.94 176.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -133.75 159.59 40.13 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.202 0.525 . . . . 0.0 111.867 177.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -117.67 173.64 6.62 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -78.46 141.89 37.92 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.89 11.69 42.54 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.555 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -105.85 147.26 28.9 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.575 0.703 . . . . 0.0 112.317 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.9 mm -102.86 127.68 56.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.668 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 62.0 mt -114.39 135.01 55.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -89.39 118.52 29.11 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.465 HD21 ' HG3' ' A' ' 36' ' ' LYS . 5.5 tt -81.27 124.24 29.16 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -175.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mm -98.66 -47.23 12.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.905 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.0 m -153.46 124.55 7.42 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.465 ' HG3' HD21 ' A' ' 33' ' ' LEU . 97.7 mttt -75.69 -25.48 56.74 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.163 0.506 . . . . 0.0 109.843 174.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -90.71 121.39 32.56 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.173 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -122.77 -2.39 8.82 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.253 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.84 -7.41 41.71 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -145.66 131.86 19.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.36 126.86 30.84 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.38 -38.22 2.18 Favored Glycine 0 C--N 1.304 -1.234 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.649 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -98.82 127.58 44.79 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 120.798 0.333 . . . . 0.0 110.483 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 31.6 m0 -108.95 153.75 23.13 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.039 176.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 65.0 tttm -114.21 128.48 56.39 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.07 173.68 28.89 Favored Glycine 0 N--CA 1.424 -2.152 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.15 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -115.52 130.35 56.85 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 124.616 1.166 . . . . 0.0 109.626 -177.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 39.3 tp -154.66 135.7 13.85 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 26.2 m120 65.59 16.26 10.42 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.397 1.079 . . . . 0.0 111.84 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.33 6.83 77.45 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.837 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.86 155.1 27.43 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -133.6 138.09 45.8 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.612 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.627 ' HA3' HD13 ' A' ' 23' ' ' LEU . . . -164.65 -156.71 9.12 Favored Glycine 0 CA--C 1.483 -1.945 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.054 -175.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.76 154.09 17.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 120.943 0.401 . . . . 0.0 111.506 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -158.53 148.85 15.63 Favored Pre-proline 0 N--CA 1.434 -1.228 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.125 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -74.35 135.76 20.86 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 121.77 1.647 . . . . 0.0 110.21 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -69.55 -7.25 36.81 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 120.821 0.343 . . . . 0.0 111.794 -176.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.6 -21.09 65.37 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.464 0.706 . . . . 0.0 112.035 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -107.11 9.77 30.31 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -173.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.93 164.3 34.15 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.9 p -131.34 135.25 59.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -78.26 133.11 37.73 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.1 mm -86.83 -67.22 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.398 -3.067 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 N--CA 1.429 -1.497 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -138.99 149.44 44.7 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.419 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.0 p -137.56 157.67 46.02 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 123.041 0.213 . . . . 0.0 110.874 -177.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.438 ' NE ' ' HA2' ' A' ' 28' ' ' GLY . 45.3 ttt180 -119.31 138.08 53.27 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.6 p -78.22 134.34 37.6 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.883 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.5 mt -98.29 -18.08 18.56 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.587 0.708 . . . . 0.0 109.566 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -142.56 150.14 53.22 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -78.5 157.75 28.85 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.875 1.716 . . . . 0.0 110.015 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -150.73 132.93 15.38 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.431 ' HA ' HG23 ' A' ' 24' ' ' THR . 82.1 m -96.14 122.38 38.93 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.967 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.77 125.97 7.21 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.1 p -90.55 -36.43 14.47 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 122.549 1.166 . . . . 0.0 108.376 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 57.3 m-80 -89.09 166.12 14.07 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.261 175.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -81.77 -33.21 31.04 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.7 3.34 14.25 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.408 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 34.7 tt0 -110.84 128.44 55.78 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tt -85.67 125.38 33.13 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.215 -170.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.431 HG23 ' HA ' ' A' ' 16' ' ' THR . 91.6 m -90.26 119.41 30.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 174.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -135.37 159.11 42.59 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -100.1 -178.37 3.82 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -91.85 137.73 32.13 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.438 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 95.83 15.66 41.85 Favored Glycine 0 CA--C 1.496 -1.103 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.858 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 20.0 mm-40 -95.94 127.25 41.8 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.9 mm -87.66 116.64 30.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 174.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.419 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 57.9 mt -105.98 144.12 15.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -88.51 109.26 19.9 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.553 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.2 tt -73.09 124.83 26.33 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -175.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.7 mm -97.37 -51.43 10.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.338 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -152.07 134.59 15.33 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.89 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.553 ' HG3' HD21 ' A' ' 33' ' ' LEU . 50.6 mtmt -90.33 -25.84 20.27 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.555 0.693 . . . . 0.0 109.169 175.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -96.44 103.05 14.93 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.19 -0.913 . . . . 0.0 108.551 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.7 p -104.11 8.81 36.48 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.132 0.968 . . . . 0.0 108.94 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.03 -22.3 38.63 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -119.06 146.92 44.68 Favored 'General case' 0 N--CA 1.413 -2.286 0 CA-C-N 114.806 -0.697 . . . . 0.0 109.529 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.86 109.97 21.18 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 132.71 -23.47 3.98 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.723 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -107.14 126.92 53.0 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.41 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 35.5 m0 -108.88 150.65 27.38 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 88.5 tttt -108.59 129.1 55.32 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -140.8 160.51 26.63 Favored Glycine 0 N--CA 1.408 -3.233 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.7 tm-20 -117.78 123.75 46.75 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.6 tp -142.77 133.73 25.65 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 67.7 17.46 9.84 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 124.079 0.862 . . . . 0.0 111.169 171.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.01 3.1 62.12 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.677 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 9.5 mptt -115.84 125.75 53.07 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 122.394 -0.474 . . . . 0.0 110.417 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 10.6 pt-20 -112.42 112.92 24.83 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.014 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -145.84 -166.66 12.08 Favored Glycine 0 N--CA 1.423 -2.229 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -177.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 34.6 m -114.21 151.09 16.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-O 120.97 0.414 . . . . 0.0 110.163 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -154.48 150.55 22.16 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.862 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 23.6 Cg_exo -66.85 130.74 23.85 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 121.953 1.769 . . . . 0.0 110.544 175.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -67.79 -9.53 45.03 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -68.87 -16.66 63.83 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.074 0.549 . . . . 0.0 111.745 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -91.45 -3.93 56.1 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.09 163.16 30.54 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.63 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.23 142.57 42.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -86.84 144.5 26.99 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.922 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.4 mm -102.98 -44.33 9.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.651 0.738 . . . . 0.0 109.355 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.413 -2.289 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -178.015 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.503 ' HA ' ' OXT' ' A' ' 64' ' ' SER . 45.6 mt-10 . . . . . 0 N--CA 1.424 -1.729 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -132.42 137.1 47.18 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.53 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 5.6 p -120.82 133.34 55.32 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.083 0.468 . . . . 0.0 109.946 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -99.55 129.84 45.75 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.3 p -62.92 128.78 37.46 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.158 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -97.35 -19.32 18.58 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -151.5 162.78 25.75 Favored Pre-proline 0 C--N 1.31 -1.141 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.7 165.68 11.94 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 121.729 1.619 . . . . 0.0 110.412 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -150.59 130.37 13.24 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.5 m -98.37 118.62 35.43 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.821 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.35 126.81 7.65 Favored Glycine 0 N--CA 1.417 -2.625 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.0 t -102.32 7.92 40.46 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 38.1 m-80 -127.6 152.36 47.74 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.77 -40.51 96.87 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -98.25 14.35 28.12 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.726 0.774 . . . . 0.0 111.602 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 44.8 tt0 -97.61 129.04 44.75 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 172.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.423 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -74.7 119.71 19.26 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.291 0.567 . . . . 0.0 111.821 -168.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.2 m -95.0 119.65 33.87 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -133.62 161.73 33.84 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -101.94 173.5 6.36 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.272 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -92.38 109.63 21.02 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.86 27.81 1.83 Allowed Glycine 0 C--N 1.304 -1.233 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.954 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -119.68 158.67 25.98 Favored 'General case' 0 C--O 1.251 1.164 0 CA-C-O 121.038 0.447 . . . . 0.0 111.146 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.6 mm -101.44 117.13 46.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 67.9 mt -94.53 134.3 32.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -89.3 109.59 20.47 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.519 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.6 tt -70.41 118.15 12.86 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.3 mm -93.27 -41.36 12.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.262 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.3 t -154.48 146.34 23.46 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.473 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.519 ' HG3' HD21 ' A' ' 33' ' ' LEU . 86.9 mttt -103.15 -3.55 25.66 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.964 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -115.1 103.14 10.59 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.603 0.716 . . . . 0.0 111.668 -176.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.5 p -118.46 9.88 12.49 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-O 122.111 0.957 . . . . 0.0 109.209 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.36 -21.28 46.36 Favored Glycine 0 N--CA 1.435 -1.402 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.044 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -125.98 142.17 51.64 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.3 125.94 30.15 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.372 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 114.38 -21.1 15.31 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.74 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -101.42 116.81 33.62 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 121.049 0.452 . . . . 0.0 110.416 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.434 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 40.6 m0 -108.77 155.54 20.65 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.589 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 16.8 ttmm -113.88 129.73 56.56 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -144.7 158.96 27.73 Favored Glycine 0 N--CA 1.414 -2.832 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 1.1 tm-20 -112.63 123.6 50.66 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.603 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 49.4 tp -147.05 130.44 16.67 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.945 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.603 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 59.3 m-80 66.05 18.65 11.07 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.716 1.206 . . . . 0.0 112.847 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.31 -18.72 20.61 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.012 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.26 144.37 44.91 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.528 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 10.1 pt-20 -102.03 116.36 32.51 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -125.63 -177.89 15.08 Favored Glycine 0 N--CA 1.409 -3.146 0 C-N-CA 119.962 -1.113 . . . . 0.0 111.067 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 27.4 m -114.23 146.69 18.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 52.7 p90 -154.38 153.85 28.68 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.814 -175.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 16.5 Cg_exo -71.08 129.34 16.06 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.303 2.002 . . . . 0.0 110.334 174.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.64 -20.87 63.87 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 124.284 1.033 . . . . 0.0 113.296 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -73.82 0.83 11.99 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -104.74 -0.86 26.92 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 122.264 -0.273 . . . . 0.0 111.529 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -141.19 146.72 37.31 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.977 -176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 p -108.22 132.43 56.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -78.76 126.81 31.22 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.373 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.1 mm -91.51 -54.12 7.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.227 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.503 ' OXT' ' HA ' ' A' ' 7' ' ' GLU . 19.4 m . . . . . 0 N--CA 1.421 -1.91 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.579 ' HB3' HE22 ' A' ' 62' ' ' GLN . 45.9 mt-10 . . . . . 0 N--CA 1.433 -1.307 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -126.47 135.3 51.18 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.496 ' SG ' HD12 ' A' ' 33' ' ' LEU . 12.9 m -126.03 164.81 20.04 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.524 HH11 ' HA2' ' A' ' 28' ' ' GLY . 65.7 ttp85 -129.96 134.35 47.4 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.414 HG21 ' HB3' ' A' ' 25' ' ' PHE . 16.8 p -74.34 136.53 42.52 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.9 mt -98.7 -18.37 18.07 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.647 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -144.7 150.31 46.39 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.74 143.49 41.85 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 121.97 1.78 . . . . 0.0 110.046 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -138.05 135.45 35.88 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.427 ' HA ' HG23 ' A' ' 24' ' ' THR . 18.9 m -111.89 128.77 56.24 Favored 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.239 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . -82.13 126.56 7.49 Favored Glycine 0 N--CA 1.421 -2.323 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.5 p -96.18 -5.96 39.33 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.326 1.06 . . . . 0.0 109.85 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -142.18 153.75 44.28 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 113.503 -1.681 . . . . 0.0 106.599 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.21 -28.99 70.07 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -171.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -82.68 -7.36 59.65 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.286 0.565 . . . . 0.0 111.235 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.512 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 42.9 tt0 -102.46 114.14 28.09 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.644 HD13 ' HA3' ' A' ' 53' ' ' GLY . 3.9 mp -83.34 145.33 29.11 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -172.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.427 HG23 ' HA ' ' A' ' 16' ' ' THR . 86.4 m -94.82 131.55 40.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.832 -1.077 . . . . 0.0 108.962 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.467 ' CD2' HD22 ' A' ' 48' ' ' LEU . 97.1 m-85 -132.07 152.87 50.95 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 123.068 0.547 . . . . 0.0 110.299 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.43 ' H ' ' HG3' ' A' ' 29' ' ' GLU . 30.6 mtm180 -100.26 -176.07 3.12 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 171.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.3 122.04 34.39 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.524 ' HA2' HH11 ' A' ' 10' ' ' ARG . . . 100.57 21.57 12.53 Favored Glycine 0 C--N 1.313 -0.712 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.617 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 26' ' ' ARG . 20.7 mm-40 -94.88 137.18 34.28 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.5 mm -89.56 124.55 42.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 108.093 -1.076 . . . . 0.0 108.093 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.5 mt -99.87 134.74 38.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -89.29 102.37 15.03 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 172.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.496 HD12 ' SG ' ' A' ' 9' ' ' CYS . 6.8 tt -72.56 125.3 27.11 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 -175.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.6 mm -98.99 -42.37 10.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.951 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.3 m -153.35 131.45 11.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.747 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -87.16 -41.02 14.08 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -87.49 105.14 17.1 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.246 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.5 p -112.04 0.02 15.83 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.77 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.92 -40.17 2.52 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.9 115.24 28.41 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.127 0.489 . . . . 0.0 109.765 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.43 124.68 22.41 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.243 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 109.52 -16.56 31.58 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.549 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -106.87 124.78 50.11 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 120.951 0.405 . . . . 0.0 110.51 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -110.82 153.07 25.91 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 86.6 tttt -106.24 129.4 54.29 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.75 166.18 25.68 Favored Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.7 tm-20 -118.8 130.42 55.77 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.467 HD22 ' CD2' ' A' ' 25' ' ' PHE . 38.6 tp -144.95 127.01 15.57 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 63.39 21.41 12.77 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.179 0.992 . . . . 0.0 111.884 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.24 4.93 62.47 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.274 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 10.3 mptt -114.73 136.98 52.47 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -125.25 127.17 46.32 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.78 0.8 . . . . 0.0 110.188 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.644 ' HA3' HD13 ' A' ' 23' ' ' LEU . . . -163.18 -157.03 8.9 Favored Glycine 0 N--CA 1.415 -2.702 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.561 -175.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.9 m -115.95 151.05 17.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-O 120.977 0.418 . . . . 0.0 111.893 -173.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -151.98 150.04 24.93 Favored Pre-proline 0 N--CA 1.434 -1.23 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.248 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 7.1 Cg_exo -74.5 128.77 12.18 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 121.831 1.688 . . . . 0.0 109.463 175.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -62.23 -20.17 63.94 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -171.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -71.77 -10.44 59.77 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.17 -1.32 57.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.248 0.546 . . . . 0.0 110.59 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -139.85 174.98 9.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.436 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.35 146.83 26.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.579 HE22 ' HB3' ' A' ' 7' ' ' GLU . 53.6 tp60 -74.62 147.87 41.23 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' A' ' 10' ' ' ARG . 45.9 mm -95.69 -55.63 5.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.9 p . . . . . 0 N--CA 1.414 -2.24 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.68 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.634 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 19.2 mm-40 . . . . . 0 N--CA 1.444 -0.758 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -120.16 132.51 55.42 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.821 0.82 . . . . 0.0 112.073 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.2 m -123.83 143.15 50.51 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.551 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -99.36 130.93 45.68 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.9 p -70.51 128.74 37.19 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 123.549 0.53 . . . . 0.0 109.917 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.0 mt -99.77 -18.57 17.14 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.591 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -140.64 145.35 39.92 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.66 141.11 40.82 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.115 1.876 . . . . 0.0 109.929 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -142.86 142.35 31.77 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 m -107.53 117.79 35.04 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.638 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.15 116.34 8.37 Favored Glycine 0 N--CA 1.425 -2.079 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 m -83.06 -20.15 35.51 Favored 'General case' 0 N--CA 1.388 -3.527 0 CA-C-O 122.438 1.113 . . . . 0.0 108.044 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -114.35 155.53 26.09 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -73.19 -29.86 63.13 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.332 0.587 . . . . 0.0 110.138 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -84.87 9.07 15.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.861 0.838 . . . . 0.0 110.533 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -112.09 133.37 54.29 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mt -78.62 133.43 37.27 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -173.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.1 m -98.08 120.14 37.96 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 173.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -134.23 155.09 50.78 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.49 169.35 8.7 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -79.39 130.33 35.32 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -175.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.14 23.38 13.12 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.999 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -107.73 138.09 44.59 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.5 mm -94.31 125.04 46.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 55.5 mt -109.17 135.45 48.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -90.52 104.68 17.23 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.634 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 4.7 tt -69.39 129.02 38.6 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.508 -177.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.7 mm -100.07 -37.85 6.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.443 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.9 m -148.87 122.16 8.99 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 121.522 -0.736 . . . . 0.0 111.589 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.562 ' HG3' HD21 ' A' ' 33' ' ' LEU . 37.6 mtmt -80.77 -2.95 49.2 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.526 0.679 . . . . 0.0 111.651 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -136.32 124.68 23.34 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.495 0.664 . . . . 0.0 109.665 173.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.1 p -113.18 17.07 18.95 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 122.015 0.912 . . . . 0.0 109.217 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.97 -12.79 62.35 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 107.918 -2.073 . . . . 0.0 107.918 -170.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -131.65 149.55 52.45 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.82 104.29 13.94 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.71 -27.66 1.32 Allowed Glycine 0 C--N 1.297 -1.625 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -112.97 121.83 45.83 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -107.98 147.9 30.45 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.971 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -105.83 130.01 53.89 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -146.99 163.89 28.61 Favored Glycine 0 N--CA 1.417 -2.572 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -109.43 123.39 49.27 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.4 tp -136.77 121.07 18.01 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.617 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 63.94 23.08 13.21 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 124.154 0.909 . . . . 0.0 111.437 174.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.08 -19.79 37.03 Favored Glycine 0 N--CA 1.427 -1.911 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.748 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -100.23 126.4 46.52 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 117.717 0.758 . . . . 0.0 111.2 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 6.7 pt-20 -102.04 100.89 11.19 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.991 175.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -131.57 -163.92 10.97 Favored Glycine 0 C--N 1.286 -2.235 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.638 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.5 m -114.47 150.99 16.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 116.871 0.335 . . . . 0.0 110.812 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -147.61 155.16 45.26 Favored Pre-proline 0 N--CA 1.433 -1.296 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.438 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.53 133.79 38.57 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.153 1.902 . . . . 0.0 110.851 176.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -62.72 -15.12 51.56 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.249 1.02 . . . . 0.0 112.842 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -101.77 -13.19 17.82 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -80.8 -7.5 59.43 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.176 0.512 . . . . 0.0 111.964 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -136.88 139.54 41.71 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.03 125.47 57.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -78.35 113.99 16.84 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.426 0.632 . . . . 0.0 111.047 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.0 pt -85.36 -48.32 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.946 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.2 m . . . . . 0 N--CA 1.408 -2.564 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.456 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 41.6 mt-10 . . . . . 0 N--CA 1.432 -1.336 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -122.87 138.4 54.67 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.278 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.8 m -128.26 137.23 51.9 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.689 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -101.48 136.89 40.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.1 p -72.93 133.63 44.43 Favored 'General case' 0 N--CA 1.417 -2.077 0 O-C-N 123.519 0.512 . . . . 0.0 109.944 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.2 mt -99.13 -18.17 17.83 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -144.87 150.72 47.23 Favored Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.38 154.21 21.36 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 121.807 1.671 . . . . 0.0 110.383 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -150.97 136.11 17.56 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.463 ' HA ' HG23 ' A' ' 24' ' ' THR . 26.0 m -103.11 128.75 49.92 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.9 137.15 16.17 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 t -89.48 -15.42 33.1 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 122.345 1.069 . . . . 0.0 108.331 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 87.7 m-20 -115.42 157.25 24.21 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.778 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.75 -30.6 71.29 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.937 0.875 . . . . 0.0 110.351 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.01 12.22 27.0 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.8 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 33.8 tt0 -114.37 115.0 26.65 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 174.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.4 HD21 ' HB3' ' A' ' 48' ' ' LEU . 1.1 tt -70.78 120.03 15.79 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.479 -166.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 16' ' ' THR . 87.0 m -89.76 120.1 30.73 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.018 175.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -135.13 161.8 34.3 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -105.17 174.98 5.65 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -87.8 123.25 32.4 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.25 8.05 15.54 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -92.81 137.11 32.65 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.763 0.316 . . . . 0.0 110.401 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mm -99.05 117.28 43.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.2 mt -102.99 141.72 18.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -174.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -90.09 114.72 26.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.7 tt -74.07 127.53 33.16 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.6 mm -102.95 -52.48 8.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.216 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 45' ' ' LYS . 20.0 m -143.96 130.98 20.51 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.958 -0.11 . . . . 0.0 110.799 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.474 ' HG3' HD21 ' A' ' 33' ' ' LEU . 97.8 mttt -88.29 -15.98 34.33 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.823 0.821 . . . . 0.0 110.379 177.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -114.07 121.67 44.55 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.79 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.0 p -123.64 17.48 9.57 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.05 -47.85 1.0 Allowed Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -100.63 161.3 13.69 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.687 -0.757 . . . . 0.0 109.812 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.03 85.52 2.22 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 176.15 -47.96 0.12 Allowed Glycine 0 CA--C 1.49 -1.486 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -82.85 121.3 26.76 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.9 m0 -107.9 144.19 35.48 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 64.0 tttp -103.31 129.33 50.29 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.19 168.23 27.15 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -123.28 129.11 50.89 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HB3' HD21 ' A' ' 23' ' ' LEU . 64.4 tp -138.79 115.77 10.89 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.796 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 62.97 23.93 14.28 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 123.907 0.883 . . . . 0.0 111.672 173.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.28 -14.28 39.82 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.885 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 9.6 mptt -103.27 136.37 43.17 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.0 146.68 46.44 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.67 -160.99 26.21 Favored Glycine 0 N--CA 1.422 -2.276 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.03 152.36 16.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 116.947 0.374 . . . . 0.0 110.122 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 53.2 p90 -149.76 152.05 33.9 Favored Pre-proline 0 N--CA 1.425 -1.684 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 55' ' ' PHE . 6.2 Cg_exo -76.06 129.29 11.29 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.678 1.586 . . . . 0.0 111.611 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -49.93 -29.7 8.83 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.509 1.524 . . . . 0.0 113.507 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -68.08 -10.58 55.02 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -96.31 -9.55 29.92 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.79 160.84 38.71 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.967 -175.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 p -128.3 133.51 66.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.484 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 51.5 tt0 -73.9 116.86 15.01 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.334 0.588 . . . . 0.0 110.007 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.4 pt -91.3 -23.76 5.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.57 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.419 -1.98 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.785 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.429 -1.523 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -123.38 158.29 31.43 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.508 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.2 p -135.84 134.12 38.52 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.146 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -100.24 135.73 41.21 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.4 p -60.85 135.68 57.85 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 124.856 1.262 . . . . 0.0 110.867 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.445 HD11 ' HB ' ' A' ' 61' ' ' VAL . 92.4 mt -108.13 -19.08 13.61 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.232 0.539 . . . . 0.0 109.904 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -148.05 152.38 39.85 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.53 148.37 42.38 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.587 1.525 . . . . 0.0 109.538 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -139.11 132.78 30.57 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.5 m -107.38 129.87 54.87 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.68 138.9 15.12 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -91.8 -16.49 26.73 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -125.63 169.92 12.02 Favored 'General case' 0 N--CA 1.402 -2.852 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.905 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -77.32 -28.11 53.08 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -174.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.27 -12.15 57.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.255 1.026 . . . . 0.0 110.154 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.03 107.58 18.49 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.419 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 2.7 tm? -71.96 133.41 45.34 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.24 -169.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.3 m -102.5 120.85 41.23 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.162 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -133.85 161.75 33.89 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -111.28 171.39 7.51 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -84.58 113.3 21.15 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.47 24.01 2.48 Favored Glycine 0 N--CA 1.425 -2.074 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.879 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -119.94 147.47 44.71 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.7 mm -100.36 119.85 49.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.508 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 61.7 mt -103.07 138.1 28.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -88.63 112.87 23.59 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.522 HD21 ' HG3' ' A' ' 36' ' ' LYS . 5.0 tt -76.1 122.45 24.3 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -174.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.522 HD11 ' HB2' ' A' ' 47' ' ' GLU . 41.1 mt -97.01 -39.14 8.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.335 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.2 t -160.56 138.77 9.92 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.285 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.522 ' HG3' HD21 ' A' ' 33' ' ' LEU . 89.9 mttt -89.75 -8.4 52.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.283 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.35 129.99 49.9 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.357 0.598 . . . . 0.0 110.269 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.9 p -125.42 23.9 7.43 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.79 0.805 . . . . 0.0 109.722 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.0 -39.39 2.86 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -174.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -104.43 139.85 38.78 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.16 102.1 14.63 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.17 -26.69 1.87 Allowed Glycine 0 C--N 1.303 -1.275 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -98.9 126.24 44.51 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.412 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 36.6 m0 -107.27 154.24 21.54 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.561 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 61.4 tttp -115.33 128.74 56.3 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.37 160.98 28.53 Favored Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.211 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.2 tm-20 -117.52 131.34 56.72 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.504 0.668 . . . . 0.0 110.748 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 68.7 tp -141.34 127.68 19.86 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 67.89 15.36 9.55 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.466 1.106 . . . . 0.0 111.395 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.74 0.77 62.19 Favored Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.353 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 4.4 mptp? -105.92 129.52 54.05 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.36 121.86 46.31 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -143.58 -174.09 15.6 Favored Glycine 0 N--CA 1.412 -2.904 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.361 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 35.4 m -115.31 150.93 17.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 O-C-N 123.884 0.403 . . . . 0.0 109.988 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -160.71 151.2 15.06 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.616 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.96 138.05 36.3 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 122.158 1.905 . . . . 0.0 110.768 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.78 -16.76 63.47 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -173.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -72.91 -1.46 16.97 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 120.987 0.423 . . . . 0.0 111.576 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -102.42 -3.09 27.54 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.78 156.02 44.92 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.89 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.445 ' HB ' HD11 ' A' ' 12' ' ' LEU . 14.4 p -118.91 136.05 57.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -78.81 117.71 20.18 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.2 pt -87.65 -9.4 10.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.433 0.635 . . . . 0.0 111.678 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--N 1.283 -2.321 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.672 177.315 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.547 ' HA ' ' OXT' ' A' ' 64' ' ' SER . 14.5 mp0 . . . . . 0 N--CA 1.426 -1.662 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -131.92 145.37 51.47 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.9 m -127.96 142.91 51.11 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.539 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -104.05 132.31 50.43 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.0 p -76.49 134.84 39.39 Favored 'General case' 0 C--N 1.288 -2.109 0 CA-C-O 121.155 0.502 . . . . 0.0 111.724 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.6 mt -95.5 -17.97 21.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.873 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -141.44 154.32 66.76 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.571 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.79 134.71 8.6 Favored 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 122.011 1.808 . . . . 0.0 109.375 169.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -135.25 138.15 43.25 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.422 ' HA ' HG23 ' A' ' 24' ' ' THR . 23.0 m -107.5 122.42 46.62 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.039 -177.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.445 ' HA2' ' HG2' ' A' ' 22' ' ' GLU . . . -82.09 106.81 2.72 Favored Glycine 0 N--CA 1.413 -2.838 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.77 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.7 -33.28 21.55 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 90.5 m-20 -88.8 153.95 20.66 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.892 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -62.11 -37.45 85.15 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.793 0.33 . . . . 0.0 111.661 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -90.91 10.67 25.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.629 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 46.8 tt0 -110.44 125.55 53.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 mt -82.86 139.51 33.43 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -175.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 16' ' ' THR . 51.4 m -99.32 119.44 37.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -134.88 159.78 40.35 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -101.11 -179.7 4.12 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -85.51 133.55 34.07 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.54 17.4 39.2 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.101 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -92.42 142.57 27.28 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.8 mm -99.99 123.55 52.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.9 mt -114.31 142.34 27.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -89.17 115.27 26.56 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 tt -66.11 133.82 51.51 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.4 mm -112.48 -49.41 5.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.427 0.632 . . . . 0.0 109.436 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.3 m -149.94 118.5 6.52 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.631 -0.668 . . . . 0.0 111.596 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -73.45 -26.08 60.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.505 0.669 . . . . 0.0 109.833 173.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -101.98 111.97 24.44 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.2 p -110.12 -2.29 17.02 Favored 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.43 -10.88 33.28 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -125.8 143.78 50.92 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.17 86.72 5.04 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.199 0.523 . . . . 0.0 109.614 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.91 -30.27 0.39 Allowed Glycine 0 CA--C 1.489 -1.591 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -89.63 123.22 33.49 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -108.99 134.21 51.94 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 84.6 tttt -99.12 129.61 45.39 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -142.54 165.18 26.85 Favored Glycine 0 N--CA 1.423 -2.195 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 41.7 tt0 -110.77 131.95 54.61 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 123.772 0.337 . . . . 0.0 110.346 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.9 tp -148.27 119.72 7.92 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.098 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 62.06 34.08 16.73 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.965 0.906 . . . . 0.0 112.212 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.9 -10.99 68.2 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.651 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 4.6 mptp? -105.82 129.7 53.95 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-N 117.482 0.641 . . . . 0.0 111.083 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 46' ' ' GLY 0.383 0.0 OUTLIER -111.99 106.29 14.93 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 122.662 1.22 . . . . 0.0 111.002 170.831 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -134.61 -171.57 12.55 Favored Glycine 0 N--CA 1.425 -2.084 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.354 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.0 m -114.63 150.82 16.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-O 121.303 0.573 . . . . 0.0 111.403 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -152.42 148.76 21.43 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.956 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.67 129.76 21.85 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 121.569 1.512 . . . . 0.0 109.498 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.75 -22.6 58.24 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -172.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -69.19 -8.2 43.46 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -91.96 -0.7 57.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.641 0.257 . . . . 0.0 110.907 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -144.73 165.95 26.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.719 0.295 . . . . 0.0 110.861 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 p -131.57 134.37 60.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -71.27 118.2 13.77 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.3 pt -96.51 -23.78 4.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-O 121.953 0.882 . . . . 0.0 110.522 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.547 ' OXT' ' HA ' ' A' ' 7' ' ' GLU . 44.9 m . . . . . 0 N--CA 1.4 -2.938 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 . . . . . 0 N--CA 1.418 -2.038 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -130.23 139.45 50.79 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.49 -175.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.405 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 13.8 p -124.01 147.62 47.67 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.342 -178.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -108.15 135.61 49.21 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.411 HG21 ' CD1' ' A' ' 25' ' ' PHE . 43.2 p -79.44 136.65 37.0 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.399 0.619 . . . . 0.0 112.268 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.0 mt -99.96 -18.01 17.28 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.672 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -145.55 156.37 52.95 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -84.2 151.2 12.23 Favored 'Trans proline' 0 C--O 1.253 1.265 0 C-N-CA 122.142 1.895 . . . . 0.0 111.323 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -137.55 125.8 23.16 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.446 ' HA ' HG23 ' A' ' 24' ' ' THR . 23.5 m -112.99 110.88 21.23 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.47 144.49 44.2 Favored Glycine 0 N--CA 1.412 -2.958 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.992 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.1 p -89.93 -21.44 22.47 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -121.11 157.2 30.64 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -87.87 12.01 14.2 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.471 1.129 . . . . 0.0 109.853 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -78.65 -31.35 46.76 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 170.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -82.32 150.03 27.43 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 113.333 -1.758 . . . . 0.0 107.148 173.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 48' ' ' LEU . 3.2 tm? -103.58 126.33 50.66 Favored 'General case' 0 C--N 1.281 -2.396 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.625 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.446 HG23 ' HA ' ' A' ' 16' ' ' THR . 94.3 m -94.53 120.43 34.75 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.204 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 11' ' ' THR . 23.4 p90 -134.77 158.88 43.02 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.411 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -99.63 -179.3 4.15 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -81.1 133.77 35.53 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.2 27.29 28.52 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.118 176.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -105.97 151.47 24.57 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mm -101.26 124.48 55.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.405 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 62.7 mt -110.02 143.88 19.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -89.33 104.97 17.48 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.578 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.4 tt -71.62 128.23 35.13 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.215 0.531 . . . . 0.0 109.758 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.35 -50.51 9.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.957 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.8 m -144.21 131.24 20.5 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.944 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.578 ' HG3' HD21 ' A' ' 33' ' ' LEU . 44.5 mtmt -97.98 -22.52 16.25 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.598 0.713 . . . . 0.0 110.476 174.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -109.8 86.44 2.3 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 p -87.4 -18.23 30.48 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.703 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.81 -43.0 1.02 Allowed Glycine 0 C--N 1.28 -2.571 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -120.36 111.14 17.38 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.85 109.25 1.69 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 152.14 -33.0 0.87 Allowed Glycine 0 C--N 1.287 -2.183 0 N-CA-C 107.545 -2.222 . . . . 0.0 107.545 -174.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -100.34 124.6 46.03 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 35.6 m0 -107.86 146.09 32.78 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.21 129.09 55.78 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.22 159.65 27.93 Favored Glycine 0 N--CA 1.41 -3.082 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.2 tm-20 -110.73 130.55 55.54 Favored 'General case' 0 N--CA 1.414 -2.244 0 O-C-N 124.402 0.707 . . . . 0.0 109.358 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.517 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 43.0 tp -144.66 127.42 16.26 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.254 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.517 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 51.9 m-80 65.26 17.98 11.22 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.754 1.221 . . . . 0.0 111.484 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.01 -15.4 55.28 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.36 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 12.1 mptt -100.52 133.54 44.81 Favored 'General case' 0 CA--C 1.489 -1.379 0 CA-C-N 117.013 0.406 . . . . 0.0 110.31 -175.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -111.38 121.61 45.69 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.041 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.22 -170.01 13.93 Favored Glycine 0 C--N 1.287 -2.168 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.1 m -115.22 150.88 17.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 120.796 0.332 . . . . 0.0 110.591 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -156.13 149.06 18.23 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.134 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 34.8 Cg_exo -66.72 136.99 44.11 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.072 1.848 . . . . 0.0 111.398 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -63.2 -13.36 36.59 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.108 0.963 . . . . 0.0 112.743 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -71.91 -10.6 60.01 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.165 0.586 . . . . 0.0 111.922 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -107.61 8.62 29.24 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.666 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.13 154.33 43.79 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.427 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.16 131.6 72.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -76.53 127.54 33.02 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.8 mm -90.51 -49.79 13.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.41 -2.475 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -179.709 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 . . . . . 0 N--CA 1.438 -1.067 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -110.8 134.42 52.52 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.594 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.473 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 12.9 p -120.03 146.32 45.99 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-O 121.173 0.511 . . . . 0.0 110.233 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -106.0 134.66 48.77 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.0 p -66.74 140.12 57.85 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 123.823 0.849 . . . . 0.0 110.25 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.5 mt -107.04 -20.22 13.38 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.818 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -153.4 152.27 27.23 Favored Pre-proline 0 C--N 1.316 -0.853 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -177.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.28 110.85 3.15 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 121.626 1.551 . . . . 0.0 111.29 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -109.4 131.4 55.1 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.509 ' HA ' HG23 ' A' ' 24' ' ' THR . 24.2 m -110.6 129.6 55.77 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.94 150.28 39.1 Favored Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.0 t -98.74 5.66 47.44 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.734 1.254 . . . . 0.0 108.284 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -156.0 173.25 17.07 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.504 -1.68 . . . . 0.0 106.658 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -79.62 -30.35 41.39 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -174.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.13 -21.77 60.66 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.182 0.992 . . . . 0.0 109.313 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -87.99 110.45 20.6 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.1 135.13 38.57 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.581 0.705 . . . . 0.0 111.6 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 16' ' ' THR . 94.7 m -98.92 122.54 42.3 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.569 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -133.39 157.77 44.71 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.529 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -109.84 -167.41 1.2 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 122.745 0.418 . . . . 0.0 110.568 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -89.22 141.71 28.29 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.85 29.97 49.61 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.272 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.03 157.53 23.35 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 122.154 -0.615 . . . . 0.0 112.272 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.6 mm -111.73 124.78 68.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.473 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 65.3 mt -114.48 143.62 23.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -89.49 116.01 27.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.5 tt -79.73 118.99 22.04 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 47' ' ' GLU . 61.3 mt -89.52 -47.99 14.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.52 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.1 m -155.88 140.77 17.2 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 122.149 -0.344 . . . . 0.0 110.621 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -90.86 -16.56 28.02 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -106.9 103.03 12.35 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.063 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.0 p -107.18 3.02 25.19 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.784 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.86 -14.91 41.1 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -130.54 116.38 18.08 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.31 118.59 10.21 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.48 -22.76 7.32 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -105.3 122.37 45.81 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.7 m0 -108.18 155.06 20.86 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -110.56 129.85 55.7 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.85 164.23 25.51 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.526 ' HB2' HD11 ' A' ' 34' ' ' ILE . 25.2 tt0 -124.94 123.93 40.95 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.4 tp -125.2 117.45 23.88 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 m120 66.14 21.85 11.12 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.193 0.997 . . . . 0.0 110.82 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.16 -10.02 58.1 Favored Glycine 0 N--CA 1.435 -1.393 0 CA-C-N 115.661 -0.699 . . . . 0.0 113.712 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 3.3 mptp? -97.84 132.3 43.57 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 117.852 0.826 . . . . 0.0 109.405 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.85 148.05 29.0 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 123.673 0.608 . . . . 0.0 111.917 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.49 -172.06 40.81 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.21 156.58 16.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 116.809 0.304 . . . . 0.0 110.809 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -158.35 156.05 26.82 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.114 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -74.48 136.21 21.24 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.116 1.877 . . . . 0.0 110.913 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -61.33 -21.97 64.49 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -174.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -73.16 -4.65 34.13 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -102.45 4.52 38.85 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.933 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.92 164.38 33.92 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.1 p -134.64 140.64 45.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 52.6 tt0 -85.28 133.01 34.17 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.255 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.6 mt -79.3 -67.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 N--CA 1.403 -2.822 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 177.763 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 N--CA 1.441 -0.897 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -120.22 133.5 55.47 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.578 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.564 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 3.4 p -122.3 149.3 43.93 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.993 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 51.2 ttt180 -118.79 133.92 55.51 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.507 HG23 HD11 ' A' ' 31' ' ' ILE . 4.3 p -74.92 135.66 41.45 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.4 mt -103.01 -17.6 15.36 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -138.44 150.86 67.85 Favored Pre-proline 0 N--CA 1.438 -1.07 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.304 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -76.7 161.03 34.16 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.09 1.86 . . . . 0.0 110.643 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -149.19 124.59 10.27 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.7 m -101.92 124.85 48.24 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.98 134.07 12.52 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.1 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -95.31 -15.16 23.33 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 122.304 1.05 . . . . 0.0 108.493 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -112.38 168.41 9.66 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -86.43 -27.5 24.1 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.729 0.776 . . . . 0.0 109.647 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.86 -28.03 60.5 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.863 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -82.36 116.78 22.0 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.55 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -89.72 143.22 26.98 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.046 0.45 . . . . 0.0 110.481 -169.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.2 m -92.66 128.38 38.5 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.177 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 98.8 m-85 -129.03 147.08 50.86 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.143 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 26' ' ' ARG . 37.2 mmt180 -104.62 171.61 7.23 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 172.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -78.71 133.95 37.12 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 122.557 0.343 . . . . 0.0 110.871 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.56 16.88 57.93 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.995 -0.621 . . . . 0.0 113.388 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 27.5 mm-40 -92.72 147.38 22.92 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.1 mm -98.72 118.31 45.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.564 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 53.4 mt -99.13 135.22 35.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.075 -175.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -89.65 107.1 18.89 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.525 HD21 ' HG3' ' A' ' 36' ' ' LYS . 8.0 tt -70.5 140.22 51.81 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 121.11 0.481 . . . . 0.0 110.706 -173.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mm -108.72 -44.92 6.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.311 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.3 t -157.44 145.23 18.89 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.525 ' HG3' HD21 ' A' ' 33' ' ' LEU . 51.1 mtpt -102.86 1.23 33.71 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-O 121.746 0.784 . . . . 0.0 109.645 175.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -121.63 115.76 23.34 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.609 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -124.63 3.76 8.25 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.806 0.812 . . . . 0.0 109.847 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.23 -21.62 39.04 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -114.8 135.46 54.16 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.764 -0.718 . . . . 0.0 109.195 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.65 99.8 11.54 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 134.25 -14.2 4.57 Favored Glycine 0 N--CA 1.421 -2.327 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.187 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -107.45 125.74 51.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.287 0.565 . . . . 0.0 110.329 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.518 ' CZ2' ' HE3' ' A' ' 36' ' ' LYS . 43.3 m0 -113.71 164.9 13.11 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.235 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -118.31 129.97 55.76 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.54 158.02 27.4 Favored Glycine 0 N--CA 1.421 -2.358 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 1.1 tm-20 -112.1 131.52 55.39 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 123.239 0.616 . . . . 0.0 109.831 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 51.0 tp -144.56 132.62 21.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 68.76 13.79 8.91 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.407 1.083 . . . . 0.0 111.838 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.14 9.47 56.99 Favored Glycine 0 N--CA 1.427 -1.903 0 C-N-CA 121.151 -0.547 . . . . 0.0 111.776 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -123.75 126.75 47.07 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.073 0.463 . . . . 0.0 110.849 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -99.69 125.87 45.63 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.297 177.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.26 -172.47 17.48 Favored Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.3 m -115.13 158.19 15.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 117.215 0.507 . . . . 0.0 110.871 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -162.03 156.46 19.01 Favored Pre-proline 0 C--N 1.319 -0.726 0 O-C-N 124.004 0.815 . . . . 0.0 109.595 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 6.6 Cg_exo -75.8 127.58 10.25 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.206 1.937 . . . . 0.0 109.428 172.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -65.6 -17.54 64.66 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.627 0.371 . . . . 0.0 111.941 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -65.7 -14.03 60.45 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -87.32 -2.9 58.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.179 0.514 . . . . 0.0 110.818 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.94 177.82 7.61 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.431 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.49 135.54 43.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -81.65 129.48 34.71 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.85 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.2 mm -77.38 -68.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.399 -3.004 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.341 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 9.3 mm-40 . . . . . 0 N--CA 1.426 -1.661 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -121.85 138.85 54.23 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.592 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 8.0 p -125.47 142.25 51.61 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.75 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -101.61 135.79 42.53 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 64.2 p -77.5 128.63 34.51 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-O 121.258 0.551 . . . . 0.0 111.65 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.1 mt -98.9 -18.14 18.02 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.138 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -142.52 143.95 28.59 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -74.24 141.75 29.51 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.9 1.733 . . . . 0.0 109.853 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -137.37 128.43 27.6 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.521 ' HA ' HG23 ' A' ' 24' ' ' THR . 24.3 m -100.84 118.0 36.03 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.702 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.7 125.71 17.07 Favored Glycine 0 N--CA 1.427 -1.957 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.3 p -82.26 -20.51 37.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.746 1.26 . . . . 0.0 108.633 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 44.0 m-80 -115.42 161.9 17.9 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.99 -19.81 29.81 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.582 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -79.91 -3.39 47.88 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.3 1.047 . . . . 0.0 108.9 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 36.7 tt0 -107.19 126.12 51.99 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' A' ' 48' ' ' LEU . 2.3 tm? -86.8 135.13 33.46 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.571 -167.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.521 HG23 ' HA ' ' A' ' 16' ' ' THR . 90.0 m -100.3 119.85 39.04 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.29 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -134.85 151.92 51.31 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.738 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -99.71 179.49 4.52 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 173.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.3 139.85 36.43 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.63 10.34 55.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.222 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -95.49 156.8 16.17 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 122.589 -0.359 . . . . 0.0 110.256 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.9 mm -110.33 116.25 51.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.592 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 62.5 mt -101.75 131.51 49.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -90.77 102.67 15.42 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 6.0 tt -69.03 134.47 49.47 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.656 -173.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.0 mm -101.2 -51.2 9.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.411 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.9 m -146.62 141.64 27.11 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.739 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.446 ' HG2' HD11 ' A' ' 33' ' ' LEU . 47.1 mtmt -91.58 -22.65 20.21 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 172.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -101.78 112.57 25.21 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.462 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.8 p -106.39 2.23 26.33 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.92 0.867 . . . . 0.0 109.069 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.45 -44.1 1.54 Allowed Glycine 0 N--CA 1.427 -1.925 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -99.02 134.24 42.15 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.85 102.11 7.09 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.54 -27.34 1.66 Allowed Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -99.06 128.7 45.24 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 24.5 m0 -108.06 159.92 16.2 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 53.0 tttm -128.32 128.37 44.47 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -150.12 160.08 28.38 Favored Glycine 0 N--CA 1.425 -2.094 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -175.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -107.19 127.12 53.23 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.496 ' HB3' HD11 ' A' ' 23' ' ' LEU . 68.7 tp -133.22 111.14 10.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.7 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.5 m120 63.82 18.94 11.48 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 124.712 1.205 . . . . 0.0 113.099 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.81 -25.24 5.9 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.136 -1.03 . . . . 0.0 113.846 177.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 1.5 mptm? -106.09 142.32 35.98 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 117.697 0.748 . . . . 0.0 110.888 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 14.1 pt-20 -118.76 114.22 22.34 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -132.46 -166.85 11.64 Favored Glycine 0 N--CA 1.42 -2.383 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.66 153.16 16.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -161.73 147.74 10.84 Favored Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 123.88 0.737 . . . . 0.0 109.482 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.43 134.88 29.79 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 121.833 1.688 . . . . 0.0 109.937 174.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.26 1.43 2.91 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -76.37 -22.31 54.99 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 122.942 0.497 . . . . 0.0 110.635 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -91.38 2.09 56.65 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -174.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.12 171.29 15.55 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 122.363 -0.21 . . . . 0.0 110.529 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.47 132.04 40.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -70.18 117.34 11.62 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.031 0.443 . . . . 0.0 110.736 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.6 mt -67.81 -50.16 62.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.426 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 N--CA 1.411 -2.405 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 . . . . . 0 N--CA 1.445 -0.693 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -121.45 144.48 48.66 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.598 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.5 p -131.12 150.49 52.12 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.526 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -110.14 133.99 52.65 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.602 HG23 HD11 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -75.92 125.99 30.15 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-O 121.011 0.434 . . . . 0.0 111.313 175.416 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.1 mt -96.41 -9.58 29.57 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.936 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -142.27 141.14 20.37 Favored Pre-proline 0 N--CA 1.431 -1.379 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.708 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.33 132.1 18.75 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.065 1.843 . . . . 0.0 109.648 171.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 24' ' ' THR . 87.1 t80 -124.94 122.28 36.88 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.0 m -101.44 120.54 40.44 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.34 143.28 38.82 Favored Glycine 0 N--CA 1.423 -2.192 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.276 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 p -85.18 -33.63 22.25 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 122.605 1.193 . . . . 0.0 108.309 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 40.8 m-80 -103.67 158.4 16.4 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 173.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.39 5.67 49.81 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.737 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.94 -20.23 42.5 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 170.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 19' ' ' ASN . 17.6 mt-10 -81.61 159.3 24.07 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 113.548 -1.66 . . . . 0.0 106.992 171.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.437 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -121.06 136.32 55.01 Favored 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 118.932 -1.107 . . . . 0.0 108.593 -178.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 88.7 m -89.53 121.04 31.36 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.304 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 89.1 m-85 -121.91 159.16 27.44 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.561 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -117.29 165.59 13.28 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.39 125.33 23.38 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 123.416 0.686 . . . . 0.0 110.028 174.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.97 13.06 57.03 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.512 -0.851 . . . . 0.0 114.028 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -92.41 144.68 25.12 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.8 mm -99.07 123.96 52.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.602 HD11 HG23 ' A' ' 11' ' ' THR . 50.6 mt -106.93 135.28 45.97 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.588 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -89.86 117.75 28.93 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 171.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.527 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.4 tt -73.94 119.82 18.67 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.749 -175.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.1 mm -92.82 -40.35 11.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.392 -176.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.6 t -161.17 144.48 12.86 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.043 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.527 ' HG3' HD21 ' A' ' 33' ' ' LEU . 94.6 mttt -100.46 4.21 43.54 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -120.84 102.39 8.34 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.456 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.2 p -115.96 7.44 14.38 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.38 -17.44 53.59 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 108.671 -1.771 . . . . 0.0 108.671 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -121.62 151.04 40.84 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.885 -0.657 . . . . 0.0 110.253 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.42 99.29 9.33 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.26 -38.9 1.01 Allowed Glycine 0 CA--C 1.49 -1.476 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -176.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -95.79 119.9 35.11 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -109.08 159.18 17.07 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -108.22 129.84 55.18 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.42 159.4 25.26 Favored Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.37 135.29 54.08 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.001 0.429 . . . . 0.0 110.654 -177.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.4 tp -138.88 122.31 17.22 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 124.039 0.935 . . . . 0.0 108.882 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.8 m120 68.87 11.56 8.38 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.307 1.043 . . . . 0.0 112.513 175.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.56 -8.17 43.47 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 3.5 mptp? -102.76 130.93 49.88 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -120.9 135.05 55.28 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-O 121.333 0.587 . . . . 0.0 111.183 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -153.22 -167.22 15.41 Favored Glycine 0 N--CA 1.416 -2.692 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.3 m -115.32 153.51 16.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 120.772 0.32 . . . . 0.0 111.091 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -157.12 150.95 19.33 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.49 136.74 19.79 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 121.559 1.506 . . . . 0.0 109.758 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.66 -16.19 62.44 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.068 0.461 . . . . 0.0 110.795 -176.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -53.39 -29.27 33.8 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 124.481 1.113 . . . . 0.0 111.687 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -94.02 -1.1 55.0 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.32 148.54 36.45 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -174.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.67 134.0 61.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -78.81 128.15 32.99 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.113 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.42 -58.25 3.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.404 -2.754 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 177.654 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 N--CA 1.439 -0.975 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -114.17 138.98 49.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.53 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 7.8 p -122.56 133.17 54.57 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.904 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -99.69 135.21 41.44 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.8 p -81.05 129.3 34.48 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.258 0.552 . . . . 0.0 111.135 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.1 mt -97.69 -16.65 19.85 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.571 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -142.84 153.27 60.82 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -81.79 142.59 12.76 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.927 1.751 . . . . 0.0 110.079 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -126.89 130.48 50.24 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.486 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.435 ' HA ' HG23 ' A' ' 24' ' ' THR . 49.7 m -100.32 113.38 26.05 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.16 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.97 145.37 29.71 Favored Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 176.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.9 p -92.19 -35.53 13.78 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.01 0.91 . . . . 0.0 108.701 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -107.28 -179.04 3.81 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.737 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -93.93 8.27 41.93 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.905 0.86 . . . . 0.0 109.472 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -91.22 -32.15 15.89 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.93 156.27 32.16 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.874 172.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.0 tt -102.44 115.18 30.04 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.435 HG23 ' HA ' ' A' ' 16' ' ' THR . 63.8 m -83.59 120.04 25.47 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -134.36 161.83 33.89 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -96.66 170.04 9.47 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -82.99 137.08 34.29 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.55 26.15 21.24 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.481 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -102.65 148.81 25.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mm -105.27 112.5 39.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 58.9 mt -100.94 139.0 23.3 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -88.24 106.75 18.41 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.66 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.5 tt -68.66 122.64 18.94 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.491 -174.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 47' ' ' GLU . 50.7 mt -97.42 -44.71 12.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.378 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.0 m -150.12 138.86 20.8 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.795 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.66 ' HG3' HD21 ' A' ' 33' ' ' LEU . 50.3 mtmt -97.75 5.14 49.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.4 118.81 32.15 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 113.638 -1.619 . . . . 0.0 108.656 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.9 p -133.57 -0.29 3.22 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.37 0.605 . . . . 0.0 110.273 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.25 -41.41 2.14 Favored Glycine 0 C--N 1.306 -1.126 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -174.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -97.79 116.45 30.03 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.39 114.05 6.49 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 128.3 -17.71 5.88 Favored Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -174.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -113.94 128.96 56.62 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.847 0.356 . . . . 0.0 111.118 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.403 ' CE2' ' HG2' ' A' ' 36' ' ' LYS . 34.0 m0 -108.87 169.67 8.53 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 58.9 tttm -137.54 128.92 28.04 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -152.49 173.07 31.61 Favored Glycine 0 C--N 1.297 -1.605 0 C-N-CA 120.285 -0.96 . . . . 0.0 112.121 -175.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.476 ' HB2' HD11 ' A' ' 34' ' ' ILE . 9.0 tt0 -108.91 134.22 51.88 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 123.67 0.788 . . . . 0.0 109.814 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.7 tp -153.47 129.71 10.47 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 64.3 20.03 12.01 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.714 0.806 . . . . 0.0 112.403 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.46 3.66 64.67 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 116.13 -0.487 . . . . 0.0 113.039 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -117.4 150.67 38.48 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 9.1 pt-20 -121.87 140.81 51.94 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 172.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -160.54 -169.31 23.65 Favored Glycine 0 C--N 1.288 -2.086 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.53 152.14 16.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.064 0.459 . . . . 0.0 110.307 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -157.45 148.68 16.69 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.283 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 20.3 Cg_exo -65.69 125.89 15.11 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.487 1.458 . . . . 0.0 109.245 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -61.29 -18.68 59.67 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -171.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -72.57 -14.36 61.61 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.936 0.335 . . . . 0.0 111.239 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -80.35 -14.74 58.1 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.597 0.237 . . . . 0.0 111.192 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.06 166.55 20.81 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.57 142.3 35.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -70.3 140.87 52.38 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.9 pt -91.17 -42.14 13.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-O 121.255 0.55 . . . . 0.0 111.316 -173.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.411 -2.377 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.555 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 35.8 mt-10 . . . . . 0 N--CA 1.43 -1.456 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -128.45 137.96 52.07 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.97 0.414 . . . . 0.0 110.138 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.436 ' SG ' HD12 ' A' ' 33' ' ' LEU . 59.8 m -124.47 153.81 41.44 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.986 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -117.46 132.17 56.61 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.425 HG23 HD11 ' A' ' 31' ' ' ILE . 6.5 p -72.46 128.51 35.82 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 120.811 0.339 . . . . 0.0 111.235 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.8 mt -89.16 -18.03 27.98 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.99 157.21 64.54 Favored Pre-proline 0 C--N 1.309 -1.181 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.43 138.63 15.77 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.297 1.332 . . . . 0.0 109.462 173.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 24' ' ' THR . 68.8 t80 -122.6 117.94 27.02 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.792 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 m -109.98 127.54 54.85 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.91 153.37 28.14 Favored Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.57 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -98.15 -20.71 17.15 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -105.16 166.57 10.31 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -82.72 -9.58 59.29 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.654 0.74 . . . . 0.0 109.538 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -78.32 -30.05 48.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.699 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -78.86 151.49 31.8 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.181 173.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.448 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -112.91 139.2 48.75 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 96.2 m -95.13 120.67 35.75 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.668 0.747 . . . . 0.0 111.121 -177.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 91.7 m-85 -122.55 147.17 46.7 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.829 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -90.29 172.55 8.69 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 176.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -75.41 129.94 38.15 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.3 39.03 20.2 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.793 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -117.97 154.9 31.18 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.0 mm -96.21 128.61 47.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 O-C-N 123.556 0.535 . . . . 0.0 109.994 -175.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 11' ' ' THR . 52.7 mt -112.23 134.54 54.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -90.04 110.23 21.23 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 171.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.5 tt -74.45 123.84 25.46 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mm -96.94 -43.66 12.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.387 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.9 m -156.39 135.23 11.81 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.267 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -85.54 -27.01 25.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 170.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -95.35 102.71 14.54 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.639 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.3 p -109.2 -0.91 19.03 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.802 0.811 . . . . 0.0 109.98 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.12 -41.25 1.58 Allowed Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 107.746 -2.141 . . . . 0.0 107.746 -173.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -115.32 166.32 11.99 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.436 -0.882 . . . . 0.0 109.639 175.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.81 149.13 23.69 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 171.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 100.38 -25.86 26.71 Favored Glycine 0 C--N 1.301 -1.39 0 C-N-CA 120.369 -0.919 . . . . 0.0 110.88 -176.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -111.56 116.9 31.61 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -108.89 157.26 18.79 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.577 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -105.06 130.02 53.35 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.34 147.55 19.26 Favored Glycine 0 N--CA 1.417 -2.569 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.96 136.28 44.74 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.473 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 27.4 tp -145.47 128.19 16.24 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.473 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 38.3 m-80 62.91 20.31 12.14 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.938 0.895 . . . . 0.0 112.067 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.42 -3.42 75.55 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.321 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -102.41 133.71 46.92 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.34 120.85 43.13 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -136.67 -172.09 12.45 Favored Glycine 0 C--N 1.286 -2.216 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.76 151.13 16.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.162 0.506 . . . . 0.0 110.848 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -151.4 150.86 27.86 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.3 Cg_exo -76.75 135.92 16.43 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 121.872 1.715 . . . . 0.0 110.748 175.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -64.72 -14.87 60.35 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.893 0.377 . . . . 0.0 111.432 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -63.42 -19.87 65.06 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.436 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -98.78 0.86 45.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -144.52 167.85 21.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.173 0.511 . . . . 0.0 111.759 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.3 p -132.88 139.17 50.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -83.18 128.34 34.4 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.8 pt -101.77 -30.71 3.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.058 0.456 . . . . 0.0 110.719 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.416 -2.17 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.717 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 3.4 mm-40 . . . . . 0 N--CA 1.42 -1.943 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -130.96 138.22 49.61 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.1 p -123.57 138.85 54.48 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 65.3 ttt180 -107.86 134.26 51.05 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.411 HG21 ' CD1' ' A' ' 25' ' ' PHE . 45.4 p -77.81 133.97 38.1 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-O 121.504 0.669 . . . . 0.0 111.59 -176.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.22 -7.77 24.31 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.783 0.801 . . . . 0.0 109.515 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -147.17 156.03 46.7 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -85.59 155.63 10.48 Favored 'Trans proline' 0 N--CA 1.436 -1.876 0 C-N-CA 121.852 1.702 . . . . 0.0 109.008 170.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -149.19 129.61 13.86 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.509 ' HA ' HG23 ' A' ' 24' ' ' THR . 19.0 m -115.69 125.81 53.31 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.048 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.93 151.84 24.18 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.0 t -94.73 1.52 55.48 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 122.629 1.204 . . . . 0.0 108.256 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -141.69 165.16 28.23 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.67 -6.73 58.11 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -83.27 -24.28 32.32 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 122.168 0.985 . . . . 0.0 109.103 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -94.44 131.09 40.49 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -87.41 129.39 35.06 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.972 0.891 . . . . 0.0 112.512 -169.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 16' ' ' THR . 91.1 m -97.1 121.37 38.91 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.205 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 11' ' ' THR . 10.5 p90 -133.69 160.09 38.6 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.045 0.45 . . . . 0.0 112.175 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -94.23 171.32 8.9 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.62 145.66 31.58 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.33 16.23 78.61 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.419 -0.42 . . . . 0.0 113.263 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 8.9 tp10 -97.98 148.29 23.63 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.849 0.357 . . . . 0.0 110.732 -175.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.3 mm -96.86 121.17 47.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.4 mt -113.84 140.85 32.21 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -89.43 121.9 32.11 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.0 tt -79.01 133.2 36.83 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -174.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 47' ' ' GLU . 36.4 mt -106.84 -44.0 7.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-O 121.128 0.489 . . . . 0.0 110.232 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -150.17 130.77 13.97 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 121.973 -0.455 . . . . 0.0 111.839 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -88.36 -23.71 23.31 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -97.87 109.5 22.24 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.556 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.7 p -111.61 -5.64 14.48 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.776 0.798 . . . . 0.0 110.126 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.94 -17.16 30.09 Favored Glycine 0 C--N 1.309 -0.967 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -128.36 128.94 45.49 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.39 115.04 16.83 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.66 -15.59 6.29 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -110.34 124.1 51.07 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -108.77 155.51 20.68 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.775 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 38.3 ttmt -117.2 129.46 55.96 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.61 173.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.64 168.13 26.0 Favored Glycine 0 N--CA 1.416 -2.68 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.511 ' HB2' HD11 ' A' ' 34' ' ' ILE . 1.8 tm-20 -115.34 129.9 56.74 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.097 0.475 . . . . 0.0 110.365 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.8 tp -156.64 138.82 14.62 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 73.02 12.24 5.07 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.659 1.184 . . . . 0.0 110.921 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.44 14.76 59.58 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 27.3 mmmt -126.06 154.98 42.26 Favored 'General case' 0 CA--C 1.468 -2.21 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -175.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.29 126.23 34.85 Favored 'General case' 0 C--N 1.257 -3.427 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.117 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -156.75 -161.66 10.92 Favored Glycine 0 CA--C 1.469 -2.832 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -176.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.5 147.51 17.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.793 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -150.51 154.87 36.07 Favored Pre-proline 0 N--CA 1.426 -1.626 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.679 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.06 128.05 13.51 Favored 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 122.14 1.893 . . . . 0.0 111.372 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.26 -19.38 64.5 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.031 0.933 . . . . 0.0 112.264 -175.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.39 -4.78 44.13 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -102.31 -0.33 33.0 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 121.127 0.489 . . . . 0.0 112.104 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -141.42 155.58 45.87 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.209 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 p -120.75 139.3 48.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.445 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 50.0 tt0 -79.83 122.06 26.17 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.679 0.752 . . . . 0.0 111.613 -177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.6 mm -93.7 -31.06 4.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.541 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.42 -1.967 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 -178.691 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 . . . . . 0 N--CA 1.431 -1.407 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -113.11 153.19 28.62 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.592 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.6 p -133.99 138.36 45.38 Favored 'General case' 0 C--N 1.267 -2.983 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.205 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -99.7 138.23 37.08 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 42.4 p -63.09 142.93 58.19 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 124.332 1.053 . . . . 0.0 110.406 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.7 mt -113.08 -18.78 12.08 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.322 0.582 . . . . 0.0 110.165 175.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -149.4 147.66 23.96 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.38 123.64 8.84 Favored 'Trans proline' 0 C--O 1.253 1.264 0 C-N-CA 122.052 1.835 . . . . 0.0 110.51 173.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -129.98 134.0 47.16 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.483 ' HA ' HG23 ' A' ' 24' ' ' THR . 46.8 m -116.28 131.69 56.87 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 120.933 0.397 . . . . 0.0 110.544 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.04 134.68 11.86 Favored Glycine 0 N--CA 1.413 -2.887 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.5 p -91.15 -34.71 14.92 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -79.27 145.93 33.26 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 113.377 -1.738 . . . . 0.0 108.692 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.41 -35.86 80.55 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.775 0.672 . . . . 0.0 110.631 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.426 ' O ' HG22 ' A' ' 54' ' ' VAL . 31.0 t70 -86.42 4.96 37.29 Favored 'General case' 0 C--O 1.203 -1.371 0 CA-C-O 121.62 0.724 . . . . 0.0 110.213 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -104.35 134.7 47.11 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.19 135.42 33.8 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.73 0.3 . . . . 0.0 111.564 -170.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.483 HG23 ' HA ' ' A' ' 16' ' ' THR . 94.1 m -103.24 120.06 40.04 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -135.02 154.42 51.73 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -104.94 -176.69 3.15 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.94 122.96 35.84 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 176.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.39 8.73 8.29 Favored Glycine 0 C--N 1.294 -1.796 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.244 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -110.41 154.33 23.72 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.1 mm -108.13 122.48 62.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.114 0.483 . . . . 0.0 109.762 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.592 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 58.6 mt -105.79 130.15 57.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.95 127.51 36.04 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.99 121.75 20.62 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mm -100.59 -41.33 8.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.603 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 45' ' ' LYS . 25.4 m -151.68 139.55 19.94 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.272 -0.268 . . . . 0.0 111.524 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -103.4 -14.32 16.31 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.89 0.476 . . . . 0.0 110.366 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -110.47 97.42 6.87 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-O 121.986 0.898 . . . . 0.0 109.375 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 p -105.18 0.5 27.38 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.058 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.52 -25.83 18.3 Favored Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -174.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -117.78 174.73 6.01 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.885 -0.657 . . . . 0.0 109.557 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.39 141.28 37.18 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.73 -30.23 5.47 Favored Glycine 0 C--N 1.312 -0.774 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.411 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -81.98 115.35 21.1 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.135 0.493 . . . . 0.0 110.166 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 44.9 m0 -108.57 154.19 22.31 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.897 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 19.3 ttmm -116.29 129.64 56.38 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 176.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.07 176.51 23.3 Favored Glycine 0 N--CA 1.413 -2.876 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -123.04 133.87 54.31 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.3 tp -149.97 139.7 21.74 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.429 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.8 m120 67.66 10.07 7.51 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.794 1.237 . . . . 0.0 111.35 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.47 -2.97 49.97 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.21 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.38 138.43 51.36 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 122.375 -0.485 . . . . 0.0 110.203 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -93.5 144.06 25.71 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -160.36 177.93 36.6 Favored Glycine 0 N--CA 1.413 -2.836 0 C-N-CA 119.851 -1.166 . . . . 0.0 111.186 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 34.3 m -114.51 152.01 16.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -160.19 147.69 12.69 Favored Pre-proline 0 N--CA 1.419 -1.983 0 O-C-N 124.184 0.928 . . . . 0.0 108.824 -177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -69.05 129.31 18.11 Favored 'Trans proline' 0 C--O 1.251 1.159 0 C-N-CA 121.736 1.624 . . . . 0.0 108.954 172.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -57.83 -20.7 37.96 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 123.974 0.91 . . . . 0.0 113.091 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -69.04 -13.21 62.31 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -91.69 2.46 56.46 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.256 0.55 . . . . 0.0 111.315 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -140.37 169.86 16.89 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.541 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 p -128.93 122.2 56.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -73.07 121.59 20.43 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.5 pt -85.77 -6.81 10.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -173.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 C--N 1.298 -1.663 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.559 174.837 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 64' ' ' SER . 44.7 mt-10 . . . . . 0 N--CA 1.437 -1.093 0 CA-C-O 120.97 0.414 . . . . 0.0 109.897 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -139.93 151.1 45.3 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 121.4 0.619 . . . . 0.0 111.233 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.6 p -130.19 153.38 48.62 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.051 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.553 HH11 ' HA2' ' A' ' 28' ' ' GLY . 59.5 ttp85 -113.41 134.41 54.66 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.6 p -79.36 131.56 36.15 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.01 -177.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.5 mt -95.18 -12.07 27.0 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.672 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -133.17 149.86 73.82 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.632 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -85.98 120.65 1.97 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.282 1.988 . . . . 0.0 108.925 168.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 89.1 t80 -146.45 123.11 11.17 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.381 0.61 . . . . 0.0 111.328 -173.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.575 ' HA ' HG23 ' A' ' 24' ' ' THR . 87.9 m -91.93 135.33 34.03 Favored 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.87 125.8 33.33 Favored Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -36.75 67.24 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 22' ' ' GLU . 93.4 m-20 -101.19 148.08 25.51 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 112.791 -2.004 . . . . 0.0 105.956 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -15.54 57.17 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.138 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -73.66 -20.51 60.54 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.722 172.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 19' ' ' ASN . 38.4 tt0 -89.06 143.31 26.94 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 tt -84.7 125.11 32.23 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.093 0.473 . . . . 0.0 111.132 -171.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.575 HG23 ' HA ' ' A' ' 16' ' ' THR . 91.1 m -87.65 121.02 29.54 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.039 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 15' ' ' TYR . 36.1 p90 -133.89 161.43 34.79 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.246 0.546 . . . . 0.0 111.945 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -112.99 173.64 6.28 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -78.69 123.86 27.59 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.553 ' HA2' HH11 ' A' ' 10' ' ' ARG . . . 102.09 13.48 31.25 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.525 -0.845 . . . . 0.0 114.16 177.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -93.58 143.98 25.8 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 117.079 0.44 . . . . 0.0 110.165 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.9 mm -99.33 113.04 33.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.9 mt -107.43 134.06 50.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -88.58 127.88 35.56 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.58 HD21 ' HG3' ' A' ' 36' ' ' LYS . 3.8 tt -74.15 126.26 30.18 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.055 -174.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 47' ' ' GLU . 59.7 mt -101.39 -52.81 8.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.3 m -143.26 128.54 18.81 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.697 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.58 ' HG3' HD21 ' A' ' 33' ' ' LEU . 58.2 mtpt -85.5 -33.41 21.81 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -97.68 108.19 20.85 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.575 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.1 p -119.33 6.43 11.17 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.435 0.636 . . . . 0.0 110.635 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.06 -22.15 7.65 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -141.28 139.31 33.65 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.16 89.63 7.34 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 169.42 -30.74 0.16 Allowed Glycine 0 CA--C 1.483 -1.914 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -99.69 121.88 41.88 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.465 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 25.8 m0 -107.94 141.64 39.26 Favored 'General case' 0 C--N 1.273 -2.737 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 23.0 ttmm -102.54 129.47 49.09 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 175.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -145.94 175.16 25.58 Favored Glycine 0 N--CA 1.417 -2.619 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.546 ' HB2' HD11 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -123.95 129.69 51.36 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.187 0.494 . . . . 0.0 109.79 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.464 ' HG ' HD22 ' A' ' 49' ' ' ASN . 47.4 tp -137.96 119.6 15.05 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.959 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.464 HD22 ' HG ' ' A' ' 48' ' ' LEU . 59.3 m-80 64.82 21.6 12.39 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.742 1.217 . . . . 0.0 112.543 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.74 -11.58 49.78 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.728 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 4.0 mptp? -103.57 134.82 46.27 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 116.884 0.342 . . . . 0.0 110.48 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -112.39 141.48 46.07 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -167.16 -165.19 24.15 Favored Glycine 0 CA--C 1.467 -2.946 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 26.0 m -114.4 147.03 18.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 120.99 0.424 . . . . 0.0 110.56 -178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -147.95 150.6 36.12 Favored Pre-proline 0 C--N 1.296 -1.738 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.201 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 8.2 Cg_exo -71.58 136.77 29.0 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 121.798 1.665 . . . . 0.0 112.202 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -69.02 -8.16 42.34 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.659 0.784 . . . . 0.0 112.488 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -96.49 0.22 49.96 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 120.817 0.341 . . . . 0.0 111.487 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -99.92 -11.43 20.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.197 0.522 . . . . 0.0 110.996 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.12 145.08 41.2 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.598 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.02 125.76 66.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -68.99 121.52 16.79 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.476 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.4 mm -85.34 -45.79 17.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 43.9 m . . . . . 0 N--CA 1.41 -2.467 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 64' ' ' SER . 4.7 mm-40 . . . . . 0 N--CA 1.42 -1.928 0 CA-C-O 120.77 0.319 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -146.24 144.67 30.03 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.995 0.426 . . . . 0.0 111.187 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 8.0 p -126.71 147.85 49.92 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.655 -172.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -101.9 136.0 42.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.0 p -69.17 139.47 54.62 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.66 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.0 mt -107.75 -18.87 13.71 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.482 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -147.37 151.05 39.31 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.18 141.12 23.02 Favored 'Trans proline' 0 C--O 1.25 1.101 0 C-N-CA 121.977 1.784 . . . . 0.0 111.091 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -147.41 139.14 24.09 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.1 m -112.79 131.34 55.73 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 120.978 0.418 . . . . 0.0 110.622 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.76 119.9 5.22 Favored Glycine 0 N--CA 1.409 -3.139 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.9 m -82.08 -28.62 32.26 Favored 'General case' 0 N--CA 1.383 -3.807 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -94.31 165.93 12.34 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.788 -1.551 . . . . 0.0 107.85 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -26.62 33.07 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-O 121.425 0.631 . . . . 0.0 109.856 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -92.61 9.75 33.39 Favored 'General case' 0 C--O 1.212 -0.886 0 CA-C-O 121.643 0.735 . . . . 0.0 110.712 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -109.85 131.43 55.07 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.19 130.97 35.52 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.513 -169.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.3 m -93.79 119.7 33.09 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -134.39 145.63 49.12 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.321 0.581 . . . . 0.0 112.366 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -96.47 161.69 13.8 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.391 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.64 123.13 24.3 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.39 11.41 21.8 Favored Glycine 0 C--N 1.294 -1.772 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -100.06 152.74 19.87 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-O 120.93 0.395 . . . . 0.0 110.625 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.3 mm -109.35 111.82 37.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.457 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 67.8 mt -96.42 135.54 30.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -88.31 117.49 27.27 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 6.3 tt -76.78 124.7 28.08 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.35 -50.15 12.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.258 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.5 m -156.3 133.24 10.45 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.083 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -84.45 -16.5 42.36 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.882 0.848 . . . . 0.0 108.972 172.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -98.03 99.21 10.47 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.257 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.4 p -105.98 -3.38 21.76 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.89 0.852 . . . . 0.0 109.836 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.96 -42.46 1.49 Allowed Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -176.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -121.61 128.09 51.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.18 121.32 14.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.489 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.95 -25.58 4.12 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -106.57 123.53 48.24 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 177.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.426 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 43.6 m0 -108.7 153.4 23.5 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 60.0 tttp -114.82 129.45 56.7 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -141.49 160.74 26.95 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -117.8 125.17 50.07 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -178.736 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.9 tp -147.62 119.01 7.86 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.459 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 72.12 21.81 3.85 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.193 0.997 . . . . 0.0 113.036 174.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.37 0.29 35.1 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.664 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 8.5 mptt -127.22 132.66 50.37 Favored 'General case' 0 CA--C 1.488 -1.423 0 O-C-N 122.419 -0.459 . . . . 0.0 110.073 -177.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 10.5 pt-20 -107.65 95.85 5.98 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 122.502 1.144 . . . . 0.0 109.433 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -113.94 -175.45 18.98 Favored Glycine 0 C--N 1.274 -2.9 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.495 -173.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 33.0 m -114.14 152.56 15.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -152.89 155.43 32.2 Favored Pre-proline 0 N--CA 1.418 -2.041 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.662 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.28 134.46 12.78 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.746 1.631 . . . . 0.0 111.284 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -44.86 -37.34 3.82 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 125.458 1.503 . . . . 0.0 113.21 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -63.09 -16.97 61.71 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -96.24 1.56 52.23 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.86 170.38 16.0 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.038 0.446 . . . . 0.0 111.696 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.22 131.42 40.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -83.32 125.69 31.9 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.194 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.1 mm -89.95 -52.5 10.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 23.2 t . . . . . 0 N--CA 1.413 -2.305 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 N--CA 1.44 -0.931 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -124.8 139.37 53.91 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.587 0.708 . . . . 0.0 110.597 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.695 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 5.6 p -129.59 162.28 28.61 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HB2' HD11 ' A' ' 63' ' ' ILE . 29.8 ttp180 -121.11 145.8 47.42 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.649 HG21 ' HB3' ' A' ' 25' ' ' PHE . 72.0 p -71.31 141.41 50.48 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.794 0.683 . . . . 0.0 109.631 177.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -105.13 -18.79 14.03 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -141.71 156.29 66.17 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -177.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -76.73 120.9 5.68 Favored 'Trans proline' 0 N--CA 1.429 -2.275 0 N-CA-C 108.065 -1.552 . . . . 0.0 108.065 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -111.4 115.37 29.14 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.407 ' HA ' HG23 ' A' ' 24' ' ' THR . 36.0 m -98.38 111.3 23.69 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.715 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.43 135.63 18.73 Favored Glycine 0 N--CA 1.425 -2.05 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 176.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -113.6 5.55 16.6 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -127.15 156.24 42.1 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.54 -1.664 . . . . 0.0 107.324 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.15 -24.77 43.05 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -95.16 -4.4 46.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.806 0.812 . . . . 0.0 110.42 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -93.07 115.82 28.46 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 24' ' ' THR . 0.5 OUTLIER -83.78 144.58 29.22 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.874 0.369 . . . . 0.0 110.023 -170.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.409 ' N ' HD13 ' A' ' 23' ' ' LEU . 88.6 m -98.88 129.41 45.23 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.35 0.595 . . . . 0.0 111.492 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.649 ' HB3' HG21 ' A' ' 11' ' ' THR . 90.9 m-85 -127.74 151.84 48.49 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.221 -176.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.439 ' N ' ' HD2' ' A' ' 26' ' ' ARG . 3.5 mpt_? -108.82 174.5 5.84 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -81.75 116.37 21.42 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 117.914 0.324 . . . . 0.0 111.864 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.12 38.12 4.42 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.527 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.432 ' OE2' HD21 ' A' ' 48' ' ' LEU . 9.5 pt-20 -131.56 156.85 45.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 117.942 0.871 . . . . 0.0 111.871 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.9 mm -87.92 137.24 21.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.463 -173.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.695 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 40.1 mt -114.12 136.9 49.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.89 116.96 28.36 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.7 tt -77.93 123.78 27.2 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.8 mm -103.53 -40.69 6.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.319 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.0 m -153.04 134.96 14.69 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.007 -0.433 . . . . 0.0 111.892 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 94.8 mttt -91.9 -9.93 41.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.683 0.754 . . . . 0.0 109.539 173.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -117.78 119.52 35.17 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.96 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 p -115.34 0.1 13.34 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-O 121.576 0.703 . . . . 0.0 109.415 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.54 1.46 53.25 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -148.66 132.11 16.66 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.57 106.06 6.93 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 149.12 -31.12 1.19 Allowed Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -105.81 131.16 53.49 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.966 0.412 . . . . 0.0 110.724 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.4 ' CD1' ' HA ' ' A' ' 36' ' ' LYS . 17.4 m0 -113.24 151.26 31.27 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 172.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 84.5 tttt -109.2 129.03 55.5 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.29 157.94 22.73 Favored Glycine 0 N--CA 1.412 -2.914 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.221 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -116.67 129.29 56.05 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.432 HD21 ' OE2' ' A' ' 29' ' ' GLU . 55.4 tp -162.92 149.48 12.61 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 72.4 0.58 3.65 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.603 1.161 . . . . 0.0 111.216 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.79 0.53 42.44 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.83 169.88 10.33 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -175.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -130.25 142.03 50.58 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.475 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 45' ' ' LYS . . . -163.53 -173.13 31.86 Favored Glycine 0 C--N 1.291 -1.951 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -114.71 152.83 16.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 120.843 0.354 . . . . 0.0 110.706 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -153.87 150.94 23.83 Favored Pre-proline 0 N--CA 1.439 -1.022 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.671 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 17.1 Cg_exo -70.16 132.12 22.05 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.723 1.616 . . . . 0.0 109.692 173.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.6 -10.75 20.07 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -62.59 -31.95 72.86 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 124.41 1.084 . . . . 0.0 111.211 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -88.97 4.02 49.56 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -173.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.2 171.09 14.91 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -138.31 136.3 44.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -80.99 127.75 32.93 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.141 0.496 . . . . 0.0 111.528 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' A' ' 10' ' ' ARG . 33.1 mm -86.37 -62.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 N--CA 1.405 -2.68 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.878 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 . . . . . 0 N--CA 1.424 -1.758 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -125.51 143.83 50.83 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.904 -1.118 . . . . 0.0 111.188 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.668 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 7.2 p -125.48 153.08 44.09 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.255 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -116.18 134.09 55.31 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.8 p -62.77 149.1 44.88 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 122.8 0.44 . . . . 0.0 112.037 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.54 -19.17 10.15 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -151.86 153.93 32.22 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.49 143.41 38.46 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.859 1.706 . . . . 0.0 109.224 169.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -135.0 127.86 31.28 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.4 m -93.27 115.85 28.44 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.306 -177.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.87 118.47 5.04 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.2 p -106.63 -7.32 17.43 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.983 0.897 . . . . 0.0 109.742 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -108.87 149.96 28.37 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -69.54 -22.95 63.52 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.094 0.474 . . . . 0.0 112.276 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -94.17 -2.44 52.59 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.296 1.046 . . . . 0.0 109.972 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -103.83 127.37 51.33 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.689 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.627 HD13 ' HA3' ' A' ' 53' ' ' GLY . 3.0 mp -84.89 135.66 33.97 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -177.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.2 m -96.2 123.26 39.76 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.94 176.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -133.75 159.59 40.13 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.202 0.525 . . . . 0.0 111.867 177.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -117.67 173.64 6.62 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -78.46 141.89 37.92 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.89 11.69 42.54 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.555 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -105.85 147.26 28.9 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.575 0.703 . . . . 0.0 112.317 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.9 mm -102.86 127.68 56.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.668 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 62.0 mt -114.39 135.01 55.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -89.39 118.52 29.11 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.465 HD21 ' HG3' ' A' ' 36' ' ' LYS . 5.5 tt -81.27 124.24 29.16 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -175.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mm -98.66 -47.23 12.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.905 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.0 m -153.46 124.55 7.42 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.465 ' HG3' HD21 ' A' ' 33' ' ' LEU . 97.7 mttt -75.69 -25.48 56.74 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.163 0.506 . . . . 0.0 109.843 174.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -90.71 121.39 32.56 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.173 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -122.77 -2.39 8.82 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.253 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.84 -7.41 41.71 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -145.66 131.86 19.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.36 126.86 30.84 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.38 -38.22 2.18 Favored Glycine 0 C--N 1.304 -1.234 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.649 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -98.82 127.58 44.79 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 120.798 0.333 . . . . 0.0 110.483 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 31.6 m0 -108.95 153.75 23.13 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.039 176.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 65.0 tttm -114.21 128.48 56.39 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.07 173.68 28.89 Favored Glycine 0 N--CA 1.424 -2.152 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.15 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -115.52 130.35 56.85 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 124.616 1.166 . . . . 0.0 109.626 -177.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 39.3 tp -154.66 135.7 13.85 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.422 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 56.4 m-80 65.59 16.26 10.42 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.397 1.079 . . . . 0.0 111.84 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.33 6.83 77.45 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.837 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.86 155.1 27.43 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -133.6 138.09 45.8 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.612 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.627 ' HA3' HD13 ' A' ' 23' ' ' LEU . . . -164.65 -156.71 9.12 Favored Glycine 0 CA--C 1.483 -1.945 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.054 -175.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.76 154.09 17.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 120.943 0.401 . . . . 0.0 111.506 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -158.53 148.85 15.63 Favored Pre-proline 0 N--CA 1.434 -1.228 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.125 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -74.35 135.76 20.86 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 121.77 1.647 . . . . 0.0 110.21 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -69.55 -7.25 36.81 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 120.821 0.343 . . . . 0.0 111.794 -176.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.6 -21.09 65.37 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.464 0.706 . . . . 0.0 112.035 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -107.11 9.77 30.31 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -173.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.93 164.3 34.15 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.9 p -131.34 135.25 59.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -78.26 133.11 37.73 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.1 mm -86.83 -67.22 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.398 -3.067 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.964 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.675 0 N-CA-C 111.833 -0.507 . . . . 0.0 111.833 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.54 156.89 20.57 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 ttt -139.06 99.55 3.79 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.06 95.32 0.16 Allowed Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.165 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.61 23.47 12.63 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 80.97 75.5 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 125.786 1.634 . . . . 0.0 109.138 -174.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -98.52 151.27 20.81 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 113.799 -1.546 . . . . 0.0 108.706 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -138.99 149.44 44.7 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.419 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.0 p -137.56 157.67 46.02 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 123.041 0.213 . . . . 0.0 110.874 -177.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.438 ' NE ' ' HA2' ' A' ' 28' ' ' GLY . 45.3 ttt180 -119.31 138.08 53.27 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 176.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.6 p -78.22 134.34 37.6 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.883 177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 98.5 mt -98.29 -18.08 18.56 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.587 0.708 . . . . 0.0 109.566 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -142.56 150.14 53.22 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -78.5 157.75 28.85 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.875 1.716 . . . . 0.0 110.015 174.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -150.73 132.93 15.38 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.431 ' HA ' HG23 ' A' ' 24' ' ' THR . 82.1 m -96.14 122.38 38.93 Favored 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.967 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.77 125.97 7.21 Favored Glycine 0 N--CA 1.422 -2.255 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 177.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.1 p -90.55 -36.43 14.47 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 122.549 1.166 . . . . 0.0 108.376 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 57.3 m-80 -89.09 166.12 14.07 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 114.123 -1.399 . . . . 0.0 108.261 175.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -81.77 -33.21 31.04 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -77.7 3.34 14.25 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.408 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.554 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 34.7 tt0 -110.84 128.44 55.78 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -178.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 tt -85.67 125.38 33.13 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.215 -170.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.431 HG23 ' HA ' ' A' ' 16' ' ' THR . 91.6 m -90.26 119.41 30.54 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 174.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -135.37 159.11 42.59 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 75.9 mtt180 -100.1 -178.37 3.82 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -91.85 137.73 32.13 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.438 ' HA2' ' NE ' ' A' ' 10' ' ' ARG . . . 95.83 15.66 41.85 Favored Glycine 0 CA--C 1.496 -1.103 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.858 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.431 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 20.0 mm-40 -95.94 127.25 41.8 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -177.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.9 mm -87.66 116.64 30.14 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 174.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.419 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 57.9 mt -105.98 144.12 15.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 -175.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -88.51 109.26 19.9 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.553 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.2 tt -73.09 124.83 26.33 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 -175.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.7 mm -97.37 -51.43 10.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.338 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -152.07 134.59 15.33 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.89 -177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.553 ' HG3' HD21 ' A' ' 33' ' ' LEU . 50.6 mtmt -90.33 -25.84 20.27 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.555 0.693 . . . . 0.0 109.169 175.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -96.44 103.05 14.93 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 115.19 -0.913 . . . . 0.0 108.551 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.7 p -104.11 8.81 36.48 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 122.132 0.968 . . . . 0.0 108.94 177.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.03 -22.3 38.63 Favored Glycine 0 N--CA 1.433 -1.509 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -176.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -119.06 146.92 44.68 Favored 'General case' 0 N--CA 1.413 -2.286 0 CA-C-N 114.806 -0.697 . . . . 0.0 109.529 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -90.86 109.97 21.18 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 132.71 -23.47 3.98 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.723 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -107.14 126.92 53.0 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.41 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 35.5 m0 -108.88 150.65 27.38 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 176.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 88.5 tttt -108.59 129.1 55.32 Favored 'General case' 0 N--CA 1.418 -2.025 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 175.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -140.8 160.51 26.63 Favored Glycine 0 N--CA 1.408 -3.233 0 N-CA-C 110.222 -1.151 . . . . 0.0 110.222 -178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.7 tm-20 -117.78 123.75 46.75 Favored 'General case' 0 N--CA 1.414 -2.237 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.6 tp -142.77 133.73 25.65 Favored 'General case' 0 C--N 1.287 -2.122 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 67.7 17.46 9.84 Favored 'General case' 0 C--N 1.314 -0.965 0 O-C-N 124.079 0.862 . . . . 0.0 111.169 171.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.01 3.1 62.12 Favored Glycine 0 N--CA 1.442 -0.946 0 C-N-CA 121.099 -0.572 . . . . 0.0 111.677 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.484 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 9.5 mptt -115.84 125.75 53.07 Favored 'General case' 0 CA--C 1.488 -1.436 0 O-C-N 122.394 -0.474 . . . . 0.0 110.417 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 10.6 pt-20 -112.42 112.92 24.83 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.014 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -145.84 -166.66 12.08 Favored Glycine 0 N--CA 1.423 -2.229 0 N-CA-C 110.329 -1.108 . . . . 0.0 110.329 -177.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 34.6 m -114.21 151.09 16.05 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-O 120.97 0.414 . . . . 0.0 110.163 -176.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -154.48 150.55 22.16 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.862 -179.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 23.6 Cg_exo -66.85 130.74 23.85 Favored 'Trans proline' 0 C--O 1.243 0.742 0 C-N-CA 121.953 1.769 . . . . 0.0 110.544 175.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -67.79 -9.53 45.03 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -174.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -68.87 -16.66 63.83 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 123.074 0.549 . . . . 0.0 111.745 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -91.45 -3.93 56.1 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.09 163.16 30.54 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.0 -0.68 . . . . 0.0 112.63 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.7 p -126.23 142.57 42.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -86.84 144.5 26.99 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.922 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.4 mm -102.98 -44.33 9.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.651 0.738 . . . . 0.0 109.355 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 N--CA 1.413 -2.289 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 -178.015 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.349 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.89 -39.05 2.42 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 117.251 0.525 . . . . 0.0 110.218 179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 mmt -113.11 2.11 15.55 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.702 0.763 . . . . 0.0 110.02 -179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.01 167.17 33.74 Favored Glycine 0 N--CA 1.424 -2.114 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.38 -27.57 46.87 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.979 0.419 . . . . 0.0 110.908 179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -142.43 93.29 2.51 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.611 0.72 . . . . 0.0 110.324 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.503 ' HA ' ' OXT' ' A' ' 64' ' ' SER . 45.6 mt-10 -108.44 132.52 53.7 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.047 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -132.42 137.1 47.18 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.53 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 5.6 p -120.82 133.34 55.32 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-O 121.083 0.468 . . . . 0.0 109.946 177.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -99.55 129.84 45.75 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 43.3 p -62.92 128.78 37.46 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.158 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.4 mt -97.35 -19.32 18.58 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -151.5 162.78 25.75 Favored Pre-proline 0 C--N 1.31 -1.141 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -84.7 165.68 11.94 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 121.729 1.619 . . . . 0.0 110.412 175.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -150.59 130.37 13.24 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.5 m -98.37 118.62 35.43 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.821 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -79.35 126.81 7.65 Favored Glycine 0 N--CA 1.417 -2.625 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.0 t -102.32 7.92 40.46 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.421 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 38.1 m-80 -127.6 152.36 47.74 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 176.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.77 -40.51 96.87 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -98.25 14.35 28.12 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.726 0.774 . . . . 0.0 111.602 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 44.8 tt0 -97.61 129.04 44.75 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 172.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.423 HD21 ' HB3' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -74.7 119.71 19.26 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 121.291 0.567 . . . . 0.0 111.821 -168.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.2 m -95.0 119.65 33.87 Favored 'General case' 0 N--CA 1.429 -1.524 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.7 p90 -133.62 161.73 33.84 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -178.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.4 mtt85 -101.94 173.5 6.36 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.922 -1.035 . . . . 0.0 108.272 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -92.38 109.63 21.02 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.86 27.81 1.83 Allowed Glycine 0 C--N 1.304 -1.233 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.954 178.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -119.68 158.67 25.98 Favored 'General case' 0 C--O 1.251 1.164 0 CA-C-O 121.038 0.447 . . . . 0.0 111.146 178.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.6 mm -101.44 117.13 46.26 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 67.9 mt -94.53 134.3 32.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -89.3 109.59 20.47 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.519 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.6 tt -70.41 118.15 12.86 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -176.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.3 mm -93.27 -41.36 12.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.262 -178.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.3 t -154.48 146.34 23.46 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.473 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.519 ' HG3' HD21 ' A' ' 33' ' ' LEU . 86.9 mttt -103.15 -3.55 25.66 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.964 174.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -115.1 103.14 10.59 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-O 121.603 0.716 . . . . 0.0 111.668 -176.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 21.5 p -118.46 9.88 12.49 Favored 'General case' 0 C--N 1.288 -2.106 0 CA-C-O 122.111 0.957 . . . . 0.0 109.209 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.36 -21.28 46.36 Favored Glycine 0 N--CA 1.435 -1.402 0 CA-C-N 114.627 -1.17 . . . . 0.0 111.044 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -125.98 142.17 51.64 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.3 125.94 30.15 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.372 178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 114.38 -21.1 15.31 Favored Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.74 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -101.42 116.81 33.62 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 121.049 0.452 . . . . 0.0 110.416 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.434 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 40.6 m0 -108.77 155.54 20.65 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.589 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 16.8 ttmm -113.88 129.73 56.56 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 177.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -144.7 158.96 27.73 Favored Glycine 0 N--CA 1.414 -2.832 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 1.1 tm-20 -112.63 123.6 50.66 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.603 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 49.4 tp -147.05 130.44 16.67 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.945 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.603 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 59.3 m-80 66.05 18.65 11.07 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.716 1.206 . . . . 0.0 112.847 177.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 113.31 -18.72 20.61 Favored Glycine 0 N--CA 1.435 -1.376 0 C-N-CA 120.897 -0.668 . . . . 0.0 113.012 172.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.26 144.37 44.91 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.474 -0.491 . . . . 0.0 110.528 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 10.1 pt-20 -102.03 116.36 32.51 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 175.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -125.63 -177.89 15.08 Favored Glycine 0 N--CA 1.409 -3.146 0 C-N-CA 119.962 -1.113 . . . . 0.0 111.067 -177.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 27.4 m -114.23 146.69 18.42 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 52.7 p90 -154.38 153.85 28.68 Favored Pre-proline 0 C--N 1.297 -1.702 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.814 -175.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 16.5 Cg_exo -71.08 129.34 16.06 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.303 2.002 . . . . 0.0 110.334 174.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -61.64 -20.87 63.87 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 124.284 1.033 . . . . 0.0 113.296 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -73.82 0.83 11.99 Favored 'General case' 0 C--O 1.246 0.91 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -104.74 -0.86 26.92 Favored 'General case' 0 C--N 1.312 -1.039 0 O-C-N 122.264 -0.273 . . . . 0.0 111.529 177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -141.19 146.72 37.31 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.977 -176.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 p -108.22 132.43 56.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -78.76 126.81 31.22 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.373 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 43.1 mm -91.51 -54.12 7.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.227 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.503 ' OXT' ' HA ' ' A' ' 7' ' ' GLU . 19.4 m . . . . . 0 N--CA 1.421 -1.91 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.477 -2.331 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 42.95 -79.03 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.327 1.851 . . . . 0.0 115.799 171.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.4 mtp -86.89 -4.73 59.21 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 122.969 0.508 . . . . 0.0 112.06 -173.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.98 -119.62 0.84 Allowed Glycine 0 C--N 1.3 -1.462 0 C-N-CA 120.338 -0.934 . . . . 0.0 114.574 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.67 -153.95 0.42 Allowed 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 123.288 0.635 . . . . 0.0 109.831 -174.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -62.4 125.15 22.92 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 123.543 0.527 . . . . 0.0 109.837 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.579 ' HB3' HE22 ' A' ' 62' ' ' GLN . 45.9 mt-10 -106.15 145.31 31.67 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.872 -0.603 . . . . 0.0 109.468 -176.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -126.47 135.3 51.18 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -176.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.496 ' SG ' HD12 ' A' ' 33' ' ' LEU . 12.9 m -126.03 164.81 20.04 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.524 HH11 ' HA2' ' A' ' 28' ' ' GLY . 65.7 ttp85 -129.96 134.35 47.4 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 176.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.414 HG21 ' HB3' ' A' ' 25' ' ' PHE . 16.8 p -74.34 136.53 42.52 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 71.9 mt -98.7 -18.37 18.07 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.551 -0.749 . . . . 0.0 109.647 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -144.7 150.31 46.39 Favored Pre-proline 0 C--N 1.314 -0.977 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.74 143.49 41.85 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 121.97 1.78 . . . . 0.0 110.046 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 80.6 t80 -138.05 135.45 35.88 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 -177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.427 ' HA ' HG23 ' A' ' 24' ' ' THR . 18.9 m -111.89 128.77 56.24 Favored 'General case' 0 C--N 1.291 -1.971 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.239 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.512 ' HA3' ' O ' ' A' ' 22' ' ' GLU . . . -82.13 126.56 7.49 Favored Glycine 0 N--CA 1.421 -2.323 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.5 p -96.18 -5.96 39.33 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.326 1.06 . . . . 0.0 109.85 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -142.18 153.75 44.28 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 113.503 -1.681 . . . . 0.0 106.599 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -62.21 -28.99 70.07 Favored 'General case' 0 C--N 1.311 -1.085 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -171.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -82.68 -7.36 59.65 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.286 0.565 . . . . 0.0 111.235 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.512 ' O ' ' HA3' ' A' ' 17' ' ' GLY . 42.9 tt0 -102.46 114.14 28.09 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 177.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.644 HD13 ' HA3' ' A' ' 53' ' ' GLY . 3.9 mp -83.34 145.33 29.11 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -172.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.427 HG23 ' HA ' ' A' ' 16' ' ' THR . 86.4 m -94.82 131.55 40.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 114.832 -1.077 . . . . 0.0 108.962 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.467 ' CD2' HD22 ' A' ' 48' ' ' LEU . 97.1 m-85 -132.07 152.87 50.95 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 123.068 0.547 . . . . 0.0 110.299 -177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.43 ' H ' ' HG3' ' A' ' 29' ' ' GLU . 30.6 mtm180 -100.26 -176.07 3.12 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 171.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.3 122.04 34.39 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 176.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.524 ' HA2' HH11 ' A' ' 10' ' ' ARG . . . 100.57 21.57 12.53 Favored Glycine 0 C--N 1.313 -0.712 0 C-N-CA 120.111 -1.042 . . . . 0.0 113.617 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.43 ' HG3' ' H ' ' A' ' 26' ' ' ARG . 20.7 mm-40 -94.88 137.18 34.28 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.5 mm -89.56 124.55 42.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 108.093 -1.076 . . . . 0.0 108.093 175.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.5 mt -99.87 134.74 38.26 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 -174.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -89.29 102.37 15.03 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 172.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.496 HD12 ' SG ' ' A' ' 9' ' ' CYS . 6.8 tt -72.56 125.3 27.11 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.642 -0.874 . . . . 0.0 108.642 -175.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.6 mm -98.99 -42.37 10.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.951 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.3 m -153.35 131.45 11.86 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.747 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -87.16 -41.02 14.08 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -87.49 105.14 17.1 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.246 177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.5 p -112.04 0.02 15.83 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.77 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.92 -40.17 2.52 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 110.329 -1.109 . . . . 0.0 110.329 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -98.9 115.24 28.41 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-O 121.127 0.489 . . . . 0.0 109.765 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -64.43 124.68 22.41 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.243 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 109.52 -16.56 31.58 Favored Glycine 0 C--N 1.311 -0.827 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.549 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -106.87 124.78 50.11 Favored 'General case' 0 N--CA 1.434 -1.249 0 CA-C-O 120.951 0.405 . . . . 0.0 110.51 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 41.4 m0 -110.82 153.07 25.91 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 86.6 tttt -106.24 129.4 54.29 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -139.75 166.18 25.68 Favored Glycine 0 N--CA 1.417 -2.571 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.7 tm-20 -118.8 130.42 55.77 Favored 'General case' 0 C--N 1.29 -2.018 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.467 HD22 ' CD2' ' A' ' 25' ' ' PHE . 38.6 tp -144.95 127.01 15.57 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 63.39 21.41 12.77 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.179 0.992 . . . . 0.0 111.884 174.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.24 4.93 62.47 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.274 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 10.3 mptt -114.73 136.98 52.47 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -125.25 127.17 46.32 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.78 0.8 . . . . 0.0 110.188 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.644 ' HA3' HD13 ' A' ' 23' ' ' LEU . . . -163.18 -157.03 8.9 Favored Glycine 0 N--CA 1.415 -2.702 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.561 -175.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.9 m -115.95 151.05 17.77 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-O 120.977 0.418 . . . . 0.0 111.893 -173.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -151.98 150.04 24.93 Favored Pre-proline 0 N--CA 1.434 -1.23 0 CA-C-N 114.889 -1.051 . . . . 0.0 108.248 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 7.1 Cg_exo -74.5 128.77 12.18 Favored 'Trans proline' 0 C--O 1.248 1.016 0 C-N-CA 121.831 1.688 . . . . 0.0 109.463 175.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -62.23 -20.17 63.94 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -171.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -71.77 -10.44 59.77 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 -178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -88.17 -1.32 57.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.248 0.546 . . . . 0.0 110.59 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -139.85 174.98 9.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 115.868 -0.606 . . . . 0.0 109.436 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.35 146.83 26.13 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 175.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.579 HE22 ' HB3' ' A' ' 7' ' ' GLU . 53.6 tp60 -74.62 147.87 41.23 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' A' ' 10' ' ' ARG . 45.9 mm -95.69 -55.63 5.93 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.9 p . . . . . 0 N--CA 1.414 -2.24 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.68 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.588 0 N-CA-C 111.823 -0.511 . . . . 0.0 111.823 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.64 -5.78 59.33 Favored 'General case' 0 C--O 1.242 0.681 0 O-C-N 122.681 -0.305 . . . . 0.0 111.446 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.6 ttt -71.17 140.78 50.65 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 173.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.9 133.58 17.27 Favored Glycine 0 N--CA 1.427 -1.912 0 N-CA-C 114.811 0.684 . . . . 0.0 114.811 -173.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.02 -68.64 0.78 Allowed 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.505 ' HA ' ' NE2' ' A' ' 32' ' ' HIS . 48.8 mtpt -144.06 76.83 1.52 Allowed 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 170.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.634 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 19.2 mm-40 -101.56 118.14 36.34 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.09 -176.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -120.16 132.51 55.42 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.821 0.82 . . . . 0.0 112.073 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 41.2 m -123.83 143.15 50.51 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.551 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -99.36 130.93 45.68 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.9 p -70.51 128.74 37.19 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 123.549 0.53 . . . . 0.0 109.917 177.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.0 mt -99.77 -18.57 17.14 Favored 'General case' 0 C--N 1.317 -0.813 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.591 -177.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -140.64 145.35 39.92 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -178.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.66 141.11 40.82 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 122.115 1.876 . . . . 0.0 109.929 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -142.86 142.35 31.77 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 -177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.6 m -107.53 117.79 35.04 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.638 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -66.15 116.34 8.37 Favored Glycine 0 N--CA 1.425 -2.079 0 N-CA-C 108.873 -1.691 . . . . 0.0 108.873 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.6 m -83.06 -20.15 35.51 Favored 'General case' 0 N--CA 1.388 -3.527 0 CA-C-O 122.438 1.113 . . . . 0.0 108.044 -174.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -114.35 155.53 26.09 Favored 'General case' 0 N--CA 1.418 -2.073 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 175.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -73.19 -29.86 63.13 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.332 0.587 . . . . 0.0 110.138 -178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -84.87 9.07 15.3 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.861 0.838 . . . . 0.0 110.533 178.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -112.09 133.37 54.29 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.6 mt -78.62 133.43 37.27 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -173.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 97.1 m -98.08 120.14 37.96 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 173.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -134.23 155.09 50.78 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 113.202 0.816 . . . . 0.0 113.202 -176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -108.49 169.35 8.7 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -79.39 130.33 35.32 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -175.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.14 23.38 13.12 Favored Glycine 0 N--CA 1.44 -1.063 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.999 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -107.73 138.09 44.59 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.5 mm -94.31 125.04 46.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 55.5 mt -109.17 135.45 48.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -176.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.505 ' NE2' ' HA ' ' A' ' 6' ' ' LYS . 19.2 t-80 -90.52 104.68 17.23 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.634 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 4.7 tt -69.39 129.02 38.6 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.508 -177.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.7 mm -100.07 -37.85 6.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 114.977 -1.01 . . . . 0.0 110.443 -176.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.9 m -148.87 122.16 8.99 Favored 'General case' 0 C--N 1.315 -0.931 0 O-C-N 121.522 -0.736 . . . . 0.0 111.589 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.562 ' HG3' HD21 ' A' ' 33' ' ' LEU . 37.6 mtmt -80.77 -2.95 49.2 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.526 0.679 . . . . 0.0 111.651 175.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -136.32 124.68 23.34 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.495 0.664 . . . . 0.0 109.665 173.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.1 p -113.18 17.07 18.95 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-O 122.015 0.912 . . . . 0.0 109.217 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.97 -12.79 62.35 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 107.918 -2.073 . . . . 0.0 107.918 -170.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -131.65 149.55 52.45 Favored 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 176.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.82 104.29 13.94 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.71 -27.66 1.32 Allowed Glycine 0 C--N 1.297 -1.625 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -175.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -112.97 121.83 45.83 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 173.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -107.98 147.9 30.45 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.512 -0.767 . . . . 0.0 108.971 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -105.83 130.01 53.89 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 177.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -146.99 163.89 28.61 Favored Glycine 0 N--CA 1.417 -2.572 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -109.43 123.39 49.27 Favored 'General case' 0 N--CA 1.412 -2.358 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.4 tp -136.77 121.07 18.01 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.617 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 63.94 23.08 13.21 Favored 'General case' 0 C--N 1.32 -0.699 0 O-C-N 124.154 0.909 . . . . 0.0 111.437 174.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.08 -19.79 37.03 Favored Glycine 0 N--CA 1.427 -1.911 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.748 178.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -100.23 126.4 46.52 Favored 'General case' 0 CA--C 1.491 -1.29 0 CA-C-N 117.717 0.758 . . . . 0.0 111.2 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 6.7 pt-20 -102.04 100.89 11.19 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 115.326 -0.852 . . . . 0.0 108.991 175.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -131.57 -163.92 10.97 Favored Glycine 0 C--N 1.286 -2.235 0 CA-C-N 114.641 -1.163 . . . . 0.0 110.638 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.5 m -114.47 150.99 16.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-N 116.871 0.335 . . . . 0.0 110.812 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.9 p90 -147.61 155.16 45.26 Favored Pre-proline 0 N--CA 1.433 -1.296 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.438 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.53 133.79 38.57 Favored 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.153 1.902 . . . . 0.0 110.851 176.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -62.72 -15.12 51.56 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.249 1.02 . . . . 0.0 112.842 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -101.77 -13.19 17.82 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -80.8 -7.5 59.43 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.176 0.512 . . . . 0.0 111.964 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -136.88 139.54 41.71 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.0 p -103.03 125.47 57.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -78.35 113.99 16.84 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-O 121.426 0.632 . . . . 0.0 111.047 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.0 pt -85.36 -48.32 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.946 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.2 m . . . . . 0 N--CA 1.408 -2.564 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.456 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.692 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.74 105.15 17.51 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 175.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 88.1 mmm -95.05 122.94 38.23 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.387 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.92 -29.95 1.52 Allowed Glycine 0 N--CA 1.429 -1.815 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -174.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 68.41 -61.58 0.4 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.753 1.621 . . . . 0.0 112.414 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -110.98 96.72 6.33 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.624 0.726 . . . . 0.0 109.445 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 41.6 mt-10 -119.45 140.24 50.76 Favored 'General case' 0 C--N 1.277 -2.57 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -122.87 138.4 54.67 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 120.198 -0.601 . . . . 0.0 110.278 -173.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 56.8 m -128.26 137.23 51.9 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.689 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -101.48 136.89 40.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 45.1 p -72.93 133.63 44.43 Favored 'General case' 0 N--CA 1.417 -2.077 0 O-C-N 123.519 0.512 . . . . 0.0 109.944 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.2 mt -99.13 -18.17 17.83 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -144.87 150.72 47.23 Favored Pre-proline 0 N--CA 1.437 -1.115 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.38 154.21 21.36 Favored 'Trans proline' 0 N--CA 1.444 -1.438 0 C-N-CA 121.807 1.671 . . . . 0.0 110.383 176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -150.97 136.11 17.56 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.463 ' HA ' HG23 ' A' ' 24' ' ' THR . 26.0 m -103.11 128.75 49.92 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.9 137.15 16.17 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 177.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 t -89.48 -15.42 33.1 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 122.345 1.069 . . . . 0.0 108.331 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.404 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 87.7 m-20 -115.42 157.25 24.21 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 114.328 -1.305 . . . . 0.0 107.778 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.75 -30.6 71.29 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 121.937 0.875 . . . . 0.0 110.351 178.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.01 12.22 27.0 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 114.524 -1.216 . . . . 0.0 110.8 -179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 33.8 tt0 -114.37 115.0 26.65 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 174.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.4 HD21 ' HB3' ' A' ' 48' ' ' LEU . 1.1 tt -70.78 120.03 15.79 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.479 -166.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.463 HG23 ' HA ' ' A' ' 16' ' ' THR . 87.0 m -89.76 120.1 30.73 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.018 175.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -135.13 161.8 34.3 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -105.17 174.98 5.65 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -87.8 123.25 32.4 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.25 8.05 15.54 Favored Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 111.435 -0.666 . . . . 0.0 111.435 -177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -92.81 137.11 32.65 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 120.763 0.316 . . . . 0.0 110.401 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.2 mm -99.05 117.28 43.92 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 62.2 mt -102.99 141.72 18.34 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -174.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -90.09 114.72 26.68 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.7 tt -74.07 127.53 33.16 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.6 mm -102.95 -52.48 8.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.216 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 45' ' ' LYS . 20.0 m -143.96 130.98 20.51 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.958 -0.11 . . . . 0.0 110.799 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.474 ' HG3' HD21 ' A' ' 33' ' ' LEU . 97.8 mttt -88.29 -15.98 34.33 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-O 121.823 0.821 . . . . 0.0 110.379 177.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -114.07 121.67 44.55 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.879 -1.055 . . . . 0.0 109.79 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.0 p -123.64 17.48 9.57 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.05 -47.85 1.0 Allowed Glycine 0 N--CA 1.428 -1.855 0 N-CA-C 107.725 -2.15 . . . . 0.0 107.725 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -100.63 161.3 13.69 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.687 -0.757 . . . . 0.0 109.812 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.03 85.52 2.22 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 176.15 -47.96 0.12 Allowed Glycine 0 CA--C 1.49 -1.486 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -82.85 121.3 26.76 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 173.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.9 m0 -107.9 144.19 35.48 Favored 'General case' 0 C--N 1.282 -2.358 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 35' ' ' SER . 64.0 tttp -103.31 129.33 50.29 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.19 168.23 27.15 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -123.28 129.11 50.89 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HB3' HD21 ' A' ' 23' ' ' LEU . 64.4 tp -138.79 115.77 10.89 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.796 -179.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 62.97 23.93 14.28 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 123.907 0.883 . . . . 0.0 111.672 173.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.28 -14.28 39.82 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 121.092 -0.575 . . . . 0.0 112.885 178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 9.6 mptt -103.27 136.37 43.17 Favored 'General case' 0 CA--C 1.487 -1.446 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.0 146.68 46.44 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -179.67 -160.99 26.21 Favored Glycine 0 N--CA 1.422 -2.276 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.6 m -115.03 152.36 16.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 116.947 0.374 . . . . 0.0 110.122 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 53.2 p90 -149.76 152.05 33.9 Favored Pre-proline 0 N--CA 1.425 -1.684 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 55' ' ' PHE . 6.2 Cg_exo -76.06 129.29 11.29 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.678 1.586 . . . . 0.0 111.611 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -49.93 -29.7 8.83 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.509 1.524 . . . . 0.0 113.507 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -68.08 -10.58 55.02 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -96.31 -9.55 29.92 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.79 160.84 38.71 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.967 -175.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.6 p -128.3 133.51 66.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.484 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 51.5 tt0 -73.9 116.86 15.01 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-O 121.334 0.588 . . . . 0.0 110.007 178.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 31.4 pt -91.3 -23.76 5.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.57 -177.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.419 -1.98 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.785 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.612 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.491 ' HB1' ' HB2' ' A' ' 36' ' ' LYS . . . -142.93 145.96 33.53 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 117.064 0.432 . . . . 0.0 110.09 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.8 ptm -137.81 -165.7 1.83 Allowed 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -176.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.21 80.92 0.23 Allowed Glycine 0 N--CA 1.433 -1.517 0 N-CA-C 108.824 -1.71 . . . . 0.0 108.824 174.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.36 -60.16 2.49 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 121.446 0.641 . . . . 0.0 110.864 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -144.05 25.17 1.6 Allowed 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -86.36 137.06 32.87 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 114.842 -1.072 . . . . 0.0 108.787 -178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -123.38 158.29 31.43 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.508 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.2 p -135.84 134.12 38.52 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.146 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.4 ttt180 -100.24 135.73 41.21 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 40.4 p -60.85 135.68 57.85 Favored 'General case' 0 C--N 1.284 -2.243 0 C-N-CA 124.856 1.262 . . . . 0.0 110.867 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.445 HD11 ' HB ' ' A' ' 61' ' ' VAL . 92.4 mt -108.13 -19.08 13.61 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.232 0.539 . . . . 0.0 109.904 176.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -148.05 152.38 39.85 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -73.53 148.37 42.38 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 121.587 1.525 . . . . 0.0 109.538 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -139.11 132.78 30.57 Favored 'General case' 0 C--N 1.29 -1.985 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.5 m -107.38 129.87 54.87 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.68 138.9 15.12 Favored Glycine 0 N--CA 1.427 -1.953 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 176.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.9 t -91.8 -16.49 26.73 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -125.63 169.92 12.02 Favored 'General case' 0 N--CA 1.402 -2.852 0 CA-C-N 114.243 -1.344 . . . . 0.0 107.905 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -77.32 -28.11 53.08 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -174.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -83.27 -12.15 57.01 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 122.255 1.026 . . . . 0.0 110.154 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.03 107.58 18.49 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.419 ' HB2' ' HA3' ' A' ' 53' ' ' GLY . 2.7 tm? -71.96 133.41 45.34 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.531 -0.758 . . . . 0.0 111.24 -169.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.3 m -102.5 120.85 41.23 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.162 -176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -133.85 161.75 33.89 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 -177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -111.28 171.39 7.51 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -84.58 113.3 21.15 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 121.47 24.01 2.48 Favored Glycine 0 N--CA 1.425 -2.074 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.879 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -119.94 147.47 44.71 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.7 mm -100.36 119.85 49.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.508 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 61.7 mt -103.07 138.1 28.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -88.63 112.87 23.59 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 106.083 -1.821 . . . . 0.0 106.083 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.522 HD21 ' HG3' ' A' ' 36' ' ' LYS . 5.0 tt -76.1 122.45 24.3 Favored 'General case' 0 C--N 1.293 -1.868 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -174.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.522 HD11 ' HB2' ' A' ' 47' ' ' GLU . 41.1 mt -97.01 -39.14 8.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.335 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.2 t -160.56 138.77 9.92 Favored 'General case' 0 C--N 1.315 -0.904 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.285 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.522 ' HG3' HD21 ' A' ' 33' ' ' LEU . 89.9 mttt -89.75 -8.4 52.33 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.283 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.35 129.99 49.9 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-O 121.357 0.598 . . . . 0.0 110.269 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.9 p -125.42 23.9 7.43 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-O 121.79 0.805 . . . . 0.0 109.722 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.0 -39.39 2.86 Favored Glycine 0 N--CA 1.437 -1.266 0 N-CA-C 108.545 -1.822 . . . . 0.0 108.545 -174.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -104.43 139.85 38.78 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.16 102.1 14.63 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 145.17 -26.69 1.87 Allowed Glycine 0 C--N 1.303 -1.275 0 N-CA-C 110.476 -1.05 . . . . 0.0 110.476 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -98.9 126.24 44.51 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 176.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.412 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 36.6 m0 -107.27 154.24 21.54 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.561 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 61.4 tttp -115.33 128.74 56.3 Favored 'General case' 0 C--N 1.284 -2.25 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.37 160.98 28.53 Favored Glycine 0 N--CA 1.422 -2.257 0 C-N-CA 120.68 -0.772 . . . . 0.0 111.211 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.2 tm-20 -117.52 131.34 56.72 Favored 'General case' 0 C--N 1.293 -1.861 0 CA-C-O 121.504 0.668 . . . . 0.0 110.748 -178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 68.7 tp -141.34 127.68 19.86 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 67.89 15.36 9.55 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.466 1.106 . . . . 0.0 111.395 177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.74 0.77 62.19 Favored Glycine 0 N--CA 1.433 -1.543 0 C-N-CA 120.72 -0.752 . . . . 0.0 111.353 -177.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 4.4 mptp? -105.92 129.52 54.05 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.36 121.86 46.31 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.419 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -143.58 -174.09 15.6 Favored Glycine 0 N--CA 1.412 -2.904 0 C-N-CA 120.28 -0.962 . . . . 0.0 111.361 -178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 35.4 m -115.31 150.93 17.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 O-C-N 123.884 0.403 . . . . 0.0 109.988 -178.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -160.71 151.2 15.06 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.616 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.96 138.05 36.3 Favored 'Trans proline' 0 C--O 1.248 0.985 0 C-N-CA 122.158 1.905 . . . . 0.0 110.768 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.78 -16.76 63.47 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -173.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -72.91 -1.46 16.97 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 120.987 0.423 . . . . 0.0 111.576 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -102.42 -3.09 27.54 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.78 156.02 44.92 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.137 -0.625 . . . . 0.0 111.89 -176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.445 ' HB ' HD11 ' A' ' 12' ' ' LEU . 14.4 p -118.91 136.05 57.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -78.81 117.71 20.18 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.2 pt -87.65 -9.4 10.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-O 121.433 0.635 . . . . 0.0 111.678 -177.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--N 1.283 -2.321 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.672 177.315 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.957 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.43 87.15 2.27 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.1 mtt 60.13 80.92 0.19 Allowed 'General case' 0 CA--C 1.516 -0.349 0 O-C-N 125.248 1.592 . . . . 0.0 111.071 -177.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -151.98 63.38 0.38 Allowed Glycine 0 N--CA 1.423 -2.21 0 C-N-CA 120.354 -0.926 . . . . 0.0 112.546 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -128.88 -43.58 1.35 Allowed 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.55 0.69 . . . . 0.0 110.57 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -121.85 11.37 10.37 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 122.404 1.097 . . . . 0.0 108.25 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.547 ' HA ' ' OXT' ' A' ' 64' ' ' SER . 14.5 mp0 -95.61 114.96 26.76 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 112.929 -1.941 . . . . 0.0 109.437 -177.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -131.92 145.37 51.47 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.9 m -127.96 142.91 51.11 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 120.839 -0.345 . . . . 0.0 110.539 -178.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -104.05 132.31 50.43 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.0 p -76.49 134.84 39.39 Favored 'General case' 0 C--N 1.288 -2.109 0 CA-C-O 121.155 0.502 . . . . 0.0 111.724 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.6 mt -95.5 -17.97 21.03 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.26 -0.882 . . . . 0.0 109.873 -178.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -141.44 154.32 66.76 Favored Pre-proline 0 C--N 1.308 -1.214 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.571 -177.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.79 134.71 8.6 Favored 'Trans proline' 0 N--CA 1.446 -1.312 0 C-N-CA 122.011 1.808 . . . . 0.0 109.375 169.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 81.2 t80 -135.25 138.15 43.25 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -175.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.422 ' HA ' HG23 ' A' ' 24' ' ' THR . 23.0 m -107.5 122.42 46.62 Favored 'General case' 0 N--CA 1.429 -1.513 0 C-N-CA 120.559 -0.456 . . . . 0.0 111.039 -177.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.445 ' HA2' ' HG2' ' A' ' 22' ' ' GLU . . . -82.09 106.81 2.72 Favored Glycine 0 N--CA 1.413 -2.838 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.77 176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.7 -33.28 21.55 Favored 'General case' 0 N--CA 1.411 -2.376 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.462 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 90.5 m-20 -88.8 153.95 20.66 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 114.199 -1.364 . . . . 0.0 108.892 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -62.11 -37.45 85.15 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.793 0.33 . . . . 0.0 111.661 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -90.91 10.67 25.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.629 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 46.8 tt0 -110.44 125.55 53.38 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 mt -82.86 139.51 33.43 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -175.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.422 HG23 ' HA ' ' A' ' 16' ' ' THR . 51.4 m -99.32 119.44 37.94 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 174.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -134.88 159.78 40.35 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -101.11 -179.7 4.12 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 176.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -85.51 133.55 34.07 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 94.54 17.4 39.2 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.101 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -92.42 142.57 27.28 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.8 mm -99.99 123.55 52.88 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.979 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 56.9 mt -114.31 142.34 27.36 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.4 m-70 -89.17 115.27 26.56 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.0 tt -66.11 133.82 51.51 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.4 mm -112.48 -49.41 5.85 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 CA-C-O 121.427 0.632 . . . . 0.0 109.436 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.3 m -149.94 118.5 6.52 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 121.631 -0.668 . . . . 0.0 111.596 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -73.45 -26.08 60.78 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.505 0.669 . . . . 0.0 109.833 173.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -101.98 111.97 24.44 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.2 p -110.12 -2.29 17.02 Favored 'General case' 0 C--N 1.266 -3.031 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.43 -10.88 33.28 Favored Glycine 0 N--CA 1.438 -1.201 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -170.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.4 mp0 -125.8 143.78 50.92 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -94.17 86.72 5.04 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.199 0.523 . . . . 0.0 109.614 176.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 159.91 -30.27 0.39 Allowed Glycine 0 CA--C 1.489 -1.591 0 N-CA-C 111.107 -0.797 . . . . 0.0 111.107 -177.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -89.63 123.22 33.49 Favored 'General case' 0 N--CA 1.424 -1.757 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 15.6 m0 -108.99 134.21 51.94 Favored 'General case' 0 C--N 1.279 -2.495 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 176.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 84.6 tttt -99.12 129.61 45.39 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -142.54 165.18 26.85 Favored Glycine 0 N--CA 1.423 -2.195 0 N-CA-C 110.579 -1.009 . . . . 0.0 110.579 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 41.7 tt0 -110.77 131.95 54.61 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 123.772 0.337 . . . . 0.0 110.346 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.9 tp -148.27 119.72 7.92 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.098 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 62.06 34.08 16.73 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.965 0.906 . . . . 0.0 112.212 175.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.9 -10.99 68.2 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.651 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 4.6 mptp? -105.82 129.7 53.95 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-N 117.482 0.641 . . . . 0.0 111.083 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 46' ' ' GLY 0.383 0.0 OUTLIER -111.99 106.29 14.93 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-O 122.662 1.22 . . . . 0.0 111.002 170.831 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -134.61 -171.57 12.55 Favored Glycine 0 N--CA 1.425 -2.084 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.354 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.0 m -114.63 150.82 16.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-O 121.303 0.573 . . . . 0.0 111.403 -174.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -152.42 148.76 21.43 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 114.436 -1.256 . . . . 0.0 107.956 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.67 129.76 21.85 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 121.569 1.512 . . . . 0.0 109.498 175.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.75 -22.6 58.24 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -172.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -69.19 -8.2 43.46 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -91.96 -0.7 57.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.641 0.257 . . . . 0.0 110.907 177.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -144.73 165.95 26.61 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.719 0.295 . . . . 0.0 110.861 -178.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 p -131.57 134.37 60.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -71.27 118.2 13.77 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.3 pt -96.51 -23.78 4.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-O 121.953 0.882 . . . . 0.0 110.522 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.547 ' OXT' ' HA ' ' A' ' 7' ' ' GLU . 44.9 m . . . . . 0 N--CA 1.4 -2.938 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 37' ' ' GLU . . . . . . . . 0 CA--C 1.506 -0.53 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.0 148.69 48.54 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 177.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 47.2 ttp -99.49 94.2 6.29 Favored 'General case' 0 C--N 1.294 -1.814 0 CA-C-O 121.729 0.776 . . . . 0.0 112.573 -172.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.465 ' O ' ' HG3' ' A' ' 6' ' ' LYS . . . 80.72 -4.6 68.66 Favored Glycine 0 N--CA 1.437 -1.233 0 CA-C-N 115.058 -0.974 . . . . 0.0 114.827 174.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.42 24.1 13.67 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 121.95 0.881 . . . . 0.0 110.543 -178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 4' ' ' GLY . 58.5 mttp -109.14 26.45 10.61 Favored 'General case' 0 CA--C 1.499 -1.001 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.53 137.56 40.61 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -130.23 139.45 50.79 Favored 'General case' 0 CA--C 1.486 -1.483 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.49 -175.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.405 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 13.8 p -124.01 147.62 47.67 Favored 'General case' 0 C--N 1.289 -2.035 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.342 -178.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -108.15 135.61 49.21 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 175.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.411 HG21 ' CD1' ' A' ' 25' ' ' PHE . 43.2 p -79.44 136.65 37.0 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 121.399 0.619 . . . . 0.0 112.268 -177.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.0 mt -99.96 -18.01 17.28 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.672 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -145.55 156.37 52.95 Favored Pre-proline 0 C--N 1.309 -1.171 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -84.2 151.2 12.23 Favored 'Trans proline' 0 C--O 1.253 1.265 0 C-N-CA 122.142 1.895 . . . . 0.0 111.323 174.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -137.55 125.8 23.16 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.446 ' HA ' HG23 ' A' ' 24' ' ' THR . 23.5 m -112.99 110.88 21.23 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -67.47 144.49 44.2 Favored Glycine 0 N--CA 1.412 -2.958 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.992 178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 22.1 p -89.93 -21.44 22.47 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -121.11 157.2 30.64 Favored 'General case' 0 N--CA 1.426 -1.652 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -87.87 12.01 14.2 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 122.471 1.129 . . . . 0.0 109.853 178.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -78.65 -31.35 46.76 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 170.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -82.32 150.03 27.43 Favored 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 113.333 -1.758 . . . . 0.0 107.148 173.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 48' ' ' LEU . 3.2 tm? -103.58 126.33 50.66 Favored 'General case' 0 C--N 1.281 -2.396 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.625 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.446 HG23 ' HA ' ' A' ' 16' ' ' THR . 94.3 m -94.53 120.43 34.75 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.969 -1.014 . . . . 0.0 110.204 -176.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 11' ' ' THR . 23.4 p90 -134.77 158.88 43.02 Favored 'General case' 0 N--CA 1.435 -1.225 0 CA-C-N 115.017 -0.992 . . . . 0.0 111.411 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -99.63 -179.3 4.15 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -81.1 133.77 35.53 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.2 27.29 28.52 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.118 176.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -105.97 151.47 24.57 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.1 mm -101.26 124.48 55.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.405 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 62.7 mt -110.02 143.88 19.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -89.33 104.97 17.48 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.578 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.4 tt -71.62 128.23 35.13 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-O 121.215 0.531 . . . . 0.0 109.758 -174.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.35 -50.51 9.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.41 -0.813 . . . . 0.0 109.957 -177.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.8 m -144.21 131.24 20.5 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.944 -176.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.578 ' HG3' HD21 ' A' ' 33' ' ' LEU . 44.5 mtmt -97.98 -22.52 16.25 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.598 0.713 . . . . 0.0 110.476 174.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.425 ' HB3' ' HA2' ' A' ' 1' ' ' GLY . 33.9 tt0 -109.8 86.44 2.3 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.3 p -87.4 -18.23 30.48 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.624 -1.171 . . . . 0.0 110.703 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 143.81 -43.0 1.02 Allowed Glycine 0 C--N 1.28 -2.571 0 N-CA-C 107.384 -2.286 . . . . 0.0 107.384 -176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -120.36 111.14 17.38 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.85 109.25 1.69 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 152.14 -33.0 0.87 Allowed Glycine 0 C--N 1.287 -2.183 0 N-CA-C 107.545 -2.222 . . . . 0.0 107.545 -174.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -100.34 124.6 46.03 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 173.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 35.6 m0 -107.86 146.09 32.78 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -110.21 129.09 55.78 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -145.22 159.65 27.93 Favored Glycine 0 N--CA 1.41 -3.082 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 2.2 tm-20 -110.73 130.55 55.54 Favored 'General case' 0 N--CA 1.414 -2.244 0 O-C-N 124.402 0.707 . . . . 0.0 109.358 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.517 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 43.0 tp -144.66 127.42 16.26 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 114.898 -1.047 . . . . 0.0 108.254 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.517 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 51.9 m-80 65.26 17.98 11.22 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.754 1.221 . . . . 0.0 111.484 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.01 -15.4 55.28 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.36 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 12.1 mptt -100.52 133.54 44.81 Favored 'General case' 0 CA--C 1.489 -1.379 0 CA-C-N 117.013 0.406 . . . . 0.0 110.31 -175.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -111.38 121.61 45.69 Favored 'General case' 0 C--N 1.288 -2.093 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.041 178.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -145.22 -170.01 13.93 Favored Glycine 0 C--N 1.287 -2.168 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 23.1 m -115.22 150.88 17.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 120.796 0.332 . . . . 0.0 110.591 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.3 p90 -156.13 149.06 18.23 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.134 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 34.8 Cg_exo -66.72 136.99 44.11 Favored 'Trans proline' 0 C--O 1.243 0.762 0 C-N-CA 122.072 1.848 . . . . 0.0 111.398 175.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -63.2 -13.36 36.59 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.108 0.963 . . . . 0.0 112.743 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -71.91 -10.6 60.01 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 123.165 0.586 . . . . 0.0 111.922 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -107.61 8.62 29.24 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 120.259 -0.577 . . . . 0.0 111.666 -176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.13 154.33 43.79 Favored 'General case' 0 C--N 1.317 -0.837 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.427 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.16 131.6 72.62 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 175.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -76.53 127.54 33.02 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 -177.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.8 mm -90.51 -49.79 13.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.41 -2.475 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 -179.709 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.266 0 N-CA-C 112.81 -0.116 . . . . 0.0 112.81 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.91 81.07 6.97 Favored 'General case' 0 C--O 1.25 1.094 0 CA-C-O 121.658 0.742 . . . . 0.0 111.684 -177.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.6 ttp -149.96 134.67 17.62 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.1 -164.92 16.87 Favored Glycine 0 C--N 1.297 -1.603 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.37 -34.9 2.44 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 121.258 0.551 . . . . 0.0 110.296 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -98.12 75.65 2.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.538 0.685 . . . . 0.0 110.414 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -146.69 111.76 5.41 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 172.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -110.8 134.42 52.52 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.594 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.473 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 12.9 p -120.03 146.32 45.99 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-O 121.173 0.511 . . . . 0.0 110.233 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -106.0 134.66 48.77 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -177.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.0 p -66.74 140.12 57.85 Favored 'General case' 0 C--N 1.292 -1.917 0 C-N-CA 123.823 0.849 . . . . 0.0 110.25 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.5 mt -107.04 -20.22 13.38 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 119.565 -0.854 . . . . 0.0 110.818 176.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -153.4 152.27 27.23 Favored Pre-proline 0 C--N 1.316 -0.853 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 -177.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -76.28 110.85 3.15 Favored 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 121.626 1.551 . . . . 0.0 111.29 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -109.4 131.4 55.1 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.509 ' HA ' HG23 ' A' ' 24' ' ' THR . 24.2 m -110.6 129.6 55.77 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.94 150.28 39.1 Favored Glycine 0 N--CA 1.424 -2.15 0 N-CA-C 109.986 -1.245 . . . . 0.0 109.986 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 15.0 t -98.74 5.66 47.44 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.734 1.254 . . . . 0.0 108.284 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -156.0 173.25 17.07 Favored 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 113.504 -1.68 . . . . 0.0 106.658 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -79.62 -30.35 41.39 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -174.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -73.13 -21.77 60.66 Favored 'General case' 0 N--CA 1.486 1.359 0 CA-C-O 122.182 0.992 . . . . 0.0 109.313 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -87.99 110.45 20.6 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -77.1 135.13 38.57 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.581 0.705 . . . . 0.0 111.6 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 16' ' ' THR . 94.7 m -98.92 122.54 42.3 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.569 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -133.39 157.77 44.71 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.529 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.6 mtm180 -109.84 -167.41 1.2 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 122.745 0.418 . . . . 0.0 110.568 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -89.22 141.71 28.29 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.85 29.97 49.61 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 116.127 -0.488 . . . . 0.0 113.272 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -115.03 157.53 23.35 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 122.154 -0.615 . . . . 0.0 112.272 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.6 mm -111.73 124.78 68.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.473 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 65.3 mt -114.48 143.62 23.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 15.9 m-70 -89.49 116.01 27.34 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.5 tt -79.73 118.99 22.04 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 47' ' ' GLU . 61.3 mt -89.52 -47.99 14.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.52 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.1 m -155.88 140.77 17.2 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 122.149 -0.344 . . . . 0.0 110.621 -177.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -90.86 -16.56 28.02 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 171.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -106.9 103.03 12.35 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.063 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.0 p -107.18 3.02 25.19 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.784 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 106.86 -14.91 41.1 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.816 -1.313 . . . . 0.0 109.816 -176.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -130.54 116.38 18.08 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.31 118.59 10.21 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.48 -22.76 7.32 Favored Glycine 0 N--CA 1.438 -1.194 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -105.3 122.37 45.81 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 42.7 m0 -108.18 155.06 20.86 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -110.56 129.85 55.7 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -137.85 164.23 25.51 Favored Glycine 0 N--CA 1.418 -2.558 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.526 ' HB2' HD11 ' A' ' 34' ' ' ILE . 25.2 tt0 -124.94 123.93 40.95 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.4 tp -125.2 117.45 23.88 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.4 m120 66.14 21.85 11.12 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.193 0.997 . . . . 0.0 110.82 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 101.16 -10.02 58.1 Favored Glycine 0 N--CA 1.435 -1.393 0 CA-C-N 115.661 -0.699 . . . . 0.0 113.712 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 3.3 mptp? -97.84 132.3 43.57 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-N 117.852 0.826 . . . . 0.0 109.405 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.85 148.05 29.0 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 123.673 0.608 . . . . 0.0 111.917 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -176.49 -172.06 40.81 Favored Glycine 0 N--CA 1.422 -2.289 0 N-CA-C 110.489 -1.045 . . . . 0.0 110.489 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.9 m -115.21 156.58 16.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 116.809 0.304 . . . . 0.0 110.809 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -158.35 156.05 26.82 Favored Pre-proline 0 C--N 1.312 -1.03 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.114 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -74.48 136.21 21.24 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.116 1.877 . . . . 0.0 110.913 175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -61.33 -21.97 64.49 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -174.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -73.16 -4.65 34.13 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -176.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -102.45 4.52 38.85 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.624 -0.43 . . . . 0.0 111.933 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.92 164.38 33.92 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.1 p -134.64 140.64 45.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 176.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 52.6 tt0 -85.28 133.01 34.17 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.255 -178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 40.6 mt -79.3 -67.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 N--CA 1.403 -2.822 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 177.763 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.038 0 N-CA-C 110.166 -1.174 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.483 ' HB1' ' OE2' ' A' ' 7' ' ' GLU . . . 51.85 -163.11 0.07 Allowed 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.466 1.106 . . . . 0.0 111.066 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -102.31 -6.54 22.97 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.396 172.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.79 -131.15 10.31 Favored Glycine 0 N--CA 1.434 -1.455 0 N-CA-C 117.06 1.584 . . . . 0.0 117.06 164.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.0 -29.83 3.8 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 116.448 2.018 . . . . 0.0 116.448 -168.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.251 27.3 mtpp -98.85 19.98 13.96 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 -178.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' OE2' ' HB1' ' A' ' 2' ' ' ALA . 43.8 mt-10 -99.18 125.95 44.87 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 170.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -120.22 133.5 55.47 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.578 -177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.564 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 3.4 p -122.3 149.3 43.93 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.993 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 51.2 ttt180 -118.79 133.92 55.51 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -177.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.507 HG23 HD11 ' A' ' 31' ' ' ILE . 4.3 p -74.92 135.66 41.45 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.4 mt -103.01 -17.6 15.36 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -138.44 150.86 67.85 Favored Pre-proline 0 N--CA 1.438 -1.07 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.304 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -76.7 161.03 34.16 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.09 1.86 . . . . 0.0 110.643 174.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -149.19 124.59 10.27 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 35.7 m -101.92 124.85 48.24 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -82.98 134.07 12.52 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.453 -0.879 . . . . 0.0 111.1 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.3 p -95.31 -15.16 23.33 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 122.304 1.05 . . . . 0.0 108.493 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -112.38 168.41 9.66 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 176.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -86.43 -27.5 24.1 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 121.729 0.776 . . . . 0.0 109.647 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -74.86 -28.03 60.5 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.863 175.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.4 tt0 -82.36 116.78 22.0 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 174.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.55 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.3 OUTLIER -89.72 143.22 26.98 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.046 0.45 . . . . 0.0 110.481 -169.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 99.2 m -92.66 128.38 38.5 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.177 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 98.8 m-85 -129.03 147.08 50.86 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.143 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 26' ' ' ARG . 37.2 mmt180 -104.62 171.61 7.23 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 172.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -78.71 133.95 37.12 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 122.557 0.343 . . . . 0.0 110.871 -176.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.56 16.88 57.93 Favored Glycine 0 N--CA 1.44 -1.095 0 C-N-CA 120.995 -0.621 . . . . 0.0 113.388 177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 27.5 mm-40 -92.72 147.38 22.92 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.1 mm -98.72 118.31 45.09 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.564 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 53.4 mt -99.13 135.22 35.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.075 -175.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -89.65 107.1 18.89 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 175.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.525 HD21 ' HG3' ' A' ' 36' ' ' LYS . 8.0 tt -70.5 140.22 51.81 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 121.11 0.481 . . . . 0.0 110.706 -173.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mm -108.72 -44.92 6.74 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.311 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.3 t -157.44 145.23 18.89 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.525 ' HG3' HD21 ' A' ' 33' ' ' LEU . 51.1 mtpt -102.86 1.23 33.71 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-O 121.746 0.784 . . . . 0.0 109.645 175.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.0 mp0 -121.63 115.76 23.34 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.609 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -124.63 3.76 8.25 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.806 0.812 . . . . 0.0 109.847 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.23 -21.62 39.04 Favored Glycine 0 N--CA 1.437 -1.254 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -114.8 135.46 54.16 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-N 114.764 -0.718 . . . . 0.0 109.195 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.65 99.8 11.54 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 134.25 -14.2 4.57 Favored Glycine 0 N--CA 1.421 -2.327 0 C-N-CA 120.414 -0.898 . . . . 0.0 111.187 -176.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 52.7 m95 -107.45 125.74 51.63 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.287 0.565 . . . . 0.0 110.329 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.518 ' CZ2' ' HE3' ' A' ' 36' ' ' LYS . 43.3 m0 -113.71 164.9 13.11 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.235 179.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -118.31 129.97 55.76 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.54 158.02 27.4 Favored Glycine 0 N--CA 1.421 -2.358 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 52' ' ' GLU . 1.1 tm-20 -112.1 131.52 55.39 Favored 'General case' 0 C--N 1.292 -1.908 0 C-N-CA 123.239 0.616 . . . . 0.0 109.831 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 51.0 tp -144.56 132.62 21.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 68.76 13.79 8.91 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.407 1.083 . . . . 0.0 111.838 177.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.14 9.47 56.99 Favored Glycine 0 N--CA 1.427 -1.903 0 C-N-CA 121.151 -0.547 . . . . 0.0 111.776 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -123.75 126.75 47.07 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-O 121.073 0.463 . . . . 0.0 110.849 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -99.69 125.87 45.63 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.297 177.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -147.26 -172.47 17.48 Favored Glycine 0 N--CA 1.427 -1.939 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.3 m -115.13 158.19 15.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 117.215 0.507 . . . . 0.0 110.871 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -162.03 156.46 19.01 Favored Pre-proline 0 C--N 1.319 -0.726 0 O-C-N 124.004 0.815 . . . . 0.0 109.595 -177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 6.6 Cg_exo -75.8 127.58 10.25 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.206 1.937 . . . . 0.0 109.428 172.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -65.6 -17.54 64.66 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 122.627 0.371 . . . . 0.0 111.941 -174.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -65.7 -14.03 60.45 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -87.32 -2.9 58.95 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.179 0.514 . . . . 0.0 110.818 175.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.94 177.82 7.61 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.431 -175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.49 135.54 43.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 172.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -81.65 129.48 34.71 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.565 -0.854 . . . . 0.0 108.85 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 41.2 mm -77.38 -68.3 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.399 -3.004 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 176.341 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.691 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -138.47 79.94 1.76 Allowed 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 121.063 0.458 . . . . 0.0 110.488 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 mmt -101.91 152.01 21.43 Favored 'General case' 0 C--O 1.251 1.159 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.951 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -130.2 148.28 18.5 Favored Glycine 0 N--CA 1.419 -2.445 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.969 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.42 -55.1 1.02 Allowed 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -93.7 16.52 13.75 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.357 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 9.3 mm-40 -90.54 108.19 19.64 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -175.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -121.85 138.85 54.23 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.592 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 8.0 p -125.47 142.25 51.61 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.75 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 43.3 ttp180 -101.61 135.79 42.53 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 177.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 64.2 p -77.5 128.63 34.51 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-O 121.258 0.551 . . . . 0.0 111.65 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.1 mt -98.9 -18.14 18.02 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.138 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -142.52 143.95 28.59 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -74.24 141.75 29.51 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.9 1.733 . . . . 0.0 109.853 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -137.37 128.43 27.6 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.521 ' HA ' HG23 ' A' ' 24' ' ' THR . 24.3 m -100.84 118.0 36.03 Favored 'General case' 0 N--CA 1.417 -2.108 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.702 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.7 125.71 17.07 Favored Glycine 0 N--CA 1.427 -1.957 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 178.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.3 p -82.26 -20.51 37.42 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.746 1.26 . . . . 0.0 108.633 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.5 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 44.0 m-80 -115.42 161.9 17.9 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.99 -19.81 29.81 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.582 177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -79.91 -3.39 47.88 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 122.3 1.047 . . . . 0.0 108.9 174.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 19' ' ' ASN . 36.7 tt0 -107.19 126.12 51.99 Favored 'General case' 0 N--CA 1.416 -2.128 0 N-CA-C 103.624 -2.732 . . . . 0.0 103.624 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' A' ' 48' ' ' LEU . 2.3 tm? -86.8 135.13 33.46 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.571 -167.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.521 HG23 ' HA ' ' A' ' 16' ' ' THR . 90.0 m -100.3 119.85 39.04 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.29 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -134.85 151.92 51.31 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.738 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 26.2 ptt180 -99.71 179.49 4.52 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 173.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.3 139.85 36.43 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 96.63 10.34 55.56 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.222 176.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -95.49 156.8 16.17 Favored 'General case' 0 C--N 1.311 -1.08 0 O-C-N 122.589 -0.359 . . . . 0.0 110.256 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.9 mm -110.33 116.25 51.86 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.592 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 62.5 mt -101.75 131.51 49.51 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.101 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -90.77 102.67 15.42 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 6.0 tt -69.03 134.47 49.47 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.656 -173.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 50.0 mm -101.2 -51.2 9.7 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.411 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.9 m -146.62 141.64 27.11 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.739 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.446 ' HG2' HD11 ' A' ' 33' ' ' LEU . 47.1 mtmt -91.58 -22.65 20.21 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 172.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -101.78 112.57 25.21 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.462 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 14.8 p -106.39 2.23 26.33 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.92 0.867 . . . . 0.0 109.069 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 115.45 -44.1 1.54 Allowed Glycine 0 N--CA 1.427 -1.925 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.6 mm-40 -99.02 134.24 42.15 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.85 102.11 7.09 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 177.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 146.54 -27.34 1.66 Allowed Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -99.06 128.7 45.24 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 24.5 m0 -108.06 159.92 16.2 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 53.0 tttm -128.32 128.37 44.47 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -150.12 160.08 28.38 Favored Glycine 0 N--CA 1.425 -2.094 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 -175.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -107.19 127.12 53.23 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.496 ' HB3' HD11 ' A' ' 23' ' ' LEU . 68.7 tp -133.22 111.14 10.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.7 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 12.5 m120 63.82 18.94 11.48 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 124.712 1.205 . . . . 0.0 113.099 174.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 124.81 -25.24 5.9 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.136 -1.03 . . . . 0.0 113.846 177.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 1.5 mptm? -106.09 142.32 35.98 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-N 117.697 0.748 . . . . 0.0 110.888 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.449 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 14.1 pt-20 -118.76 114.22 22.34 Favored 'General case' 0 N--CA 1.425 -1.686 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -132.46 -166.85 11.64 Favored Glycine 0 N--CA 1.42 -2.383 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -177.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 34.8 m -114.66 153.16 16.2 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -161.73 147.74 10.84 Favored Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 123.88 0.737 . . . . 0.0 109.482 -178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -69.43 134.88 29.79 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 121.833 1.688 . . . . 0.0 109.937 174.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.26 1.43 2.91 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -76.37 -22.31 54.99 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 122.942 0.497 . . . . 0.0 110.635 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -91.38 2.09 56.65 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -174.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.12 171.29 15.55 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 122.363 -0.21 . . . . 0.0 110.529 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 p -138.47 132.04 40.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 174.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -70.18 117.34 11.62 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 121.031 0.443 . . . . 0.0 110.736 177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.6 mt -67.81 -50.16 62.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.426 -176.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 48.7 m . . . . . 0 N--CA 1.411 -2.405 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.977 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.914 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.38 127.17 6.15 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 mmt -114.43 21.74 14.32 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.008 0.432 . . . . 0.0 110.541 -177.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 33' ' ' LEU . . . 67.81 52.07 31.33 Favored Glycine 0 N--CA 1.435 -1.406 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.215 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.99 -78.45 0.21 Allowed 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -149.78 78.05 1.34 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.371 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -135.57 121.92 20.47 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 175.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -121.45 144.48 48.66 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.598 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.5 p -131.12 150.49 52.12 Favored 'General case' 0 C--N 1.285 -2.2 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.526 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -110.14 133.99 52.65 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.602 HG23 HD11 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -75.92 125.99 30.15 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-O 121.011 0.434 . . . . 0.0 111.313 175.416 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 92.1 mt -96.41 -9.58 29.57 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.936 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -142.27 141.14 20.37 Favored Pre-proline 0 N--CA 1.431 -1.379 0 CA-C-N 114.694 -1.139 . . . . 0.0 108.708 178.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -72.33 132.1 18.75 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 122.065 1.843 . . . . 0.0 109.648 171.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 24' ' ' THR . 87.1 t80 -124.94 122.28 36.88 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.0 m -101.44 120.54 40.44 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -69.34 143.28 38.82 Favored Glycine 0 N--CA 1.423 -2.192 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.276 178.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.9 p -85.18 -33.63 22.25 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 122.605 1.193 . . . . 0.0 108.309 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 22' ' ' GLU . 40.8 m-80 -103.67 158.4 16.4 Favored 'General case' 0 N--CA 1.419 -1.989 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 173.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -92.39 5.67 49.81 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.737 178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.94 -20.23 42.5 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 170.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 19' ' ' ASN . 17.6 mt-10 -81.61 159.3 24.07 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 113.548 -1.66 . . . . 0.0 106.992 171.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.437 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -121.06 136.32 55.01 Favored 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 118.932 -1.107 . . . . 0.0 108.593 -178.75 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 88.7 m -89.53 121.04 31.36 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.304 -178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 89.1 m-85 -121.91 159.16 27.44 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.561 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -117.29 165.59 13.28 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -61.39 125.33 23.38 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 123.416 0.686 . . . . 0.0 110.028 174.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.97 13.06 57.03 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.512 -0.851 . . . . 0.0 114.028 175.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.6 mm-40 -92.41 144.68 25.12 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.8 mm -99.07 123.96 52.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.602 HD11 HG23 ' A' ' 11' ' ' THR . 50.6 mt -106.93 135.28 45.97 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.588 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -89.86 117.75 28.93 Favored 'General case' 0 N--CA 1.422 -1.861 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 171.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.527 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.4 tt -73.94 119.82 18.67 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.268 -0.878 . . . . 0.0 108.749 -175.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.1 mm -92.82 -40.35 11.97 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.392 -176.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.6 t -161.17 144.48 12.86 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 120.154 -0.618 . . . . 0.0 111.043 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.527 ' HG3' HD21 ' A' ' 33' ' ' LEU . 94.6 mttt -100.46 4.21 43.54 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 174.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -120.84 102.39 8.34 Favored 'General case' 0 N--CA 1.424 -1.764 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.456 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 53.2 p -115.96 7.44 14.38 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.38 -17.44 53.59 Favored Glycine 0 N--CA 1.433 -1.529 0 N-CA-C 108.671 -1.771 . . . . 0.0 108.671 -172.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -121.62 151.04 40.84 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 114.885 -0.657 . . . . 0.0 110.253 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.42 99.29 9.33 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 173.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 148.26 -38.9 1.01 Allowed Glycine 0 CA--C 1.49 -1.476 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -176.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 70.1 m95 -95.79 119.9 35.11 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 176.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 45.4 m0 -109.08 159.18 17.07 Favored 'General case' 0 C--N 1.289 -2.037 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -108.22 129.84 55.18 Favored 'General case' 0 C--N 1.297 -1.716 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -138.42 159.4 25.26 Favored Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 -178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -123.37 135.29 54.08 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.001 0.429 . . . . 0.0 110.654 -177.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.4 tp -138.88 122.31 17.22 Favored 'General case' 0 C--N 1.314 -0.945 0 C-N-CA 124.039 0.935 . . . . 0.0 108.882 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.8 m120 68.87 11.56 8.38 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.307 1.043 . . . . 0.0 112.513 175.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.56 -8.17 43.47 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 3.5 mptp? -102.76 130.93 49.88 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -120.9 135.05 55.28 Favored 'General case' 0 C--N 1.283 -2.297 0 CA-C-O 121.333 0.587 . . . . 0.0 111.183 -176.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -153.22 -167.22 15.41 Favored Glycine 0 N--CA 1.416 -2.692 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.3 m -115.32 153.51 16.83 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 120.772 0.32 . . . . 0.0 111.091 -177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -157.12 150.95 19.33 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_exo -75.49 136.74 19.79 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 121.559 1.506 . . . . 0.0 109.758 173.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.66 -16.19 62.44 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.068 0.461 . . . . 0.0 110.795 -176.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -53.39 -29.27 33.8 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 124.481 1.113 . . . . 0.0 111.687 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -94.02 -1.1 55.0 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -176.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.32 148.54 36.45 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -174.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.67 134.0 61.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -78.81 128.15 32.99 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.113 -178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 47.9 mm -81.42 -58.25 3.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.404 -2.754 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 177.654 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.541 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -173.62 157.49 3.17 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 175.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.5 ptt? -130.9 16.63 5.18 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.513 0.673 . . . . 0.0 111.881 -171.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -153.94 141.66 8.47 Favored Glycine 0 N--CA 1.414 -2.822 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 175.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.09 -33.54 59.51 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 175.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -110.98 76.37 0.97 Allowed 'General case' 0 N--CA 1.423 -1.815 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.062 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -107.78 124.62 50.31 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 172.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -114.17 138.98 49.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.53 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 7.8 p -122.56 133.17 54.57 Favored 'General case' 0 C--N 1.28 -2.453 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.904 178.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -99.69 135.21 41.44 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 68.8 p -81.05 129.3 34.48 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 121.258 0.552 . . . . 0.0 111.135 -179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 72.1 mt -97.69 -16.65 19.85 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.571 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -142.84 153.27 60.82 Favored Pre-proline 0 C--N 1.308 -1.235 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -81.79 142.59 12.76 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 121.927 1.751 . . . . 0.0 110.079 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -126.89 130.48 50.24 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.486 -177.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.435 ' HA ' HG23 ' A' ' 24' ' ' THR . 49.7 m -100.32 113.38 26.05 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.16 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -77.97 145.37 29.71 Favored Glycine 0 N--CA 1.427 -1.921 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 176.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 6.9 p -92.19 -35.53 13.78 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 122.01 0.91 . . . . 0.0 108.701 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -107.28 -179.04 3.81 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-N 114.193 -1.367 . . . . 0.0 107.737 177.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -93.93 8.27 41.93 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-O 121.905 0.86 . . . . 0.0 109.472 176.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -91.22 -32.15 15.89 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -76.93 156.27 32.16 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 114.867 -1.061 . . . . 0.0 108.874 172.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.0 tt -102.44 115.18 30.04 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.435 HG23 ' HA ' ' A' ' 16' ' ' THR . 63.8 m -83.59 120.04 25.47 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -134.36 161.83 33.89 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 113.367 0.877 . . . . 0.0 113.367 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -96.66 170.04 9.47 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 176.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -82.99 137.08 34.29 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.55 26.15 21.24 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.481 178.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -102.65 148.81 25.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mm -105.27 112.5 39.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 58.9 mt -100.94 139.0 23.3 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -177.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -88.24 106.75 18.41 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.66 HD21 ' HG3' ' A' ' 36' ' ' LYS . 6.5 tt -68.66 122.64 18.94 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.491 -174.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.476 HD11 ' HB2' ' A' ' 47' ' ' GLU . 50.7 mt -97.42 -44.71 12.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.378 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.0 m -150.12 138.86 20.8 Favored 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.795 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.66 ' HG3' HD21 ' A' ' 33' ' ' LEU . 50.3 mtmt -97.75 5.14 49.59 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -119.4 118.81 32.15 Favored 'General case' 0 N--CA 1.413 -2.299 0 CA-C-N 113.638 -1.619 . . . . 0.0 108.656 -177.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 39.9 p -133.57 -0.29 3.22 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.37 0.605 . . . . 0.0 110.273 177.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.25 -41.41 2.14 Favored Glycine 0 C--N 1.306 -1.126 0 N-CA-C 110.533 -1.027 . . . . 0.0 110.533 -174.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -97.79 116.45 30.03 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.39 114.05 6.49 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 128.3 -17.71 5.88 Favored Glycine 0 N--CA 1.427 -1.901 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 -174.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -113.94 128.96 56.62 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.847 0.356 . . . . 0.0 111.118 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.403 ' CE2' ' HG2' ' A' ' 36' ' ' LYS . 34.0 m0 -108.87 169.67 8.53 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 58.9 tttm -137.54 128.92 28.04 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -152.49 173.07 31.61 Favored Glycine 0 C--N 1.297 -1.605 0 C-N-CA 120.285 -0.96 . . . . 0.0 112.121 -175.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.476 ' HB2' HD11 ' A' ' 34' ' ' ILE . 9.0 tt0 -108.91 134.22 51.88 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 123.67 0.788 . . . . 0.0 109.814 -178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.7 tp -153.47 129.71 10.47 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 64.3 20.03 12.01 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.714 0.806 . . . . 0.0 112.403 176.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.46 3.66 64.67 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 116.13 -0.487 . . . . 0.0 113.039 178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -117.4 150.67 38.48 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.415 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 9.1 pt-20 -121.87 140.81 51.94 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 172.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -160.54 -169.31 23.65 Favored Glycine 0 C--N 1.288 -2.086 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.53 152.14 16.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.064 0.459 . . . . 0.0 110.307 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -157.45 148.68 16.69 Favored Pre-proline 0 C--N 1.301 -1.532 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.283 -178.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 20.3 Cg_exo -65.69 125.89 15.11 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.487 1.458 . . . . 0.0 109.245 175.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -61.29 -18.68 59.67 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -171.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -72.57 -14.36 61.61 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.936 0.335 . . . . 0.0 111.239 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -80.35 -14.74 58.1 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 120.597 0.237 . . . . 0.0 111.192 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.06 166.55 20.81 Favored 'General case' 0 N--CA 1.433 -1.302 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.3 p -138.57 142.3 35.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.935 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -70.3 140.87 52.38 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 46.9 pt -91.17 -42.14 13.64 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 CA-C-O 121.255 0.55 . . . . 0.0 111.316 -173.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.411 -2.377 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.555 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.298 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.37 63.83 2.03 Favored 'General case' 0 C--O 1.246 0.891 0 C-N-CA 124.263 1.025 . . . . 0.0 112.309 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 44.2 tpp -145.98 106.77 4.11 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.049 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.98 61.92 1.55 Allowed Glycine 0 C--N 1.312 -0.767 0 C-N-CA 121.062 -0.589 . . . . 0.0 111.638 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -169.49 174.01 6.16 Favored 'General case' 0 N--CA 1.428 -1.553 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -118.35 93.7 4.22 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-O 121.625 0.726 . . . . 0.0 109.307 175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 35.8 mt-10 -101.89 142.16 33.63 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 120.146 -0.621 . . . . 0.0 109.352 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -128.45 137.96 52.07 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 120.97 0.414 . . . . 0.0 110.138 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.436 ' SG ' HD12 ' A' ' 33' ' ' LEU . 59.8 m -124.47 153.81 41.44 Favored 'General case' 0 C--N 1.289 -2.039 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.986 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -117.46 132.17 56.61 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 175.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.425 HG23 HD11 ' A' ' 31' ' ' ILE . 6.5 p -72.46 128.51 35.82 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 120.811 0.339 . . . . 0.0 111.235 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.8 mt -89.16 -18.03 27.98 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -141.99 157.21 64.54 Favored Pre-proline 0 C--N 1.309 -1.181 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -78.43 138.63 15.77 Favored 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.297 1.332 . . . . 0.0 109.462 173.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.465 ' O ' ' HA ' ' A' ' 24' ' ' THR . 68.8 t80 -122.6 117.94 27.02 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.792 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 m -109.98 127.54 54.85 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.91 153.37 28.14 Favored Glycine 0 N--CA 1.417 -2.59 0 C-N-CA 120.525 -0.845 . . . . 0.0 111.57 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.8 t -98.15 -20.71 17.15 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.9 m-80 -105.16 166.57 10.31 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -82.72 -9.58 59.29 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.654 0.74 . . . . 0.0 109.538 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -78.32 -30.05 48.05 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.699 -177.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.1 mt-10 -78.86 151.49 31.8 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 113.829 -1.532 . . . . 0.0 108.181 173.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.448 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -112.91 139.2 48.75 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 96.2 m -95.13 120.67 35.75 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.668 0.747 . . . . 0.0 111.121 -177.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 91.7 m-85 -122.55 147.17 46.7 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.986 -1.006 . . . . 0.0 108.829 -178.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -90.29 172.55 8.69 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 176.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -75.41 129.94 38.15 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.3 39.03 20.2 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 121.1 -0.572 . . . . 0.0 112.793 176.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -117.97 154.9 31.18 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.0 mm -96.21 128.61 47.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 O-C-N 123.556 0.535 . . . . 0.0 109.994 -175.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.425 HD11 HG23 ' A' ' 11' ' ' THR . 52.7 mt -112.23 134.54 54.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -90.04 110.23 21.23 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 171.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.54 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.5 tt -74.45 123.84 25.46 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -176.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 43.7 mm -96.94 -43.66 12.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.387 -178.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.9 m -156.39 135.23 11.81 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.267 -177.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 57.4 mttp -85.54 -27.01 25.85 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 170.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -95.35 102.71 14.54 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.639 176.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.3 p -109.2 -0.91 19.03 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.802 0.811 . . . . 0.0 109.98 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.12 -41.25 1.58 Allowed Glycine 0 N--CA 1.429 -1.804 0 N-CA-C 107.746 -2.141 . . . . 0.0 107.746 -173.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -115.32 166.32 11.99 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.436 -0.882 . . . . 0.0 109.639 175.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.81 149.13 23.69 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 171.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.611 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 100.38 -25.86 26.71 Favored Glycine 0 C--N 1.301 -1.39 0 C-N-CA 120.369 -0.919 . . . . 0.0 110.88 -176.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -111.56 116.9 31.61 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -108.89 157.26 18.79 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.577 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -105.06 130.02 53.35 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -136.34 147.55 19.26 Favored Glycine 0 N--CA 1.417 -2.569 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.96 136.28 44.74 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.473 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 27.4 tp -145.47 128.19 16.24 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 176.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.473 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 38.3 m-80 62.91 20.31 12.14 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 123.938 0.895 . . . . 0.0 112.067 178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.42 -3.42 75.55 Favored Glycine 0 N--CA 1.441 -0.987 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.321 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -102.41 133.71 46.92 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.34 120.85 43.13 Favored 'General case' 0 C--N 1.286 -2.177 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -136.67 -172.09 12.45 Favored Glycine 0 C--N 1.286 -2.216 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 33.8 m -114.76 151.13 16.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 CA-C-O 121.162 0.506 . . . . 0.0 110.848 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -151.4 150.86 27.86 Favored Pre-proline 0 N--CA 1.429 -1.48 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -178.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.611 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 4.3 Cg_exo -76.75 135.92 16.43 Favored 'Trans proline' 0 N--CA 1.447 -1.224 0 C-N-CA 121.872 1.715 . . . . 0.0 110.748 175.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -64.72 -14.87 60.35 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 120.893 0.377 . . . . 0.0 111.432 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -63.42 -19.87 65.06 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.436 178.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -98.78 0.86 45.28 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -144.52 167.85 21.54 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.173 0.511 . . . . 0.0 111.759 -175.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.3 p -132.88 139.17 50.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 175.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -83.18 128.34 34.4 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 28.8 pt -101.77 -30.71 3.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.058 0.456 . . . . 0.0 110.719 -177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.416 -2.17 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 179.717 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.891 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.99 -28.89 16.91 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 51.4 ttm -166.85 89.99 0.37 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 174.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -128.89 -38.1 0.37 Allowed Glycine 0 CA--C 1.497 -1.084 0 C-N-CA 119.703 -1.237 . . . . 0.0 112.298 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.03 25.74 4.25 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.4 mptt 66.55 97.56 0.05 Allowed 'General case' 0 C--O 1.246 0.916 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.493 -173.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 33' ' ' LEU . 3.4 mm-40 -91.58 137.12 32.62 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 -174.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -130.96 138.22 49.61 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 -177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 17.1 p -123.57 138.85 54.48 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.543 ' HA ' ' O ' ' A' ' 29' ' ' GLU . 65.3 ttt180 -107.86 134.26 51.05 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.411 HG21 ' CD1' ' A' ' 25' ' ' PHE . 45.4 p -77.81 133.97 38.1 Favored 'General case' 0 C--N 1.279 -2.461 0 CA-C-O 121.504 0.669 . . . . 0.0 111.59 -176.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -100.22 -7.77 24.31 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.783 0.801 . . . . 0.0 109.515 -178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -147.17 156.03 46.7 Favored Pre-proline 0 C--N 1.313 -1.01 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -85.59 155.63 10.48 Favored 'Trans proline' 0 N--CA 1.436 -1.876 0 C-N-CA 121.852 1.702 . . . . 0.0 109.008 170.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -149.19 129.61 13.86 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.509 ' HA ' HG23 ' A' ' 24' ' ' THR . 19.0 m -115.69 125.81 53.31 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.048 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -86.93 151.84 24.18 Favored Glycine 0 N--CA 1.432 -1.621 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 175.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.0 t -94.73 1.52 55.48 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 122.629 1.204 . . . . 0.0 108.256 -179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -141.69 165.16 28.23 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.67 -6.73 58.11 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -83.27 -24.28 32.32 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 122.168 0.985 . . . . 0.0 109.103 178.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -94.44 131.09 40.49 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 105.002 -2.221 . . . . 0.0 105.002 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -87.41 129.39 35.06 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 121.972 0.891 . . . . 0.0 112.512 -169.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 16' ' ' THR . 91.1 m -97.1 121.37 38.91 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.205 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CD1' HG21 ' A' ' 11' ' ' THR . 10.5 p90 -133.69 160.09 38.6 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.045 0.45 . . . . 0.0 112.175 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 19.4 ptt180 -94.23 171.32 8.9 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 175.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.62 145.66 31.58 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.33 16.23 78.61 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.419 -0.42 . . . . 0.0 113.263 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 10' ' ' ARG . 8.9 tp10 -97.98 148.29 23.63 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-O 120.849 0.357 . . . . 0.0 110.732 -175.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.3 mm -96.86 121.17 47.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 61.4 mt -113.84 140.85 32.21 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.633 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -89.43 121.9 32.11 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.568 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 5.0 tt -79.01 133.2 36.83 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -174.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 47' ' ' GLU . 36.4 mt -106.84 -44.0 7.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 CA-C-O 121.128 0.489 . . . . 0.0 110.232 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.8 m -150.17 130.77 13.97 Favored 'General case' 0 C--N 1.315 -0.933 0 O-C-N 121.973 -0.455 . . . . 0.0 111.839 -177.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -88.36 -23.71 23.31 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.7 mp0 -97.87 109.5 22.24 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.556 177.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.7 p -111.61 -5.64 14.48 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-O 121.776 0.798 . . . . 0.0 110.126 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.94 -17.16 30.09 Favored Glycine 0 C--N 1.309 -0.967 0 N-CA-C 109.757 -1.337 . . . . 0.0 109.757 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -128.36 128.94 45.49 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -77.39 115.04 16.83 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.66 -15.59 6.29 Favored Glycine 0 C--N 1.305 -1.188 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -110.34 124.1 51.07 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 22.2 m0 -108.77 155.51 20.68 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.775 178.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 38.3 ttmt -117.2 129.46 55.96 Favored 'General case' 0 N--CA 1.42 -1.954 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.61 173.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -142.64 168.13 26.0 Favored Glycine 0 N--CA 1.416 -2.68 0 N-CA-C 108.202 -1.959 . . . . 0.0 108.202 177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.511 ' HB2' HD11 ' A' ' 34' ' ' ILE . 1.8 tm-20 -115.34 129.9 56.74 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.097 0.475 . . . . 0.0 110.365 -178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 53.8 tp -156.64 138.82 14.62 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 73.02 12.24 5.07 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.659 1.184 . . . . 0.0 110.921 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.44 14.76 59.58 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 27.3 mmmt -126.06 154.98 42.26 Favored 'General case' 0 CA--C 1.468 -2.21 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -175.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.29 126.23 34.85 Favored 'General case' 0 C--N 1.257 -3.427 0 CA-C-N 114.236 -1.347 . . . . 0.0 108.117 176.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -156.75 -161.66 10.92 Favored Glycine 0 CA--C 1.469 -2.832 0 N-CA-C 109.984 -1.247 . . . . 0.0 109.984 -176.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 27.0 m -114.5 147.51 17.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.793 -176.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -150.51 154.87 36.07 Favored Pre-proline 0 N--CA 1.426 -1.626 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.679 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -72.06 128.05 13.51 Favored 'Trans proline' 0 C--O 1.246 0.923 0 C-N-CA 122.14 1.893 . . . . 0.0 111.372 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -63.26 -19.38 64.5 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.031 0.933 . . . . 0.0 112.264 -175.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.39 -4.78 44.13 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 112.708 0.632 . . . . 0.0 112.708 -178.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -102.31 -0.33 33.0 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-O 121.127 0.489 . . . . 0.0 112.104 -178.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -141.42 155.58 45.87 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.209 -177.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 p -120.75 139.3 48.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.445 ' NE2' ' HB3' ' A' ' 7' ' ' GLU . 50.0 tt0 -79.83 122.06 26.17 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-O 121.679 0.752 . . . . 0.0 111.613 -177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.6 mm -93.7 -31.06 4.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.541 -175.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.42 -1.967 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 -178.691 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.04 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.15 106.31 17.54 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.0 -8.42 55.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.601 0.715 . . . . 0.0 111.823 -175.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -142.98 148.92 20.82 Favored Glycine 0 N--CA 1.412 -2.947 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.59 11.09 15.75 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.013 0.435 . . . . 0.0 110.326 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -137.34 37.18 2.5 Favored 'General case' 0 C--O 1.252 1.222 0 CA-C-O 122.199 1.0 . . . . 0.0 109.183 -178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -94.69 131.26 40.68 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.789 -1.096 . . . . 0.0 108.492 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -113.11 153.19 28.62 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.592 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 6.6 p -133.99 138.36 45.38 Favored 'General case' 0 C--N 1.267 -2.983 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.205 178.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -99.7 138.23 37.08 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 42.4 p -63.09 142.93 58.19 Favored 'General case' 0 C--N 1.283 -2.315 0 C-N-CA 124.332 1.053 . . . . 0.0 110.406 178.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.7 mt -113.08 -18.78 12.08 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.322 0.582 . . . . 0.0 110.165 175.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -149.4 147.66 23.96 Favored Pre-proline 0 C--N 1.312 -1.039 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.38 123.64 8.84 Favored 'Trans proline' 0 C--O 1.253 1.264 0 C-N-CA 122.052 1.835 . . . . 0.0 110.51 173.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -129.98 134.0 47.16 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -176.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.483 ' HA ' HG23 ' A' ' 24' ' ' THR . 46.8 m -116.28 131.69 56.87 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 120.933 0.397 . . . . 0.0 110.544 -179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -97.04 134.68 11.86 Favored Glycine 0 N--CA 1.413 -2.887 0 N-CA-C 110.521 -1.031 . . . . 0.0 110.521 178.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.5 p -91.15 -34.71 14.92 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -79.27 145.93 33.26 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 113.377 -1.738 . . . . 0.0 108.692 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -62.41 -35.86 80.55 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 123.775 0.672 . . . . 0.0 110.631 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.426 ' O ' HG22 ' A' ' 54' ' ' VAL . 31.0 t70 -86.42 4.96 37.29 Favored 'General case' 0 C--O 1.203 -1.371 0 CA-C-O 121.62 0.724 . . . . 0.0 110.213 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -104.35 134.7 47.11 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 177.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -91.19 135.42 33.8 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-O 120.73 0.3 . . . . 0.0 111.564 -170.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.483 HG23 ' HA ' ' A' ' 16' ' ' THR . 94.1 m -103.24 120.06 40.04 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 174.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -135.02 154.42 51.73 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -104.94 -176.69 3.15 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 175.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -92.94 122.96 35.84 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 176.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 120.39 8.73 8.29 Favored Glycine 0 C--N 1.294 -1.796 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.244 176.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -110.41 154.33 23.72 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.1 mm -108.13 122.48 62.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-O 121.114 0.483 . . . . 0.0 109.762 -177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.592 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 58.6 mt -105.79 130.15 57.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -176.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.95 127.51 36.04 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.3 tt -72.99 121.75 20.62 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 47.5 mm -100.59 -41.33 8.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.603 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 45' ' ' LYS . 25.4 m -151.68 139.55 19.94 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 122.272 -0.268 . . . . 0.0 111.524 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -103.4 -14.32 16.31 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 122.89 0.476 . . . . 0.0 110.366 174.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -110.47 97.42 6.87 Favored 'General case' 0 N--CA 1.427 -1.619 0 CA-C-O 121.986 0.898 . . . . 0.0 109.375 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 p -105.18 0.5 27.38 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.058 -177.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.52 -25.83 18.3 Favored Glycine 0 N--CA 1.432 -1.632 0 N-CA-C 109.24 -1.544 . . . . 0.0 109.24 -174.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -117.78 174.73 6.01 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 114.885 -0.657 . . . . 0.0 109.557 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -105.39 141.28 37.18 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.73 -30.23 5.47 Favored Glycine 0 C--N 1.312 -0.774 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.411 178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -81.98 115.35 21.1 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.135 0.493 . . . . 0.0 110.166 178.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.466 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 44.9 m0 -108.57 154.19 22.31 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.232 -0.894 . . . . 0.0 108.897 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 19.3 ttmm -116.29 129.64 56.38 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 176.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -144.07 176.51 23.3 Favored Glycine 0 N--CA 1.413 -2.876 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -123.04 133.87 54.31 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 56.3 tp -149.97 139.7 21.74 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.429 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 11.8 m120 67.66 10.07 7.51 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.794 1.237 . . . . 0.0 111.35 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.47 -2.97 49.97 Favored Glycine 0 N--CA 1.436 -1.359 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.21 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.38 138.43 51.36 Favored 'General case' 0 CA--C 1.497 -1.09 0 O-C-N 122.375 -0.485 . . . . 0.0 110.203 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -93.5 144.06 25.71 Favored 'General case' 0 N--CA 1.427 -1.615 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 175.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -160.36 177.93 36.6 Favored Glycine 0 N--CA 1.413 -2.836 0 C-N-CA 119.851 -1.166 . . . . 0.0 111.186 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 34.3 m -114.51 152.01 16.2 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -160.19 147.69 12.69 Favored Pre-proline 0 N--CA 1.419 -1.983 0 O-C-N 124.184 0.928 . . . . 0.0 108.824 -177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -69.05 129.31 18.11 Favored 'Trans proline' 0 C--O 1.251 1.159 0 C-N-CA 121.736 1.624 . . . . 0.0 108.954 172.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -57.83 -20.7 37.96 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 123.974 0.91 . . . . 0.0 113.091 -174.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -69.04 -13.21 62.31 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -91.69 2.46 56.46 Favored 'General case' 0 C--O 1.243 0.759 0 CA-C-O 121.256 0.55 . . . . 0.0 111.315 178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -140.37 169.86 16.89 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.541 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 p -128.93 122.2 56.17 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 174.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -73.07 121.59 20.43 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.5 pt -85.77 -6.81 10.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -173.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 C--N 1.298 -1.663 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.559 174.837 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.823 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -114.95 -32.49 5.74 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 122.968 0.507 . . . . 0.0 110.218 -176.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 93.1 mmm -102.19 6.39 40.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.149 0.5 . . . . 0.0 110.157 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 150.2 -168.17 30.17 Favored Glycine 0 N--CA 1.433 -1.533 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -110.32 18.14 20.17 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 121.477 0.656 . . . . 0.0 110.318 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -120.67 25.0 10.0 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.006 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 64' ' ' SER . 44.7 mt-10 -93.8 123.0 36.86 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.897 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -139.93 151.1 45.3 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 121.4 0.619 . . . . 0.0 111.233 -179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 8.6 p -130.19 153.38 48.62 Favored 'General case' 0 C--N 1.285 -2.205 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.051 -176.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.553 HH11 ' HA2' ' A' ' 28' ' ' GLY . 59.5 ttp85 -113.41 134.41 54.66 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.6 p -79.36 131.56 36.15 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 116.103 -0.499 . . . . 0.0 112.01 -177.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 74.5 mt -95.18 -12.07 27.0 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.672 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -133.17 149.86 73.82 Favored Pre-proline 0 C--N 1.311 -1.091 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.632 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -85.98 120.65 1.97 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.282 1.988 . . . . 0.0 108.925 168.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.427 ' HB3' ' CZ ' ' A' ' 25' ' ' PHE . 89.1 t80 -146.45 123.11 11.17 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-O 121.381 0.61 . . . . 0.0 111.328 -173.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.575 ' HA ' HG23 ' A' ' 24' ' ' THR . 87.9 m -91.93 135.33 34.03 Favored 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 176.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -63.87 125.8 33.33 Favored Glycine 0 N--CA 1.421 -2.314 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.94 -36.75 67.24 Favored 'General case' 0 N--CA 1.408 -2.542 0 N-CA-C 106.341 -1.725 . . . . 0.0 106.341 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 22' ' ' GLU . 93.4 m-20 -101.19 148.08 25.51 Favored 'General case' 0 N--CA 1.407 -2.606 0 CA-C-N 112.791 -2.004 . . . . 0.0 105.956 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -15.54 57.17 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.138 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -73.66 -20.51 60.54 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.722 172.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 19' ' ' ASN . 38.4 tt0 -89.06 143.31 26.94 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -177.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.3 tt -84.7 125.11 32.23 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.093 0.473 . . . . 0.0 111.132 -171.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.575 HG23 ' HA ' ' A' ' 16' ' ' THR . 91.1 m -87.65 121.02 29.54 Favored 'General case' 0 C--O 1.246 0.881 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.039 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 15' ' ' TYR . 36.1 p90 -133.89 161.43 34.79 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.246 0.546 . . . . 0.0 111.945 -178.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -112.99 173.64 6.28 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -78.69 123.86 27.59 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.553 ' HA2' HH11 ' A' ' 10' ' ' ARG . . . 102.09 13.48 31.25 Favored Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.525 -0.845 . . . . 0.0 114.16 177.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -93.58 143.98 25.8 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 117.079 0.44 . . . . 0.0 110.165 -178.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.9 mm -99.33 113.04 33.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.9 mt -107.43 134.06 50.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -88.58 127.88 35.56 Favored 'General case' 0 CA--C 1.491 -1.293 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.58 HD21 ' HG3' ' A' ' 36' ' ' LYS . 3.8 tt -74.15 126.26 30.18 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.055 -174.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.546 HD11 ' HB2' ' A' ' 47' ' ' GLU . 59.7 mt -101.39 -52.81 8.15 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.3 m -143.26 128.54 18.81 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.697 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.58 ' HG3' HD21 ' A' ' 33' ' ' LEU . 58.2 mtpt -85.5 -33.41 21.81 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -97.68 108.19 20.85 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.575 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.1 p -119.33 6.43 11.17 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.435 0.636 . . . . 0.0 110.635 -178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 122.06 -22.15 7.65 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -174.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -141.28 139.31 33.65 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 175.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.16 89.63 7.34 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 169.42 -30.74 0.16 Allowed Glycine 0 CA--C 1.483 -1.914 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 -176.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -99.69 121.88 41.88 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.465 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 25.8 m0 -107.94 141.64 39.26 Favored 'General case' 0 C--N 1.273 -2.737 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 23.0 ttmm -102.54 129.47 49.09 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 175.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -145.94 175.16 25.58 Favored Glycine 0 N--CA 1.417 -2.619 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.546 ' HB2' HD11 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -123.95 129.69 51.36 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 117.187 0.494 . . . . 0.0 109.79 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.464 ' HG ' HD22 ' A' ' 49' ' ' ASN . 47.4 tp -137.96 119.6 15.05 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.959 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.464 HD22 ' HG ' ' A' ' 48' ' ' LEU . 59.3 m-80 64.82 21.6 12.39 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.742 1.217 . . . . 0.0 112.543 178.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.74 -11.58 49.78 Favored Glycine 0 N--CA 1.435 -1.407 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.728 177.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 47' ' ' GLU . 4.0 mptp? -103.57 134.82 46.27 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 116.884 0.342 . . . . 0.0 110.48 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.426 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 0.2 OUTLIER -112.39 141.48 46.07 Favored 'General case' 0 N--CA 1.427 -1.617 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -167.16 -165.19 24.15 Favored Glycine 0 CA--C 1.467 -2.946 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 26.0 m -114.4 147.03 18.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.935 0 CA-C-O 120.99 0.424 . . . . 0.0 110.56 -178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -147.95 150.6 36.12 Favored Pre-proline 0 C--N 1.296 -1.738 0 CA-C-N 114.761 -1.109 . . . . 0.0 108.201 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 8.2 Cg_exo -71.58 136.77 29.0 Favored 'Trans proline' 0 C--O 1.244 0.806 0 C-N-CA 121.798 1.665 . . . . 0.0 112.202 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -69.02 -8.16 42.34 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.659 0.784 . . . . 0.0 112.488 -175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 25.4 p-10 -96.49 0.22 49.96 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 120.817 0.341 . . . . 0.0 111.487 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -99.92 -11.43 20.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.197 0.522 . . . . 0.0 110.996 177.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.12 145.08 41.2 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.598 -178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -109.02 125.76 66.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -68.99 121.52 16.79 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.476 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 36.4 mm -85.34 -45.79 17.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -177.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 43.9 m . . . . . 0 N--CA 1.41 -2.467 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.77 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -158.78 92.4 1.11 Allowed 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -165.33 142.18 5.67 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.92 -1.036 . . . . 0.0 108.376 -178.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.419 ' H ' ' CD ' ' A' ' 7' ' ' GLU . . . -74.16 -72.58 1.0 Allowed Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 176.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.18 -73.23 0.15 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.332 0.587 . . . . 0.0 110.344 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.0 mptp? -114.64 94.14 4.64 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 64' ' ' SER . 4.7 mm-40 -104.03 127.33 51.58 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.642 -171.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -146.24 144.67 30.03 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 120.995 0.426 . . . . 0.0 111.187 174.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 8.0 p -126.71 147.85 49.92 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.655 -172.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -101.9 136.0 42.49 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.0 p -69.17 139.47 54.62 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.66 177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.0 mt -107.75 -18.87 13.71 Favored 'General case' 0 C--N 1.308 -1.216 0 C-N-CA 120.486 -0.485 . . . . 0.0 110.482 176.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -147.37 151.05 39.31 Favored Pre-proline 0 C--N 1.311 -1.069 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -178.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.18 141.12 23.02 Favored 'Trans proline' 0 C--O 1.25 1.101 0 C-N-CA 121.977 1.784 . . . . 0.0 111.091 174.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -147.41 139.14 24.09 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -177.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 53.1 m -112.79 131.34 55.73 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 120.978 0.418 . . . . 0.0 110.622 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -85.76 119.9 5.22 Favored Glycine 0 N--CA 1.409 -3.139 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 177.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.9 m -82.08 -28.62 32.26 Favored 'General case' 0 N--CA 1.383 -3.807 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -94.31 165.93 12.34 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.788 -1.551 . . . . 0.0 107.85 177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -82.24 -26.62 33.07 Favored 'General case' 0 C--N 1.305 -1.37 0 CA-C-O 121.425 0.631 . . . . 0.0 109.856 179.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -92.61 9.75 33.39 Favored 'General case' 0 C--O 1.212 -0.886 0 CA-C-O 121.643 0.735 . . . . 0.0 110.712 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 64.5 tt0 -109.85 131.43 55.07 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.19 130.97 35.52 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.513 -169.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.3 m -93.79 119.7 33.09 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 173.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -134.39 145.63 49.12 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.321 0.581 . . . . 0.0 112.366 -178.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -96.47 161.69 13.8 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.391 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -74.64 123.13 24.3 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.39 11.41 21.8 Favored Glycine 0 C--N 1.294 -1.772 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -100.06 152.74 19.87 Favored 'General case' 0 N--CA 1.435 -1.213 0 CA-C-O 120.93 0.395 . . . . 0.0 110.625 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.3 mm -109.35 111.82 37.8 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.457 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 67.8 mt -96.42 135.54 30.2 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.256 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -88.31 117.49 27.27 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 7' ' ' GLU . 6.3 tt -76.78 124.7 28.08 Favored 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -173.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.8 mm -94.35 -50.15 12.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.258 -178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 52.5 m -156.3 133.24 10.45 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.083 -177.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -84.45 -16.5 42.36 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 121.882 0.848 . . . . 0.0 108.972 172.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -98.03 99.21 10.47 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.257 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 18.4 p -105.98 -3.38 21.76 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.89 0.852 . . . . 0.0 109.836 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.96 -42.46 1.49 Allowed Glycine 0 N--CA 1.426 -2.022 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -176.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -121.61 128.09 51.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.18 121.32 14.93 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.489 -178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.95 -25.58 4.12 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 81.9 m95 -106.57 123.53 48.24 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 177.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.426 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 43.6 m0 -108.7 153.4 23.5 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 60.0 tttp -114.82 129.45 56.7 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 52' ' ' GLU . . . -141.49 160.74 26.95 Favored Glycine 0 N--CA 1.427 -1.919 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.417 ' HA ' ' O ' ' A' ' 51' ' ' LYS . 0.5 OUTLIER -117.8 125.17 50.07 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -178.736 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.9 tp -147.62 119.01 7.86 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.459 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 72.12 21.81 3.85 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.193 0.997 . . . . 0.0 113.036 174.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.37 0.29 35.1 Favored Glycine 0 N--CA 1.44 -1.08 0 CA-C-N 116.129 -0.487 . . . . 0.0 113.664 173.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HD2' ' N ' ' A' ' 51' ' ' LYS . 8.5 mptt -127.22 132.66 50.37 Favored 'General case' 0 CA--C 1.488 -1.423 0 O-C-N 122.419 -0.459 . . . . 0.0 110.073 -177.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 10.5 pt-20 -107.65 95.85 5.98 Favored 'General case' 0 N--CA 1.427 -1.593 0 CA-C-O 122.502 1.144 . . . . 0.0 109.433 177.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 45' ' ' LYS . . . -113.94 -175.45 18.98 Favored Glycine 0 C--N 1.274 -2.9 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.495 -173.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 44' ' ' TRP . 33.0 m -114.14 152.56 15.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -152.89 155.43 32.2 Favored Pre-proline 0 N--CA 1.418 -2.041 0 CA-C-N 114.804 -1.089 . . . . 0.0 108.662 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.28 134.46 12.78 Favored 'Trans proline' 0 N--CA 1.443 -1.462 0 C-N-CA 121.746 1.631 . . . . 0.0 111.284 177.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -44.86 -37.34 3.82 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 125.458 1.503 . . . . 0.0 113.21 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -63.09 -16.97 61.71 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -176.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -96.24 1.56 52.23 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -143.86 170.38 16.0 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.038 0.446 . . . . 0.0 111.696 -177.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.22 131.42 40.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -83.32 125.69 31.9 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.194 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 30.1 mm -89.95 -52.5 10.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -176.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.574 ' O ' ' HA ' ' A' ' 7' ' ' GLU . 23.2 t . . . . . 0 N--CA 1.413 -2.305 0 N-CA-C 105.783 -1.932 . . . . 0.0 105.783 -178.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.98 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.06 80.13 7.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 117.232 0.516 . . . . 0.0 110.63 -177.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 40.5 tpp -114.94 97.09 6.03 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -101.51 -58.96 0.8 Allowed Glycine 0 N--CA 1.425 -2.089 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.577 -178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.43 -171.98 3.9 Favored 'General case' 0 N--CA 1.41 -2.448 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -176.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -92.48 91.57 7.68 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -101.68 147.76 26.06 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.565 -174.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -124.8 139.37 53.91 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 121.587 0.708 . . . . 0.0 110.597 -177.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.695 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 5.6 p -129.59 162.28 28.61 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.4 ' HB2' HD11 ' A' ' 63' ' ' ILE . 29.8 ttp180 -121.11 145.8 47.42 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.649 HG21 ' HB3' ' A' ' 25' ' ' PHE . 72.0 p -71.31 141.41 50.48 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.794 0.683 . . . . 0.0 109.631 177.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -105.13 -18.79 14.03 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -141.71 156.29 66.17 Favored Pre-proline 0 C--N 1.305 -1.341 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -177.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -76.73 120.9 5.68 Favored 'Trans proline' 0 N--CA 1.429 -2.275 0 N-CA-C 108.065 -1.552 . . . . 0.0 108.065 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -111.4 115.37 29.14 Favored 'General case' 0 C--N 1.28 -2.423 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.407 ' HA ' HG23 ' A' ' 24' ' ' THR . 36.0 m -98.38 111.3 23.69 Favored 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.715 -176.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -75.43 135.63 18.73 Favored Glycine 0 N--CA 1.425 -2.05 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 176.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.1 t -113.6 5.55 16.6 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -127.15 156.24 42.1 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 113.54 -1.664 . . . . 0.0 107.324 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -79.15 -24.77 43.05 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -173.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -95.16 -4.4 46.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.806 0.812 . . . . 0.0 110.42 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -93.07 115.82 28.46 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 175.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.409 HD13 ' N ' ' A' ' 24' ' ' THR . 0.5 OUTLIER -83.78 144.58 29.22 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 120.874 0.369 . . . . 0.0 110.023 -170.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.409 ' N ' HD13 ' A' ' 23' ' ' LEU . 88.6 m -98.88 129.41 45.23 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.35 0.595 . . . . 0.0 111.492 -178.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.649 ' HB3' HG21 ' A' ' 11' ' ' THR . 90.9 m-85 -127.74 151.84 48.49 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.221 -176.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.439 ' N ' ' HD2' ' A' ' 26' ' ' ARG . 3.5 mpt_? -108.82 174.5 5.84 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -81.75 116.37 21.42 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-N 117.914 0.324 . . . . 0.0 111.864 -177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.12 38.12 4.42 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.028 -0.606 . . . . 0.0 114.527 173.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.432 ' OE2' HD21 ' A' ' 48' ' ' LEU . 9.5 pt-20 -131.56 156.85 45.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 117.942 0.871 . . . . 0.0 111.871 177.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.9 mm -87.92 137.24 21.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.463 -173.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.695 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 40.1 mt -114.12 136.9 49.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -89.89 116.96 28.36 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.7 tt -77.93 123.78 27.2 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -175.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 51.8 mm -103.53 -40.69 6.71 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.319 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.0 m -153.04 134.96 14.69 Favored 'General case' 0 C--N 1.312 -1.044 0 O-C-N 122.007 -0.433 . . . . 0.0 111.892 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HA ' ' CD1' ' A' ' 44' ' ' TRP . 94.8 mttt -91.9 -9.93 41.44 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.683 0.754 . . . . 0.0 109.539 173.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -117.78 119.52 35.17 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 115.429 -0.805 . . . . 0.0 108.96 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.9 p -115.34 0.1 13.34 Favored 'General case' 0 C--N 1.279 -2.5 0 CA-C-O 121.576 0.703 . . . . 0.0 109.415 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.54 1.46 53.25 Favored Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -176.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -148.66 132.11 16.66 Favored 'General case' 0 N--CA 1.428 -1.548 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -75.57 106.06 6.93 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 56' ' ' PRO . . . 149.12 -31.12 1.19 Allowed Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -105.81 131.16 53.49 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-O 120.966 0.412 . . . . 0.0 110.724 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.4 ' CD1' ' HA ' ' A' ' 36' ' ' LYS . 17.4 m0 -113.24 151.26 31.27 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 172.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 53' ' ' GLY . 84.5 tttt -109.2 129.03 55.5 Favored 'General case' 0 N--CA 1.416 -2.127 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -132.29 157.94 22.73 Favored Glycine 0 N--CA 1.412 -2.914 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.221 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -116.67 129.29 56.05 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.432 HD21 ' OE2' ' A' ' 29' ' ' GLU . 55.4 tp -162.92 149.48 12.61 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.2 m-20 72.4 0.58 3.65 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 124.603 1.161 . . . . 0.0 111.216 176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.79 0.53 42.44 Favored Glycine 0 N--CA 1.428 -1.887 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -121.83 169.88 10.33 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -175.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -130.25 142.03 50.58 Favored 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.475 178.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.426 ' O ' ' HG3' ' A' ' 45' ' ' LYS . . . -163.53 -173.13 31.86 Favored Glycine 0 C--N 1.291 -1.951 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 29.8 m -114.71 152.83 16.29 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 120.843 0.354 . . . . 0.0 110.706 -176.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -153.87 150.94 23.83 Favored Pre-proline 0 N--CA 1.439 -1.022 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.671 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.559 ' HA ' ' O ' ' A' ' 42' ' ' GLY . 17.1 Cg_exo -70.16 132.12 22.05 Favored 'Trans proline' 0 N--CA 1.449 -1.104 0 C-N-CA 121.723 1.616 . . . . 0.0 109.692 173.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.6 -10.75 20.07 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -62.59 -31.95 72.86 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 124.41 1.084 . . . . 0.0 111.211 178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -88.97 4.02 49.56 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -173.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -138.2 171.09 14.91 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -138.31 136.3 44.33 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 175.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -80.99 127.75 32.93 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.141 0.496 . . . . 0.0 111.528 -177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.4 HD11 ' HB2' ' A' ' 10' ' ' ARG . 33.1 mm -86.37 -62.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.4 m . . . . . 0 N--CA 1.405 -2.68 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.878 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.38 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 36' ' ' LYS . . . -167.1 -176.55 3.39 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.2 mmt -104.03 -178.71 3.74 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 121.346 0.593 . . . . 0.0 111.886 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.08 46.94 0.18 Allowed Glycine 0 C--N 1.299 -1.509 0 N-CA-C 107.311 -2.315 . . . . 0.0 107.311 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.84 52.99 2.67 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.492 -0.854 . . . . 0.0 112.502 -169.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.1 mttp 55.1 57.08 5.85 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 122.742 1.258 . . . . 0.0 109.173 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -101.12 151.28 22.02 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 113.222 -1.808 . . . . 0.0 106.786 -175.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -125.51 143.83 50.83 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 118.904 -1.118 . . . . 0.0 111.188 -177.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.668 ' SG ' ' HB ' ' A' ' 31' ' ' ILE . 7.2 p -125.48 153.08 44.09 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.255 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -116.18 134.09 55.31 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.8 p -62.77 149.1 44.88 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 122.8 0.44 . . . . 0.0 112.037 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.54 -19.17 10.15 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 174.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -151.86 153.93 32.22 Favored Pre-proline 0 C--N 1.317 -0.828 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -177.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.49 143.41 38.46 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.859 1.706 . . . . 0.0 109.224 169.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -135.0 127.86 31.28 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.4 m -93.27 115.85 28.44 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.306 -177.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -87.87 118.47 5.04 Favored Glycine 0 N--CA 1.428 -1.881 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 175.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.2 p -106.63 -7.32 17.43 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 121.983 0.897 . . . . 0.0 109.742 -176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -108.87 149.96 28.37 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -69.54 -22.95 63.52 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.094 0.474 . . . . 0.0 112.276 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -94.17 -2.44 52.59 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.296 1.046 . . . . 0.0 109.972 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -103.83 127.37 51.33 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.524 -1.216 . . . . 0.0 108.689 -177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.627 HD13 ' HA3' ' A' ' 53' ' ' GLY . 3.0 mp -84.89 135.66 33.97 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -177.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.2 m -96.2 123.26 39.76 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.94 176.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -133.75 159.59 40.13 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.202 0.525 . . . . 0.0 111.867 177.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -117.67 173.64 6.62 Favored 'General case' 0 C--N 1.288 -2.086 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -78.46 141.89 37.92 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.89 11.69 42.54 Favored Glycine 0 N--CA 1.437 -1.262 0 C-N-CA 120.48 -0.867 . . . . 0.0 112.555 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -105.85 147.26 28.9 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.575 0.703 . . . . 0.0 112.317 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.9 mm -102.86 127.68 56.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.668 ' HB ' ' SG ' ' A' ' 9' ' ' CYS . 62.0 mt -114.39 135.01 55.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -176.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -89.39 118.52 29.11 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.465 HD21 ' HG3' ' A' ' 36' ' ' LYS . 5.5 tt -81.27 124.24 29.16 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -175.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 mm -98.66 -47.23 12.34 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.701 -0.682 . . . . 0.0 109.905 -177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.0 m -153.46 124.55 7.42 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.465 ' HG3' HD21 ' A' ' 33' ' ' LEU . 97.7 mttt -75.69 -25.48 56.74 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.163 0.506 . . . . 0.0 109.843 174.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -90.71 121.39 32.56 Favored 'General case' 0 N--CA 1.422 -1.839 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.173 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 22.8 p -122.77 -2.39 8.82 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.253 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.84 -7.41 41.71 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 -176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -145.66 131.86 19.46 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.36 126.86 30.84 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 127.38 -38.22 2.18 Favored Glycine 0 C--N 1.304 -1.234 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.649 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -98.82 127.58 44.79 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-O 120.798 0.333 . . . . 0.0 110.483 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 31.6 m0 -108.95 153.75 23.13 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.039 176.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 53' ' ' GLY . 65.0 tttm -114.21 128.48 56.39 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -149.07 173.68 28.89 Favored Glycine 0 N--CA 1.424 -2.152 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.15 -174.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -115.52 130.35 56.85 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 124.616 1.166 . . . . 0.0 109.626 -177.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.422 ' HG ' ' ND2' ' A' ' 49' ' ' ASN . 39.3 tp -154.66 135.7 13.85 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.422 ' ND2' ' HG ' ' A' ' 48' ' ' LEU . 56.4 m-80 65.59 16.26 10.42 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.397 1.079 . . . . 0.0 111.84 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.33 6.83 77.45 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.837 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.86 155.1 27.43 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -133.6 138.09 45.8 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.612 175.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.627 ' HA3' HD13 ' A' ' 23' ' ' LEU . . . -164.65 -156.71 9.12 Favored Glycine 0 CA--C 1.483 -1.945 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.054 -175.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 28.9 m -115.76 154.09 17.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 CA-C-O 120.943 0.401 . . . . 0.0 111.506 -177.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -158.53 148.85 15.63 Favored Pre-proline 0 N--CA 1.434 -1.228 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.125 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -74.35 135.76 20.86 Favored 'Trans proline' 0 C--O 1.243 0.749 0 C-N-CA 121.77 1.647 . . . . 0.0 110.21 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -69.55 -7.25 36.81 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 120.821 0.343 . . . . 0.0 111.794 -176.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -62.6 -21.09 65.37 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 123.464 0.706 . . . . 0.0 112.035 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -107.11 9.77 30.31 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -173.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -147.93 164.3 34.15 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 -179.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.9 p -131.34 135.25 59.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -78.26 133.11 37.73 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.1 mm -86.83 -67.22 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 N--CA 1.398 -3.067 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 174.964 . . . . . . . . 0 0 . 1 stop_ save_